0000930413-15-002456.txt : 20150512 0000930413-15-002456.hdr.sgml : 20150512 20150512162841 ACCESSION NUMBER: 0000930413-15-002456 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20150331 FILED AS OF DATE: 20150512 DATE AS OF CHANGE: 20150512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Everyday Health, Inc. CENTRAL INDEX KEY: 0001358483 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36371 FILM NUMBER: 15854790 BUSINESS ADDRESS: STREET 1: 345 HUDSON STREET STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 718-797-0722 MAIL ADDRESS: STREET 1: 345 HUDSON STREET STREET 2: 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: WATERFRONT MEDIA INC DATE OF NAME CHANGE: 20060405 10-Q 1 c81206_10q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2015

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-36371

Everyday Health, Inc.

(Exact name of registrant as specified in its charter)

Delaware		80-0036062
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

345 Hudson Street, 16th Floor New York, NY		10014
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (646) 728-9500

(former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer		o		Accelerated filer		o
Non-accelerated filer		x (Do not check if a smaller reporting company)		Smaller reporting company		o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

The number of shares outstanding of the Registrant’s common stock, $0.01 par value per share, on May 8, 2015, was 31,674,117.

EVERYDAY HEALTH, INC.

QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2015

TABLE OF CONTENTS

	Page No
PART I. FINANCIAL INFORMATION		3
ITEM 1. Financial Statements:		3
Consolidated Balance Sheets as of March 31, 2015 (Unaudited) and December 31, 2014		3
Consolidated Statements of Operations for the three months ended March 31, 2015 and 2014 (Unaudited)		4
Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2015 (Unaudited)		5
Consolidated Statements of Cash Flows for the three months ended March 31, 2015 and 2014 (Unaudited)		6
Notes to Consolidated Financial Statements (Unaudited)		7
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		17
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk		26
ITEM 4. Controls and Procedures		26
PART II. OTHER INFORMATION		27
ITEM 1. Legal Proceedings		27
ITEM 1A. Risk Factors		27
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds		28
ITEM 3. Defaults Upon Senior Securities		28
ITEM 4. Mine Safety Disclosures		28
ITEM 5. Other Information		28
ITEM 6. Exhibits		29
SIGNATURES		30

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

EVERYDAY HEALTH, INC.

Consolidated Balance Sheets

(in thousands, except share and per share data)

	March 31, 2015 (unaudited)			December 31, 2014
Assets
Current assets:
Cash and cash equivalents	$	48,530		$	50,729
Accounts receivable, net of allowance for doubtful accounts of $523 and $637 as of March 31, 2015 and December 31, 2014, respectively		57,611			68,007
Deferred tax asset		656			656
Prepaid expenses and other current assets		9,377			5,529
Total current assets		116,174			124,921
Property and equipment, net		25,847			25,502
Goodwill		143,165			127,115
Intangible assets, net		43,777			30,716
Other assets		5,811			5,237
Total assets	$	334,774		$	313,491

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable and accrued expenses	$	25,060		$	31,722
Deferred revenue		8,821			6,740
Current portion of long-term debt		2,625			3,000
Other current liabilities		8,977			965
Total current liabilities		45,483			42,427
Long-term debt		110,125			87,000
Deferred tax liabilities		6,912			6,673
Other long-term liabilities		4,016			4,105
Stockholders’ equity:
Preferred stock, $0.01 par value: 10,000,000 shares authorized at March 31, 2015 and December 31, 2014; no shares issued and outstanding at March 31, 2015 and December 31, 2014		—			—
Common stock, $0.01 par value: 90,000,000 shares authorized at March 31, 2015 and December 31, 2014; 31,562,028 and 31,489,196 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively		315			314
Treasury stock		(55	)		(55	)
Additional paid-in capital		295,136			292,117
Accumulated deficit		(127,158	)		(119,090	)
Total stockholders’ equity		168,238			173,286
Total liabilities and stockholders’ equity	$	334,774		$	313,491

See accompanying notes to consolidated financial statements.

EVERYDAY HEALTH, INC.

Consolidated Statements of Operations

(in thousands, except share and per share data, unaudited)

	Three months ended March 31,
	2015			2014
Revenues:
Advertising and sponsorship revenues	$	36,338		$	32,692
Premium services revenues		4,836			4,813
Total revenues		41,174			37,505
Operating expenses:
Cost of revenues		14,076			11,421
Sales and marketing		12,725			10,220
Product development		12,602			10,762
General and administrative		9,804			6,595
Total operating expenses		49,207			38,998
Loss from operations		(8,033	)		(1,493	)
Interest expense, net		(953	)		(1,863	)
Other expense		—			(4,114	)
Loss from operations before benefit (provision) for income taxes		(8,986	)		(7,470	)
Benefit (provision) for income taxes		918			(289	)
Net loss		(8,068	)		(7,759	)
Net loss per common share-basic and diluted	$	(0.26	)	$	(1.44	)
Weighted-average common shares outstanding-basic and diluted		31,525,559			5,403,846

See accompanying notes to consolidated financial statements.

EVERYDAY HEALTH, INC.

Consolidated Statement of Stockholders’ Equity

(in thousands, except share data, unaudited)

	Common stock
	Shares		Amount		Preferred stock		Treasury stock			Additional paid-in capital		Accumulated deficit			Total stockholders’ equity

Balance at December 31, 2014		31,489,196	$	314	$	—	$	(55	)	$	292,117	$	(119,090	)	$	173,286
Exercise of stock options		72,832		1		—		—			528		—			529
Stock-based compensation expense		—		—		—		—			2,491		—			2,491
Net loss		—		—		—		—			—		(8,068	)		(8,068	)
Balance at March 31, 2015		31,562,028	$	315	$	—	$	(55	)	$	295,136	$	(127,158	)	$	168,238

See accompanying notes to consolidated financial statements.

EVERYDAY HEALTH, INC.

Consolidated Statements of Cash Flows

(in thousands, unaudited)

	Three months ended March 31,
	2015			2014
Cash flows from operating activities
Net loss	$	(8,068	)	$	(7,759	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		4,662			3,558
Provision for doubtful accounts		—			215
Stock-based compensation		2,491			1,069
Amortization and write-off of financing costs		107			4,169
Provision for deferred income taxes		241			241
Changes in operating assets and liabilities:
Accounts receivable		14,802			10,935
Prepaid expenses and other current assets		(3,641	)		(2,645	)
Accounts payable and accrued expenses		(9,322	)		(8,610	)
Deferred revenue		1,884			568
Other current liabilities		32			32
Other long-term liabilities		17			307
Net cash provided by operating activities		3,205			2,080
Cash flows from investing activities
Additions to property and equipment, net		(3,005	)		(3,476	)
Proceeds from sale of business		—			152
Payment for business purchased, net of cash acquired		(24,747	)		—
Payment of security deposits and other assets		40			5
Net cash used in investing activities		(27,712	)		(3,319	)
Cash flows from financing activities
Proceeds from the exercise of stock options		460			1,172
Repayments of principal under former revolver credit facility		—			(30,000	)
Repayment of principal under former term loan facility		—			(41,333	)
Borrowings under revolver credit facility		25,000			32,300
Repayment of principal under revolver credit facility		(10,000	)		—
Borrowings under term loan facility		8,500			40,000
Repayment of principal under term loan facility		(750	)		—
Principal payments on capital lease obligations		(180	)		(145	)
Payments of credit facility financing costs		(722	)		(2,227	)
Net cash provided by (used in) financing activities		22,308			(233	)
Net decrease in cash and cash equivalents		(2,199	)		(1,472	)
Cash and cash equivalents, beginning of period		50,729			16,242
Cash and cash equivalents, end of period	$	48,530		$	14,770
Supplemental disclosure of cash flow information
Interest paid	$	1,253		$	2,262
Income taxes paid	$	10		$	16
Supplemental disclosure of non-cash investing and financing activities
Issuance of common stock for acquired business	$	—		$	919
Due to sellers of acquired business	$	8,000		$	—
Due from stock option exercises	$	111		$	—
Warrants issued in connection with website partner agreement	$	—		$	1,131
Capital lease obligations incurred	$	—		$	193

See accompanying notes to consolidated financial statements.

EVERYDAY HEALTH, INC.

Notes to Consolidated Financial Statements (Unaudited)

(in thousands, except share and per share data)

1. Business

Everyday Health, Inc. (the “Company”) operates a portfolio of health and wellness websites and mobile applications that provides consumers, healthcare professionals, advertisers and partners with content and advertising-based services. The Company was incorporated in the State of Delaware in January 2002 as Agora Media Inc., and changed its name to Waterfront Media Inc. in January 2004. In January 2010, the Company changed its name to Everyday Health, Inc. to better align its corporate identity with the Everyday Health brand.

2. Significant Accounting Policies

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The results of operations for companies acquired are included in the consolidated financial statements from the effective date of the acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation.

Interim Financial Statements

The accompanying interim unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) on the same basis as the audited consolidated financial statements for the year ended December 31, 2014 and, in the opinion of management, include all adjustments of a normal recurring nature considered necessary to present fairly the Company’s financial position, results of operations and cash flows for the interim periods ended March 31, 2015 and 2014. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015 or any other future periods, due to seasonality and other business factors. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted under the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto for the year ended December 31, 2014, which are included in the Company’s Annual Report on Form 10-K filed with the SEC on March 5, 2015.

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, current business factors and other available information. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition and deferred revenue, allowance for doubtful accounts, internal software development costs and website development costs, valuation of long-lived assets, goodwill and other intangible assets, income taxes and stock-based compensation.

Reclassifications

Certain reclassifications have been made to the prior period financial statements to conform to the March 31, 2015 presentation.

Initial Public Offering

On April 2, 2014, the Company closed its initial public offering of common stock (“IPO”). The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters’ exercise of their over-allotment option, resulted in net proceeds of $70,622, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling $8,848. As a result of the IPO, the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, all of the Company’s redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision.

Revenue Recognition and Deferred Revenue

The Company generates its revenue primarily through advertising and sponsorships, and premium services, including subscriptions and licensing fees.

Advertising revenue is recognized in the period in which the advertisement is delivered. Revenue from sponsorships is recognized over the period the Company substantially satisfies its contractual obligations as required under the respective sponsorship agreements. When contractual arrangements contain multiple elements, revenue is allocated to each element based on its relative fair value determined using prices charged when elements are sold separately. In instances where individual deliverables are not sold separately, or when third-party evidence is not available, fair value is determined based on management’s best estimate of selling price.

Subscriptions are generally paid in advance on a monthly, quarterly or annual basis. Subscription revenue, after deducting refunds and charge-backs, is recognized on a straight-line basis ratably over the subscription periods. Licensing revenue is generally recognized over the life of the contract.

Deferred revenue relates to: (i) subscription fees for which amounts have been collected but for which revenue has not been recognized, and (ii) advertising and sponsorship fees and licensing fees billed in advance of when the revenue is to be earned.

Cost of Revenues

Cost of revenues consists principally of the expenses associated with aggregating the total audience across the Company’s portfolio of websites, including (i) royalty expenses for licensing content for certain websites within the portfolio and for the portion of advertising revenue the Company pays to the owners of certain other websites within the portfolio, and (ii) media costs associated with audience aggregation activities. Cost of revenues also includes credit card fees and service charges associated with subscription fees for the Company’s premium services.

Media costs consist primarily of fees paid to online publishers, internet search companies and other media channels for search engine and database marketing, and display and television advertising. These media activities are attributable to revenue-generating and audience aggregation events, designed to increase the audience to the websites the Company operates, increase the number of subscribers to premium services and grow the Company’s registered user base.

Other Expense

There were no charges reflected as other expense in the three months ended March 31, 2015. In connection with the refinancing of its credit facilities in March 2014, the Company wrote-off unamortized deferred financing costs totaling $2,845 and incurred prepayment fees of $1,016, which, together with the mark-to-market adjustment on certain preferred stock warrants of $253, is reflected as other expense in the accompanying consolidated statements of operations for the three months ended March 31, 2014.

Comprehensive Income

The Company has no items of other comprehensive income, and accordingly net loss is equal to comprehensive loss for all periods presented.

Fair Value of Financial Instruments

Due to their short-term maturities, the carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value. Cash equivalents principally consist of the Company’s investment in highly liquid money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value of the Company’s debt approximates the recorded amounts as the interest rates on the credit facilities are based on market interest rates.

Property and Equipment

Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from three to five years. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the improvement.

The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of payroll and related benefits, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.

The Company also incurs costs to develop its websites and mobile applications. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of third-party consultants and related charges, and the costs of content determined to provide a future economic benefit, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.

The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s property and equipment during the three months ended March 31, 2015 and 2014.

Segment Information

The Company and its subsidiaries are organized in a single operating segment, providing online health solutions, and the Company also has one reportable segment. Substantially all of the Company’s revenues are derived from U.S. sources.

Recent Accounting Standards

In April 2014, the FASB issued amended guidance for reporting discontinued operations. Under the new guidance, only disposals that represent a strategic shift having a material impact on an entity’s operations and financial results shall be reported as discontinued operations, with expanded disclosures. This amendment will be effective for the first annual reporting period beginning after December 15, 2015. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

In May 2014, the FASB issued amended guidance for revenue recognition. This amendment provides a comprehensive new revenue recognition model. The core principle of the guidance is to recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. As currently issued, this amendment is effective for fiscal years beginning after December 15, 2016, and for interim periods within those fiscal years. Early adoption is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company has not yet selected a transition method and is currently evaluating the effect that the new standard will have on the consolidated financial statements and related disclosures.

In June 2014, the FASB issued updated guidance on stock compensation accounting requiring that a performance target that affects vesting and could be achieved after the requisite service period should be treated as a performance condition. Current GAAP does not contain explicit guidance on how to account for such share-based payments. This updated guidance is effective for fiscal years beginning after December 15, 2015, and for interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

In April 2015, the FASB issued updated guidance on the presentation of debt issuance costs in financial statements. The new guidance requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs will continue to be reported as interest expense. This guidance will be effective for the Company beginning in the first quarter of 2016 on a retrospective basis for all periods presented, with early adoption optional. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

3. Acquisitions

In March 2015, the Company acquired 100% of the limited liability company membership interests of Cambridge BioMarketing Group, LLC (“Cambridge”), a provider of strategic launch and marketing solutions for orphan and rare disease products, for a total purchase price of $32,273, of which $24,273 was paid in cash at closing. The remaining $8,000 obligation is comprised of convertible notes, which will either convert into shares of the Company’s common stock or be repaid in cash by May 15, 2015, at the discretion of the Company. The total purchase price is subject to any working capital adjustments that may arise. As of March 31, 2015, the $8,000 unpaid purchase price obligation is included in other current liabilities in the accompanying consolidated balance sheet. In addition to the purchase price described above, the former members of Cambridge are eligible to receive up to an additional $5,000 in cash based on Cambridge’s achievement of certain revenue and Adjusted EBITDA targets for 2015. This earn-out payment is contingent upon the continued employment with the Company of certain former members of Cambridge at the time the earn-out payment is due to be paid in the first quarter of 2016. The Company records any such earn-out as compensation expense for the applicable period. The Company expects that the acquisition will broaden its strategic marketing and communications solutions to pharmaceutical brands targeting orphan and rare disease segments in the market.

The acquisition was accounted for as a business combination and, accordingly, the purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed on a preliminary basis based on the respective fair values. The results of operations of Cambridge have been included in the consolidated financial statements of the Company from March 20, 2015, the closing date of the acquisition. For the three months ended March 31, 2015, acquisition-related costs of $169 are included in general and administrative expenses in the accompanying consolidated statement of operations.

Accounts receivable	$	4,406
Other current assets		137
Property and equipment		783
Goodwill		15,576
Intangible assets		14,280
Accounts payable and accrued expenses		(2,659	)
Deferred revenue		(197	)
Other current liabilities		(53	)
Total consideration paid	$	32,273

4. Goodwill and Other Intangible Assets

During the three months ended March 31, 2015, goodwill of $15,576 and definite-lived intangible assets of $14,280 were recorded in connection with the Cambridge acquisition (see Note 3). Additionally, there was $474 of goodwill recorded during the three months ended March 31, 2015 for a working capital purchase price adjustment related to a November 2014 acquisition. The preliminary value of the intangible assets acquired in connection with the Cambridge acquisition consist of customer relationships of $8,810 and trade names of $5,470, each of which has an estimated useful life of 10 years.

The carrying value of the Company’s goodwill was $143,165 as of March 31, 2015. Goodwill is tested for impairment on an annual basis as of October 1, and whenever events or circumstances indicate that the carrying value of the asset may not be recoverable. Application of the impairment test requires judgment and results in impairment being recognized if the carrying value of the asset exceeds its fair value. No indicators of impairment were noted during or since the Company’s last evaluation of goodwill at October 1, 2014. Similarly, the Company’s definite-lived intangible assets with a net carrying value of $43,777 at March 31, 2015, consisting principally of trade names and customer relationships, is reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s definite-lived intangible assets during the three months ended March 31, 2015 and 2014.

Definite-lived intangible assets consist of the following:

	March 31, 2015								December 31, 2014
	Gross carrying amount		Accumulated amortization		Net carrying amount		Weighted- average remaining useful life ⁽¹⁾		Gross carrying amount		Accumulated amortization		Net carrying amount		Weighted- average remaining useful life ⁽¹⁾
Customer relationships	$	36,110	$	(11,775)	$	24,335		9.5	$	27,300	$	(11,247)	$	16,053		9.5
Trade names		24,085		(4,922)		19,163		7.3		18,615		(4,370)		14,245		6.5
Other intangibles		3,900		(3,621)		279		0.5		3,900		(3,482)		418		0.7
Total	$	64,095	$	(20,318)	$	43,777			$	49,815	$	(19,099)	$	30,716

⁽¹⁾

The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period.

Amortization expense relating to the definite-lived intangible assets totaled $1,219 and $545 for the three months ended March 31, 2015 and 2014, respectively, and is included in general and administrative expense in the accompanying consolidated statements of operations.

Future amortization expense of the intangible assets is estimated to be as follows:

Year ending December 31:
2015 (April 1st to December 31st)	$	4,527
2016		5,373
2017		5,365
2018		5,176
2019		5,176
Thereafter		18,160
Total	$	43,777

5. Long-Term Debt

The Company entered into a credit facility agreement with a syndicated bank group in March 2014, which replaced its then-existing credit facility. The new credit facility consisted of a revolver (“Revolver”) with a maximum borrowing limit of $35,000 and a term loan (“Term Loan”) of $40,000. In November 2014, in connection with the acquisition of DoctorDirectory.com, Inc., the credit facility was amended and restated to, among other things, (i) increase the maximum borrowing limit of the Revolver from $35,000 to $55,000; (ii) increase the Term Loan from $39,000 outstanding as of such date to $60,000; (iii) extend the maturity date of the Term Loan and the due date of principal on the Revolver from March 2019 to November 2019; and (iv) effect certain modifications to the covenants and terms set forth in the credit facility agreement. In March 2015, the amended and restated credit facility was amended twice (as amended, the “Credit Facility”) to, among other things, (i) consent to the acquisition of Cambridge, (ii) increase the Term Loan from $59,250 outstanding as of such date to $67,750; (iii) increase the maximum borrowing limit of the Revolver from $55,000 to $82,250; and (iv) effect certain modifications to the covenants and terms set forth in the Credit Facility agreement. All other materials terms of the Credit Facility, including the applicable interest rates and maturity dates, remained unchanged by the March 2015 amendments.

The repayment terms of the Revolver provide for quarterly interest payments, with the principal being due in full in November 2019. The repayment terms of the Term Loan provide for quarterly interest and principal payments, with a maturity date of November 2019. The interest rate on the Credit Facility is equal to the London Inter-Bank Offered Rate, or LIBOR, plus a variable rate ranging from 2.75% to 4.0% depending on the Company’s consolidated leverage ratio, as defined in the Credit Facility agreement, and there is a 0.50% commitment fee on the unused portion of the Revolver. As of March 31, 2015, the interest rate on the Credit Facility was 3.52%. As of March 31, 2015, there was $67,750 outstanding on the Term Loan and $45,000 outstanding on the Revolver, with $37,250 available to be drawn on the Revolver.

The Credit Facility contains certain financial and operational covenants, including requirements to maintain a minimum consolidated fixed charge coverage ratio and a maximum consolidated leverage ratio, each as defined in the Credit Facility agreement, as well as restrictions on certain types of dispositions, mergers and acquisitions, indebtedness, investments, liens and capital expenditures, issuance of capital stock and the Company’s ability to pay dividends. The Credit Facility is secured by a first priority security interest in substantially all of the Company’s existing and future assets. The Company was in compliance with the financial and operational covenants of the Credit Facility as of March 31, 2015.

In connection with the March 2014 refinancing and the November 2014 amendment and restatement, the Company incurred financing costs totaling $2,899 and, in connection with the March 2015 amendments, the Company incurred financing costs of $722, each of which have been deferred and amortized using the effective interest rate method through the final maturities of the Credit Facility. Deferred financing costs are recorded in other assets in the accompanying consolidated balance sheets. Amortization expense relating to deferred financing costs is included in interest expense in the accompanying consolidated statements of operations.

6. Common Stock and Preferred Stock

As of March 31, 2015 and December 31, 2014, there were no shares of preferred stock issued and outstanding. The redeemable convertible preferred stock, Series A-G (collectively, the “Preferred Stock”), which was outstanding at the time of the Company’s IPO, fully converted to common stock in connection with the IPO.

In March 2014, the Company’s Board of Directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation effecting a 1-for-1.5 reverse stock split of the Company’s issued and outstanding shares of common stock. The par value of the common stock was not adjusted as a result of the reverse stock split. All issued and outstanding common stock and per share amounts contained in the Company’s consolidated financial statements and related notes thereto have been retroactively adjusted to reflect this reverse stock split for all periods presented. The reverse stock split was effected on March 14, 2014.

In April 2014, in connection with the closing of the Company’s IPO, the Company filed an amended and restated certificate of incorporation with the Secretary of State of the State of Delaware that amended and restated in its entirety the Company’s certificate of incorporation to, among other things, increase the total number of shares of the Company’s common stock that the Company is authorized to issue to 90,000,000, eliminate all references to the various series of preferred stock that were previously authorized (including certain protective measures held by the various series of preferred stock), and to authorize up to 10,000,000 shares of undesignated preferred stock that may be issued from time to time with terms to be set by the Company’s Board of Directors, which rights could be senior to those of the Company’s common stock.

7. Stock-Based Compensation

The Company has granted non-statutory stock options and restricted stock unit awards to employees, directors and consultants of the Company pursuant to its 2003 Stock Option Plan, as amended (the “2003 Plan”), or 2014 Equity Incentive Plan (the “2014 Plan”), which became effective immediately upon the signing of the underwriting agreement related to the IPO on March 27, 2014. Upon the effectiveness of the 2014 Plan, no additional awards have been or will be granted under the 2003 Plan. The 2014 Plan provides for the grant of stock options, restricted stock units, and other awards based on the Company’s common stock.

As of March 31, 2015, 339,829 shares have been reserved for issuance under the 2014 Plan. The number of shares of common stock reserved for issuance under the 2014 Plan is subject to an automatic increase on January 1 of each year through January 1, 2024, by the lesser of (a) 4% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year and (b) a number of shares determined by the Board of Directors.

Stock Options

The following table summarizes stock option activity for the three months ended March 31, 2015:

	Number of options			Weighted- average exercise price		Weighted- average remaining contractual life (years)		Aggregate intrinsic value
Outstanding at December 31, 2014		5,893,698		$	9.94		6.48	$	29,249
Granted		726,100			12.22
Exercised		(72,832	)		7.27
Cancelled		(7,415	)		12.84
Outstanding at March 31, 2015		6,539,551		$	10.23		6.65	$	20,931
Exercisable at March 31, 2015		3,896,925		$	8.45		5.01	$	17,987

Proceeds from the exercise of options and the total intrinsic value of the options exercised were $460 and $484, respectively, for the three months ended March 31, 2015, and $1,172 and $910, respectively, for the three months ended March 31, 2014.

The weighted-average fair value per share at date of grant for options granted was $5.49 and $7.56 during the three months ended March 31, 2015 and 2014, respectively. The fair value of options granted is estimated on the date of grant using the Black-Scholes option pricing model and recognized in expense over the vesting period of the options using the graded attribution method.

The following table presents the weighted-average assumptions used to estimate the fair value of options granted in the three months ended March 31, 2015 and 2014:

	2015		2014
Volatility	44.29	%	49.77	%
Expected life (years)	6.25		6.25
Risk-free interest rate	1.72	%	1.92	%
Dividend yield	—		—

The expected stock price volatilities are estimated based on historical realized volatilities of comparable publicly traded company stock prices over a period of time commensurate with the expected term of the option award. The expected life represents the period of time for which the options granted are expected to be outstanding. The Company used the simplified method for determining expected life for options qualifying for treatment due to the limited history the Company currently has with option exercise activity. The risk-free interest rate is based on the U.S. Treasury yield curve for periods equal to the expected term of the options on the grant date.

Total stock-based compensation expense related to stock options was $1,958 and $1,069 for the three months ended March 31, 2015 and 2014, respectively.

At March 31, 2015, there was approximately $8,713 of unrecognized compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 1.5 years. The total fair value of stock options vested during the three months ended March 31, 2015 and 2014 was $2,613 and $953, respectively.

Restricted Stock Unit Awards

The Company’s restricted stock unit awards (“RSUs”) are agreements to issue shares of the Company’s common stock to employees in the future, upon the satisfaction of certain vesting conditions, which cause them to be subject to risk of forfeiture and restrict the awardholder’s ability to sell or otherwise transfer such RSUs until they vest. Generally, the Company’s RSU grants vest over three years from the grant date subject to continued employment on the applicable vesting dates. The following table summarizes the RSU activity for the three months ended March 31, 2015:

	Number of RSUs		Weighted Average Grant Date Fair Value
Outstanding at December 31, 2014		—	$	—
Granted ⁽¹⁾		548,424		11.99
Vested		—
Cancelled		—
Outstanding at March 31, 2015		548,424	$	11.99

⁽¹⁾

RSUs granted during the three months ended March 31, 2015 includes the grant of 40,000 units of performance-based RSUs that are dependent upon the Company meeting certain performance criteria.

Total stock-based compensation expense related to RSUs was $262 for the three months ended March 31, 2015. As RSUs were issued for the first time in March 2015, there was no stock-based compensation expense related to RSUs in 2014.

At March 31, 2015, there was approximately $5,904 of unrecognized compensation expense related to unvested RSUs, which is expected to be recognized over a weighted-average period of 1.63 years.

2014 Employee Stock Purchase Plan

The 2014 Employee Stock Purchase Plan (“ESPP”), which became effective immediately upon the signing of the underwriting agreement related to the IPO on March 27, 2014, authorizes the issuance of 500,000 shares of the Company’s common stock pursuant to purchase rights granted to employees. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1 of each calendar year from January 1, 2015 through January 1, 2024 by the least of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, (b) 400,000 shares and (c) a number determined by the Board of Directors that is less than (a) and (b). Unless otherwise determined by the Board of Directors, common stock will be purchased for participating employees at a price per share equal to the lower of (a) 85% of the fair market value of a share of the common stock on the first date of an offering, or (b) 85% of the fair market value of a share of the common stock on the date of purchase. Generally, all regular employees may participate in the ESPP and may contribute, through payroll deductions, up to 15% of their earnings toward the purchase of common stock under the ESPP. Under the terms of the ESPP, there are defined limitations as to the amount and value of common stock that can be purchased by each employee.

For the three months ended March 31, 2015, charges incurred under the ESPP totaled $271, and such charges were not material during the three months ended March 31, 2014. As of March 31, 2015, 676,707 shares of common stock were reserved for future issuance under the ESPP.

8. Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding for the period.

	Three months ended
	March 31,
	2015			2014
Numerator:
Net loss	$	(8,068	)	$	(7,759	)

Denominator:
Weighted-average number of common shares outstanding - basic and diluted		31,525,559			5,403,846
Net loss per common share - basic and diluted	$	(0.26	)	$	(1.44	)

	Three months ended
	March 31,
	2015		2014
Warrants to purchase common stock⁽¹⁾		143,782		692,501
Warrants to purchase redeemable convertible preferred stock⁽¹⁾		—		148,650
Redeemable convertible preferred stock⁽¹⁾		—		26,820,270
Stock option awards		6,539,511		6,673,806
RSU awards		548,424		—
Employee stock purchase plan		80,037		—
Total anti-dilutive securities		7,311,754		34,335,227

⁽¹⁾

Upon closing of the IPO on April 2, 2014, all of the Company’s outstanding redeemable convertible preferred stock automatically converted into shares of common stock. In addition, the outstanding warrants to purchase redeemable convertible preferred stock automatically converted into warrants to purchase common stock, or were automatically exercised upon closing of the IPO.

9. Income Taxes

The Company’s expected and historic annual net tax provision is generally comprised of a deferred tax provision pertaining to basis differences in indefinite lived intangible assets that cannot be offset by current year deferred tax assets, as well as, to a much lesser extent, a current tax provision for federal, state, local and foreign taxes. Effective March 31, 2015, the tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate, adjusted for discrete items arising in the quarter, as applicable. As a result of using an estimated annual effective tax rate the Company recorded a benefit for the quarter, which is expected to reverse over the remaining quarters. In each quarter, the Company’s estimate of the annual effective tax rate will be updated and any changes will be recognized in the interim period in which the change occurs. In interim periods prior to March 31, 2015, the tax provision was based upon the estimated deferred and current tax provision for the year rather than the estimated annual effective tax rate, as the Company had historically experienced pretax losses in certain quarters and pretax income in others, and the annual results were expected to be at or near breakeven, and believed that using an annual effective tax rate would result in significant variances in the customary relationship between income tax expense (benefit) and pretax income or loss in interim periods.

The Company’s deferred tax assets relate primarily to net operating loss carryforwards and to a smaller extent stock based compensation and other items. The Company has provided a valuation allowance against deferred tax assets to the extent the Company has determined that it is more likely than not that such net deferred tax assets will not be realizable. In determining realizability, the Company considered various factors including historical profitability and reversing temporary differences, exclusive of indefinite-lived intangibles. The Company’s deferred tax liabilities arose primarily from basis differences in indefinite-lived intangible assets that cannot be offset by current year deferred tax assets.

At December 31, 2014, the Company had approximately $107,000 of net operating loss, or NOL, carryforwards available to offset future taxable income, which expire from 2020 through 2033. The full utilization of these losses in the future is dependent upon the Company’s ability to generate taxable income and may also be limited due to ownership changes, as defined under the provisions of Section 382 of the Internal Revenue Code of 1986, as amended. The Company’s NOL carryforwards at December 31, 2014 included $7,433 of income tax deductions related to equity compensation that are greater than the compensation recognized for financial reporting, which will be reflected as a credit to additional paid-in-capital as realized.

The Company is subject to taxation in the U.S. and various federal, state, local and foreign jurisdictions. In March 2014, an audit of the Company’s U.S. Federal tax return for the year ended December 31, 2011 commenced. As of March 31, 2015, none of the Company’s other tax returns have been examined by any income taxing authority. The Company is not subject to U.S. federal, state or non-U.S. income tax examinations by tax authorities for years prior to 2010. However, to the extent U.S. federal and state NOL carryforwards are utilized, the use of NOLs could be subject to examination by the tax authorities. The Company believes that it has appropriate support for the income tax positions taken and to be taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on assessment of many factors, including past experience and interpretations of tax law. The Company regularly assesses the adequacy of its income tax contingencies in accordance with ASC 740. As a result, the Company may adjust its income tax contingency liabilities for the impact of new facts and developments, such as changes in interpretations of relevant tax law and assessments from taxing authorities.

10. Commitments and Contingencies

The Company is subject to certain claims that have arisen in the ordinary conduct of business. Based on the advice of counsel and an assessment of the nature and status of any potential claim, and taking into account any accruals the Company may have established for them, the Company currently believes that any liabilities ultimately resulting from such claims will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

11. Subsequent Events

The Company has completed an evaluation of all subsequent events through the issuance date of these financial statements and concluded that no subsequent events occurred that required recognition to the financial statements or disclosures in the notes to the consolidated financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition, results of operations and cash flows should be read in conjunction with (1) the unaudited interim consolidated financial statements and the related notes thereto included elsewhere in this Quarterly Report on Form 10-Q, and (2) the audited consolidated financial statements and notes thereto and management’s discussion and analysis of financial condition and results of operations for the fiscal year ended December 31, 2014 included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission, or SEC, on March 5, 2015.

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These statements are often identified by the use of words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “will,” “would” or the negative or plural of these words or similar expressions or variations. Such forward-looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified herein, and those discussed in Item 1A—Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2014 and in our other SEC filings. You should not rely upon forward-looking statements as predictions of future events. Furthermore, such forward-looking statements speak only as of the date of this report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.

Overview

Everyday Health, Inc., or “we” or “us,” is a leading digital health and wellness company. By combining premium health and wellness content with our sophisticated proprietary data assets and analytics tools, we enable consumers to manage their health, healthcare professionals to stay informed and make better decisions for their patients, and marketers to communicate and engage with consumers and healthcare professionals. Our properties fall into the following categories: (i) properties that we own and/or operate in partnership with leading offline providers of health content or prominent health and wellness experts and personalities, including Everyday Health, MedPage Today, DoctorDirectory.com, Cambridge BioMarketing, What to Expect, Dr. Sanjay Gupta, Jillian Michaels and The South Beach Diet; and (ii) properties where we manage and sell advertising opportunities on behalf of third parties, including MayoClinic.org and Drugstore.com. We utilize our proprietary technology, together with our extensive data assets, to personalize the content experience, empower our users to make more-informed health decisions and drive better health outcomes. We deliver our content and solutions whenever, wherever and however a user makes a health-related decision through multiple channels, including desktop, mobile web, and mobile phone and tablet applications, as well as video and social media.

We also utilize the data we collect to enable health and wellness marketers to:

· reach and engage the right audience at the right time;

· influence purchase decisions;

· drive health compliance and health outcomes; and

· quantitatively prove the efficacy of the marketing solutions we implement.

We derive a significant majority of our revenues from the sale of advertising, sponsorships and other marketing solutions across a variety of health and wellness categories, including pharmaceuticals, over-the-counter products, food, retail and lifestyle. To a lesser extent, we generate revenues from the sale of our premium services, which consist primarily of subscriptions sold to individuals who purchase access to one or more properties in our portfolio.

In late 2010, we made a strategic decision to expand our business into the market for providing content and marketing solutions targeting healthcare professionals through our acquisition of MedPage Holdings, Inc., or MPT. We believe that the entry into the healthcare professional market provided us with a significant revenue opportunity because pharmaceutical companies spend a larger percentage of their marketing budgets on healthcare professionals as compared to consumers. In addition, the acquisition of MPT enabled us to offer marketers the ability to target both healthcare professionals and consumers with a single marketing solution.

In late 2014, we expanded further into the healthcare professional sector with the acquisition of DoctorDirectory.com, Inc., or DD, a provider of multi-channel marketing solutions for pharmaceutical brands seeking to influence healthcare professionals. We expect that the acquisition of DD will deepen our penetration into the healthcare professional market by significantly increasing our physician reach and enhancing our sophisticated return on investment, or ROI, based marketing solutions that we offer advertisers seeking to engage with healthcare professionals. Following the DD acquisition, we reach more than two-thirds of practicing physicians in the U.S. and expect increased user engagement by offering an expanded suite of content and tools to healthcare professionals.

In March 2015, we continued the expansion of our business through the acquisition of Cambridge BioMarketing Group, LLC, or Cambridge, a provider of strategic launch and marketing solutions for orphan and rare disease products. The acquisition broadens the strategic marketing and communications solutions we can offer to pharmaceutical brands. Following this acquisition, we believe that we can service our partners across the entire spectrum of therapeutic areas, including orphan, specialty and mass market brands, as well as provide solutions throughout the entire lifecycle of pharmaceutical marketing, from the strategic phase of pre-launch, during the growth years and beyond the loss of patent exclusivity.

Finally, we have also begun to focus on leveraging our existing assets to generate revenue from new customer channels across the broader healthcare landscape, particularly payors and providers. Specifically, our healthcare solutions business will concentrate on utilizing our large, highly-engaged audience, premium content and tools, and advanced data and analytics capabilities to engage and influence consumers on behalf of payors and providers. We may also explore partnering relationships and corporate development opportunities to more effectively execute on our growth strategy in this large market opportunity.

For the year ended December 31, 2015, we expect our revenue to increase. We also expect our operating expenses to increase in 2015, and to decrease slightly as a percentage of revenues. As a result, we expect that our Adjusted EBITDA will improve in 2015, and expect that our capital expenditures will decline as a percentage of revenues over the same period.

Background Information

Key Trends Affecting Our Business

We believe that the following key trends drive our ability to continue to grow our business:

Marketers are allocating an increasing proportion of their advertising spending to online advertising and are seeking solutions that better target their audience and maximize ROI. We believe that the ability to offer complex data-driven solutions that demonstrate ROI will be a key determinant in our success in attracting marketing dollars in the coming years. We also believe that the online percentage of the total health-related advertising market is still relatively small, and that this percentage will increase in the coming years.

The Internet and digital and mobile devices have become indispensable for both consumers seeking to take a more active role in managing their diverse health and wellness needs and healthcare professionals striving to provide better care for their patients and manage their practices more efficiently. We believe that individuals will increasingly seek out digital content and solutions, and spend more time interacting with these digital channels, to educate themselves, directly manage and monitor their health and wellness, and make a wide array of other health-related purchase decisions, including purchasing health insurance.

The pharmaceutical industry is experiencing a major shift from large mass-market “blockbuster” drugs to niche or specialty medications that target discrete patient populations. At the same time, dramatically-reduced sales forces and other restrictions on interacting directly with physicians have made it more difficult for pharmaceutical companies to efficiently market their products and services. As a result, we believe the need for these companies to interact with consumers and physicians more directly through digital channels will increase significantly.

The evolving healthcare environment is forcing many health-related companies to face new challenges and adopt, in many cases for the first time, strategies targeting consumers and healthcare professionals. We believe our large and engaged audience, premium brands and rich database of user information afford us a significant opportunity to grow our revenues as these entities, including health insurance companies, pharmacy benefit management companies and health information technology vendors, seek new ways to drive down costs, acquire new customers and utilize technology to achieve better health outcomes.

Key Metric

We use the following key financial metric in measuring the performance of our business, allocating resources and making decisions regarding operating strategies.

Average Advertising and Sponsorship Revenues per Advertiser. Average advertising and sponsorship revenues per advertiser is our advertising and sponsorship revenues from advertisers that marketed their products and services on the Everyday Health portfolio during a specific period divided by the total number of advertisers. We use this metric to assess our success in expanding our advertising and sponsorship relationships and increasing our market share of advertising dollars from each of our customers.

The following represents our recent performance with respect to this key metric:

	Three months ended March 31,⁽¹⁾
	2015	2014
Advertising and sponsorship revenues per advertiser (in thousands)	$193.9	$196.9

⁽¹⁾

Based on 178 and 166 total advertisers for the three months ended March 31, 2015 and 2014, respectively. The figures for the three months ended March 31, 2015 exclude Cambridge, which was acquired in March 2015. With respect to DD, which was acquired in November 2014, only ROI-based marketing campaigns for pharmaceutical clients are included in the figures for the three months ended March 31, 2015.

Revenues

We generate revenues primarily through advertising and sponsorships, and premium services, including subscriptions and licensing fees.

Our advertising and sponsorship revenues, also referred to as marketing solutions revenue, consist primarily of revenues generated from:

display advertisements on properties in the Everyday Health portfolio and in our free e-mail newsletters, which are primarily sold based on a cost-per-impression advertising model;

interactive brand sponsorships, which consist of our integrated database marketing programs and sponsorships within the Everyday Health portfolio, which typically include both components that are sold based on a cost-per-impression basis (in which we are paid based on the number of advertisements we display) and components that are sold based on a cost-per-visitor basis (in which we are paid for delivering a visitor to an advertiser’s website), and sometimes include a production fee;

customer acquisition marketing programs, which are sold based on the number of qualified potential customers that are provided to our advertisers;

our Health Reach marketing programs that allow marketers the opportunity to target specific audiences outside of the Everyday Health portfolio using our audience data and analytics;

marketing programs that provide for revenues based upon the ROI we deliver for our customers; and

marketing programs that are sold based on a time and materials basis.

Although we typically do not distinguish between desktop and mobile channels in the structuring and pricing of our marketing campaigns, mobile channels have become increasingly important in fulfilling these campaigns, including our interactive brand sponsorships. Revenues delivered via mobile channels increased 34.6% to $15.6 million in the first quarter of 2015 from $11.6 million in the first quarter of 2014.

In addition, by virtue of our acquisition of DD, we now conduct certain marketing campaigns that provide for revenues based entirely upon the ROI we deliver for our customers. Furthermore, by virtue of our recent acquisition of Cambridge, we now conduct strategic launch and marketing solutions for orphan and rare disease products that are sold based on a time and materials basis.

Our advertisers and sponsors consist primarily of pharmaceutical companies, manufacturers and retailers of over-the-counter products and consumer-packaged-goods, and healthcare providers, such as hospitals and other healthcare professionals.

Our premium services revenues consist primarily of revenues generated from subscriptions sold to individuals who purchase access for a defined period of time to one or more of the properties in the Everyday Health portfolio. Our subscription services are designed to provide the consumer with the ability to access consumer health content from well-recognized sources, and to personalize or customize a specific health or wellness program.

Over the last several years, we have intentionally focused more directly on increasing our advertising and sponsorship revenues, which represents a much larger revenue opportunity than premium services. As a result, the mix of our total revenues from advertising and sponsorship services and premium services has changed. In the three months ended March 31, 2015, our advertising and sponsorship revenues accounted for 88.3% of total revenues, compared to 87.2% in the three months ended March 31, 2014. In the three months ended March 31, 2015, our premium services revenues accounted for 11.7% of total revenues, compared to 12.8% in the three months ended March 31, 2014.

We anticipate that revenues derived from advertising and sponsorship services will continue to grow in the future as a percentage of total revenues. Our premium services, however, generate a significant portion of our registered users, and the valuable data that is voluntarily provided to us through our premium services, including demographic information and health-related interests, enables us to grow our advertising and sponsorship revenues. As a result, while we expect that premium services revenues will continue to decrease as a percentage of total revenues, our subscription products will continue to serve as an important source for registered users that will drive our advertising and sponsorship revenues and potentially offset any decline in our direct revenue from premium services. Although to date, revenues from payors, providers and employers have been immaterial, we expect that these revenues will likely increase as we seek to utilize our existing assets to address the consumer engagement needs of these entities. To the extent that our revenues from these sources increase in the future, this may alter the trends described above.

The timing of our revenues is affected by certain seasonal factors. Our advertising and sponsorship revenues are traditionally the lowest in the first quarter of the year, due primarily to the seasonal spend patterns of our advertising customers, and increases throughout the remainder of the year. Conversely, due to high consumer demand for diet and fitness programs at the start of each year associated with annual resolutions to live healthier lifestyles, we traditionally increase our media expenditures in the first calendar quarter to promote properties in the Everyday Health portfolio that focus on diet and fitness. As a result of these trends, our gross margin tends to be lowest in the first quarter of each calendar year, typically increasing with each consecutive quarter. We anticipate that, as our revenues increase, our gross profit will continue to increase while our period-over-period gross margin may not increase commensurately.

Cost of Revenues, Gross Profit and Gross Margin

The Everyday Health portfolio includes properties that we own, properties that we operate in partnership with leading offline health brands and properties where we manage and sell advertising opportunities on behalf of partners. Cost of revenues consists primarily of the expenses associated with aggregating the total audience across the Everyday Health portfolio or delivering an audience to fulfill a marketing campaign. These costs include:

· media costs;

· royalty payments to the Everyday Health portfolio partners; and

· to a lesser extent, transaction processing costs associated with subscription fees for our premium services, ad serving and other expenses.

Media costs consist primarily of fees paid to online publishers, Internet search companies and other media channels where we advertise our Everyday Health portfolio. These media activities are directly attributable to generating revenue, increasing the audience to the properties we operate, increasing the number of individuals subscribing to our premium services and growing our registered user base. Our partner royalties are generally based on the amount of revenues generated on the particular property. In some cases, we guarantee the partner a minimum annual payment.

We carefully monitor our gross profit and gross margin because they are key indicators of our financial performance and success in aggregating and monetizing our audience across the entire Everyday Health portfolio. Gross profit is defined as total revenues minus cost of revenues. Gross margin is defined as our gross profit as a percentage of our total revenues. While we focus on the growth of both gross profit and gross margin, we may make investments from time to time that will position us for growth at the expense of gross margin.

Since our operating decisions are based on aggregating and monetizing the Everyday Health portfolio audience as a whole, we believe that our aggregate gross profit is an important measure of our overall performance and do not believe that the gross profit associated with any individual property or category of properties is meaningful to an analysis of our overall operating performance. The gross margin we realize on revenues generated on our owned and our operated properties, however, is generally higher than the gross margin generated from properties within our portfolio that are operated by our partners because we typically pay a higher royalty rate to partners that operate their own properties. At the same time, some of the other costs to operate the properties in the Everyday Health portfolio, such as product development expenses, website hosting and maintenance expenses, are included in operating expenses and not reflected in our cost of revenues. As a result, we also believe that our Adjusted EBITDA is an important metric for measuring our overall financial performance (for a detailed description of Adjusted EBITDA, see “Supplemental Financial Information” below).

Both our revenues and gross profit increased for the three months ended March 31, 2015, compared to the prior year period, as shown in the table below.


	Three months ended March 31,
(dollars in thousands)	2015			2014

Revenues	$	41,174		$	37,505
Revenue growth		9.8	%		23.0	%
Cost of revenues	$	14,076		$	11,421
Gross profit	$	27,098		$	26,084
Gross margin		65.8	%		69.5	%

We expect our gross profit to continue to improve in the near term as we continue to aggregate our audience more efficiently and enhance our monetization capabilities across the entire Everyday Health portfolio. While we expect our cost of revenues to continue to increase on an absolute basis in the foreseeable future, we do not believe that any such increases will negatively impact our gross profit or Adjusted EBITDA since we anticipate that the growth in our total revenues will continue to exceed the increase in our cost of revenues.

Operating Expenses

Sales and Marketing. Sales and marketing expenses consist primarily of personnel-related costs, including commissions and non-cash stock compensation, for our account management, research, marketing, sales and data analytics and creative design personnel, as well as fees for third-party professional marketing and analytical services and depreciation and amortization expense pertaining to property and equipment. Our sales and marketing departments include data analytics personnel that analyze traffic and advertising ROI data to determine the effectiveness of advertising and marketing campaigns. We expect our sales and marketing expenses to increase as we increase the number of sales, sales support and analytical personnel.

Product Development. Product development expenses consist of costs related to the products and services we provide to our audience, including the costs associated with the operation and maintenance of the properties in the Everyday Health portfolio that we operate. These costs primarily consist of personnel-related expenses, including non-cash stock compensation, for our editorial, product management, technology and customer service personnel. Product development expenses also include fees paid to editorial and technology consultants; other technology costs; and depreciation and amortization expense pertaining to property and equipment and capitalized technology costs, including website and mobile development costs. We expect our investment in product development to increase as we continue to increase our editorial, product development and technology personnel, and as we enhance our product offerings by creating and licensing content, tools and applications, including new offerings for payors, providers and employers.

General and Administrative. General and administrative expenses consist primarily of personnel-related expenses, including non-cash stock compensation, for our executive, finance, legal, human resources and other administrative personnel, as well as accounting and legal professional fees and other general corporate expenses, including insurance, facilities expenses and depreciation and amortization expense pertaining to property and equipment and amortization of definite-lived intangible assets. We expect our general and administrative expenses, including accounting and legal-related expenses and insurance costs, to increase as we have transitioned to being a public company.

Interest Expense, Net

These amounts consist principally of interest expense, partially offset by interest income, as well as amortization expense related to deferred financing costs. Interest expense is primarily related to our credit facilities.

Other Expense

Other expense consists of certain non-operating expenses, primarily the write-off of unamortized deferred financing costs and prepayment fees incurred in connection with refinancing our credit facilities.

Income Taxes

We are subject to tax at the federal, state and local level in the U.S. and in one foreign jurisdiction. Earnings from our limited non-U.S. activities are subject to local country income tax and may also be subject to U.S. income tax.

As of December 31, 2014, we had approximately $107 million of U.S. federal and state net operating loss, or NOL, carryforwards available to offset future taxable income. The U.S. federal NOL carryforwards will expire from 2020 through 2033. The full utilization of these NOL carryforwards in the future will be dependent upon our ability to generate taxable income and could be limited due to ownership changes, as defined under the provisions of Section 382 of the Internal Revenue Code of 1986, as amended. Specifically, Section 382 contains rules that limit the ability of a company that undergoes an ownership change, which is generally any change in ownership of more than 50% of its stock over a three-year period, to use its previously-recognized NOL carryforwards and specified built-in losses in years after the ownership change. We completed an analysis in 2013 to determine the impact that past ownership changes may have on our ability to use our NOL carryforwards and have determined that, through 2012, approximately $0.5 million of the then-existing NOL carryforwards will be limited by Section 382. However, changes in our stock ownership resulting from our initial public offering, or IPO, or other potential future transactions, could result in additional ownership changes under Section 382. Our NOLs may also be limited under similar provisions of state law. The NOL carryforwards at December 31, 2014 include approximately $7.4 million in income tax deductions related to stock options, which will be reflected as a credit to additional paid-in-capital as realized.

Results of Operations

The following table sets forth our consolidated statement of operations data for the periods presented. The period-to-period comparisons of the results are not necessarily indicative of our results for future periods.

	Three months ended March 31,
(in thousands)	2015			2014
Revenues:
Advertising and sponsorship revenues	$	36,338		$	32,692
Premium services revenues		4,836			4,813
Total revenues		41,174			37,505
Operating expenses:
Cost of revenues		14,076			11,421
Sales and marketing		12,725			10,220
Product development		12,602			10,762
General and administrative		9,804			6,595
Total operating expenses		49,207			38,998
Loss from operations		(8,033	)		(1,493	)
Interest expense, net		(953	)		(1,863	)
Other expense		—			(4,114	)
Loss from operations before benefit (provision) for income taxes		(8,986	)		(7,470	)
Benefit (provision) for income taxes		918			(289	)
Net loss	$	(8,068	)	$	(7,759	)

Comparison of Three Months Ended March 31, 2015 and 2014

Revenues

Our total revenues increased 9.8% to $41.2 million during the three months ended March 31, 2015 from $37.5 million during the three months ended March 31, 2014. The $3.7 million increase in total revenues resulted from an increase in advertising and sponsorship revenues. For the three months ended March 31, 2015 and 2014, no advertiser accounted for 10% or more of total revenues.

Advertising and sponsorship revenues increased 11.2% to $36.3 million during the three months ended March 31, 2015 from $32.7 million during the three months ended March 31, 2014. The $3.7 million increase in advertising and sponsorship revenues was primarily driven by an increase in our professional revenues, particularly professional revenues attributable to DD, which was acquired in November 2014, offset primarily by a decline in consumer revenues due to commencement delays for certain marketing campaigns in the three months ended March 31, 2015.

Premium services revenues remained consistent at $4.8 million during the three months ended March 31, 2015 and 2014. While subscription fee revenues for certain of our brands decreased due to the general decline in the popularity of such brands, the decrease was offset by an increase in subscription fee revenue from a new subscription brand which launched in June 2014.

Costs and Expenses

Cost of Revenues. Cost of revenues increased 23.2% to $14.1 million during the three months ended March 31, 2015 from $11.4 million during the three months ended March 31, 2014. The $2.7 million increase in cost of revenues was primarily attributable to cost of revenue related to the acquired DD business, as well as an increase in royalties to our portfolio partners and higher media spend during the three months ended March 31, 2015. Cost of revenues as a percentage of total revenues increased to 34.2% during the three months ended March 31, 2015 from 30.5% during the three months ended March 31, 2014.

Sales and Marketing. Sales and marketing expenses increased 24.5% to $12.7 million during the three months ended March 31, 2015 from $10.2 million during the three months ended March 31, 2014. The $2.5 million increase was primarily due to higher levels of compensation expense, including increased staffing and related cash and non-cash stock compensation expense for the sales development, sales operations and data analytics teams in the three months ended March 31, 2015 compared to the three months ended March 31, 2014, including compensation expense related to the acquired DD business. Sales and marketing expenses as a percentage of total revenues increased to 30.9% during the three months ended March 31, 2015, as compared to 27.2% during the three months ended March 31, 2014.

Product Development. Product development expenses increased 17.1% to $12.6 million during the three months ended March 31, 2015 from $10.8 million during the three months ended March 31, 2014. This $1.8 million increase was primarily due to an increase in product development expense related to the acquired DD business. Product development expenses as a percentage of total revenues increased to 30.6% during the three months ended March 31, 2015, as compared to 28.7% during the three months ended March 31, 2014.

General and Administrative. General and administrative expenses increased 48.7% to $9.8 million during the three months ended March 31, 2015 from $6.6 million during the three months ended March 31, 2014. This $3.2 million increase was primarily due to increases in cash and non-cash stock compensation expense, including executive transition charges incurred during the first quarter of 2015, as well as higher amortization expense on intangible assets related to DD. General and administrative expenses as a percentage of total revenues increased to 23.8% during the three months ended March 31, 2015, as compared to 17.6% during the three months ended March 31, 2014.

Interest Expense, Net. Interest expense, net, decreased 48.8% to $1.0 million during the three months ended March 31, 2015, compared to $1.9 million during the three months ended March 31, 2014. The $0.9 million decrease in interest expense was primarily due to the refinancing of our credit facility in March 2014 at a lower interest rate compared to the prior credit facilities, partially offset by a net increase in the weighted-average outstanding borrowings under our credit facilities during the three months ended March 31, 2015 as compared to the three months ended March 31, 2014.

Other Expense. Other expense during the three months ended March 31, 2014 consisted of the write-off of unamortized deferred financing costs totaling $2.8 million and prepayment penalties totaling $1.0 million related to the March 2014 credit facility refinancing, and $0.3 million expense relating to a mark-to-market adjustment on certain preferred stock warrants. There were no such expenses during the three months ended March 31, 2015.

Benefit (Provision) for Income Taxes. The benefit (provision) for income taxes was approximately $0.9 million and $(0.3) million for the three months ended March 31, 2015 and 2014, respectively. For the three months ended March 31, 2015, as a result of using an estimated annual effective tax rate, we recorded a benefit for the quarter, which is expected to reverse over the remaining quarters due to seasonality of our business. For the three months ended March 31, 2014, the provision for income taxes was based upon the estimated deferred and current tax provision for the year rather than the estimated annual effective tax rate, as the annual results were expected to be at or near breakeven and we believed that using an annual effective tax rate would result in significant variances in the customary relationship between income tax expense (benefit) and pretax income or loss in interim periods.

Supplemental Financial Information

The following discussion provides information regarding Adjusted EBITDA, a performance measure that is not determined in accordance with U.S. generally accepted accounting principles, or GAAP, as well as information regarding certain non-cash operating expenses that are reflected in the Adjusted EBITDA calculation. We use Adjusted EBITDA in conjunction with GAAP operating performance measures as part of our overall assessment of our performance, for planning purposes, including the preparation of our annual operating budget, to evaluate the effectiveness of our business strategies and to communicate with our Board of Directors concerning our financial performance.

We define Adjusted EBITDA as net loss plus: interest expense, net; income tax (benefit) provision; depreciation and amortization expense; stock-based compensation expense; compensation expense related to acquisition earnout arrangements; write-offs of unamortized deferred financing and other debt extinguishment costs; reduction in force severance charges and executive transition charges; loss from discontinued operations; and certain other non-cash charges such as asset impairment charges and preferred stock warrant mark-to-market adjustments. We believe that Adjusted EBITDA is useful to investors and other users of our financial statements in evaluating our operating performance because it provides them with an additional tool to compare business performance across companies and across periods. Furthermore, we believe that:

Adjusted EBITDA provides investors and other users of our financial information consistency and comparability with our past financial performance, facilitates period-to-period comparisons of operations and comparisons with our peer companies, many of which use similar non-GAAP financial measures to supplement their GAAP results; and

It is useful to exclude certain non-cash charges, such as depreciation and amortization and stock-based compensation and non-core operational charges, such as asset impairment charges and write-off of debt extinguishment costs, from Adjusted EBITDA because the amount of such expenses in any specific period may not be directly correlated to the underlying performance of our business operations and these expenses can vary significantly between periods.

We do not place undue reliance on Adjusted EBITDA as our only measure of operating performance. Adjusted EBITDA should not be considered as a substitute for other measures of financial performance reported in accordance with GAAP. There are limitations to using non-GAAP financial measures, including that other companies may calculate these measures differently than we do, that they do not reflect our capital expenditures or future requirements for capital expenditures and that they do not reflect changes in, or cash requirements for, our working capital.

As Adjusted EBITDA is a non-GAAP measure, the following table presents a reconciliation of net loss to Adjusted EBITDA.

	Three months ended March 31,
(in thousands)	2015			2014
Net loss	$	(8,068	)	$	(7,759	)
Add (deduct):
Interest expense, net		953			1,863
Income tax (benefit) provision		(918	)		289
Depreciation and amortization expense		4,662			3,558
Stock-based compensation expense		2,491			1,069
Warrant mark-to-market adjustment		—			252
Compensation expense related to acquisition earnout		—			84
Write-off of unamortized deferred financing costs		—			3,861
Executive transition charges		1,150			—
Adjusted EBITDA	$	270		$	3,217

The following table summarizes our depreciation and amortization and stock compensation expenses included in the Adjusted EBITDA reconciliation table above and details the breakdown of such expenses in the respective statements of operations line-items.

	Three months ended March 31,
	Depreciation / amortization				Stock compensation ⁽¹⁾
(in thousands)	2015		2014		2015		2014
Sales and marketing	$	223	$	299	$	946	$	274
Product development		3,135		2,829		520		437
General and administrative		1,304		430		1,025		358
Total expense	$	4,662	$	3,558	$	2,491	$	1,069

⁽¹⁾

Stock compensation expense includes charges related to our 2014 Employee Stock Purchase Plan beginning in the second quarter of 2014. Refer to “Note 7—Stock-Based Compensation” in the notes to the consolidated financial statements (unaudited) included in Part I, Item 1 of this Form 10-Q.

Liquidity and Capital Resources

Working Capital

As of March 31, 2015, we had cash and cash equivalents of $48.5 million and working capital of $70.7 million.

Sources of Liquidity and Long-Term Debt

Our primary sources of cash have historically been proceeds from the issuance of convertible redeemable preferred stock, bank borrowings and our IPO. Since the beginning of 2003, we have issued convertible redeemable preferred stock for aggregate net proceeds of $82.0 million. Our IPO resulted in net proceeds of $70.6 million after deducting underwriting discounts and commissions and other offering costs. As of March 31, 2015, we had $112.8 million of borrowings outstanding under our credit facility.

On March 31, 2015, we refinanced our debt. Under our existing credit facility, or the Credit Facility, with Silicon Valley Bank and certain other lenders, we maintain a revolver, with a maximum borrowing limit of $82.25 million, and also have a $67.75 million term loan. As of March 31, 2015, there was $67.75 million outstanding on the term loan and $45.0 million outstanding on the revolver. The repayment terms for any balance outstanding on the revolver provide for quarterly interest payments, with the principal being due in full in November 2019. The repayment terms for the term loan provide for quarterly interest and principal payments, with a maturity date of November 2019. The interest rate on the revolver and the term loan is equal to the London Inter-Bank Offered Rate, or LIBOR, plus a variable rate ranging from 2.75% to 4.0% depending on our consolidated leverage ratio, as defined in the Credit Facility agreement, and we are charged a commitment fee of 0.50% on the unused portion of the revolver. As of March 31, 2015, the interest rate on our Credit Facility was 3.52%. The Credit Facility contains certain financial and operational covenants with which we must comply, whether or not there are any borrowings outstanding. Such covenants include requirements to maintain a minimum consolidated fixed charge coverage ratio and a maximum consolidated leverage ratio, each as defined in the Credit Facility, as well as restrictions on certain types of dispositions, mergers and acquisitions, indebtedness, investments, liens and capital expenditures, issuance of capital stock and our ability to pay dividends and make other distributions. We were in compliance with the financial and operational covenants of the Credit Facility as of March 31, 2015. The Credit Facility is secured by a first priority security interest in substantially all of our existing and future assets.

Operating and Capital Expenditure Requirements

Our principal uses of cash historically have been to fund operating losses, finance business acquisitions and capital expenditures relating to purchases of property and equipment to support our infrastructure and capitalized product development costs. We currently expect that our existing cash and cash equivalents, together with anticipated cash flows from operations, will be sufficient to fund our anticipated cash needs for at least the next twelve months. Our liquidity could be negatively affected by a decrease in demand for our marketing solutions, including the impact of changes in advertiser spending behavior, and by other factors outside of our control, including general economic conditions, as well as the other risks to our business discussed in Item 1A—Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2014. Our cash requirements going forward may require us to raise additional funds through borrowing or the issuance of additional equity or equity-linked securities. Any increase in the amount of our borrowings will result in an increase in our interest expense. Future issuance of equity or equity-linked securities will result in dilution to the holders of our common stock. In addition, if the banking system or the financial markets are volatile, our ability to raise additional debt or equity capital could be adversely affected. Additional financing may not be available on commercially reasonable terms or at all.

Components of Liquidity and Capital Resources

	Three months ended March 31,
(in thousands)	2015			2014
Net cash provided by operating activities	$	3,205		$	2,080
Net cash used in investing activities		(27,712	)		(3,319	)
Net cash provided by (used in) financing activities		22,308			(233	)
Net decrease in cash and cash equivalents	$	(2,199	)	$	(1,472	)

Operating Activities

For the quarter ended March 31, 2015, net cash provided by operating activities was $3.2 million, consisting of a net loss of $8.1 million, adjusted for non-cash expenses of $7.5 million, including depreciation and amortization and non-cash stock-based compensation expense. Additionally, changes in operating assets and liabilities provided $3.8 million of cash, which was primarily due to a decrease in accounts receivable of $14.8 million from higher collections and an increase in deferred revenue of $1.9 million, partially offset by a decrease of $9.3 million in accounts payable and accrued expenses due to the timing of vendor payments as well as an increase of $3.6 million in prepaid expenses and other current assets.

Net cash provided by operating activities was $1.1 million higher in the quarter ended March 31, 2015 compared to the quarter ended March 31, 2014, resulting primarily from an increase in depreciation and amortization of $1.1 million, an increase in non-cash stock based compensation expense of $1.4 million, a decrease in deferred revenue of $1.3 million and a $3.9 million decrease in accounts receivable. These increases were partially offset by a $4.1 million decrease in non-cash amortization of deferred financing costs, a $1.0 million decrease in prepaid expenses and other current assets and an $0.7 million decrease in accounts payable and accrued expenses for the quarter ended March 31, 2015 compared to the same period in 2014.

For the quarter ended March 31, 2014, net cash provided by operating activities was $2.1 million, consisting of a net loss of $7.8 million, adjusted for non-cash expenses of $9.3 million, including depreciation and amortization, non-cash stock-based compensation expense and amortization and write-off of deferred financing costs. Additionally, changes in operating assets and liabilities provided $0.6 million of cash, which was primarily due to a decrease in accounts receivable of $10.9 million from higher collections and an increase in deferred revenue of $0.6 million, partially offset by an $8.6 million decrease in accounts payable and accrued expenses due to the timing of vendor payments and a $2.6 million increase in prepaid expense and other current assets primarily related to the costs associated with our IPO.

Investing Activities

Our primary investing activities have historically consisted of additions to property and equipment, including computer hardware and software, leasehold improvements and capitalized product development costs. Additionally, our investing activities included payments made to acquire businesses.

We used $27.7 million of net cash in investing activities during the quarter ended March 31, 2015, consisting of $3.0 million of additions to property and equipment and $24.7 million for purchase price payments, primarily relating to the Cambridge acquisition. Net cash used in investing activities was $24.4 million higher than in the quarter ended March 31, 2014.

We used $3.3 million of net cash in investing activities during the quarter ended March 31, 2014, primarily for additions to property and equipment.

Financing Activities

Our financing activities have historically consisted primarily of borrowings and repayments under our revolver and term loan credit facilities, and related financing costs, and proceeds from the exercise of stock options. In addition to such activities, upon closing our IPO in April 2014, we received proceeds from our IPO, net of underwriting discounts and commissions and related offering costs.

We generated $22.3 million of net cash in financing activities during the quarter ended March 31, 2015, primarily from $22.8 million of additional net borrowings under our revolver and term loan credit facilities and $0.5 million proceeds from the exercise of stock options, partially offset by the payment of $0.7 million of related financing costs. Net cash provided by financing activities was $22.5 million higher than in the quarter ended March 31, 2014.

We used $0.2 million of net cash in financing activities during the quarter ended March 31, 2014. This primarily related to the debt refinancing in March 2014, which consisted of $72.3 million in proceeds from our revolver and term loan credit facilities, offset by a $71.3 million repayment of outstanding borrowings under our former credit facilities along with prepayment fees on the former credit facilities of $1.0 million and closing costs on the new facility of $1.2 million. Additionally, we received $1.2 million in proceeds from the exercise of stock options in the quarter ended March 31, 2014.

Off-Balance Sheet Arrangements

We do not engage in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, as part of our ongoing business. Accordingly, our operating results, financial condition and cash flows are not subject to off-balance sheet risks.

Critical Accounting Policies and Estimates

Our consolidated financial statements are prepared in accordance with GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses, and related disclosures. These estimates and assumptions are often based on judgments that we believe to be reasonable under the circumstances at the time made, but all such estimates and assumptions are inherently uncertain and unpredictable. Actual results may differ from those estimates and assumptions and it is possible that other professionals, applying their own judgment to the same facts and circumstances, could develop and support alternative estimates and assumptions that would result in material changes to our

operating results and financial condition. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances.

We believe the judgments and estimates involved in revenue recognition and deferred revenue, capitalized software and website development cost, goodwill, other long-lived assets and stock-based compensation have the greatest potential impact on our consolidated financial statements, and consider these to be our critical accounting policies and estimates.

There have been no material changes to our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our Annual Report on Form 10-K, filed with the SEC on March 5, 2015.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk related to changes in interest rates, foreign currency exchange rates and inflation. We do not use derivative financial instruments for speculative, hedging or trading purposes, although in the future we may enter into interest rate or exchange rate hedging arrangements to manage the risks described below.

Interest Rate Risk. Our interest income is primarily generated from interest earned on highly liquid, short-term money market funds. Our exposure to market risks related to interest expense is limited to borrowings under our credit facility. Based on the $112.8 million of borrowings outstanding under our credit facility as of March 31, 2015 and the interest rates in effect at that date, our annual interest expense would amount to $4.0 million. A hypothetical interest rate increase of 1% on our credit facility would increase annual interest expense by $1.1 million. We do not enter into interest rate swaps, caps or collars or other hedging instruments.

Foreign Currency Risk. Substantially all of our revenues and expenses are denominated in U.S. dollars and, therefore, our exposure to market risks related to fluctuations in foreign currency exchange rates is not material.

Inflation Risk. We do not believe that inflation has had a material effect on our business, financial condition or results of operations. Nonetheless, if our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition and results of operations.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2015. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of March 31, 2015, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II: OTHER INFORMATION

Item 1. Legal Proceedings

We are not currently subject to any material litigation or other legal proceeding.

Item 1A. Risk Factors

Please refer to Item 1A-Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2014, filed with the SEC on March 5, 2015, for a description of certain significant risks and uncertainties to which our business, operations and financial condition are subject. During the three months ended March 31, 2015, we did not identify any additional risk factors or any material changes to the risk factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2014.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

	(a)	Recent Sales of Unregistered Equity Securities

None.

	(b)	Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

Item 6. Exhibits

	Exhibit Number		Description of Document

	3.1		Amended and Restated Certificate of Incorporation.⁽¹⁾

	3.2		Amended and Restated Bylaws.⁽²⁾

	10.1		First Amendment to Amended and Restated Credit Agreement and Consent, dated as of March 19, 2015, by and among the Registrant, Silicon Valley Bank, as Administrative Agent, certain of the Registrant’s wholly-owned subsidiaries and the other lenders party thereto.

	10.2		Second Amendment to Amended and Restated Credit Agreement, dated as of March 31, 2015, by and among the Registrant, Silicon Valley Bank, as Administrative Agent, certain of the Registrant’s wholly-owned subsidiaries and the other lenders party thereto.

	10.3		Letter Agreement between the Registrant and Michael du Toit, dated January 18, 2015.

	10.4		Transition Agreement between the Registrant and Paul Slavin, dated February 3, 2015.

	31.1		Certification by Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

	31.2		Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

	32.1		Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.⁽³⁾

	32.2		Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.⁽³⁾

	101.INS		XBRL Instance Document

	101.SCH		XBRL Taxonomy Extension Schema

	101.CAL		XBRL Taxonomy Extension Calculation Linkbase

	101.DEF		XBRL Taxonomy Extension Definition Linkbase

	101.LAB		XBRL Taxonomy Extension Label Linkbase

	101.PRE		XBRL Taxonomy Extension Presentation Linkbase

(1)	Incorporated herein by reference to Exhibit 3.1 to the Registrant’s Form 8-K (File No. 001-36371) filed on April 7, 2014.
(2)	Incorporated herein by reference to Exhibit 3.4 to the Registrant’s Registration Statement on Form S-1 (File No. 333-194097), originally filed on February 24, 2014, as amended.
(3)	These certifications are being furnished solely to accompany this quarterly report pursuant to 18 U.S.C. Section 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and are not to be incorporated by reference into any filing of the registrant, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	EVERYDAY HEALTH, INC.

	By:	/s/ Benjamin Wolin
		Benjamin Wolin
		Chief Executive Officer and Director
		(Principal Executive Officer)

	By:	/s/ Brian Cooper
		Brian Cooper
		Executive Vice President & Chief Financial Officer
		(Principal Financial and Accounting Officer)

Date: May 12, 2015

EX-10.1 2 c81206_ex10-1.htm

Exhibit 10.1

FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT AND CONSENT

This First Amendment to Amended and Restated Credit Agreement and Consent (this “Amendment”) dated as of March 19, 2015, is by and among EVERYDAY HEALTH, INC., a Delaware corporation (“EDH”), EVERYDAY HEALTH MEDIA, LLC, a Delaware limited liability company (“EDH Media”), MEDPAGE TODAY, L.L.C., a New Jersey limited liability company (“MedPage” and together with EDH, EDH Media, and MedPage, individually and collectively, jointly and severally, the “Borrower”), DOCTORDIRECTORY.COM, LLC, a Delaware limited liability company (the “Guarantor”), the several banks and other financial institutions or entities party to this Amendment as a “Lender” hereunder (each a “Lender” and, collectively, the “Lenders”), SILICON VALLEY BANK (“SVB”), as administrative agent and collateral agent for the Lenders (in such capacities, the “Administrative Agent”), SVB, as the Issuing Lender (as defined in the Credit Agreement referred to below), and SVB, as the Swingline Lender (as defined in the Credit Agreement referred to below).

WITNESSETH:

WHEREAS, the parties hereto are party to that certain Amended and Restated Credit Agreement dated as of November 10, 2014 (as amended, modified, supplemented or restated and in effect from time to time, the “Credit Agreement”); and

WHEREAS, EDH, Cambridge BioMarketing Group, LLC, a Delaware limited liability company (“Cambridge”), the members of Cambridge and the other parties thereto are entering into that certain Membership Interest Purchase Agreement dated on or about March 19, 2015 (as amended, supplemented or otherwise modified from time to time, in accordance with the provisions hereof and thereof, the “Cambridge Acquisition Agreement”; and together with all schedules, exhibits and annexes thereto and all side letters and agreements affecting the terms thereof or entered into in connection therewith, the “Cambridge Acquisition Documentation”), pursuant to which EDH will purchase all of the membership interests in Cambridge, and thereafter, Cambridge will be a wholly-owned Subsidiary of EDH (the “Cambridge Acquisition”); and

WHEREAS, the Borrower has requested that the Required Lenders and the Administrative Agent consent to the Borrower’s consummation of the Cambridge Acquisition and agree to modify and amend certain terms and conditions of the Credit Agreement.

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

1. Capitalized Terms. All capitalized terms used herein and not otherwise defined shall have the same meaning herein as in the Credit Agreement.

2. Amendment to Section 1.1 of the Credit Agreement. The following new definitions are hereby added to Section 1.1 of the Credit Agreement in appropriate alphabetical order:

““Cambridge Acquisition”: as defined in the First Amendment.”

““Cambridge Acquisition Documentation”: as defined in the First Amendment.”

““Cambridge Note”: the convertible promissory notes issued by EDH to the sellers under the Cambridge Acquisition Documentation in the aggregate principal amount not to exceed $8,000,000 in form and substance and subject to terms and conditions reasonably satisfactory to the Administrative Agent.”

““First Amendment”: the First Amendment to Amended and Restated Credit Agreement and Consent dated as of March 19, 2015, by and among, among others, the Loan Parties, the Administrative Agent, and the Required Lenders.”

3. Amendment to Section 7.2 of the Credit Agreement. Section 7.2 of the Credit Agreement is hereby amended by (a) amending and restating clause (p) thereof in its entirety as follows:

“(p) Indebtedness in the form of purchase price adjustments, earn-outs (including, without limitation, the contingent consideration or other earn-outs described in the Cambridge Acquisition Documentation, but excluding the Cambridge Note), deferred compensation, or other arrangements representing acquisition consideration or deferred payments of a similar nature incurred in connection with any Permitted Acquisition or other Investment permitted by Section 7.8 (collectively, “Deferred Payment Obligations”);”

(b) deleting the period at the end of clause (q) thereof and inserting “; and” in lieu thereof, and

“(r) the Cambridge Note.”

4. Amendment to Section 7.8 of the Credit Agreement. Section 7.8)(k)(x) of the Credit Agreement is hereby amended and restated in its entirety as follows:

“(x) (A) the aggregate amount of the cash consideration paid by the Group Members in connection with any particular Permitted Acquisition (excluding the DD Acquisition) shall not exceed $45,000,000, and (B) the aggregate amount of the cash consideration paid by all Group Members in connection with all such Permitted Acquisitions consummated from and after the Closing Date (excluding the Cambridge Acquisition and the DD Acquisition) shall not exceed $125,000,000;”.

5. Consent. The Administrative Agent and the Required Lenders hereby consent to the Borrower consummating the Cambridge Acquisition and agree that the Cambridge Acquisition shall be a “Permitted Acquisition” under the Agreement; provided that such consent is expressly conditioned on the following:

(a)

the Borrower shall have provided to the Administrative Agent a copy of the executed Cambridge Acquisition Documentation, which shall be in form and substance reasonably satisfactory to the Administrative Agent;

(b)

the Cambridge Acquisition shall be consummated in accordance with applicable law and the Cambridge Acquisition Documentation without any amendment or modification thereof that is materially adverse to the Group Members, the Administrative Agent or the Lenders;

(c)

all conditions to the consummation of the Cambridge Acquisition set forth in the Cambridge Acquisition Documentation shall have been satisfied; provided that no terms or conditions shall have been waived (other than any waiver that is not adverse to the Group Members, the Administrative Agent, or the Lenders), without the consent of the Administrative Agent;

(d)

no Loan Party shall, as a result of or in connection with the Cambridge Acquisition, assume or incur any direct or contingent liabilities (whether relating to environmental, tax, litigation or other matters) that, as of the date of the Cambridge Acquisition, could reasonably be expected to result in the existence or incurrence of a Material Adverse Effect;

(e)

(i) immediately before and immediately after giving effect to the Cambridge Acquisition, no Default or Event of Default shall have occurred and be continuing, (ii) immediately after giving effect to the Cambridge Acquisition, the Borrower and its Subsidiaries shall be in compliance with each of the covenants set forth in Section 7.1 of the Credit Agreement, based upon financial statements delivered to the Administrative Agent prior to the Cambridge Acquisition which give effect, on a Pro Forma Basis, to the Cambridge Acquisition and (iii) the Loan Parties shall have Liquidity in an amount equal to or greater than $35,000,000 immediately after giving effect to the consummation of such acquisition;

(f)

no Indebtedness shall be assumed or incurred in connection with the Cambridge Acquisition, other than the Cambridge Note;

(g)

the Cambridge Acquisition shall not constitute an Unfriendly Acquisition;

(h)

the Borrower shall have delivered to the Administrative Agent prior to the date the Cambridge acquisition is to be consummated (or such later date as is agreed by the Administrative Agent in its sole discretion), a certificate of a Responsible Officer of the Borrower, in form and substance reasonably satisfactory to the Administrative Agent, certifying that all of the requirements set forth in this Section 5 have been satisfied or will be satisfied concurrently with or prior to the consummation of the Cambridge Acquisition; and

(i)

the Cambridge Acquisition shall have been consummated on or prior to March 31, 2015 (or such later date as the Administrative Agent may agree in its sole discretion).

6. Covenants.

(a)

Cambridge and the Loan Parties shall comply with the requirements of Section 6.12 of the Credit Agreement (without any regarding to the time limits set forth therein) and shall provide updated Collateral Information Certificates, legal opinions and such other documentation reasonably requested by the Administrative Agent in connection therewith, in each case, within five (5) Business Days after the consummation of the Cambridge Acquisition (or such longer period of time as the Administrative Agent may agree in its sole discretion).

(b)

The Borrower shall deliver to the Administrative Agent either (x) evidence of the inclusion of Cambridge on Borrower’s existing insurance policies, or (y) certificates of insurance and endorsements with respect to Cambridge’s liability, casualty and property insurance policies naming the Administrative Agent as an additional insured or lender loss payee, as the case may be, in each case, in form and substance reasonably satisfactory to the Administrative Agent, in either case within forty-five (45) days after the consummation of the Cambridge Acquisition.

(c)

The Loan Parties shall cause Cambridge to comply with all provisions in Section 6.10 of the Credit Agreement within ninety (90)days after the consummation of the Cambridge Acquisition (or such longer period of time as the Administrative Agent may agree in its sole discretion) and deliver to the Administrative Agent Securities Account Control Agreements and Deposit Account Control Agreements with respect to each deposit account and securities account of Cambridge.

(d)

Prior to the effectiveness thereof, the Borrower shall deliver copies of substantially final drafts of any proposed amendment, supplement, waiver or other modification with respect to the Cambridge Acquisition Documentation.

(e)

The Borrower shall not and shall cause each of its Subsidiaries not to (a) amend, supplement or otherwise modify (pursuant to a waiver or otherwise) the terms and conditions of the Cambridge Acquisition Documentation in a manner that is materially adverse to the interests of the Group Members, the Administrative Agent or the Lenders with respect thereto; or (b) fail to enforce, in a commercially reasonable manner, the Loan Parties’ rights (including rights to indemnification) under the Cambridge Acquisition Documentation.

Notwithstanding anything in the Credit Agreement (including, without limitation, Section 8 thereof), the failure of the Loan Parties to comply with any of the foregoing covenants shall constitute an immediate Event of Default.

7. Conditions Precedent to Effectiveness. This Amendment shall not be effective until each of the following conditions precedent have been fulfilled to the satisfaction of the Administrative Agent:

(a) This Amendment shall have been duly executed and delivered by the respective parties hereto. The Administrative Agent shall have received a fully executed copy hereof.

(b) All necessary consents and approvals to this Amendment shall have been obtained by the Loan Parties.

(d) After giving effect to this Amendment, the representations and warranties herein and in the Credit Agreement and the other Loan Documents shall be (i) to the extent qualified by materiality, true and correct in all respects, and (ii) to the extent not qualified by materiality, true and correct in all material respects, in each case on and as of the date hereof, as though made on such date (except to the extent that such representations and warranties relate solely to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects as of such earlier date).

(e) The Administrative Agent shall have received, for the pro rata account of each Lender party to the Credit Agreement on the date hereof, a non-refundable amendment fee in an amount equal to $115,000 payable in immediately available funds, which amendment fee shall be fully earned when paid. The foregoing amendment fee shall be credited against the amendment fee payable to such Lenders in connection with the execution and delivery of the proposed amendment to the Credit Agreement to, among other things, increase the Commitments; provided that nothing contained herein shall be deemed a commitment of any Lender to enter into such amendment.

(f) The Administrative Agent shall have received the fees costs and expenses required to be paid pursuant to Section 10 of this Amendment (including the reasonable and documented fees and disbursements of legal counsel required to be paid thereunder).

8. Representations and Warranties. Each Loan Party hereby represents and warrants to the Administrative Agent and the Lenders as follows:

(a) This Amendment is, and each other Loan Document to which it is or will be a party, when executed and delivered by each Loan Party that is a party thereto, will be the legally valid and binding obligation of such Loan Party, enforceable against such Loan Party in accordance with its respective terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws relating to or limiting creditors’ rights generally and equitable principals (whether enforcement is sought by proceedings in equity or at law).

(b) Its representations and warranties set forth in this Amendment, the Credit Agreement, as amended by this Amendment and after giving effect hereto, and the other Loan Documents to which it is a party are (i) to the extent qualified by materiality, true and correct in all respects and (ii) to the extent not qualified by materiality, true and correct in all material respects, in each case, on and as of the date hereof, as though made on such date (except to the extent that such representations and warranties relate solely to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects as of such earlier date).

(c) The execution and delivery by each Loan Party of this Amendment, the performance by such Loan Party of its obligations hereunder and the performance of the Borrower under the Credit Agreement, as amended by this Amendment, (i) have been duly authorized by all necessary organizational action on the part of such Loan Party and (ii) will not (A) violate any provisions of the certificate of incorporation or formation or organization or by-laws or limited liability company agreement or limited partnership agreement of such Loan Party or (B) constitute a violation by such Loan Party of any applicable material Requirement of Law.

9. Each Loan Party acknowledges that the Administrative Agent and the Lenders have acted in good faith and have conducted in a commercially reasonable manner their relationships with each Loan Party in connection with this Amendment and in connection with the other Loan Documents. Each Loan Party understands and acknowledges that the Administrative Agent and the Lenders are entering into this Amendment in reliance upon, and in partial consideration for, the above representations, warranties, and acknowledgements, and agrees that such reliance is reasonable and appropriate.

10. Payment of Costs and Expenses. The Borrower shall pay to the Administrative Agent all reasonable costs and out-of-pocket expenses of every kind in connection with the preparation, negotiation, execution and delivery of this Amendment and any documents and instruments relating hereto or thereto (which costs include, without limitation, the reasonable and documented fees and expenses of any attorneys retained by the Administrative Agent).

11. Choice of Law. THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. Each party hereto submits to the exclusive jurisdiction of the State and Federal courts in the Southern District of the State of New York; provided, however, that nothing in the Credit Agreement, as amended by this Amendment, or this Amendment, shall be deemed to operate to preclude the Administrative Agent or any Lender from bringing suit or taking other legal action in any other jurisdiction to realize on the Collateral or any other security for the Obligations, or to enforce a judgment or other court order in favor of such Agent or such Lender. TO THE EXTENT PERMITTED BY APPLICABLE LAW, EACH PARTY HERETO WAIVES ITS RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AMENDMENT, THE OTHER LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS. EACH PARTY HERETO ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS ALREADY RELIED ON THIS WAIVER IN ENTERING INTO THIS AMENDMENT, AND THAT EACH WILL CONTINUE TO RELY ON THIS WAIVER IN ITS RELATED FUTURE DEALINGS. EACH PARTY HERETO FURTHER WARRANTS AND REPRESENTS THAT IT HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL AND THAT IT KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.

12. Counterpart Execution. This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, shall be deemed to be an original, and all of which, when taken together, shall constitute but one and the same Amendment. Delivery of an executed counterpart of this Amendment by telefacsimile or by e-mail transmission of an Adobe file format document (also known as a PDF file) shall be equally as effective as delivery of an original executed counterpart of this Amendment. Any party delivering an executed counterpart of this Amendment by telefacsimile or by e-mail transmission of an Adobe file format document (also known as a PDF file) also shall deliver an original executed counterpart of this Amendment but the failure to deliver an original executed counterpart shall not affect the validity, enforceability, and binding effect of this Amendment.

13. Effect on Loan Documents.

(a) The amendments and consent set forth herein shall be limited precisely as written and shall not be deemed (a) to be a forbearance, waiver, or modification of any other term or condition of the Credit Agreement or of any Loan Documents or to prejudice any right or remedy which the Administrative Agent may now have or may have in the future under or in connection with the Loan Documents; (b) to be a consent to any future consent or modification, forbearance, or waiver to the Credit Agreement or any other Loan Document, or to any waiver of any of the provisions thereof; or (c) to limit or impair the Administrative Agent’s right to demand strict performance of all terms and covenants as of any date. Each Loan Party hereby ratifies and reaffirms its obligations under the Credit Agreement and the other Loan Documents to which it is a party and agrees that none of the consents or modifications to the Credit Agreement set forth in this Amendment shall impair such Loan Party’s obligations under the Loan Documents or the Administrative Agent’s rights under the Loan Documents. Each Loan Party hereby further ratifies and reaffirms the validity and enforceability of all of the Liens heretofore granted, pursuant to and in connection with the Guarantee and Collateral Agreement or any other Loan Document to the Administrative Agent on behalf and for the benefit of the Secured Parties, as collateral security for the obligations under the Loan Documents, in accordance with their respective terms, and acknowledges that all of such Liens, and all collateral heretofore pledged as security for such obligations, continues to be and remain collateral for such obligations from and after the date hereof. Each Loan Party acknowledges and agrees that the Credit Agreement and each other Loan Document is still in full force and effect and acknowledges as of the date hereof that such Loan Party has no defenses to enforcement of the Loan Documents. Each Loan Party waives any and all defenses to enforcement of the Credit Agreement as amended hereby and each other Loan Documents that might otherwise be available as a result of this Amendment of the Credit Agreement. To the extent any terms or provisions of this Amendment conflict with those of the Credit Agreement or other Loan Documents, the terms and provisions of this Amendment shall control.

(b) To the extent that any terms and conditions in any of the Loan Documents shall contradict or be in conflict with any terms or conditions of the Credit Agreement, after giving effect to this Amendment, such terms and conditions are hereby deemed modified or amended accordingly to reflect the terms and conditions of the Credit Agreement as modified or amended hereby.

14. Entire Agreement. This Amendment constitutes the entire agreement between the Loan Parties and the Lenders pertaining to the subject matter contained herein and supersedes all prior agreements, understandings, offers and negotiations, oral or written, with respect hereto and no extrinsic evidence whatsoever may be introduced in any judicial or arbitration proceeding, if any, involving this Amendment. All of the terms and provisions of this Amendment are hereby incorporated by reference into the Credit Agreement, as applicable, as if such terms and provisions were set forth in full therein, as applicable. All references in the Credit Agreement to “this Agreement”, “hereto”, “hereof”, “hereunder” or words of like import shall mean the Credit Agreement as amended hereby.

15. Release. Each of the Borrower and each Guarantor may have certain Claims against the Released Parties, as those terms are defined below, regarding or relating to the Credit Agreement or the other Loan Documents. The Administrative Agent, the Lenders, the Issuing Lender, the Swingline Lender, the Borrower and the Guarantors desire to resolve each and every one of such Claims in conjunction with the execution of this Amendment and thus each of the Borrower and each Guarantor makes the releases contained in this Section 15. In consideration of the Administrative Agent and the Lenders entering into this Amendment, each of the Borrower and each Guarantor hereby fully and unconditionally releases and forever discharges each of the Administrative Agent, the Lenders, the Issuing Lender, the Swingline Lender and their respective directors, officers, employees, subsidiaries, branches, affiliates, attorneys, agents, representatives, successors and assigns and all persons, firms, corporations and organizations acting on any of their behalves (collectively, the “Released Parties”), of and from any and all claims, allegations, causes of action, costs or demands and liabilities, of whatever kind or nature, from the beginning of the world to the date on which this Amendment is executed, whether known or unknown, liquidated or unliquidated, fixed or contingent, asserted or unasserted, foreseen or unforeseen, matured or unmatured, suspected or unsuspected, anticipated or unanticipated, which the Borrower or any Guarantor has, had, claims to have had or hereafter claims to have against the Released Parties by reason of any act or omission on the part of the Released Parties, or any of them, occurring prior to the date on which this Amendment is executed, including all such loss or damage of any kind heretofore sustained or that may arise as a consequence of the dealings among the parties up to and including the date on which this Amendment is executed, including the administration or enforcement of the Loans, the Obligations, the Credit Agreement or any of the Loan Documents (collectively, all of the foregoing, the “Claims”). Each of the Borrower and each Guarantor represents and warrants that it has no knowledge of any claim by it against the Released Parties or of any facts or acts of omissions of the Released Parties which on the date hereof would be the basis of a claim by the Borrower or any Guarantor against the Released Parties which is not released hereby. Each of the Borrower and each Guarantor represents and warrants that the foregoing constitutes a full and complete release of all Claims.

16. Severability. The provisions of this Amendment are severable, and if any clause or provision shall be held invalid or unenforceable in whole or in part in any jurisdiction, then such invalidity or unenforceability shall affect only such clause or provision, or part thereof, in such jurisdiction and shall not in any manner affect such clause or provision in any other jurisdiction, or any other clause or provision in this Amendment in any jurisdiction.

[SIGNATURE PAGES FOLLOW]

In Witness Whereof, the parties hereto have caused this Amendment to be duly executed and delivered by their proper and duly authorized officers as of the day and year first above written.

	BORROWER:

	EVERYDAY HEALTH, INC.

	By:	/s/ Alan Shapiro
	Name: Alan Shapiro
	Title: EVP and General Counsel

	EVERYDAY HEALTH MEDIA, LLC

	By:	/s/ Alan Shapiro
	Name: Alan Shapiro
	Title: EVP and General Counsel

	MEDPAGE TODAY, L.L.C.

	By:	/s/ Alan Shapiro
	Name: Alan Shapiro
	Title: President

	GUARANTOR:

DOCTORDIRECTORY.COM, LLC


	By:	/s/ Alan Shapiro
	Name: Alan Shapiro
	Title: President

	SILICON VALLEY BANK,
	as Administrative Agent, as a Lender, as Issuing Lender and as Swingline Lender

	By:	/s/ Jennie T. Bartlett
	Name: Jennie T. Bartlett
	Title: Vice President

	COMERICA BANK,
	as a Lender

	By:	/s/ John Benetti
	Name:	John Benetti
	Title: Senior Vice President

	SUNTRUST BANK,
	as a Lender

	By:	/s/ Brian Guffin
	Name:	Brian Guffin
	Title: Director

	CIT FINANCE LLC,
	as a Lender

	By:	/s/ Timothy G. Beh
	Name:	Timothy G. Beh
	Title: Vice President

	MUFG UNION BANK, N.A.,
	as a Lender

	By:	/s/ Michael J. McCutchin
	Name:	Michael J. McCutchin
	Title: Director

	STIFEL BANK & TRUST,
	as a Lender

	By:	/s/ Christian Jon Bugyis
	Name:	Christian Jon Bugyis
	Title: Sr. Vice President

EX-10.2 3 c81206_ex10-2.htm

Exhibit 10.2

SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

This Second Amendment to Amended and Restated Credit Agreement (this “Amendment”) dated as of March 31, 2015, is by and among EVERYDAY HEALTH, INC., a Delaware corporation (“EDH”), EVERYDAY HEALTH MEDIA, LLC, a Delaware limited liability company (“EDH Media”), MEDPAGE TODAY, L.L.C., a New Jersey limited liability company (“MedPage” and together with EDH, EDH Media, and MedPage, individually and collectively, jointly and severally, the “Borrower”), DOCTORDIRECTORY.COM, LLC, a Delaware limited liability company (“DoctorDirectory”), Cambridge BioMarketing Group, LLC, a Delaware limited liability company (“Cambridge”, and together with DoctorDirectory, individually and collectively, jointly and severally, the “Guarantor”), the several banks and other financial institutions or entities party to this Amendment as a “Lender” hereunder (each a “Lender” and, collectively, the “Lenders”), SILICON VALLEY BANK (“SVB”), as administrative agent and collateral agent for the Lenders (in such capacities, the “Administrative Agent”), SVB, as the Issuing Lender (as defined in the Credit Agreement referred to below), and SVB, as the Swingline Lender (as defined in the Credit Agreement referred to below).

WITNESSETH:

WHEREAS, the parties hereto are party to that certain Amended and Restated Credit Agreement dated as of November 10, 2014, as amended by that certain First Amendment to Amended and Restated Credit Agreement and Consent dated as of March 19, 2015 (as the same may be further amended, modified, supplemented or restated and in effect from time to time, the “Credit Agreement”); and

WHEREAS, the Borrower has requested an Increase (as defined in the Credit Agreement prior to giving effect to this Amendment) of $35,750,000 pursuant to Section 2.8 of the Credit Agreement consisting of (a) an increase in the aggregate amount of the Term Loans to $67,750,000 (inclusive of the Term Loans in the principal amount of $59,250,000 outstanding immediately prior to the effectiveness of this Amendment) and (b) an increase in the Total Revolving Commitments to $82,250,000, and that the Required Lenders and the Administrative Agent agree to modify and amend certain terms and conditions of the Credit Agreement.

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

1. Capitalized Terms. All capitalized terms used herein and not otherwise defined shall have the same meaning herein as in the Credit Agreement.

2. Amendment to Section 1.1 of the Credit Agreement.

(a)

The definition of “Applicable Margin” is hereby amended by and restated in its entirety as follows:

“Applicable Margin”: commencing on the date on which the Administrative Agent receives copies of the consolidated financial statements of EDH and its Subsidiaries in respect of the fiscal quarter of EDH ending March 31, 2015, together with a Compliance Certificate in respect thereof as contemplated by Section 6.2(b), the rate per annum set forth under the relevant column heading below:

TERM LOANS

Consolidated Leverage Ratio	Eurodollar Loans	ABR Loans
>2.50:1.00	4.00%	3.00%
≤ 2.50:1.00 but ≥ 1.00:1.00	3.25%	2.25%
< 1.00:1.00	2.75%	1.75%

REVOLVING LOANS

Consolidated Leverage Ratio	Eurodollar Loans	ABR Loans
>2.50:1.00	4.00%	3.00%
≤ 2.50:1.00 but ≥ 1.00:1.00	3.25%	2.25%
< 1.00:1.00	2.75%	1.75%

SWINGLINE LOANS

Consolidated Leverage Ratio		Swingline Loans
>2.50:1.00		3.00%
≤ 2.50:1.00 but ≥ 1.00:1.00		2.25%
< 1.00:1.00		1.75%

Notwithstanding the foregoing, (a) commencing on the Second Amendment Effective Date and until the delivery of the first Compliance Certificate required to be delivered pursuant to Section 6.2(b) in connection with the delivery by the Borrower of the consolidated financial statements required to be delivered to the Administrative Agent pursuant to Sections 6.1 in respect of the fiscal quarter of EDH ending March 31, 2015, the Applicable Margin shall be the rates corresponding to a Consolidated Leverage Ratio >2.50:1.00 in the foregoing tables, (b) if the Borrower fails to deliver the financial statements required by Section 6.1 and the related Compliance Certificate required by Section 6.2(b), by the respective date required thereunder after the end of any related fiscal quarter of EDH, the Applicable Margin shall be the rates corresponding to the Consolidated Leverage Ratio of >2.50:1.00 in the foregoing table until such financial statements and Compliance Certificate are delivered, and (c) no reduction to the Applicable Margin shall become effective at any time when an Event of Default has occurred and is continuing.

		If, as a result of any restatement of or other adjustment to the financial statements of the Loan Parties or for any other reason, the Administrative Agent determines that (x) the Consolidated Leverage Ratio as calculated by EDH as of any applicable date was inaccurate and (y) a proper calculation of the Consolidated Leverage Ratio would have resulted in different pricing for any period, then (i) if the proper calculation of the Consolidated Leverage Ratio would have resulted in higher pricing for such period, the Borrower shall automatically and retroactively be obligated to pay to the Administrative Agent, for the benefit of the applicable Lenders, promptly on demand by the Administrative Agent, an amount equal to the excess of the amount of interest and fees that should have been paid for such period over the amount of interest and fees actually paid for such period; and (ii) if the proper calculation of the Consolidated Leverage Ratio would have resulted in lower pricing for such period, neither the Administrative Agent nor any Lender shall have any obligation to repay any interest or fees to the Borrower.

	(b)	The definition of “*Available Revolving Increase Amount*” is hereby amended by and restated in its entirety as follows:

		““*Available Revolving Increase Amount*”: as of any date of determination, an amount equal to the result of (a) $50,000,000 minus (b) the aggregate principal amount of Revolver Increases previously made after the Second Amendment Effective Date, minus (c) the aggregate principal amount of all Additional Term Loans previously made after the Second Amendment Effective Date.”

	(c)	The definition of “*Commitment Fee Rate*” is hereby amended by and restated in its entirety as follows:

		“*Commitment Fee Rate”: commencing on the Second Amendment Effective Date, 0.50% per annum; provided that commencing on the date on which the Administrative Agent receives copies of the consolidated financial statements of the Borrower and its Subsidiaries in respect of the fiscal quarter of the Borrower ending March 31, 2015, together with a Compliance Certificate in respect thereof as contemplated by Section 6.2(b), “Commitment Fee Rate”* shall mean the rate per annum set forth under the relevant column heading below:

Consolidated Leverage Ratio		Commitment Fee Rate
>2.50:1.00		0.50%
≤ 2.50:1.00 but ≥ 1.00:1.00		0.50%
< 1.00:1.00		0.375%

(d)

The definition of “Consolidated EBITDA” is hereby amended by (i) amending clause (a)(xii) to read “expenses and related costs associated with the management transition of Cambridge’s prior Chairman in an amount not to exceed $567,000 per fiscal year for fiscal years 2014-2016” and (ii) inserting the following text as the last sentence thereof: “For the avoidance of doubt,

		Consolidated EBITDA shall be calculated on a Pro Forma Basis giving effect to the Cambridge Acquisition for any periods prior to the Second Amendment Effective Date.”

	(e)	The definition of “*Consolidated Fixed Charge Coverage Ratio*” is hereby amended by and restated in its entirety as follows:

		““*Consolidated Fixed Charge Coverage Ratio*”: with respect to EDH and its consolidated Subsidiaries for any period, the ratio of (a) the sum of (i) Consolidated EBITDA for such period minus (ii) the portion of taxes based on income actually paid in cash (net of any cash refunds received) during such period, minus (iii) cash dividends and distributions paid to any Person that is not a Loan Party during such period minus (iv) Consolidated Capital Expenditures (excluding the principal amount funded with the Loans) incurred in connection with such expenditures) to (b) Consolidated Fixed Charges for such period; provided, however, that the principal and interest payments under the Credit Agreement made prior the Second Amendment Effective Date shall be excluded from this calculation for any 12-month testing period that includes any period prior to the Second Amendment Effective Date, and principal and interest payments for the period of time since the Second Amendment Effective Date shall be substituted in lieu thereof and annualized, as appropriate; provided, further that (x) for the fiscal quarter ending March 31, 2015, Consolidated Fixed Charges shall be deemed to include a principal payment of $846,875 and (y) for the fiscal quarter ending June 30, 2015, Consolidated Fixed Charges shall be deemed to include a principal payment of $846,875.”

	(f)	The definition of “*Term Commitment*” is hereby amended and restated in its entirety as follows:

		““*Term Commitment*”: as to any Lender, the obligation of such Lender, if any, to make a Term Loan to the Borrower in an aggregate principal amount not to exceed the amount set forth under the heading “Term Commitment” opposite such Lender’s name on Schedule 1.1A. The aggregate amount of the Term Commitments on the Closing Date was $21,000,000. The aggregate amount of the Term Commitments in respect of the Second Amendment Term Loan on the Second Amendment Effective Date is $8,500,000.”

	(g)	The definition of “*Total Revolving Commitments*” is hereby amended by and restated in its entirety as follows:

		““*Total Revolving Commitments*”: at any time, the aggregate amount of the Revolving Commitments then in effect. The original amount of the Total Revolving Commitments was $55,000,000. The amount of the Total Revolving Commitments on the Second Amendment Effective Date is $82,250,000. The L/C Commitment and the Swingline Commitment are each sublimits of the Total Revolving Commitments.”

	(h)	The following new definitions are hereby added in their appropriate alphabetical order:

		““*Cambridge Earn-Outs*”: obligations of the Borrower to make any earn-out payments in an aggregate amount not to exceed $5,000,000 pursuant to the terms and subject to the conditions of the Cambridge Acquisition Documentation as in effect on March 20, 2015.”

		““*Second Amendment*”: the Second Amendment to Amended and Restated Credit Agreement dated as of March 31, 2015, by and among, among others, the Loan Parties, the Administrative Agent, and the Required Lenders.”

		““*Second Amendment Effective Date*”: as defined in the Second Amendment.”

		““*Second Amendment Term Loan*”: as defined in the Second Amendment.”

3. Amendments to Section 2.1 of the Credit Agreement. Section 2.1 of the Credit Agreement is hereby amended by adding the following sentence to the end thereof:

“Notwithstanding anything herein to the contrary, upon the funding of the Second Amendment Term Loan, the Second Amendment Term Loan shall be part of the Term Loan.”

4. Amendment to Section 2.3 of the Credit Agreement. The provisions of Section 2.3 are hereby amended and restated in their entirety as follows:

“Repayment of Term Loans. Beginning on July 1, 2015, the Term Loans shall be repaid in consecutive quarterly installments on the first day of each fiscal quarter, each of which installments shall be in an amount equal to such Lender’s Term Percentage multiplied by the installment amount set forth below opposite such installment payment date:

Installment Payment Dates		Installment Amount
July 1, 2015		$846,875 (plus, if applicable, 1.25% of the initial amount of any Additional Term Loans made after the Second Amendment Effective Date)
October 1, 2015		$846,875 (plus, if applicable, 1.25% of the initial amount of any Additional Term Loans made after the Second Amendment Effective Date)
The first day of each fiscal quarter thereafter		$1,693,750 (plus, if applicable, 2.50% of the initial amount of any Additional Term Loans made after the Second Amendment Effective Date)

To the extent not previously paid, all then outstanding Term Loans shall be due and payable on the Term Loan Maturity Date, together with accrued and unpaid interest on the principal amount to be paid to but excluding the date of payment.

5. Amendment to Section 2.8 of the Credit Agreement. The provisions of Section 2.8(a) are hereby amended by changing the references from “$40,000,000” to “$50,000,000” and from “Closing Date” to “Second Amendment Effective Date” respectively.

6. Amendment to Section 7.6 of the Credit Agreement. Section 7.6 of the Credit Agreement is hereby amended by (a) deleting the word “and” at the end of clause (d) thereof, (b) deleting the period at the end of clause (e) thereof and inserting “; and” in lieu thereof, and (c) adding the following new clause (f) as follows:

“(f) notwithstanding clause (e) above, if the Cambridge Note is converted into Capital Stock of EDH and no cash payments in lieu thereof have been made, the Borrower and its Subsidiaries may make payments in respect of the Cambridge Earn-Outs in accordance with the terms of the Cambridge Acquisition Documentation.”

7. Amendment to Section 7.7 of the Credit Agreement. The chart contained in Section 7.7 is hereby amended and restated as follows:

Fiscal Year		Consolidated Capital Expenditures
2014		$16,000,000
2015		$17,500,000
2016		$18,500,000
2017		$19,500,000
2018		$20,500,000
2019		$21,500,000

8. Amendment to Schedules to the Credit Agreement. The schedules to the Credit Agreement are hereby amended and restated in their entirety and replaced with Schedule 1 attached hereto

9. Amendment to Schedules to the Guarantee and Collateral Agreement. The schedules to the Guarantee and Collateral Agreement are hereby amended and restated in their entirety and replaced with Schedule 2 attached hereto.

10. Amendment to Exhibit B of the Credit Agreement. Exhibit B of the Credit Agreement is hereby amended and restated in its entirety and replaced with Exhibit B attached hereto.

11. Conditions Precedent to Effectiveness. This Amendment shall not be effective until each of the following conditions precedent have been fulfilled to the satisfaction of and in form

and substance satisfactory to, as applicable, the Administrative Agent (such date, the “Second Amendment Effective Date”):

(a) This Amendment shall have been duly executed and delivered by the respective parties hereto. The Administrative Agent shall have received a fully executed copy hereof.

(b) The Lenders and the Administrative Agent shall have received all fees required to be paid on or prior to the Second Amendment Effective Date pursuant to this Amendment and to the Fee Letter.

(c) The Administrative Agent shall have received an updated Perfection Certificate, executed by a Responsible Officer of the Loan Parties.

(d) If required by Lender, the Administrative Agent shall have received a Note (or amendment to any existing Note) executed by the Borrower in favor of such Lender.

(e) All necessary consents and approvals to this Amendment shall have been obtained by the Loan Parties.

(f) The Administrative Agent shall have received a certificate of each Loan Party, dated the Second Amendment Effective Date and executed by the Secretary, Managing Member or equivalent officer of such Loan Party, with appropriate insertions and attachments, including (i) the Operating Documents of such Loan Party, (ii) the relevant board resolutions or written consents of such Loan Party adopted by such Loan Party for the purposes of authorizing such Loan Party to enter into this Amendment and perform the Loan Documents (as amended by this Amendment) to which such Loan Party is party, (iii) the names, titles, incumbency and signature specimens of those representatives of such Loan Party who have been authorized by such resolutions and/or written consents to execute Loan Documents on behalf of such Loan Party, (iv) a long form good standing certificate for each Loan Party certified as of a recent date by the appropriate Governmental Authority of its respective jurisdiction of organization, and (v) certificates of qualification as a foreign corporation issued by each jurisdiction in which the failure of the applicable Loan Party to be so qualified could reasonably be expected to result in a Material Adverse Effect.

(g) After giving effect to this Amendment, no Default or Event of Default shall have occurred and be continuing.

(h) The Administrative Agent shall have received a certificate signed by a Responsible Officer of the Borrower, dated as of the Second Amendment Effective Date and in form and substance reasonably satisfactory to it, certifying (A) that the conditions specified in Sections 5.2(a) and (c) of the Credit Agreement have been satisfied, and (B) that there has been no event or condition since December 31, 2013, that has had or that could reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect.

(i) The Administrative Agent shall have received, (i) in respect of the Term Loan to be made on or about the Second Amendment Effective Date, a completed Notice of Borrowing executed by the Borrower and otherwise complying with the requirements of Section 2.2 of the Credit Agreement, and (ii) in respect of any Revolving Loans to be made on or about the Closing

Date, a completed Notice of Borrowing executed by the Borrower and otherwise complying with the requirements of Section 2.5 of the Credit Agreement.

(j) The Administrative Agent shall have received a Solvency Certificate from the chief financial officer or treasurer of the Borrower.

(k) After giving pro forma effect to the Increase (as defined in the Credit Agreement prior to giving effect to this Amendment) contemplated hereby and the use of proceeds thereof, the Borrower shall be in compliance with the financial covenants set forth in Section 7.1 of the Credit Agreement (as amended hereby) as of the end of the most recently ended month (or quarter, as applicable) for which financial statements were required to be delivered, and the Borrower shall have delivered to the Administrative Agent a Compliance Certificate evidencing compliance with the requirements hereof.

(l) The Administrative Agent shall have received the results of recent lien searches in each of the jurisdictions where any of the Loan Parties is formed or organized, and such searches shall reveal no liens on any of the assets of the Loan Parties except for Liens permitted by Section 7.3 of the Credit Agreement.

(m) The Administrative Agent shall have received the executed customary legal opinion of counsel to the Loan Parties, in form and substance reasonably satisfactory to the Administrative Agent.

(n) After giving effect to this Amendment, the representations and warranties herein and in the Credit Agreement and the other Loan Documents shall be (i) to the extent qualified by materiality, true and correct in all respects, and (ii) to the extent not qualified by materiality, true and correct in all material respects, in each case on and as of the date hereof, as though made on such date (except to the extent that such representations and warranties relate solely to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects as of such earlier date).

(o) The Administrative Agent shall have received, for the account of each Lender party to the Credit Agreement immediately prior to the Second Amendment Effective Date and who remains a Lender thereafter, a rollover fee (the “Rollover Fee”) of 171,635.87.

For purposes of determining compliance with the conditions specified in this Section 9, each Lender that has executed this Amendment shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter either sent (or made available) by the Administrative Agent to such Lender for consent, approval, acceptance or satisfaction, or required thereunder to be consented to or approved by or acceptable or satisfactory to such Lender, unless an officer of the Administrative Agent responsible for the transactions contemplated by the Loan Documents shall have received notice from such Lender prior to the Second Amendment Effective Date specifying such Lender’s objection thereto and either such objection shall not have been withdrawn by notice to the Administrative Agent to that effect on or prior to the Second Amendment Effective Date.

12. Covenants.

(a) To the extent not provided to the Administrative Agent prior to the Second Amendment Effective Date, the Borrower shall deliver to the Administrative Agent evidence satisfactory to the Administrative Agent that DoctorDirectory’s accounts with First Citizens’s Bank been have been closed or are otherwise subject to a Securities Account Control Agreement and/or Deposit Account Control Agreement, in form and substance reasonably satisfactory to the Administrative Agent within thirty (30) days of the Second Amendment Effective Date.

13. Representations and Warranties. Each Loan Party hereby represents and warrants to the Administrative Agent and the Lenders as follows:

(b) This Amendment is, and each other Loan Document to which it is or will be a party, when executed and delivered by each Loan Party that is a party thereto, will be the legally valid and binding obligation of such Loan Party, enforceable against such Loan Party in accordance with its respective terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws relating to or limiting creditors’ rights generally and equitable principals (whether enforcement is sought by proceedings in equity or at law).

(c) Its representations and warranties set forth in this Amendment, the Credit Agreement, as amended by this Amendment and after giving effect hereto, and the other Loan Documents to which it is a party are (i) to the extent qualified by materiality, true and correct in all respects and (ii) to the extent not qualified by materiality, true and correct in all material respects, in each case, on and as of the date hereof, as though made on such date (except to the extent that such representations and warranties relate solely to an earlier date, in which case such representations and warranties shall have been true and correct in all material respects as of such earlier date).

(d) The execution and delivery by each Loan Party of this Amendment, the performance by such Loan Party of its obligations hereunder and the performance of the Borrower under the Credit Agreement, as amended by this Amendment, (i) have been duly authorized by all necessary organizational action on the part of such Loan Party and (ii) will not (A) violate any provisions of the certificate of incorporation or formation or organization or by-laws or limited liability company agreement or limited partnership agreement of such Loan Party or (B) constitute a violation by such Loan Party of any applicable material Requirement of Law.

14. The Borrower hereby ratifies, confirms and reaffirms, all and singular, the terms and disclosures contained in the Collateral Information Certificate(s) delivered by the Borrower to the Administrative Agent on or before the date hereof, and acknowledges, confirms and agrees the disclosures and information the Borrower provided to the Administrative Agent in said Collateral Information Certificate(s) remains accurate and complete in all material respects, as of the date hereof.

15. Each Loan Party acknowledges that the Administrative Agent and the Lenders have acted in good faith and have conducted in a commercially reasonable manner their relationships with each Loan Party in connection with this Amendment and in connection with

the other Loan Documents. Each Loan Party understands and acknowledges that the Administrative Agent and the Lenders are entering into this Amendment in reliance upon, and in partial consideration for, the above representations, warranties, and acknowledgements, and agrees that such reliance is reasonable and appropriate.

16. Payment of Costs and Expenses. The Borrower shall pay to the Administrative Agent all reasonable costs and out-of-pocket expenses of every kind in connection with the preparation, negotiation, execution and delivery of this Amendment and any documents and instruments relating hereto or thereto (which costs include, without limitation, the reasonable and documented fees and expenses of any attorneys retained by the Administrative Agent).

17. Settlement.

(a) As of the date hereof, the aggregate outstanding principal amount of the Revolving Loans under the Credit Agreement is $55,000,000 (the “Existing Revolving Loans”). The Existing Revolving Loans (together with all accrued and unpaid interest, fees, indemnities, costs and other payment obligations that are outstanding immediately prior to the date hereof) are owing as of the Second Amendment Effective Date, and are payable without set-off, counterclaim, deduction, offset or defense. All breakage fees in connection with the Existing Revolving Loans shall be waived. All accrued and unpaid interest and fees in respect of the Existing Revolving Loans shall be repaid on the Second Amendment Effective Date. On the Second Amendment Effective Date, each Lender agrees to pay to the Administrative Agent (which may take the form of such Lender overfunding any Revolving Loans requested on the Second Amendment Effective Date or such other procedure reasonably determined by the Administrative Agent), for the account of the Revolving Lenders, the amount necessary to ensure that the outstanding principal amount of the Revolving Loans and participations under the Credit Agreement in Letters of Credit and participations under the Credit Agreement in Swingline Loans of each Revolving Lender shall equal each Revolving Lender’s respective Revolving Percentages and L/C Percentages after giving effect to the increase in the Total Revolving Commitments contemplated hereby.

(b) One or more Lenders previously made Term Loans to the Borrower prior to the Second Amendment Effective Date in an aggregate original principal amount equal to $60,000,000 (the “Pre-Second Amendment Existing Term Loans”), the aggregate outstanding principal balance of which is $59,250,000 as of the Second Amendment Effective Date. The Pre-Second Amendment Existing Term Loans (together with all accrued and unpaid interest, fees, indemnities, costs and other payment obligations that are outstanding immediately prior to the date hereof) are owing as of the Second Amendment Effective Date, and are payable without set-off, counterclaim, deduction, offset or defense. Subject to the terms and conditions hereof, each Term Lender with a Term Commitment severally agrees to make a Term Loan to the Borrower on the Second Amendment Effective Date in an amount equal to the amount of the Term Commitment of such Lender, such that after giving effect to the Term Loan to be made on the Second Amendment Effective Date, the aggregate outstanding principal balance of the Term Loans (inclusive of the Pre-Second Amendment Existing Term Loans) shall be $67,750,000 (the “Second Amendment Term Loan”). On and after the making of such Second Amendment Term Loans on the Second Amendment Effective Date, each Pre-Second Amendment Existing Term Loan and the Second Amendment Term Loans shall be made or converted (as applicable) into a

single Eurodollar Tranche and shall constitute the “Term Loans” under the Credit Agreement. All breakage fees in connection the Pre-Second Amendment Existing Term Loans shall be waived. All accrued and unpaid interest in respect of the Pre-Second Amendment Existing Term Loans shall be repaid on the Second Amendment Effective Date.

18. Choice of Law. THIS AMENDMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. Each party hereto submits to the exclusive jurisdiction of the State and Federal courts in the Southern District of the State of New York; provided, however, that nothing in the Credit Agreement, as amended by this Amendment, or this Amendment, shall be deemed to operate to preclude the Administrative Agent or any Lender from bringing suit or taking other legal action in any other jurisdiction to realize on the Collateral or any other security for the Obligations, or to enforce a judgment or other court order in favor of such Agent or such Lender. TO THE EXTENT PERMITTED BY APPLICABLE LAW, EACH PARTY HERETO WAIVES ITS RIGHT TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AMENDMENT, THE OTHER LOAN DOCUMENTS OR ANY CONTEMPLATED TRANSACTION, INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER CLAIMS. EACH PARTY HERETO ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS ALREADY RELIED ON THIS WAIVER IN ENTERING INTO THIS AMENDMENT, AND THAT EACH WILL CONTINUE TO RELY ON THIS WAIVER IN ITS RELATED FUTURE DEALINGS. EACH PARTY HERETO FURTHER WARRANTS AND REPRESENTS THAT IT HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL AND THAT IT KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS FOLLOWING CONSULTATION WITH LEGAL COUNSEL.

19. Counterpart Execution. This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, shall be deemed to be an original, and all of which, when taken together, shall constitute but one and the same Amendment. Delivery of an executed counterpart of this Amendment by telefacsimile or by e-mail transmission of an Adobe file format document (also known as a PDF file) shall be equally as effective as delivery of an original executed counterpart of this Amendment. Any party delivering an executed counterpart of this Amendment by telefacsimile or by e-mail transmission of an Adobe file format document (also known as a PDF file) also shall deliver an original executed counterpart of this Amendment but the failure to deliver an original executed counterpart shall not affect the validity, enforceability, and binding effect of this Amendment.

20. Effect on Loan Documents.

or waiver to the Credit Agreement or any other Loan Document, or to any waiver of any of the provisions thereof; or (c) to limit or impair the Administrative Agent’s right to demand strict performance of all terms and covenants as of any date. Each Loan Party hereby ratifies and reaffirms its obligations under the Credit Agreement and the other Loan Documents to which it is a party and agrees that none of the consents or modifications to the Credit Agreement set forth in this Amendment shall impair such Loan Party’s obligations under the Loan Documents or the Administrative Agent’s rights under the Loan Documents. Each Loan Party hereby further ratifies and reaffirms the validity and enforceability of all of the Liens heretofore granted, pursuant to and in connection with the Guarantee and Collateral Agreement or any other Loan Document to the Administrative Agent on behalf and for the benefit of the Secured Parties, as collateral security for the obligations under the Loan Documents, in accordance with their respective terms, and acknowledges that all of such Liens, and all collateral heretofore pledged as security for such obligations, continues to be and remain collateral for such obligations from and after the date hereof. Each Loan Party acknowledges and agrees that the Credit Agreement and each other Loan Document is still in full force and effect and acknowledges as of the date hereof that such Loan Party has no defenses to enforcement of the Loan Documents. Each Loan Party waives any and all defenses to enforcement of the Credit Agreement as amended hereby and each other Loan Documents that might otherwise be available as a result of this Amendment of the Credit Agreement. To the extent any terms or provisions of this Amendment conflict with those of the Credit Agreement or other Loan Documents, the terms and provisions of this Amendment shall control.

21. Entire Agreement. This Amendment constitutes the entire agreement between the Loan Parties and the Lenders pertaining to the subject matter contained herein and supersedes all prior agreements, understandings, offers and negotiations, oral or written, with respect hereto and no extrinsic evidence whatsoever may be introduced in any judicial or arbitration proceeding, if any, involving this Amendment. All of the terms and provisions of this Amendment are hereby incorporated by reference into the Credit Agreement, as applicable, as if such terms and provisions were set forth in full therein, as applicable. All references in the Credit Agreement to “this Agreement”, “hereto”, “hereof”, “hereunder” or words of like import shall mean the Credit Agreement as amended hereby.

22. Release. Each of the Borrower and each Guarantor may have certain Claims against the Released Parties, as those terms are defined below, regarding or relating to the Credit Agreement or the other Loan Documents. The Administrative Agent, the Lenders, the Issuing Lender, the Swingline Lender, the Borrower and the Guarantors desire to resolve each and every one of such Claims in conjunction with the execution of this Amendment and thus each of the Borrower and each Guarantor makes the releases contained in this Section 15. In consideration of the Administrative Agent and the Lenders entering into this Amendment, each of the

Borrower and each Guarantor hereby fully and unconditionally releases and forever discharges each of the Administrative Agent, the Lenders, the Issuing Lender, the Swingline Lender and their respective directors, officers, employees, subsidiaries, branches, affiliates, attorneys, agents, representatives, successors and assigns and all persons, firms, corporations and organizations acting on any of their behalves (collectively, the “Released Parties”), of and from any and all claims, allegations, causes of action, costs or demands and liabilities, of whatever kind or nature, from the beginning of the world to the date on which this Amendment is executed, whether known or unknown, liquidated or unliquidated, fixed or contingent, asserted or unasserted, foreseen or unforeseen, matured or unmatured, suspected or unsuspected, anticipated or unanticipated, which the Borrower or any Guarantor has, had, claims to have had or hereafter claims to have against the Released Parties by reason of any act or omission on the part of the Released Parties, or any of them, occurring prior to the date on which this Amendment is executed, including all such loss or damage of any kind heretofore sustained or that may arise as a consequence of the dealings among the parties up to and including the date on which this Amendment is executed, including the administration or enforcement of the Loans, the Obligations, the Credit Agreement or any of the Loan Documents (collectively, all of the foregoing, the “Claims”). Each of the Borrower and each Guarantor represents and warrants that it has no knowledge of any claim by it against the Released Parties or of any facts or acts of omissions of the Released Parties which on the date hereof would be the basis of a claim by the Borrower or any Guarantor against the Released Parties which is not released hereby. Each of the Borrower and each Guarantor represents and warrants that the foregoing constitutes a full and complete release of all Claims.

23. Severability. The provisions of this Amendment are severable, and if any clause or provision shall be held invalid or unenforceable in whole or in part in any jurisdiction, then such invalidity or unenforceability shall affect only such clause or provision, or part thereof, in such jurisdiction and shall not in any manner affect such clause or provision in any other jurisdiction, or any other clause or provision in this Amendment in any jurisdiction.

[SIGNATURE PAGES FOLLOW]

In Witness Whereof, the parties hereto have caused this Amendment to be duly executed and delivered by their proper and duly authorized officers as of the day and year first above written.

	BORROWER:

	EVERYDAY HEALTH, INC.

	By:	/s/ Alan Shapiro
	Name: Alan Shapiro
	Title: EVP and GC

	EVERYDAY HEALTH MEDIA, LLC

	By:	/s/ Alan Shapiro
	Name: Alan Shapiro
	Title: EVP and GC

	MEDPAGE TODAY, L.L.C.

	By:	/s/ Alan Shapiro
	Name: Alan Shapiro
	Title: President and Secretary

	GUARANTOR:

	DOCTORDIRECTORY.COM, LLC

	By:	/s/ Alan Shapiro
	Name: Alan Shapiro
	Title: President and CEO

Cambridge BioMarketing Group, LLC


	By:	/s/ Alan Shapiro
	Name: Alan Shapiro
	Title: President and Secretary

	SILICON VALLEY BANK,
	as Administrative Agent, as a Lender, as Issuing Lender and as Swingline Lender

	By:	/s/ Jennie T. Bartlett
	Name: Jennie T. Bartlett
	Title: Vice President

	COMERICA BANK,
	as a Lender

	By:	/s/ John Benetti
	Name:	John Benetti
	Title: Senior Vice President

	SUNTRUST BANK,
	as a Lender

	By:	/s/ Shannon Offen
	Name:	Shannon Offen
	Title: Director

	CIT FINANCE LLC,
	as a Lender

	By:	/s/ Timothy G. Beh
	Name:	Timothy G. Beh
	Title: Vice President

	MUFG UNION BANK, N.A.,
	as a Lender

	By:	/s/ Michael J. McCutchin
	Name:	Michael J. McCutchin
	Title: Director

	STIFEL BANK & TRUST,
	as a Lender

	By:	/s/ John H. Phillips
	Name:	John H. Phillips
	Title: Executive Vice President

EX-10.3 4 c81206_ex10-3.htm

Exhibit 10.3

January 18, 2015

Michael du Toit

Dear Michael,

On behalf of Everyday Health, Inc. (the “Company”), I am pleased to offer you the full-time position of President, reporting to Ben Wolin. The terms of your employment relationship with the Company will be set forth below.

Cash Compensation: Your start date is expected to be February 2, 2015, but the actual start date may change upon mutual agreement of the parties. During calendar year 2015, your annual base salary will be four hundred thousand dollars ($400,000) and during calendar year 2016, your annual base salary will be four hundred and twenty five thousand dollars ($425,000). You are an exempt employee and therefore not eligible to receive overtime pay. Company employees are paid semi-monthly on the 15^th and end of the month. The Company shall also pay you a “sign-on” bonus in the amount of $200,000, payable by February 15, 2015.

You are eligible to receive an annual performance bonus, and the target for this annual performance bonus is 100% of your base salary (i.e. $400,000 for 2015). For calendar year 2015 and 2016, the bonus structure will be as follows: (i) 50% will be based on the Company’s total 2015 and 2016 revenue, as applicable, measured against the Board-approved revenue goal for the relevant year; and (ii) 50% will be based on the Company’s total 2015 and 2016 adjusted EBITDA, as applicable, measured against the Board-approved adjusted EBITDA goal for the relevant year. The calculation of the final performance bonus payout amounts based on the Company’s revenue and adjusted EBITDA relative to the Board-approved goals (e.g. tiered payouts based on actual performance relative to goal) shall be consistent with the structure approved by the Company’s Compensation Committee for the other senior executives. Annual bonuses are paid by the Company in the latter half of the first calendar quarter, following completion of the annual audit for the prior calendar year. Notwithstanding the foregoing, the Company will guarantee 25% of your 2015 bonus target (i.e. $100,000) regardless of the Company’s financial performance. The Board-approved revenue and adjusted EBITDA goals are subject to appropriate pro forma adjustment in the event of acquisition or other similar corporate events during the course of the year.

Employee Benefits: You will be eligible for the benefits package that the Company offers to its regular, full time employees, subject to the terms and conditions of the applicable benefits plan. These benefits include participation in the Company’s 401k plan and the Company’s Employee Stock Purchase Plan (ESPP). The details of this package have been, or will be, sent to you electronically.

Equity Compensation: In connection with your hiring you will receive a grant of 110,000 restricted stock units (RSUs) pursuant to the Company’s 2014 Equity Incentive Plan. Twenty

percent of the RSUs subject to this award (i.e. 22,000 RSUs) will vest on November 15, 2015; forty percent of the RSUs subject to this award (i.e. 44,000 RSUs) will vest on November 15, 2016; and forty percent of the RSUs subject to this award (i.e. 44,000 RSUs) will vest on November 15, 2017.

In addition to the RSU award described in the preceding paragraph, you shall receive a grant of 40,000 RSUs in the first quarter of 2015. The vesting of this award shall be linked to the Company’s 2015 financial performance as follows: (i) 10,000 of such RSUs shall vest on March 31, 2016 if, and only if, the Company’s total revenue for 2015 (based on the Company’s annual audit) equals or exceeds the Board-approved revenue goal for 2015; (ii) 10,000 of such RSUs shall vest on March 31, 2016 if, and only if, the Company’s total adjusted EBITDA for 2015 (based on the Company’s annual audit) equals or exceeds the Board-approved adjusted EBITDA goal for 2015; (iii) 10,000 of such RSUs shall vest on March 31, 2016 if, and only if, the Company’s total revenue for 2015 (based on the Company’s annual audit) equals or exceeds 102.5% of the Board-approved revenue goal for 2015; and (iv) 10,000 of such RSUs shall vest on March 31, 2016 if, and only if, the Company’s total adjusted EBITDA for 2015 (based on the Company’s annual audit) equals or exceeds 102.5% of the Board-approved adjusted EBITDA goal for 2015; provided, however, that in the case of (iii) and (iv) above, in the event that the Company’s total revenue or adjusted EBITDA falls between the Board-approved target and 102.5% of the Board-approved target, then a proportionate share of the relevant RSUs shall vest. By way of example, if the total revenue for 2015 falls halfway between the Board-approved target and 102.5% of the Board-approved target, then 5,000 RSUs shall vest under (iii) above.

Similarly, you shall receive a grant of 40,000 RSUs in the first quarter of 2016. The vesting of this award shall be linked to the Company’s 2016 financial performance as follows: (i) 10,000 of such RSUs shall vest on March 31, 2017 if, and only if, the Company’s total revenue for 2016 (based on the Company’s annual audit) equals or exceeds the Board-approved revenue goal for 2016; (ii) 10,000 of such RSUs shall vest on March 31, 2017 if, and only if, the Company’s total adjusted EBITDA for 2016 (based on the Company’s annual audit) equals or exceeds the Board-approved adjusted EBITDA goal for 2016; (iii) 10,000 of such RSUs shall vest on March 31, 2017 if, and only if, the Company’s total revenue for 2016 (based on the Company’s annual audit) equals or exceeds 102.5% of the Board-approved revenue goal for 2016; and (iv) 10,000 of such RSUs shall vest on March 31, 2017 if, and only if, the Company’s total adjusted EBITDA for 2016 (based on the Company’s annual audit) equals or exceeds 102.5% of the Board-approved adjusted EBITDA goal for 2016; provided, however, that in the case of (iii) and (iv) above, in the event that the Company’s total revenue or adjusted EBITDA falls between the Board-approved target and 102.5% of the Board-approved target, then a proportionate share of the relevant RSUs shall vest. By way of example, if the total revenue for 2016 falls halfway between the Board-approved target and 102.5% of the Board-approved target, then 5,000 RSUs shall vest under (iii) above.

As with the annual bonus calculation described above, the Board-approved revenue and adjusted EBITDA goals are subject to appropriate pro forma adjustment in the event of acquisition or other similar corporate events during the course of the year.

With respect to all the RSU awards detailed above, if you remain in continuous service at the time of a “Corporate Transaction” (as defined in the 2014 Equity Incentive Plan), 50% of the then-unvested RSUs will become vested and exercisable as of immediately prior to the closing of such transaction. Beginning in 2017, you shall be eligible to receive additional equity-based awards like other senior executives of the Company, subject to the final approval of the Company’s Compensation Committee. Historically, such awards have been granted in the first calendar quarter of the year in connections with the Company’s annual employee performance review process.

Severance: If the Company terminates your employment without Cause (as defined below), and other than as a result of your death or disability, and provided such termination constitutes a “separation from service” (as defined under Treasury Regulation Section 1.409A-1(h)), then subject to your obligations below, the Company will pay to you, as severance, an amount equal to (i) twelve (12) months of your then-current base salary and (ii) your annual performance bonus target amount (collectively, the “Severance Benefits”). In addition, you will receive the Severance Benefits if you resign from employment with the Company for “Good Reason” within ten (10) days after the occurrence of one of the events specified in the definition of Good Reason, by giving notice that you intend to terminate your employment for Good Reason on the thirtieth (30) day following the Company’s receipt of your notice, if the Company has not cured the event that gives rise to Good Reason before the end of such thirty (30) day period. The Severance Benefits are conditional upon (a) your continuing to comply with your obligations under your Agreement to Protect Information, Assign Inventions, and Prevent Unfair Competition and Unfair Solicitation (the “Confidentiality Agreement”) during the period of time in which you are receiving the Severance Benefits and (b) your delivering to the Company an effective, general release of claims in favor of the Company in a form acceptable to the Company within 30 days following your termination date. The Severance Benefits will be paid on the Company’s regular payroll schedule over the 12 month period immediately following your termination date, and will be subject to applicable tax withholdings; provided, however, that no payments will be made prior to the 30th day following your termination date. In addition to the Severance Benefits, in the event of a termination without Cause by the Company or your termination of employment for Good Reason, any remaining unvested RSUs that were part of the initial grant of 110,000 time-based RSUs referenced above shall be vested as of the employment termination date.

For purposes of this Agreement, “Cause” means (A) your conviction (including a guilty plea or a no contest plea) of a felony, or of any other crime involving fraud, dishonesty or moral turpitude; (B) your attempted commission of or participation in a fraud or act of material dishonesty against the Company; (C) your material breach of any written agreement between you and the Company (including but not limited to your Confidentiality Agreement); or (D) your refusal to follow a clear and lawful directive of the Chief Executive Officer or Board of Directors or your habitual neglect of your duties, provided that if Cause is based on the occurrence of an event specified in (D) above, the Company will give you written notice that the Company intends to terminate your employment for Cause on the thirtieth (30th) day following your receipt of the Company’s notice, if you have not cured the circumstances constituting Cause before the end of such thirty (30) day period.. For purposes of this Agreement, “Good Reason” means the occurrence of any of the following without your prior written consent: (i) a reduction by the Company in your base

salary or target bonus; (ii) the assignment to you of any duties or responsibilities which result in the material diminution of your then current position; or (iii) relocation of your principal place of business more than fifty (50) miles from its current location.

It is intended that all of the Severance Benefits payable under this letter satisfy, to the greatest extent possible, the exemptions from the application of Code Section 409A provided under Treasury Regulations 1.409A-1(b)(4) and 1.409A-1(b)(9), and this letter will be construed to the greatest extent possible as consistent with those provisions. For purposes of Code Section 409A (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), your right to receive any installment payments under this letter (whether severance payments, reimbursements or otherwise) shall be treated as a right to receive a series of separate payments and, accordingly, each installment payment hereunder shall at all times be considered a separate and distinct payment. Notwithstanding any provision to the contrary in this letter, if you are deemed by the Company at the time of your separation from service to be a “specified employee” for purposes of Code Section 409A(a)(2)(B)(i), and if any of the payments upon separation from service set forth herein are deemed to be “deferred compensation”, then to the extent delayed commencement of any portion of such payments is required in order to avoid a prohibited distribution under Code Section 409A(a)(2)(B)(i) and the related adverse taxation under Section 409A, such payments shall not be provided to you prior to the earliest of (i) the expiration of the six-month period measured from the date of your Separation from Service with the Company, (ii) the date of your death or (iii) such earlier date as permitted under Section 409A without the imposition of adverse taxation. Upon the first business day following the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this paragraph shall be paid in a lump sum to you, and any remaining payments due shall be paid as otherwise provided herein.

Business Expenses: All approved business expenses will be reimbursed, following submission of an approved expense report approved by your manager. During the time your primary residence is in the Philadelphia, Pennsylvania area, the Company will provide you with housing in Manhattan (either access to a residence that is rented by the Company or reimbursement of hotel accommodations) for use during the business week and other business uses. The tax treatment for such housing allowance, and any public disclosure in the Company’s securities filings, shall be consistent with applicable tax and securities laws.

Non-Disclosure and Developments Agreement: Like all Company employees, you will be required to sign the Company’s standard “Agreement to Protect Information, Assign Inventions, and Prevent Unfair Competition and Unfair Solicitation” as a condition of employment. In addition, you will be required to abide by the Company’s strict policy that prohibits any new employee from using or bringing with him or her from any previous employer any confidential information, trade secrets, or proprietary materials or processes of such former employer.

At-Will Employment: This letter does not constitute a guarantee of employment or an employment contract for any specified period of time. You will be an employee-at-will, meaning that either you or the Company may terminate your employment relationship at any time, without notice, for any reason or no reason.

Federal Immigration Law: For purposes of federal immigration law, you are required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States. Documentation must be provided to us within three (3) business days of your commencement date, or our employment relationship with you may be terminated.

We are pleased that you are joining our team to work with us to help the Company reach its full potential. Please confirm your acceptance of this offer by signing and emailing one copy of this letter to me at ashapiro@everydayhealthinc.com. If you have any questions, please feel free to contact me at (646)-728-9715.

Sincerely,

/s/ Alan Shapiro
Alan Shapiro
EVP, General Counsel

The foregoing terms and conditions are hereby accepted:

Employee Signature:	/s/ Michael du Toit

Name:	Michael du Toit

Date:	January 18, 2015

EX-10.4 5 c81206_ex10-4.htm

Exhibit 10.4

February 3, 2015

Paul Slavin

Chief Operating Officer
Everyday Health, Inc.
345 Hudson Street, 16^th Floor

New York City, NY 10014

Dear Paul:

While the Everyday Health, Inc. (“Company”) management team and Board of Directors (“Board”) will miss your involvement in day-to-day operations and strategic vision, we understand your desire to put in place a transition plan at this time. As you prepare for your next endeavors, it is with tremendous gratitude for your friendship, service and leadership that I am pleased to set forth below the terms of your transition. These terms are referred to herein as the “Agreement.”

1. Separation Date. We have agreed that your last day of employment with the Company and your employment termination date will be March 31, 2015 (the “Separation Date”). From February 1, 2015 through March 31, 2015, you shall serve as Executive Vice President, Special Advisor to the Chief Executive Officer. This Agreement shall supersede the employment letter between you and the Company dated August 17, 2011, as amended on February 25, 2013 (collectively, the “Employment Letter”), and the Employment Letter is hereby terminated with no further force or effect.

2. Transition Period and Duties. Beginning April 1, 2015 and continuing through and including September 30, 2016 (the “Advisory Period”), you have agreed to provide advisory

and transition services to the Company. It is expected that the advisory and transition services shall focus on representing the Company at external media and other functions, assisting the Company maintain excellent relations with the celebrities and public personalities that partner with the Company and assist the Company with business development activities across the media community. During the Advisory Period, you shall also serve as a member of the Company’s Advisory Board and participate in all activities of such Advisory Board. During the Advisory Period, in light of the change in your role, you will no longer have, and will not represent that you have, legal authority to act on behalf of or to bind the Company. You understand and agree that the services you provide during the Advisory Period shall not operate to create a contract of employment with the Company. Further, such services will be provided by you as an independent contractor to the Company. Through May 31, 2015, the Company shall provide office space to you and assistant support, as well as the general administrative services of the office (including your existing Company email address).

3. Accrued Salary. On or before the first regularly scheduled payroll date following the Separation Date, the Company will pay you all accrued salary earned through the Separation Date, subject to standard payroll deductions and required withholdings.

4. Separation Payment. Pursuant to the terms of your offer letter dated August 17, 2011 and amended as of February 25, 2013, and provided you execute and do not revoke this Agreement, you will receive separation pay equal to $350,000.00, less applicable withholdings, which amount is equal to twelve months of your current base salary, paid as continued salary on the Company’s regular payroll schedule over the twelve months following your Separation Date. Because you are specified employee within the meaning of Internal Revenue Code Section 409A(a)(2)(B)(i), the payment of this amount will be delayed for a period of six months until October 1, 2015. On the next regular payroll on or following October 1, 2015, you will receive a lump sum payment equal to the amount of base salary you would have received between April 1, 2015 and the date on which the payment is made and thereafter shall continue to receive your base salary pursuant to the Company’s regular payroll schedule through March 31, 2016.

5. Advisory Services Fee.

(a) Transition Payment. The Company will pay you, as part of the transition, the gross amount of Five Hundred Thousand Dollars ($500,000.00), subject to required withholdings. This amount will be paid in two installments - $250,000 by April 15, 2015 and the remaining $250,000 by June 1, 2015.

(b) Advisory Services Fee. The Company will pay you a fee in the amount of Two Hundred Fifty Thousand Dollars ($250,000.00) as additional consideration hereunder by September 1, 2015. This fee shall not be subject to withholdings and will be reported by the

Company to the IRS via Form 1099. You understand and agree that you will be responsible for all taxes associated with such fee.

6. Stock Options. All outstanding options granted to you under the Company’s 2003 Stock Option Plan (the “Plan”) shall continue to vest during the Advisory Period. As part of this Agreement, the Company shall permit you (or in the event of your death or disability, your heirs, executors and legal representatives, as applicable) to exercise any or all of your vested options as of the end of the Advisory Period on or before September 30, 2017. Except as stated herein, your options shall be subject to the terms of the Plan and grant documents.

7. Health Benefits. You shall have the option to continue health coverage in accordance with the Consolidated Omnibus Budget Reconciliation Act (“COBRA”), and you will be provided with a separate letter addressing your rights to purchase continuing health coverage and the costs associated therewith. In the event you elect to participate in COBRA, the Company will pay your health insurance premiums pursuant to COBRA for a period not to exceed eighteen (18) months from the Separation Date.

8. No Other Compensation or Benefits. You acknowledge that, except as expressly provided in this Agreement, the Company is not obligated to provide you with any additional compensation, severance, or benefits after the Separation Date. Specifically, you understand and agree that the compensation and benefits provided to you in this Agreement are in lieu of and not in addition to any other compensation or benefit to which you may otherwise be entitled to, including, but not limited to, the compensation and benefits provided for in the Employment Letter.

9. Expense Reimbursements. You agree that, within 30 days of the Separation

Date, you will submit any final documented expenses incurred through the Separation Date, if any, for which you seek reimbursement. The Company will reimburse you for these expenses pursuant to its regular business practice. The Company will reimburse reasonable expenses incurred in connection with your duties during the Advisory Period pursuant to its regular business practice.

10. Return of Company Property. By September 30, 2016, unless requested earlier by the Company, you agree to use commercially reasonable efforts to return to the Company or delete all tangible Company documents (and all tangible copies thereof) and other tangible Company property that you have in your possession, including, but not limited to, Company files, notes, records, business plans and forecasts, and financial information, and any tangible materials of any kind that contain or embody any proprietary or confidential information of the Company (and all tangible reproductions thereof).

11. Confidential Information Obligations and Restrictive Covenants.

(a) You understand and agree that, after the Separation Date and during and after the Advisory Period, you shall hold in strict confidence and shall not disclose, directly or indirectly, to any third party, person, firm, corporation or other entity, irrespective of whether such person or entity is a competitor of the Company or is engaged in a business similar to that of the Company, any Confidential Information (as defined below) of the Company or any subsidiary of the Company obtained or developed by you from, through, or in the course of your employment with the Company or your services hereunder. “Confidential Information” means any information used by or belonging or related to the Company or any of its affiliates that is not known generally to the industry in which the Company is or may be engaged and which the

Company maintains on a confidential basis including without limitation any and all intellectual property, trade secrets and proprietary information, information relating to the Company’s business and services, employee information, customer lists and records, business processes, procedures or standards, know-how, technology, business strategies, records, financial information, in each case whether or not reduced to writing or stored electronically, as well as any information that the Company advises you should be treated as confidential information (including information conceived, discovered or developed by you), that you learn of, possess, or have access through your employment by the Company or your services under this Agreement, related to the Company, its business partners, or the business of its customers or potential customers.

(b) Notwithstanding the foregoing limitations, you shall not be required to keep confidential any information that: (i) is known or available through other lawful sources, or (ii) is or becomes publicly available or generally known in the industry through no fault of yours, your agents or another individual or entity that owes a duty of confidentiality to the Company, or (iii) is required to be disclosed pursuant to any statutes, laws, rules, regulations, ordinances, codes, directives, writs, injunctions, decrees, judgments, and orders of any governmental body (provided the Company is given reasonable prior notice).

(c) Notwithstanding anything in this Agreement to the contrary, you understand and agree that the assignment of inventions provided for in Section 4 of your Agreement to Protect Confidential Information, Assign Inventions, and Protect Unfair Competition and Unfair Solicitation (“Assignment and Disclosure of Inventions”) remains effective. You also agree to continue to cooperate with the Company, at the Company’s sole cost and expense, both during and after employment and after your services under this

Agreement, with respect to the procurement, maintenance and enforcement of copyrights, patents and other intellectual property rights (both in the United States and foreign countries) relating to assigned inventions. This includes signing all papers, including, without limitation, copyright applications, patent applications, declarations, oaths, formal assignments, assignments of priority rights, and powers of attorney, which are reasonably necessary in order to protect its rights and interests. You further agree that if the Company is unable, after reasonable effort, to secure your signature on any such papers, any officer of the Company shall be entitled to execute any such papers as your agent and attorney-in-fact, and you hereby irrevocably designate and appoint each officer of the Company as your agent and attorney-in-fact to execute any such papers on your behalf, and to take any and all actions which may be reasonably necessary to protect the Company’s rights and interests in any assigned invention.

(d) You further understand and agree that through the Advisory Period, you will not, as an officer, director, employee, consultant, owner, partner, or in any other capacity, either directly or through others, without the written approval of the Company:

(1) perform services for the following entities and any of their subsidiaries: (i) Remedy Health; (ii) Healthgrades; (iii) Sharecare; (iv) Athena Health; and (v) Physicians Interactive.

(2) interfere with or disrupt, or attempt to interfere with or disrupt, the relationship, contractual or otherwise, between the Company, or any subsidiary of the Company, and any customer, vendor, licensor, or supplier of the Company or any subsidiary of the Company; or

(3) solicit for employment or offer employment to (directly or indirectly, individually or in connection with any new employer or other business partner) any person who is a then current employee of the Company or any subsidiary of the Company or has left the Company or any subsidiary of the Company in the preceding three (3) months.

Notwithstanding the foregoing, for three years following the Separation Date, you will not, as an officer, director, employee, consultant, partner, or in any other capacity, either directly or through others, without the written approval of the Company: (i) perform services for WebMD and/or any of its subsidiaries; or (ii) work with any of the celebrities and public personalities that were partners with the Company during your employment with the Company or that you engage with as part of the advisory services that you provide the Company.

10. Confidentiality. The provisions of this Agreement will be held in strictest confidence by you and the Company and will not be publicized or disclosed in any manner whatsoever; provided, however, that: (a) you may disclose this Agreement in confidence to your immediate family, prospective employers and business partners, and financing sources; (b) the parties may disclose this Agreement in confidence to their respective attorneys, accountants, auditors, tax preparers, and financial advisors; (c) the Company may disclose this Agreement as necessary to fulfill standard or legally required corporate reporting or disclosure requirements, including but not limited to, Securities and Exchange Commission filings; and (d) the parties may disclose this Agreement insofar as such disclosure may be necessary to enforce its terms or as otherwise required by law.

11. Non-disparagement. The Company shall instruct its officers and directors not to disparage you in any manner or through any medium likely to be harmful to you or your

business, business reputation or your personal reputation. You agree not to disparage the Company and its officers and directors, in any manner or through any medium likely to be harmful to them or their business or business reputation each as related to the Company and its subsidiaries. In the event that either party violates the non-disparagement obligation (or, in the case of the Company, any of its officers or directors fail to abide by the above instruction), the other party shall be permitted to respond as they reasonably believe appropriate under the circumstances without being limited by the above restrictions.

12. No Admissions. You understand and agree that the promises and payments in consideration of this Agreement shall not be construed to be an admission of any liability by the Company to you or to any other person, and that the Company makes no such admission.

13. Release of Claims. In exchange for the mutual release provided for in this Section 13, except as provided herein, you hereby generally and completely release the Company and its directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, affiliates, and assigns from any and all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct or omissions occurring with respect to your relationship with the Company at any time prior to and including the date you sign this Agreement. This general release includes, but is not limited to claims under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; Sections 1981 through 1988 of Title 42 of the United States Code, as amended; the Employee Retirement Income Security Act of 1974, as amended; the Americans with Disabilities Act of 1990, as amended; the Age Discrimination in Employment Act of 1967, as amended (“ADEA”); New York Human Rights Laws, as amended; the New York Civil Rights Act, as amended; the New York Minimum Wage Law, as amended;

Equal Pay Law for New York, as amended; any other federal, state or local civil or human rights law or any other local, state or federal law, regulation or ordinance; and any public policy, contract, tort, or common law. The foregoing release does not encompass, and you do not release: (i) any and all claims or rights that you may have with respect to your capacity as a stockholder or optionholder of the Company, including under any stockholder agreement, option plan or option grant documents and similar instruments; (ii) claims and rights to indemnification, contribution or insurance arising from your service as an employee, officer, director, stockholder or optionholder of the Company; or (iii) your rights under this Agreement. Upon request by the Company, on or after the Separation Date, you shall re-execute the release of claims set forth in this Section in order to effectuate a full release of claims through the Separation Date.

In exchange for the mutual release provided for in this Section 13, except as provided herein, the Company on behalf of itself and its directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, affiliates, and assigns hereby generally and completely release you and your family members, affiliates, successors and assigns from any and all claims, liabilities and obligations, both known and unknown, that arise out of or are in any way related to events, acts, conduct or omissions occurring with respect to your relationship with the Company or service as an officer or director of the Company, at any time prior to and including the date you sign this Agreement. This general release includes, but is not limited to claims under: Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1991; Sections 1981 through 1988 of Title 42 of the United States Code, as amended; the Employee Retirement Income Security Act of 1974, as amended; the Americans with Disabilities Act of 1990, as amended; the Age Discrimination in Employment Act of 1967, as amended (“ADEA”); New York Human Rights Laws, as amended;

the New York Civil Rights Act, as amended; the New York Minimum Wage Law, as amended; Equal Pay Law for New York, as amended; any other federal, state or local civil or human rights law or any other local, state or federal law, regulation or ordinance; and any public policy, contract, tort, or common law. The foregoing release does not encompass, and the Company does not release its rights under this Agreement.

14. Indemnification. You shall be entitled to the benefits of all provisions of the Certificate of Incorporation of the Company, as amended, and the Bylaws of the Company, as amended, that provide for indemnification, exculpation, contribution and reimbursement of officers, directors and/or employees of the Company. In addition, without limiting such provisions of the Certificate of Incorporation or Bylaws, or any other agreement with the Company, to the fullest extent permitted by law, the Company shall indemnify you and save and hold you harmless from and against, and pay or reimburse, any and all claims, demands, liabilities, costs and expenses, including judgments, fines or amounts paid on account thereof (whether in settlement or otherwise), and reasonable expenses, including attorneys’ fees actually and reasonably incurred, if you are made a party to or witness in any action, suit or proceeding, or if a claim or liability is asserted against you (whether or not in the right of the Company), by reason of the fact that you are or were a director, officer, employee, consultant, advisor or acted in such capacity on behalf of the Company, or the rendering of services by you pursuant to this Agreement or any of your prior employment agreements with the Company (including the Employment Letter), whether or not the same shall proceed to judgment or be settled or otherwise brought to a conclusion. Upon your request, the Company will advance any reasonable expenses or costs, subject to your undertaking to repay any such advances in the event there is an unappealable final determination that you are not entitled to indemnification for

such expenses. This provision shall survive the expiration or termination of this Agreement.

15. Application of Section 409A. To the extent that any payments and benefits provided under this Agreement constitute “deferred compensation” within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (“Code”) and the regulations and other guidance thereunder and any state law of similar effect (collectively, “Section 409A”), such payments and benefits shall not commence in connection with your termination of employment unless and until you have also incurred a “separation from service” (as such term is defined in Treasury Regulation Section 1.409A-1(h)) unless the Company reasonably determines that a separation from service is not a necessary precondition to payment and as a result such amounts may be provided to you without causing you to incur the additional 20% tax under Section 409A. For the sake of clarity, it is intended that you incur a separation from service on the Separation Date, and the parties acknowledge that the amount of the advisory and transition services to be provided during the Advisory Period shall be at a level that is not greater than (and may be less than) 20% of the average level of services you provided over the thirty-six (36) months immediately preceding the Advisory Period. It is further intended that each installment of pay and benefits provided for in this Agreement is a separate “payment” for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i). For the avoidance of doubt, it is intended that payments set forth in this Agreement satisfy, to the greatest extent possible, the exceptions from the application of Section 409A provided under Treasury Regulation Sections 1.409A-1(b)(4), 1.409A-1(b)(5), and 1.409A-1(b)(9).

To the extent any indemnification payment, expense reimbursement, or the provision of any in-kind benefit is determined to be subject to Section 409A (and not exempt pursuant to Treasury Regulation § 1.409A-1(b)(9)(v)(A) or (C) or otherwise), the amount of any such

indemnification payment or expenses eligible for reimbursement, or the provision of any in-kind benefit, in one calendar year shall not affect the indemnification payment or provision of in-kind benefits or expenses eligible for reimbursement in any other calendar year (except for any life-time or other aggregate limitation applicable to medical expenses), and in no event shall any indemnification payment or expenses be reimbursed after the last day of the calendar year following the calendar year in which you incurred such indemnification payment or expenses, and in no event shall any right to indemnification payment or reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for another benefit.

16. General Provisions. This Agreement constitutes the complete, final and exclusive embodiment of the entire agreement between you and the Company with regard to its subject matter. It is entered into without reliance on any promise or representation, written or oral, other than those expressly contained herein, and it supersedes any other such promises, warranties or representations. This Agreement may not be modified or amended except in a writing signed by both you and a duly authorized officer of the Company. This Agreement will bind the heirs, personal representatives, successors and assigns of both you and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns. If any provision of this Agreement is determined to be invalid or unenforceable, in whole or in part, this determination will not affect any other provision of this Agreement and the provision in question will be modified so as to be rendered enforceable. This Agreement will be deemed to have been entered into and will be construed and enforced in accordance with the laws of the State of New York as applied to contracts made and to be performed entirely within New York. Any dispute arising out of this Agreement shall be brought in the state or federal courts of the State of New York, which shall serve as the exclusive forum for any such dispute. Any ambiguity in this

Agreement shall not be construed against either party as the drafter. Any waiver of a breach of this Agreement shall be in writing and shall not be deemed to be a waiver of any successive breach. This Agreement may be executed in counterparts and facsimile signatures will suffice as original signatures.

If this Agreement is acceptable to you, please sign below and return the original to me.

We wish you the best in your future endeavors.

Sincerely,

Everyday Health, Inc.

By:	/s/ Alan Shapiro
	Name:	Alan Shapiro
	Title:	EVP & General Counsel

I have read, understand and agree fully to the foregoing Agreement:

/s/ Paul Slavin
Paul Slavin

EX-31.1 6 c81206_ex31-1.htm

Exhibit 31.1

Certification of Chief Executive Officer Pursuant to
Rule 13a-14(a) under the Securities Exchange Act
of 1934, as Adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002

I, Benjamin Wolin, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Everyday Health, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(c)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 12, 2015	By:	/s/ Benjamin Wolin
		Benjamin Wolin
		Chief Executive Officer

EX-31.2 7 c81206_ex31-2.htm

Exhibit 31.2

Certification of Chief Financial Officer Pursuant to
Rule 13a-14(a) under the Securities Exchange Act
of 1934, as Adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002

I, Brian Cooper, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Everyday Health, Inc.;

	(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	(b)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	(c)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

	(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 12, 2015	By:	/s/ Brian Cooper
		Brian Cooper
		Executive Vice President & Chief Financial Officer

EX-32.1 8 c81206_ex32-1.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Everyday Health, Inc. (the “Company”) for the quarter ended March 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Benjamin Wolin, as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge, based upon a review of the Report:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Benjamin Wolin
Name: Benjamin Wolin
Title: Chief Executive Officer
Date: May 12, 2015

EX-32.2 9 c81206_ex32-2.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Everyday Health, Inc. (the “Company”) for the quarter ended March 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Brian Cooper, as Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge, based upon a review of the Report:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Brian Cooper
Name: Brian Cooper
Title: Chief Financial Officer
Date: May 12, 2015

EX-101.INS 10 evdy-20150331.xml 0001358483 2015-03-31 0001358483 2014-12-31 0001358483 2015-01-01 2015-03-31 0001358483 2014-01-01 2014-03-31 0001358483 us-gaap:CommonStockMember 2014-12-31 0001358483 us-gaap:PreferredStockMember 2014-12-31 0001358483 us-gaap:TreasuryStockMember 2014-12-31 0001358483 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0001358483 us-gaap:RetainedEarningsMember 2014-12-31 0001358483 us-gaap:CommonStockMember 2015-01-01 2015-03-31 0001358483 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-03-31 0001358483 us-gaap:RetainedEarningsMember 2015-01-01 2015-03-31 0001358483 us-gaap:CommonStockMember 2015-03-31 0001358483 us-gaap:PreferredStockMember 2015-03-31 0001358483 us-gaap:TreasuryStockMember 2015-03-31 0001358483 us-gaap:AdditionalPaidInCapitalMember 2015-03-31 0001358483 us-gaap:RetainedEarningsMember 2015-03-31 0001358483 evdy:FormerRevolvingCreditFacilityMember 2014-01-01 2014-03-31 0001358483 evdy:FormerTermLoanMember 2014-01-01 2014-03-31 0001358483 us-gaap:RevolvingCreditFacilityMember 2015-01-01 2015-03-31 0001358483 us-gaap:RevolvingCreditFacilityMember 2014-01-01 2014-03-31 0001358483 evdy:TermLoanFacilityMember 2015-01-01 2015-03-31 0001358483 evdy:TermLoanFacilityMember 2014-01-01 2014-03-31 0001358483 2013-12-31 0001358483 2014-03-31 0001358483 2015-05-08 0001358483 us-gaap:IPOMember 2014-04-01 2014-04-30 0001358483 us-gaap:IPOMember us-gaap:CommonStockMember 2014-04-01 2014-04-30 0001358483 us-gaap:IPOMember 2014-04-30 0001358483 us-gaap:IPOMember us-gaap:CommonStockMember 2014-04-30 0001358483 us-gaap:IPOMember us-gaap:SeriesGPreferredStockMember 2014-04-30 0001358483 us-gaap:MinimumMember 2015-01-01 2015-03-31 0001358483 us-gaap:MaximumMember 2015-01-01 2015-03-31 0001358483 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2015-01-01 2015-03-31 0001358483 evdy:WebsiteAndMobileApplicationsMember 2015-01-01 2015-03-31 0001358483 evdy:CambridgeMember 2015-03-31 0001358483 evdy:CambridgeMember 2015-01-01 2015-03-31 0001358483 evdy:CambridgeMember evdy:ClosingMember 2015-01-01 2015-03-31 0001358483 evdy:CambridgeMember evdy:RemainderMember 2015-01-01 2015-03-31 0001358483 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2015-01-01 2015-03-31 0001358483 evdy:DDMember 2015-03-31 0001358483 evdy:CambridgeMember us-gaap:CustomerRelationshipsMember 2015-03-31 0001358483 evdy:CambridgeMember us-gaap:TradeNamesMember 2015-03-31 0001358483 evdy:CambridgeMember us-gaap:CustomerRelationshipsMember 2015-01-01 2015-03-31 0001358483 evdy:CambridgeMember us-gaap:TradeNamesMember 2015-01-01 2015-03-31 0001358483 us-gaap:CustomerRelationshipsMember 2015-03-31 0001358483 us-gaap:CustomerRelationshipsMember 2015-01-01 2015-03-31 0001358483 us-gaap:CustomerRelationshipsMember 2014-12-31 0001358483 us-gaap:CustomerRelationshipsMember 2014-10-01 2014-12-31 0001358483 us-gaap:TradeNamesMember 2015-03-31 0001358483 us-gaap:TradeNamesMember 2015-01-01 2015-03-31 0001358483 us-gaap:TradeNamesMember 2014-12-31 0001358483 us-gaap:TradeNamesMember 2014-10-01 2014-12-31 0001358483 us-gaap:OtherIntangibleAssetsMember 2015-03-31 0001358483 us-gaap:OtherIntangibleAssetsMember 2015-01-01 2015-03-31 0001358483 us-gaap:OtherIntangibleAssetsMember 2014-12-31 0001358483 us-gaap:OtherIntangibleAssetsMember 2014-10-01 2014-12-31 0001358483 us-gaap:RevolvingCreditFacilityMember 2014-03-31 0001358483 evdy:TermLoanFacilityMember 2014-03-31 0001358483 evdy:DDMember us-gaap:RevolvingCreditFacilityMember 2014-11-30 0001358483 evdy:DDMember evdy:TermLoanFacilityMember 2014-11-01 0001358483 evdy:DDMember evdy:TermLoanFacilityMember 2014-11-30 0001358483 evdy:TermLoanFacilityMember 2015-03-01 0001358483 evdy:TermLoanFacilityMember 2015-03-31 0001358483 us-gaap:RevolvingCreditFacilityMember 2015-03-31 0001358483 evdy:CreditFacilityMember us-gaap:MinimumMember 2015-01-01 2015-03-31 0001358483 evdy:CreditFacilityMember us-gaap:MaximumMember 2015-01-01 2015-03-31 0001358483 evdy:CreditFacilityMember 2015-01-01 2015-03-31 0001358483 2014-01-01 2014-12-31 0001358483 2014-04-30 0001358483 evdy:Plan2014Member 2015-03-31 0001358483 evdy:Plan2014Member 2015-01-01 2015-03-31 0001358483 evdy:PerformanceRSUMember 2015-01-01 2015-03-31 0001358483 us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-03-31 0001358483 us-gaap:RestrictedStockUnitsRSUMember 2015-03-31 0001358483 us-gaap:EmployeeStockMember 2014-03-27 0001358483 us-gaap:EmployeeStockMember 2015-01-01 2015-03-31 0001358483 us-gaap:EmployeeStockMember 2015-03-31 0001358483 evdy:StockOptionActivityMember 2014-12-31 0001358483 evdy:StockOptionActivityMember 2014-12-31 2014-12-31 0001358483 evdy:StockOptionActivityMember 2015-01-01 2015-03-31 0001358483 evdy:StockOptionActivityMember 2015-03-31 0001358483 evdy:CommonStockWarrantMember 2015-01-01 2015-03-31 0001358483 evdy:CommonStockWarrantMember 2014-01-01 2014-03-31 0001358483 evdy:PreferredStockWarrantMember 2015-01-01 2015-03-31 0001358483 evdy:PreferredStockWarrantMember 2014-01-01 2014-03-31 0001358483 us-gaap:RedeemableConvertiblePreferredStockMember 2015-01-01 2015-03-31 0001358483 us-gaap:RedeemableConvertiblePreferredStockMember 2014-01-01 2014-03-31 0001358483 evdy:OptionsMember 2015-01-01 2015-03-31 0001358483 evdy:OptionsMember 2014-01-01 2014-03-31 0001358483 us-gaap:RestrictedStockUnitsRSUMember 2015-01-01 2015-03-31 0001358483 us-gaap:EmployeeStockMember 2015-01-01 2015-03-31 0001358483 us-gaap:DeferredCompensationShareBasedPaymentsMember 2014-12-31 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period. RSUs granted during the three months ended March 31, 2015 includes the grant of 40,000 units of performance-based RSUs that are dependent upon the Company meeting certain performance criteria. Upon closing of the IPO on April 2, 2014, all of the Company's outstanding redeemable convertible preferred stock automatically converted into shares of common stock. In addition, the outstanding warrants to purchase redeemable convertible preferred stock automatically converted into warrants to purchase common stock, or were automatically exercised upon closing of the IPO.

48530000

50729000

57611000

68007000

656000

9377000

5529000

116174000

124921000

25847000

25502000

143165000

127115000

43777000

30716000

5811000

5237000

334774000

313491000

25060000

31722000

8821000

6740000

2625000

3000000

8977000

965000

45483000

42427000

110125000

87000000

6912000

6673000

4016000

4105000

315000

314000

55000

295136000

292117000

-127158000

-119090000

168238000

173286000

334774000

313491000

523000

637000

0.01

10000000

0.01

31562028

31489196

31562028

31489196

90000000

36338000

32692000

4836000

4813000

41174000

37505000

14076000

11421000

12725000

10220000

12602000 10762000

9804000

6595000

49207000

38998000

-8033000

-1493000

-953000

-1863000

-4114000

-8986000

-7470000

-918000

289000

-8068000

-7759000

-0.26

-1.44

31525559

5403846

31489196

314000

-55000

292117000

-119090000

72832

1000

528000

529000

2491000

-8068000

31562028

315000

-55000

295136000

-127158000

4662000

3558000

215000

2491000

1069000

107000 4169000

241000

14802000

10935000

-3641000

-2645000

-9322000

-8610000

1884000

568000

32000

17000

307000

3205000

2080000

-3005000

-3476000

152000

-24747000

-40000

-5000

-27712000

-3319000

460000

1172000

-30000000

-41333000

25000000

32300000

-10000000

8500000

40000000

-750000

-180000

-145000

722000

2227000

22308000

-233000

-2199000

-1472000

16242000

14770000

1253000

2262000

10000

16000

919000

8000000 111000 1131000

193000

Everyday Health, Inc. 10-Q --12-31 31674117 false 0001358483 Yes No Non-accelerated Filer No 2015 Q1 2015-03-31

1. Business Everyday Health, Inc. (the “Company”) operates a portfolio of health and wellness websites and mobile applications that provides consumers, healthcare professionals, advertisers and partners with content and advertising-based services. The Company was incorporated in the State of Delaware in January 2002 as Agora Media Inc., and changed its name to Waterfront Media Inc. in January 2004. In January 2010, the Company changed its name to Everyday Health, Inc. to better align its corporate identity with the Everyday Health brand.

2. Significant Accounting Policies Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The results of operations for companies acquired are included in the consolidated financial statements from the effective date of the acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation. Interim Financial Statements The accompanying interim unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) on the same basis as the audited consolidated financial statements for the year ended December 31, 2014 and, in the opinion of management, include all adjustments of a normal recurring nature considered necessary to present fairly the Company’s financial position, results of operations and cash flows for the interim periods ended March 31, 2015 and 2014. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015 or any other future periods, due to seasonality and other business factors. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted under the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto for the year ended December 31, 2014, which are included in the Company’s Annual Report on Form 10-K filed with the SEC on March 5, 2015. Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, current business factors and other available information. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition and deferred revenue, allowance for doubtful accounts, internal software development costs and website development costs, valuation of long-lived assets, goodwill and other intangible assets, income taxes and stock-based compensation. Reclassifications Certain reclassifications have been made to the prior period financial statements to conform to the March 31, 2015 presentation. Initial Public Offering On April 2, 2014, the Company closed its initial public offering of common stock (“IPO”). The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters’ exercise of their over-allotment option, resulted in net proceeds of $70,622, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling $8,848. As a result of the IPO, the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, all of the Company’s redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision. Revenue Recognition and Deferred Revenue The Company generates its revenue primarily through advertising and sponsorships, and premium services, including subscriptions and licensing fees. Advertising revenue is recognized in the period in which the advertisement is delivered. Revenue from sponsorships is recognized over the period the Company substantially satisfies its contractual obligations as required under the respective sponsorship agreements. When contractual arrangements contain multiple elements, revenue is allocated to each element based on its relative fair value determined using prices charged when elements are sold separately. In instances where individual deliverables are not sold separately, or when third-party evidence is not available, fair value is determined based on management’s best estimate of selling price. Subscriptions are generally paid in advance on a monthly, quarterly or annual basis. Subscription revenue, after deducting refunds and charge-backs, is recognized on a straight-line basis ratably over the subscription periods. Licensing revenue is generally recognized over the life of the contract. Deferred revenue relates to: (i) subscription fees for which amounts have been collected but for which revenue has not been recognized, and (ii) advertising and sponsorship fees and licensing fees billed in advance of when the revenue is to be earned. Cost of Revenues Cost of revenues consists principally of the expenses associated with aggregating the total audience across the Company’s portfolio of websites, including (i) royalty expenses for licensing content for certain websites within the portfolio and for the portion of advertising revenue the Company pays to the owners of certain other websites within the portfolio, and (ii) media costs associated with audience aggregation activities. Cost of revenues also includes credit card fees and service charges associated with subscription fees for the Company’s premium services. Media costs consist primarily of fees paid to online publishers, internet search companies and other media channels for search engine and database marketing, and display and television advertising. These media activities are attributable to revenue-generating and audience aggregation events, designed to increase the audience to the websites the Company operates, increase the number of subscribers to premium services and grow the Company’s registered user base. Other Expense There were no charges reflected as other expense in the three months ended March 31, 2015. In connection with the refinancing of its credit facilities in March 2014, the Company wrote-off unamortized deferred financing costs totaling $2,845 and incurred prepayment fees of $1,016, which, together with the mark-to-market adjustment on certain preferred stock warrants of $253, is reflected as other expense in the accompanying consolidated statements of operations for the three months ended March 31, 2014. Comprehensive Income The Company has no items of other comprehensive income, and accordingly net loss is equal to comprehensive loss for all periods presented. Fair Value of Financial Instruments Due to their short-term maturities, the carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value. Cash equivalents principally consist of the Company’s investment in highly liquid money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value of the Company’s debt approximates the recorded amounts as the interest rates on the credit facilities are based on market interest rates. Property and Equipment Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from three to five years. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the improvement. The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of payroll and related benefits, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years. The Company also incurs costs to develop its websites and mobile applications. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of third-party consultants and related charges, and the costs of content determined to provide a future economic benefit, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years. The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s property and equipment during the three months ended March 31, 2015 and 2014. Segment Information The Company and its subsidiaries are organized in a single operating segment, providing online health solutions, and the Company also has one reportable segment. Substantially all of the Company’s revenues are derived from U.S. sources. Recent Accounting Standards In April 2014, the FASB issued amended guidance for reporting discontinued operations. Under the new guidance, only disposals that represent a strategic shift having a material impact on an entity’s operations and financial results shall be reported as discontinued operations, with expanded disclosures. This amendment will be effective for the first annual reporting period beginning after December 15, 2015. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements. In May 2014, the FASB issued amended guidance for revenue recognition. This amendment provides a comprehensive new revenue recognition model. The core principle of the guidance is to recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. As currently issued, this amendment is effective for fiscal years beginning after December 15, 2016, and for interim periods within those fiscal years. Early adoption is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company has not yet selected a transition method and is currently evaluating the effect that the new standard will have on the consolidated financial statements and related disclosures. In June 2014, the FASB issued updated guidance on stock compensation accounting requiring that a performance target that affects vesting and could be achieved after the requisite service period should be treated as a performance condition. Current GAAP does not contain explicit guidance on how to account for such share-based payments. This updated guidance is effective for fiscal years beginning after December 15, 2015, and for interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements. In April 2015, the FASB issued updated guidance on the presentation of debt issuance costs in financial statements. The new guidance requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs will continue to be reported as interest expense. This guidance will be effective for the Company beginning in the first quarter of 2016 on a retrospective basis for all periods presented, with early adoption optional. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The results of operations for companies acquired are included in the consolidated financial statements from the effective date of the acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation.

Interim Financial Statements The accompanying interim unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) on the same basis as the audited consolidated financial statements for the year ended December 31, 2014 and, in the opinion of management, include all adjustments of a normal recurring nature considered necessary to present fairly the Company’s financial position, results of operations and cash flows for the interim periods ended March 31, 2015 and 2014. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015 or any other future periods, due to seasonality and other business factors. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted under the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto for the year ended December 31, 2014, which are included in the Company’s Annual Report on Form 10-K filed with the SEC on March 5, 2015.

Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, current business factors and other available information. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition and deferred revenue, allowance for doubtful accounts, internal software development costs and website development costs, valuation of long-lived assets, goodwill and other intangible assets, income taxes and stock-based compensation.

Reclassifications Certain reclassifications have been made to the prior period financial statements to conform to the March 31, 2015 presentation.

Initial Public OfferingOn April 2, 2014, the Company closed its initial public offering of common stock (“IPO”). The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters’ exercise of their over-allotment option, resulted in net proceeds of $70,622, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling $8,848. As a result of the IPO, the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, all of the Company’s redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision.

70622000

8848000

5676414

14.00

18457235

577055

Revenue Recognition and Deferred Revenue The Company generates its revenue primarily through advertising and sponsorships, and premium services, including subscriptions and licensing fees. Advertising revenue is recognized in the period in which the advertisement is delivered. Revenue from sponsorships is recognized over the period the Company substantially satisfies its contractual obligations as required under the respective sponsorship agreements. When contractual arrangements contain multiple elements, revenue is allocated to each element based on its relative fair value determined using prices charged when elements are sold separately. In instances where individual deliverables are not sold separately, or when third-party evidence is not available, fair value is determined based on management’s best estimate of selling price. Subscriptions are generally paid in advance on a monthly, quarterly or annual basis. Subscription revenue, after deducting refunds and charge-backs, is recognized on a straight-line basis ratably over the subscription periods. Licensing revenue is generally recognized over the life of the contract. Deferred revenue relates to: (i) subscription fees for which amounts have been collected but for which revenue has not been recognized, and (ii) advertising and sponsorship fees and licensing fees billed in advance of when the revenue is to be earned.

Cost of Revenues Cost of revenues consists principally of the expenses associated with aggregating the total audience across the Company’s portfolio of websites, including (i) royalty expenses for licensing content for certain websites within the portfolio and for the portion of advertising revenue the Company pays to the owners of certain other websites within the portfolio, and (ii) media costs associated with audience aggregation activities. Cost of revenues also includes credit card fees and service charges associated with subscription fees for the Company’s premium services. Media costs consist primarily of fees paid to online publishers, internet search companies and other media channels for search engine and database marketing, and display and television advertising. These media activities are attributable to revenue-generating and audience aggregation events, designed to increase the audience to the websites the Company operates, increase the number of subscribers to premium services and grow the Company’s registered user base.

Other Expense There were no charges reflected as other expense in the three months ended March 31, 2015. In connection with the refinancing of its credit facilities in March 2014, the Company wrote-off unamortized deferred financing costs totaling $2,845 and incurred prepayment fees of $1,016, which, together with the mark-to-market adjustment on certain preferred stock warrants of $253, is reflected as other expense in the accompanying consolidated statements of operations for the three months ended March 31, 2014.

2845000

1016000

253000

Comprehensive Income The Company has no items of other comprehensive income, and accordingly net loss is equal to comprehensive loss for all periods presented.

Fair Value of Financial Instruments Due to their short-term maturities, the carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value. Cash equivalents principally consist of the Company’s investment in highly liquid money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value of the Company’s debt approximates the recorded amounts as the interest rates on the credit facilities are based on market interest rates.

Property and Equipment Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from three to five years. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the improvement. The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of payroll and related benefits, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years. The Company also incurs costs to develop its websites and mobile applications. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of third-party consultants and related charges, and the costs of content determined to provide a future economic benefit, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years. The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s property and equipment during the three months ended March 31, 2015 and 2014.

three

five

three

Segment Information The Company and its subsidiaries are organized in a single operating segment, providing online health solutions, and the Company also has one reportable segment. Substantially all of the Company’s revenues are derived from U.S. sources

Recent Accounting Standards In April 2014, the FASB issued amended guidance for reporting discontinued operations. Under the new guidance, only disposals that represent a strategic shift having a material impact on an entity’s operations and financial results shall be reported as discontinued operations, with expanded disclosures. This amendment will be effective for the first annual reporting period beginning after December 15, 2015. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements. In May 2014, the FASB issued amended guidance for revenue recognition. This amendment provides a comprehensive new revenue recognition model. The core principle of the guidance is to recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. As currently issued, this amendment is effective for fiscal years beginning after December 15, 2016, and for interim periods within those fiscal years. Early adoption is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company has not yet selected a transition method and is currently evaluating the effect that the new standard will have on the consolidated financial statements and related disclosures. In June 2014, the FASB issued updated guidance on stock compensation accounting requiring that a performance target that affects vesting and could be achieved after the requisite service period should be treated as a performance condition. Current GAAP does not contain explicit guidance on how to account for such share-based payments. This updated guidance is effective for fiscal years beginning after December 15, 2015, and for interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements. In April 2015, the FASB issued updated guidance on the presentation of debt issuance costs in financial statements. The new guidance requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs will continue to be reported as interest expense. This guidance will be effective for the Company beginning in the first quarter of 2016 on a retrospective basis for all periods presented, with early adoption optional. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

3. Acquisitions In March 2015, the Company acquired 100% of the limited liability company membership interests of Cambridge BioMarketing Group, LLC (“Cambridge”), a provider of strategic launch and marketing solutions for orphan and rare disease products, for a total purchase price of $32,273, of which $24,273 was paid in cash at closing. The remaining $8,000 obligation is comprised of convertible notes, which will either convert into shares of the Company’s common stock or be repaid in cash by May 15, 2015, at the discretion of the Company. The total purchase price is subject to any working capital adjustments that may arise. As of March 31, 2015, the $8,000 unpaid purchase price obligation is included in other current liabilities in the accompanying consolidated balance sheet. In addition to the purchase price described above, the former members of Cambridge are eligible to receive up to an additional $5,000 in cash based on Cambridge’s achievement of certain revenue and Adjusted EBITDA targets for 2015. This earn-out payment is contingent upon the continued employment with the Company of certain former members of Cambridge at the time the earn-out payment is due to be paid in the first quarter of 2016. The Company records any such earn-out as compensation expense for the applicable period. The Company expects that the acquisition will broaden its strategic marketing and communications solutions to pharmaceutical brands targeting orphan and rare disease segments in the market. The acquisition was accounted for as a business combination and, accordingly, the purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed on a preliminary basis based on the respective fair values. The results of operations of Cambridge have been included in the consolidated financial statements of the Company from March 20, 2015, the closing date of the acquisition. For the three months ended March 31, 2015, acquisition-related costs of $169 are included in general and administrative expenses in the accompanying consolidated statement of operations. The following table summarizes the preliminary allocation of the assets acquired and liabilities assumed based on their fair values on the acquisition date. The fair values presented are based on a preliminary valuation and are subject to adjustment during a measurement period of up to one year from the acquisition date. The measurement period provides the Company with the ability to adjust the fair values of acquired assets for new information that is obtained about circumstances that existed as of the acquisition date. <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="width: 85%; text-align: left; text-indent: -10pt; padding-left: 10pt; border-top: Black 1px solid"> Accounts receivable </td> <td style="width: 3%; border-top: Black 1px solid">   </td> <td style="width: 1%; text-align: left; border-top: Black 1px solid"> $ </td> <td style="width: 10%; text-align: right; border-top: Black 1px solid"> 4,406 </td> <td style="width: 1%; text-align: left; border-top: Black 1px solid">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Other current assets </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 137 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Property and equipment </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 783 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt"> Goodwill </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 15,576 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Intangible assets </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 14,280 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Accounts payable and accrued expenses </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> (2,659 </td> <td style="text-align: left"> ) </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Deferred revenue </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> (197 </td> <td style="text-align: left"> ) </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Other current liabilities </td> <td>   </td> <td style="text-align: left; border-bottom: Black 1px solid">   </td> <td style="text-align: right; border-bottom: Black 1px solid"> (53 </td> <td style="text-align: left"> ) </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt; border-bottom: Black 1px solid"> Total consideration paid </td> <td style="border-bottom: Black 1px solid">   </td> <td style="text-align: left; border-bottom: Black 1px solid"> $ </td> <td style="text-align: right; border-bottom: Black 1px solid"> 32,273 </td> <td style="text-align: left; border-bottom: Black 1px solid">   </td> </tr> <tr style="vertical-align: bottom"> <td style="text-indent: -10pt; padding-left: 10pt">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> </tr> </table>

1.00

Cambridge BioMarketing Group, LLC

32273000

24273000 8000000 5000000

169000

The following table summarizes the preliminary allocation of the assets acquired and liabilities assumed based on their fair values on the acquisition date. The fair values presented are based on a preliminary valuation and are subject to adjustment during a measurement period of up to one year from the acquisition date. The measurement period provides the Company with the ability to adjust the fair values of acquired assets for new information that is obtained about circumstances that existed as of the acquisition date. <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="width: 85%; text-align: left; text-indent: -10pt; padding-left: 10pt; border-top: Black 1px solid"> Accounts receivable </td> <td style="width: 3%; border-top: Black 1px solid">   </td> <td style="width: 1%; text-align: left; border-top: Black 1px solid"> $ </td> <td style="width: 10%; text-align: right; border-top: Black 1px solid"> 4,406 </td> <td style="width: 1%; text-align: left; border-top: Black 1px solid">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Other current assets </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 137 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Property and equipment </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 783 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -10pt; padding-left: 10pt"> Goodwill </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 15,576 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Intangible assets </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 14,280 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Accounts payable and accrued expenses </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> (2,659 </td> <td style="text-align: left"> ) </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Deferred revenue </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> (197 </td> <td style="text-align: left"> ) </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Other current liabilities </td> <td>   </td> <td style="text-align: left; border-bottom: Black 1px solid">   </td> <td style="text-align: right; border-bottom: Black 1px solid"> (53 </td> <td style="text-align: left"> ) </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt; border-bottom: Black 1px solid"> Total consideration paid </td> <td style="border-bottom: Black 1px solid">   </td> <td style="text-align: left; border-bottom: Black 1px solid"> $ </td> <td style="text-align: right; border-bottom: Black 1px solid"> 32,273 </td> <td style="text-align: left; border-bottom: Black 1px solid">   </td> </tr> <tr style="vertical-align: bottom"> <td style="text-indent: -10pt; padding-left: 10pt">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> </tr> </table>

4406000

137000

783000

15576000

14280000

-2659000

-197000

-53000

4. Goodwill and Other Intangible Assets During the three months ended March 31, 2015, goodwill of $15,576 and definite-lived intangible assets of $14,280 were recorded in connection with the Cambridge acquisition (see Note 3). Additionally, there was $474 of goodwill recorded during the three months ended March 31, 2015 for a working capital purchase price adjustment related to a November 2014 acquisition. The preliminary value of the intangible assets acquired in connection with the Cambridge acquisition consist of customer relationships of $8,810 and trade names of $5,470, each of which has an estimated useful life of 10 years. The carrying value of the Company’s goodwill was $143,165 as of March 31, 2015. Goodwill is tested for impairment on an annual basis as of October 1, and whenever events or circumstances indicate that the carrying value of the asset may not be recoverable. Application of the impairment test requires judgment and results in impairment being recognized if the carrying value of the asset exceeds its fair value. No indicators of impairment were noted during or since the Company’s last evaluation of goodwill at October 1, 2014. Similarly, the Company’s definite-lived intangible assets with a net carrying value of $43,777 at March 31, 2015, consisting principally of trade names and customer relationships, is reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s definite-lived intangible assets during the three months ended March 31, 2015 and 2014. Definite-lived intangible assets consist of the following: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-top: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-top: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="14" style="border-top: black 1px solid; border-bottom: black 1px solid; text-align: center"> March 31, 2015 </td> <td style="border-top: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-top: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="14" style="border-top: black 1px solid; border-bottom: black 1px solid; text-align: center"> December 31, 2014 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Gross carrying amount </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Accumulated amortization </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Net carrying amount </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Weighted- average remaining useful life (1) </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Gross carrying amount </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Accumulated amortization </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Net carrying amount </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Weighted- average remaining useful life (1) </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="width: 23%"> Customer relationships </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt"> $ </td> <td style="width: 5%; padding-right: 0.8pt; text-align: right"> 36,110 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt"> $ </td> <td style="width: 8%; padding-right: 0.8pt; text-align: right"> (11,775) </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt"> $ </td> <td style="width: 6%; padding-right: 0.8pt; text-align: right"> 24,335 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 3%; padding-right: 0.8pt">   </td> <td style="width: 5%; padding-right: 0.8pt; text-align: right"> 9.5 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt"> $ </td> <td style="width: 5%; padding-right: 0.8pt; text-align: right"> 27,300 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt"> $ </td> <td style="width: 8%; padding-right: 0.8pt; text-align: right"> (11,247) </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt"> $ </td> <td style="width: 5%; padding-right: 0.8pt; text-align: right"> 16,053 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 3%; padding-right: 0.8pt">   </td> <td style="width: 5%; padding-right: 0.8pt; text-align: right"> 9.5 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> Trade names </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 24,085 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> (4,922) </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 19,163 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 7.3 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 18,615 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> (4,370) </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 14,245 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 6.5 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td> Other intangibles </td> <td style="padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 3,900 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> (3,621) </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 279 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 0.5 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 3,900 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> (3,482) </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 418 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 0.7 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: black 1px solid"> Total </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 64,095 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">  $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> (20,318) </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 43,777 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 49,815 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> (19,099) </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 30,716 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> </tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%; text-align: right; vertical-align: top"> (1) </td> <td style="width: 2%; padding-right: 0.8pt">   </td> <td style="width: 91%; padding-right: 0.8pt"> The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period. </td> </tr> </table> Amortization expense relating to the definite-lived intangible assets totaled $1,219 and $545 for the three months ended March 31, 2015 and 2014, respectively, and is included in general and administrative expense in the accompanying consolidated statements of operations. Future amortization expense of the intangible assets is estimated to be as follows: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1px solid; padding-right: 0.8pt; border-top: Black 0.5pt solid"> Year ending December 31: </td> <td style="border-bottom: Black 1px solid; padding-right: 0.8pt; border-top: Black 0.5pt solid">   </td> <td colspan="2" style="border-bottom: Black 1px solid; padding-right: 1.8pt; text-align: right; border-top: Black 0.5pt solid">   </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="width: 85%"> 2015 (April 1st to December 31st) </td> <td style="width: 3%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt"> $ </td> <td style="width: 10%; padding-right: 0.8pt; text-align: right"> 4,527 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> 2016 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 5,373 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td> 2017 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 5,365 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> 2018 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 5,176 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td> 2019 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 5,176 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> Thereafter </td> <td style="padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 18,160 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="border-bottom: black 1px solid"> Total </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 43,777 </td> <td style="padding-right: 0.8pt">   </td> </tr> </table>

14280000

474000

8810000

5470000

P10Y

43777000

1219000

545000

Definite-lived intangible assets consist of the following: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-top: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-top: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="14" style="border-top: black 1px solid; border-bottom: black 1px solid; text-align: center"> March 31, 2015 </td> <td style="border-top: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-top: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="14" style="border-top: black 1px solid; border-bottom: black 1px solid; text-align: center"> December 31, 2014 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Gross carrying amount </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Accumulated amortization </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Net carrying amount </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Weighted- average remaining useful life (1) </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Gross carrying amount </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Accumulated amortization </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Net carrying amount </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td colspan="2" style="border-bottom: black 1px solid; text-align: center"> Weighted- average remaining useful life (1) </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="width: 23%"> Customer relationships </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt"> $ </td> <td style="width: 5%; padding-right: 0.8pt; text-align: right"> 36,110 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt"> $ </td> <td style="width: 8%; padding-right: 0.8pt; text-align: right"> (11,775) </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt"> $ </td> <td style="width: 6%; padding-right: 0.8pt; text-align: right"> 24,335 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 3%; padding-right: 0.8pt">   </td> <td style="width: 5%; padding-right: 0.8pt; text-align: right"> 9.5 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt"> $ </td> <td style="width: 5%; padding-right: 0.8pt; text-align: right"> 27,300 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt"> $ </td> <td style="width: 8%; padding-right: 0.8pt; text-align: right"> (11,247) </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt"> $ </td> <td style="width: 5%; padding-right: 0.8pt; text-align: right"> 16,053 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 3%; padding-right: 0.8pt">   </td> <td style="width: 5%; padding-right: 0.8pt; text-align: right"> 9.5 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> Trade names </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 24,085 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> (4,922) </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 19,163 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 7.3 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 18,615 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> (4,370) </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 14,245 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 6.5 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td> Other intangibles </td> <td style="padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 3,900 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> (3,621) </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 279 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 0.5 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 3,900 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> (3,482) </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 418 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 0.7 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: black 1px solid"> Total </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 64,095 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">  $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> (20,318) </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 43,777 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 49,815 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> (19,099) </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 30,716 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> </tr> </table><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 7%; text-align: right; vertical-align: top"> (1) </td> <td style="width: 2%; padding-right: 0.8pt">   </td> <td style="width: 91%; padding-right: 0.8pt"> The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period. </td> </tr> </table>

36110000

-11775000

24335000

P9Y6M

27300000

-11247000

16053000

P9Y6M

24085000

-4922000

19163000

P7Y109D

18615000

-4370000

14245000

P6Y6M

3900000

-3621000

279000

P6M

3900000

-3482000

418000

P255D

64095000

-20318000

49815000

-19099000

30716000

Future amortization expense of the intangible assets is estimated to be as follows: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1px solid; padding-right: 0.8pt; border-top: Black 0.5pt solid"> Year ending December 31: </td> <td style="border-bottom: Black 1px solid; padding-right: 0.8pt; border-top: Black 0.5pt solid">   </td> <td colspan="2" style="border-bottom: Black 1px solid; padding-right: 1.8pt; text-align: right; border-top: Black 0.5pt solid">   </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="width: 85%"> 2015 (April 1st to December 31st) </td> <td style="width: 3%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt"> $ </td> <td style="width: 10%; padding-right: 0.8pt; text-align: right"> 4,527 </td> <td style="width: 1%; padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> 2016 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 5,373 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td> 2017 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 5,365 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> 2018 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 5,176 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td> 2019 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 5,176 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> Thereafter </td> <td style="padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 18,160 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="border-bottom: black 1px solid"> Total </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 43,777 </td> <td style="padding-right: 0.8pt">   </td> </tr> </table>

4527000

5373000

5365000

5176000

18160000

5. Long-Term Debt The Company entered into a credit facility agreement with a syndicated bank group in March 2014, which replaced its then-existing credit facility. The new credit facility consisted of a revolver (“Revolver”) with a maximum borrowing limit of $35,000 and a term loan (“Term Loan”) of $40,000. In November 2014, in connection with the acquisition of DoctorDirectory.com, Inc., the credit facility was amended and restated to, among other things, (i) increase the maximum borrowing limit of the Revolver from $35,000 to $55,000; (ii) increase the Term Loan from $39,000 outstanding as of such date to $60,000; (iii) extend the maturity date of the Term Loan and the due date of principal on the Revolver from March 2019 to November 2019; and (iv) effect certain modifications to the covenants and terms set forth in the credit facility agreement. In March 2015, the amended and restated credit facility was amended twice (as amended, the “Credit Facility”) to, among other things, (i) consent to the acquisition of Cambridge, (ii) increase the Term Loan from $59,250 outstanding as of such date to $67,750; (iii) increase the maximum borrowing limit of the Revolver from $55,000 to $82,250; and (iv) effect certain modifications to the covenants and terms set forth in the Credit Facility agreement. All other materials terms of the Credit Facility, including the applicable interest rates and maturity dates, remained unchanged by the March 2015 amendments. The repayment terms of the Revolver provide for quarterly interest payments, with the principal being due in full in November 2019. The repayment terms of the Term Loan provide for quarterly interest and principal payments, with a maturity date of November 2019. The interest rate on the Credit Facility is equal to the London Inter-Bank Offered Rate, or LIBOR, plus a variable rate ranging from 2.75% to 4.0% depending on the Company’s consolidated leverage ratio, as defined in the Credit Facility agreement, and there is a 0.50% commitment fee on the unused portion of the Revolver. As of March 31, 2015, the interest rate on the Credit Facility was 3.52%. As of March 31, 2015, there was $67,750 outstanding on the Term Loan and $45,000 outstanding on the Revolver, with $37,250 available to be drawn on the Revolver. The Credit Facility contains certain financial and operational covenants, including requirements to maintain a minimum consolidated fixed charge coverage ratio and a maximum consolidated leverage ratio, each as defined in the Credit Facility agreement, as well as restrictions on certain types of dispositions, mergers and acquisitions, indebtedness, investments, liens and capital expenditures, issuance of capital stock and the Company’s ability to pay dividends. The Credit Facility is secured by a first priority security interest in substantially all of the Company’s existing and future assets. The Company was in compliance with the financial and operational covenants of the Credit Facility as of March 31, 2015. In connection with the March 2014 refinancing and the November 2014 amendment and restatement, the Company incurred financing costs totaling $2,899 and, in connection with the March 2015 amendments, the Company incurred financing costs of $722, each of which have been deferred and amortized using the effective interest rate method through the final maturities of the Credit Facility. Deferred financing costs are recorded in other assets in the accompanying consolidated balance sheets. Amortization expense relating to deferred financing costs is included in interest expense in the accompanying consolidated statements of operations.

35000000

40000000

55000000

39000000 60000000 59250000 67750000

82250000

The interest rate on the Credit Facility is equal to the London Inter-Bank Offered Rate, or LIBOR, plus a variable rate ranging from 2.75% to 4.0% depending on the Company’s consolidated leverage ratio, as defined in the Credit Facility agreement, and there is a 0.50% commitment fee on the unused portion of the Revolver. 0.0275 0.040

0.0050

0.0352 45000000

37250000

2899000

6. Common Stock and Preferred Stock As of March 31, 2015 and December 31, 2014, there were no shares of preferred stock issued and outstanding. The redeemable convertible preferred stock, Series A-G (collectively, the “Preferred Stock”), which was outstanding at the time of the Company’s IPO, fully converted to common stock in connection with the IPO. In March 2014, the Company’s Board of Directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation effecting a 1-for-1.5 reverse stock split of the Company’s issued and outstanding shares of common stock. The par value of the common stock was not adjusted as a result of the reverse stock split. All issued and outstanding common stock and per share amounts contained in the Company’s consolidated financial statements and related notes thereto have been retroactively adjusted to reflect this reverse stock split for all periods presented. The reverse stock split was effected on March 14, 2014. In April 2014, in connection with the closing of the Company’s IPO, the Company filed an amended and restated certificate of incorporation with the Secretary of State of the State of Delaware that amended and restated in its entirety the Company’s certificate of incorporation to, among other things, increase the total number of shares of the Company’s common stock that the Company is authorized to issue to 90,000,000, eliminate all references to the various series of preferred stock that were previously authorized (including certain protective measures held by the various series of preferred stock), and to authorize up to 10,000,000 shares of undesignated preferred stock that may be issued from time to time with terms to be set by the Company’s Board of Directors, which rights could be senior to those of the Company’s common stock.

90000000

10000000

7. Stock-Based Compensation The Company has granted non-statutory stock options and restricted stock unit awards to employees, directors and consultants of the Company pursuant to its 2003 Stock Option Plan, as amended (the “2003 Plan”), or 2014 Equity Incentive Plan (the “2014 Plan”), which became effective immediately upon the signing of the underwriting agreement related to the IPO on March 27, 2014. Upon the effectiveness of the 2014 Plan, no additional awards have been or will be granted under the 2003 Plan. The 2014 Plan provides for the grant of stock options, restricted stock units, and other awards based on the Company’s common stock. As of March 31, 2015, 339,829 shares have been reserved for issuance under the 2014 Plan. The number of shares of common stock reserved for issuance under the 2014 Plan is subject to an automatic increase on January 1 of each year through January 1, 2024, by the lesser of (a) 4% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year and (b) a number of shares determined by the Board of Directors. Stock Options The following table summarizes stock option activity for the three months ended March 31, 2015: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td colspan="2" style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif"> Number of options </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif">   </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif">   </td> <td colspan="2" style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif"> Weighted- average exercise price </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif">   </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif">   </td> <td colspan="2" style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif"> Weighted- average remaining contractual life (years) </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif">   </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif">   </td> <td colspan="2" style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif"> Aggregate intrinsic value </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255); font-family: Times New Roman, Times, Serif"> <td style="width: 43%; font-family: Times New Roman, Times, Serif"> Outstanding at December 31, 2014 </td> <td style="width: 2%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 1%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> 5,893,698 </td> <td style="width: 1%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 2%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 2%; font-family: Times New Roman, Times, Serif"> $ </td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> 9.94 </td> <td style="width: 1%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 2%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 4%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> 6.48 </td> <td style="width: 1%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 2%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 2%; font-family: Times New Roman, Times, Serif">  $ </td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> 29,249 </td> <td style="width: 1%; font-family: Times New Roman, Times, Serif">   </td> </tr> <tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"> <td style="font-family: Times New Roman, Times, Serif"> Granted </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 726,100 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 12.22 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255); font-family: Times New Roman, Times, Serif"> <td style="font-family: Times New Roman, Times, Serif"> Exercised </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> (72,832 </td> <td style="font-family: Times New Roman, Times, Serif"> ) </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 7.27 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> </tr> <tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"> <td style="font-family: Times New Roman, Times, Serif"> Cancelled </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif"> (7,415 </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1px"> ) </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 12.84 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255); font-family: Times New Roman, Times, Serif"> <td style="font-family: Times New Roman, Times, Serif"> Outstanding at March 31, 2015 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif"> 6,539,551 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif"> $ </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 10.23 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 6.65 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif"> $ </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 20,931 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> </tr> <tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif"> Exercisable at March 31, 2015 </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif"> 3,896,925 </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif"> $ </td> <td style="border-bottom: black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif"> 8.45 </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif"> 5.01 </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif"> $ </td> <td style="border-bottom: black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif"> 17,987 </td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: black 1px solid;">   </td> </tr> </table> Proceeds from the exercise of options and the total intrinsic value of the options exercised were $460 and $484, respectively, for the three months ended March 31, 2015, and $1,172 and $910, respectively, for the three months ended March 31, 2014. The weighted-average fair value per share at date of grant for options granted was $5.49 and $7.56 during the three months ended March 31, 2015 and 2014, respectively. The fair value of options granted is estimated on the date of grant using the Black-Scholes option pricing model and recognized in expense over the vesting period of the options using the graded attribution method. The following table presents the weighted-average assumptions used to estimate the fair value of options granted in the three months ended March 31, 2015 and 2014: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 73%; border-top: black 1px solid">   </td> <td style="vertical-align: bottom; width: 3%; border-top: black 1px solid; padding-right: 0.8pt">   </td> <td style="vertical-align: bottom; width: 1%; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="vertical-align: bottom; width: 9%; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center"> 2015 </td> <td style="vertical-align: bottom; width: 1%; border-top: black 1px solid; text-align: center">   </td> <td style="vertical-align: bottom; width: 2%; border-top: black 1px solid; text-align: center">   </td> <td style="vertical-align: bottom; width: 1%; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center">   </td> <td style="vertical-align: bottom; width: 9%; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center"> 2014 </td> <td style="vertical-align: bottom; width: 1%; padding-right: 0.8pt; border-top: black 1px solid; border-bottom: black 1px solid;">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td> Volatility </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 44.29 </td> <td style="padding-right: 0.8pt"> % </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 49.77 </td> <td style="padding-right: 0.8pt"> % </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> Expected life (years) </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 6.25 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 6.25 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td> Risk-free interest rate </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 1.72 </td> <td style="padding-right: 0.8pt"> % </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 1.92 </td> <td style="padding-right: 0.8pt"> % </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: black 1px solid"> Dividend yield </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> — </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> — </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> </tr> </table> The expected stock price volatilities are estimated based on historical realized volatilities of comparable publicly traded company stock prices over a period of time commensurate with the expected term of the option award. The expected life represents the period of time for which the options granted are expected to be outstanding. The Company used the simplified method for determining expected life for options qualifying for treatment due to the limited history the Company currently has with option exercise activity. The risk-free interest rate is based on the U.S. Treasury yield curve for periods equal to the expected term of the options on the grant date. Total stock-based compensation expense related to stock options was $1,958 and $1,069 for the three months ended March 31, 2015 and 2014, respectively. At March 31, 2015, there was approximately $8,713 of unrecognized compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 1.5 years. The total fair value of stock options vested during the three months ended March 31, 2015 and 2014 was $2,613 and $953, respectively. Restricted Stock Unit Awards The Company’s restricted stock unit awards (“RSUs”) are agreements to issue shares of the Company’s common stock to employees in the future, upon the satisfaction of certain vesting conditions, which cause them to be subject to risk of forfeiture and restrict the awardholder’s ability to sell or otherwise transfer such RSUs until they vest. Generally, the Company’s RSU grants vest over three years from the grant date subject to continued employment on the applicable vesting dates. The following table summarizes the RSU activity for the three months ended March 31, 2015: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; border-top: black 1px solid; border-bottom: black 1px solid">   </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right">   </td> <td colspan="2" style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 1.8pt; text-align: center">   </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 0.8pt; text-align: center">   </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 0.8pt; text-align: center">   </td> <td colspan="2" style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 1.8pt; text-align: center">   </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 0.8pt; text-align: center">   </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 0.8pt; text-align: center">   </td> <td colspan="2" style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid"> Number of RSUs </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center">   </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center">   </td> <td colspan="2" style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center"> Weighted Average Grant Date Fair Value </td> <td style="vertical-align: bottom; padding-right: 0.8pt; text-align: right">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="width: 42%"> Outstanding at December 31, 2014 </td> <td style="width: 3%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 9%; padding-right: 0.8pt; text-align: right">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt">   </td> <td style="width: 9%; padding-right: 0.8pt; text-align: right">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt">   </td> <td style="width: 4%; padding-right: 0.8pt">   </td> <td style="width: 9%; padding-right: 0.8pt; text-align: right"> — </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt"> $ </td> <td style="width: 9%; padding-right: 0.8pt; text-align: right"> — </td> <td style="width: 1%; padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> Granted (1) </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 548,424 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 11.99 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td> Vested </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> — </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> Cancelled </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> — </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="border-bottom: black 1px solid"> Outstanding at March 31, 2015 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 548,424 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 11.99 </td> <td style="padding-right: 0.8pt">   </td> </tr> </table> <table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 36pt"> </td> <td style="width: 18pt"> (1) </td> <td> RSUs granted during the three months ended March 31, 2015 includes the grant of 40,000 units of performance-based RSUs that are dependent upon the Company meeting certain performance criteria. </td> </tr> </table> Total stock-based compensation expense related to RSUs was $262 for the three months ended March 31, 2015. As RSUs were issued for the first time in March 2015, there was no stock-based compensation expense related to RSUs in 2014. At March 31, 2015, there was approximately $5,904 of unrecognized compensation expense related to unvested RSUs, which is expected to be recognized over a weighted-average period of 1.63 years. 2014 Employee Stock Purchase Plan The 2014 Employee Stock Purchase Plan (“ESPP”), which became effective immediately upon the signing of the underwriting agreement related to the IPO on March 27, 2014, authorizes the issuance of 500,000 shares of the Company’s common stock pursuant to purchase rights granted to employees. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1 of each calendar year from January 1, 2015 through January 1, 2024 by the least of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, (b) 400,000 shares and (c) a number determined by the Board of Directors that is less than (a) and (b). Unless otherwise determined by the Board of Directors, common stock will be purchased for participating employees at a price per share equal to the lower of (a) 85% of the fair market value of a share of the common stock on the first date of an offering, or (b) 85% of the fair market value of a share of the common stock on the date of purchase. Generally, all regular employees may participate in the ESPP and may contribute, through payroll deductions, up to 15% of their earnings toward the purchase of common stock under the ESPP. Under the terms of the ESPP, there are defined limitations as to the amount and value of common stock that can be purchased by each employee. For the three months ended March 31, 2015, charges incurred under the ESPP totaled $271, and such charges were not material during the three months ended March 31, 2014. As of March 31, 2015, 676,707 shares of common stock were reserved for future issuance under the ESPP.

339829

The number of shares of common stock reserved for issuance under the 2014 Plan is subject to an automatic increase on January 1 of each year through January 1, 2024, by the lesser of (a) 4% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year and (b) a number of shares determined by the Board of Directors.

484000

910000

5.49

7.56

1958000

1069000

8713000

P1Y6M

2613000

953000

40000

262000

5904000

P1Y229D

500000

The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1 of each calendar year from January 1, 2015 through January 1, 2024 by the least of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, (b) 400,000 shares and (c) a number determined by the Board of Directors that is less than (a) and (b). Unless otherwise determined by the Board of Directors, common stock will be purchased for participating employees at a price per share equal to the lower of (a) 85% of the fair market value of a share of the common stock on the first date of an offering, or (b) 85% of the fair market value of a share of the common stock on the date of purchase. 0.15

271000

676707

The following table summarizes stock option activity for the three months ended March 31, 2015: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td colspan="2" style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif"> Number of options </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif">   </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif">   </td> <td colspan="2" style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif"> Weighted- average exercise price </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif">   </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif">   </td> <td colspan="2" style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif"> Weighted- average remaining contractual life (years) </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif">   </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif">   </td> <td colspan="2" style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: center; font-family: Times New Roman, Times, Serif"> Aggregate intrinsic value </td> <td style="vertical-align: bottom; border-top: Black 0.5pt solid; border-bottom: Black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255); font-family: Times New Roman, Times, Serif"> <td style="width: 43%; font-family: Times New Roman, Times, Serif"> Outstanding at December 31, 2014 </td> <td style="width: 2%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 1%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> 5,893,698 </td> <td style="width: 1%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 2%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 2%; font-family: Times New Roman, Times, Serif"> $ </td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> 9.94 </td> <td style="width: 1%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 2%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 4%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> 6.48 </td> <td style="width: 1%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 2%; font-family: Times New Roman, Times, Serif">   </td> <td style="width: 2%; font-family: Times New Roman, Times, Serif">  $ </td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, Serif"> 29,249 </td> <td style="width: 1%; font-family: Times New Roman, Times, Serif">   </td> </tr> <tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"> <td style="font-family: Times New Roman, Times, Serif"> Granted </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 726,100 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 12.22 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255); font-family: Times New Roman, Times, Serif"> <td style="font-family: Times New Roman, Times, Serif"> Exercised </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> (72,832 </td> <td style="font-family: Times New Roman, Times, Serif"> ) </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 7.27 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> </tr> <tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"> <td style="font-family: Times New Roman, Times, Serif"> Cancelled </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif"> (7,415 </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1px"> ) </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 12.84 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255); font-family: Times New Roman, Times, Serif"> <td style="font-family: Times New Roman, Times, Serif"> Outstanding at March 31, 2015 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif"> 6,539,551 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif"> $ </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 10.23 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 6.65 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif">   </td> <td style="font-family: Times New Roman, Times, Serif"> $ </td> <td style="text-align: right; font-family: Times New Roman, Times, Serif"> 20,931 </td> <td style="font-family: Times New Roman, Times, Serif">   </td> </tr> <tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif"> Exercisable at March 31, 2015 </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif"> 3,896,925 </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif"> $ </td> <td style="border-bottom: black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif"> 8.45 </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif"> 5.01 </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif">   </td> <td style="border-bottom: black 1px solid; font-family: Times New Roman, Times, Serif"> $ </td> <td style="border-bottom: black 1px solid; text-align: right; font-family: Times New Roman, Times, Serif"> 17,987 </td> <td style="font-family: Times New Roman, Times, Serif; border-bottom: black 1px solid;">   </td> </tr> </table>

5893698

9.94

P6Y175D

29249000

726100

12.22

-72832

7.27

-7415

12.84

6539551

10.23

P6Y237D

20931000

3896925

8.45

P5Y3D

17987000

The following table presents the weighted-average assumptions used to estimate the fair value of options granted in the three months ended March 31, 2015 and 2014: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 73%; border-top: black 1px solid">   </td> <td style="vertical-align: bottom; width: 3%; border-top: black 1px solid; padding-right: 0.8pt">   </td> <td style="vertical-align: bottom; width: 1%; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="vertical-align: bottom; width: 9%; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center"> 2015 </td> <td style="vertical-align: bottom; width: 1%; border-top: black 1px solid; text-align: center">   </td> <td style="vertical-align: bottom; width: 2%; border-top: black 1px solid; text-align: center">   </td> <td style="vertical-align: bottom; width: 1%; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center">   </td> <td style="vertical-align: bottom; width: 9%; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center"> 2014 </td> <td style="vertical-align: bottom; width: 1%; padding-right: 0.8pt; border-top: black 1px solid; border-bottom: black 1px solid;">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td> Volatility </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 44.29 </td> <td style="padding-right: 0.8pt"> % </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 49.77 </td> <td style="padding-right: 0.8pt"> % </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> Expected life (years) </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 6.25 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 6.25 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td> Risk-free interest rate </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 1.72 </td> <td style="padding-right: 0.8pt"> % </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 1.92 </td> <td style="padding-right: 0.8pt"> % </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: black 1px solid"> Dividend yield </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> — </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> — </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> </tr> </table>

0.4429

0.4977

P6Y3M

0.0172

0.0192

The following table summarizes the RSU activity for the three months ended March 31, 2015: <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; border-top: black 1px solid; border-bottom: black 1px solid">   </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right">   </td> <td colspan="2" style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 1.8pt; text-align: center">   </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 0.8pt; text-align: center">   </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 0.8pt; text-align: center">   </td> <td colspan="2" style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 1.8pt; text-align: center">   </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 0.8pt; text-align: center">   </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; padding-right: 0.8pt; text-align: center">   </td> <td colspan="2" style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid"> Number of RSUs </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center">   </td> <td style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center">   </td> <td colspan="2" style="vertical-align: bottom; border-top: black 1px solid; border-bottom: black 1px solid; text-align: center"> Weighted Average Grant Date Fair Value </td> <td style="vertical-align: bottom; padding-right: 0.8pt; text-align: right">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="width: 42%"> Outstanding at December 31, 2014 </td> <td style="width: 3%; padding-right: 0.8pt">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 9%; padding-right: 0.8pt; text-align: right">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt">   </td> <td style="width: 9%; padding-right: 0.8pt; text-align: right">   </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt">   </td> <td style="width: 4%; padding-right: 0.8pt">   </td> <td style="width: 9%; padding-right: 0.8pt; text-align: right"> — </td> <td style="width: 1%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt">   </td> <td style="width: 2%; padding-right: 0.8pt"> $ </td> <td style="width: 9%; padding-right: 0.8pt; text-align: right"> — </td> <td style="width: 1%; padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> Granted (1) </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 548,424 </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> 11.99 </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td> Vested </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right"> — </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td> Cancelled </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> — </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt">   </td> <td style="padding-right: 0.8pt; text-align: right">   </td> <td style="padding-right: 0.8pt">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="border-bottom: black 1px solid"> Outstanding at March 31, 2015 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 548,424 </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt">   </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt"> $ </td> <td style="border-bottom: black 1px solid; padding-right: 0.8pt; text-align: right"> 11.99 </td> <td style="padding-right: 0.8pt">   </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 36pt"> </td> <td style="width: 18pt"> (1) </td> <td> RSUs granted during the three months ended March 31, 2015 includes the grant of 40,000 units of performance-based RSUs that are dependent upon the Company meeting certain performance criteria. </td> </tr> </table>

548424

11.99

548424

11.99

8. Net Loss Per Common Share Basic net loss per common share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding for the period. Diluted net loss per common share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding for the period, adjusted to reflect potentially dilutive securities. Potentially dilutive securities consist of incremental shares issuable upon the assumed exercise of stock options, restricted stock units, and warrants using the treasury stock method, and employee withholdings to purchase common stock under the ESPP. Due to the net losses for the three months ended March 31, 2015 and 2014, the Company had outstanding options, warrants, restricted stock units, and ESPP withholdings which were not included in the computation of diluted net loss per common share, as the effects would have been anti-dilutive. Accordingly, the basic and diluted weighted-average number of common shares outstanding are the same for the following periods presented: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-top: Black 0.5pt solid">   </td> <td style="font-weight: bold; border-top: Black 0.5pt solid">   </td> <td colspan="6" style="font-weight: bold; text-align: center; border-top: Black 0.5pt solid"> Three months ended </td> <td style="font-weight: bold; text-align: center">   </td> </tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center">   </td> <td style="font-weight: bold; padding-bottom: 1px; text-align: center;">   </td> <td colspan="6" style="font-weight: bold; border-bottom: Black 1px solid; text-align: center;"> March 31, </td> <td style="font-weight: bold; text-align: center">   </td> </tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">   </td> <td style="font-weight: bold; padding-bottom: 1px">   </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"> 2015 </td> <td style="border-bottom: Black 1px solid; font-weight: bold">   </td> <td style="font-weight: bold; border-bottom: Black 1px solid">   </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"> 2014 </td> <td style="padding-bottom: 1px; font-weight: bold">   </td> </tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline; text-indent: -10pt; padding-left: 10pt"> Numerator: </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="width: 74%; text-align: left; text-indent: -10pt; padding-left: 10pt"> Net loss </td> <td style="width: 2%">   </td> <td style="width: 1%; text-align: left"> $ </td> <td style="width: 9%; text-align: right"> (8,068 </td> <td style="width: 1%; text-align: left"> ) </td> <td style="width: 2%">   </td> <td style="width: 1%; text-align: left"> $ </td> <td style="width: 9%; text-align: right"> (7,759 </td> <td style="width: 1%; text-align: left"> ) </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: underline; text-indent: -10pt; padding-left: 10pt"> Denominator: </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Weighted-average number of common shares outstanding - basic and diluted </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 31,525,559 </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 5,403,846 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt; border-bottom: Black 1px solid"> Net loss per common share - basic and diluted </td> <td style="border-bottom: Black 1px solid">   </td> <td style="text-align: left; border-bottom: Black 1px solid"> $ </td> <td style="text-align: right; border-bottom: Black 1px solid"> (0.26 </td> <td style="text-align: left; border-bottom: Black 1px solid"> ) </td> <td style="border-bottom: Black 1px solid">   </td> <td style="text-align: left; border-bottom: Black 1px solid"> $ </td> <td style="text-align: right; border-bottom: Black 1px solid"> (1.44 </td> <td style="text-align: left"> ) </td> </tr> <tr style="vertical-align: bottom"> <td>   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> </tr> </table> The following securities were outstanding at the end of the periods presented below and have been excluded from the calculation of diluted net loss per common share because the effect is anti-dilutive: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-top: Black 0.5pt solid">   </td> <td style="font-weight: bold; border-top: Black 0.5pt solid">   </td> <td colspan="6" style="font-weight: bold; text-align: center; border-top: Black 0.5pt solid"> Three months ended </td> <td style="font-weight: bold; text-align: center">   </td> </tr> <tr style="vertical-align: bottom"> <td>   </td> <td style="font-weight: bold; padding-bottom: 1px">   </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"> March 31, </td> <td style="font-weight: bold; text-align: center;">   </td> </tr> <tr style="vertical-align: bottom"> <td>   </td> <td style="font-weight: bold; padding-bottom: 1px">   </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"> 2015 </td> <td style="border-bottom: Black 1px solid; font-weight: bold">   </td> <td style="font-weight: bold; border-bottom: Black 1px solid">   </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"> 2014 </td> <td style="padding-bottom: 1px; font-weight: bold">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="width: 74%; text-align: left; text-indent: -10pt; padding-left: 10pt"> Warrants to purchase common stock(1) </td> <td style="width: 2%">   </td> <td style="width: 1%; text-align: left">   </td> <td style="width: 9%; text-align: right"> 143,782 </td> <td style="width: 1%; text-align: left">   </td> <td style="width: 2%">   </td> <td style="width: 1%; text-align: left">   </td> <td style="width: 9%; text-align: right"> 692,501 </td> <td style="width: 1%; text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Warrants to purchase redeemable convertible preferred stock(1) </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> — </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 148,650 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Redeemable convertible preferred stock(1) </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> — </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 26,820,270 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Stock option awards </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 6,539,511 </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 6,673,806 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> RSU awards </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 548,424 </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> — </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1px; text-indent: -10pt; padding-left: 10pt"> Employee stock purchase plan </td> <td style="padding-bottom: 1px">   </td> <td style="border-bottom: Black 1px solid; text-align: left">   </td> <td style="border-bottom: Black 1px solid; text-align: right"> 80,037 </td> <td style="padding-bottom: 1px; text-align: left">   </td> <td style="padding-bottom: 1px">   </td> <td style="border-bottom: Black 1px solid; text-align: left">   </td> <td style="border-bottom: Black 1px solid; text-align: right"> — </td> <td style="padding-bottom: 1px; text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; padding-bottom: 1px; text-indent: -10pt; padding-left: 10pt; border-bottom: Black 1px solid"> Total anti-dilutive securities </td> <td style="padding-bottom: 1px; border-bottom: Black 1px solid">   </td> <td style="border-bottom: Black 1px solid; text-align: left">   </td> <td style="border-bottom: Black 1px solid; text-align: right"> 7,311,754 </td> <td style="padding-bottom: 1px; text-align: left; border-bottom: Black 1px solid">   </td> <td style="padding-bottom: 1px; border-bottom: Black 1px solid">   </td> <td style="border-bottom: Black 1px solid; text-align: left">   </td> <td style="border-bottom: Black 1px solid; text-align: right"> 34,335,227 </td> <td style="padding-bottom: 1px; text-align: left">   </td> </tr> </table> <table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 36pt"> </td> <td style="width: 18pt"> (1) </td> <td> Upon closing of the IPO on April 2, 2014, all of the Company’s outstanding redeemable convertible preferred stock automatically converted into shares of common stock. In addition, the outstanding warrants to purchase redeemable convertible preferred stock automatically converted into warrants to purchase common stock, or were automatically exercised upon closing of the IPO. </td> </tr> </table>

Diluted net loss per common share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding for the period, adjusted to reflect potentially dilutive securities. Potentially dilutive securities consist of incremental shares issuable upon the assumed exercise of stock options, restricted stock units, and warrants using the treasury stock method, and employee withholdings to purchase common stock under the ESPP. Due to the net losses for the three months ended March 31, 2015 and 2014, the Company had outstanding options, warrants, restricted stock units, and ESPP withholdings which were not included in the computation of diluted net loss per common share, as the effects would have been anti-dilutive. Accordingly, the basic and diluted weighted-average number of common shares outstanding are the same for the following periods presented: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-top: Black 0.5pt solid">   </td> <td style="font-weight: bold; border-top: Black 0.5pt solid">   </td> <td colspan="6" style="font-weight: bold; text-align: center; border-top: Black 0.5pt solid"> Three months ended </td> <td style="font-weight: bold; text-align: center">   </td> </tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center">   </td> <td style="font-weight: bold; padding-bottom: 1px; text-align: center;">   </td> <td colspan="6" style="font-weight: bold; border-bottom: Black 1px solid; text-align: center;"> March 31, </td> <td style="font-weight: bold; text-align: center">   </td> </tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">   </td> <td style="font-weight: bold; padding-bottom: 1px">   </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"> 2015 </td> <td style="border-bottom: Black 1px solid; font-weight: bold">   </td> <td style="font-weight: bold; border-bottom: Black 1px solid">   </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"> 2014 </td> <td style="padding-bottom: 1px; font-weight: bold">   </td> </tr> <tr style="vertical-align: bottom"> <td style="text-decoration: underline; text-indent: -10pt; padding-left: 10pt"> Numerator: </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="width: 74%; text-align: left; text-indent: -10pt; padding-left: 10pt"> Net loss </td> <td style="width: 2%">   </td> <td style="width: 1%; text-align: left"> $ </td> <td style="width: 9%; text-align: right"> (8,068 </td> <td style="width: 1%; text-align: left"> ) </td> <td style="width: 2%">   </td> <td style="width: 1%; text-align: left"> $ </td> <td style="width: 9%; text-align: right"> (7,759 </td> <td style="width: 1%; text-align: left"> ) </td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-decoration: underline; text-indent: -10pt; padding-left: 10pt"> Denominator: </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Weighted-average number of common shares outstanding - basic and diluted </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 31,525,559 </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 5,403,846 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt; border-bottom: Black 1px solid"> Net loss per common share - basic and diluted </td> <td style="border-bottom: Black 1px solid">   </td> <td style="text-align: left; border-bottom: Black 1px solid"> $ </td> <td style="text-align: right; border-bottom: Black 1px solid"> (0.26 </td> <td style="text-align: left; border-bottom: Black 1px solid"> ) </td> <td style="border-bottom: Black 1px solid">   </td> <td style="text-align: left; border-bottom: Black 1px solid"> $ </td> <td style="text-align: right; border-bottom: Black 1px solid"> (1.44 </td> <td style="text-align: left"> ) </td> </tr> <tr style="vertical-align: bottom"> <td>   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right">   </td> <td style="text-align: left">   </td> </tr> </table>

The following securities were outstanding at the end of the periods presented below and have been excluded from the calculation of diluted net loss per common share because the effect is anti-dilutive: <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-top: Black 0.5pt solid">   </td> <td style="font-weight: bold; border-top: Black 0.5pt solid">   </td> <td colspan="6" style="font-weight: bold; text-align: center; border-top: Black 0.5pt solid"> Three months ended </td> <td style="font-weight: bold; text-align: center">   </td> </tr> <tr style="vertical-align: bottom"> <td>   </td> <td style="font-weight: bold; padding-bottom: 1px">   </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"> March 31, </td> <td style="font-weight: bold; text-align: center;">   </td> </tr> <tr style="vertical-align: bottom"> <td>   </td> <td style="font-weight: bold; padding-bottom: 1px">   </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"> 2015 </td> <td style="border-bottom: Black 1px solid; font-weight: bold">   </td> <td style="font-weight: bold; border-bottom: Black 1px solid">   </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"> 2014 </td> <td style="padding-bottom: 1px; font-weight: bold">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="width: 74%; text-align: left; text-indent: -10pt; padding-left: 10pt"> Warrants to purchase common stock(1) </td> <td style="width: 2%">   </td> <td style="width: 1%; text-align: left">   </td> <td style="width: 9%; text-align: right"> 143,782 </td> <td style="width: 1%; text-align: left">   </td> <td style="width: 2%">   </td> <td style="width: 1%; text-align: left">   </td> <td style="width: 9%; text-align: right"> 692,501 </td> <td style="width: 1%; text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Warrants to purchase redeemable convertible preferred stock(1) </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> — </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 148,650 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Redeemable convertible preferred stock(1) </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> — </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 26,820,270 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> Stock option awards </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 6,539,511 </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 6,673,806 </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"> RSU awards </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> 548,424 </td> <td style="text-align: left">   </td> <td>   </td> <td style="text-align: left">   </td> <td style="text-align: right"> — </td> <td style="text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1px; text-indent: -10pt; padding-left: 10pt"> Employee stock purchase plan </td> <td style="padding-bottom: 1px">   </td> <td style="border-bottom: Black 1px solid; text-align: left">   </td> <td style="border-bottom: Black 1px solid; text-align: right"> 80,037 </td> <td style="padding-bottom: 1px; text-align: left">   </td> <td style="padding-bottom: 1px">   </td> <td style="border-bottom: Black 1px solid; text-align: left">   </td> <td style="border-bottom: Black 1px solid; text-align: right"> — </td> <td style="padding-bottom: 1px; text-align: left">   </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(229,255,255)"> <td style="text-align: left; padding-bottom: 1px; text-indent: -10pt; padding-left: 10pt; border-bottom: Black 1px solid"> Total anti-dilutive securities </td> <td style="padding-bottom: 1px; border-bottom: Black 1px solid">   </td> <td style="border-bottom: Black 1px solid; text-align: left">   </td> <td style="border-bottom: Black 1px solid; text-align: right"> 7,311,754 </td> <td style="padding-bottom: 1px; text-align: left; border-bottom: Black 1px solid">   </td> <td style="padding-bottom: 1px; border-bottom: Black 1px solid">   </td> <td style="border-bottom: Black 1px solid; text-align: left">   </td> <td style="border-bottom: Black 1px solid; text-align: right"> 34,335,227 </td> <td style="padding-bottom: 1px; text-align: left">   </td> </tr> </table><table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 36pt"> </td> <td style="width: 18pt"> (1) </td> <td> Upon closing of the IPO on April 2, 2014, all of the Company’s outstanding redeemable convertible preferred stock automatically converted into shares of common stock. In addition, the outstanding warrants to purchase redeemable convertible preferred stock automatically converted into warrants to purchase common stock, or were automatically exercised upon closing of the IPO. </td> </tr> </table>

143782

692501

148650

26820270

6539511

6673806

548424

80037

7311754

34335227

9. Income Taxes The Company’s expected and historic annual net tax provision is generally comprised of a deferred tax provision pertaining to basis differences in indefinite lived intangible assets that cannot be offset by current year deferred tax assets, as well as, to a much lesser extent, a current tax provision for federal, state, local and foreign taxes. Effective March 31, 2015, the tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate, adjusted for discrete items arising in the quarter, as applicable. As a result of using an estimated annual effective tax rate the Company recorded a benefit for the quarter, which is expected to reverse over the remaining quarters. In each quarter, the Company’s estimate of the annual effective tax rate will be updated and any changes will be recognized in the interim period in which the change occurs. In interim periods prior to March 31, 2015, the tax provision was based upon the estimated deferred and current tax provision for the year rather than the estimated annual effective tax rate, as the Company had historically experienced pretax losses in certain quarters and pretax income in others, and the annual results were expected to be at or near breakeven, and believed that using an annual effective tax rate would result in significant variances in the customary relationship between income tax expense (benefit) and pretax income or loss in interim periods. The Company’s deferred tax assets relate primarily to net operating loss carryforwards and to a smaller extent stock based compensation and other items. The Company has provided a valuation allowance against deferred tax assets to the extent the Company has determined that it is more likely than not that such net deferred tax assets will not be realizable. In determining realizability, the Company considered various factors including historical profitability and reversing temporary differences, exclusive of indefinite-lived intangibles. The Company’s deferred tax liabilities arose primarily from basis differences in indefinite-lived intangible assets that cannot be offset by current year deferred tax assets. At December 31, 2014, the Company had approximately $107,000 of net operating loss, or NOL, carryforwards available to offset future taxable income, which expire from 2020 through 2033. The full utilization of these losses in the future is dependent upon the Company’s ability to generate taxable income and may also be limited due to ownership changes, as defined under the provisions of Section 382 of the Internal Revenue Code of 1986, as amended. The Company’s NOL carryforwards at December 31, 2014 included $7,433 of income tax deductions related to equity compensation that are greater than the compensation recognized for financial reporting, which will be reflected as a credit to additional paid-in-capital as realized. The Company is subject to taxation in the U.S. and various federal, state, local and foreign jurisdictions. In March 2014, an audit of the Company’s U.S. Federal tax return for the year ended December 31, 2011 commenced. As of March 31, 2015, none of the Company’s other tax returns have been examined by any income taxing authority. The Company is not subject to U.S. federal, state or non-U.S. income tax examinations by tax authorities for years prior to 2010. However, to the extent U.S. federal and state NOL carryforwards are utilized, the use of NOLs could be subject to examination by the tax authorities. The Company believes that it has appropriate support for the income tax positions taken and to be taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on assessment of many factors, including past experience and interpretations of tax law. The Company regularly assesses the adequacy of its income tax contingencies in accordance with ASC 740. As a result, the Company may adjust its income tax contingency liabilities for the impact of new facts and developments, such as changes in interpretations of relevant tax law and assessments from taxing authorities.

107000000

7433000

10. Commitments and Contingencies The Company is subject to certain claims that have arisen in the ordinary conduct of business. Based on the advice of counsel and an assessment of the nature and status of any potential claim, and taking into account any accruals the Company may have established for them, the Company currently believes that any liabilities ultimately resulting from such claims will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

11. Subsequent Events The Company has completed an evaluation of all subsequent events through the issuance date of these financial statements and concluded that no subsequent events occurred that required recognition to the financial statements or disclosures in the notes to the consolidated financial statements.

EX-101.SCH 11 evdy-20150331.xsd 001 - Statement - Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Business link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Acquisitions link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Goodwill and Other Intangible Assets link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Long-Term Debt link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Common Stock and Preferred Stock link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Net Loss Per Common Share link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Acquisitions (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Goodwill and Other Intangible Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Net Loss Per Common Share (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Acquisitions (Details) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Acquisitions (Details) - Preliminary allocation of the assets acquired and liabilities assumed link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Goodwill and Other Intangible Assets (Details) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Goodwill and Other Intangible Assets (Details) - Schedule of future amortization expense of intangible assets link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Long-Term Debt (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Common Stock and Preferred Stock (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Stock-Based Compensation (Details) - Schedule of stock option activity link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Stock-Based Compensation (Details) - Schedule of weighted-average assumptions link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Stock-Based Compensation (Details) - Schedule of restricted stock unit awards link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Net Loss Per Common Share (Details) - Basic and diluted net income (loss) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Net Loss Per Common Share (Details) - Securities excluded from calculations of diluted net loss per common share link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Disclosure - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 12 evdy-20150331_cal.xml EX-101.DEF 13 evdy-20150331_def.xml EX-101.LAB 14 evdy-20150331_lab.xml Statement of Financial Position [Abstract] Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Accounts receivable, net of allowance for doubtful accounts of $523 and $637 as of March 31, 2015 and December 31, 2014, respectively Allowance for doubtful accounts (in Dollars) Deferred tax asset Prepaid expenses and other current assets Total current assets Property and equipment, net Property and equipment Goodwill Intangible assets, net Intangible assets Other assets Total assets Accounts payable and accrued expenses Deferred revenue Current portion of long-term debt Other current liabilities Total current liabilities Long-term debt Deferred tax liabilities Other long-term liabilities Preferred stock, $0.01 par value: 10,000,000 shares authorized at March 31, 2015 and December 31, 2014; no shares issued and outstanding at March 31, 2015 and December 31, 2014 Preferred stock, par value (in Dollars per share) Preferred stock, shares authorized Preferred Stock, Shares Authorized Preferred stock, shares issued Preferred Stock, Shares Issued Preferred stock, shares outstanding Preferred Stock, Shares Outstanding Common stock, $0.01 par value: 90,000,000 shares authorized at March 31, 2015 and December 31, 2014; 31,562,028 and 31,489,196 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively Common stock, par value (in Dollars per share) Common stock, shares issued Common stock, shares outstanding Common stock, shares authorized Common Stock, Shares Authorized Common Stock, Shares Authorized (in Shares) Treasury stock Additional paid-in capital Accumulated deficit Total stockholders’ equity Balance Balance Total liabilities and stockholders’ equity Income Statement [Abstract] Advertising and sponsorship revenues Premium services revenues Total revenues Cost of revenues Sales and marketing Product development General and administrative Total operating expenses Loss from operations Interest expense, net Other expense Loss from operations before benefit (provision) for income taxes Benefit (provision) for income taxes Net loss Net loss Net loss Net loss per common share-basic and diluted (in Dollars per share) Net loss per common share - basic and diluted Weighted-average common shares outstanding-basic and diluted (in Shares) Weighted-average number of common shares outstanding - basic and diluted Statement of Stockholders' Equity [Abstract] Balance (in Shares) Balance (in Shares) Exercise of stock options (in Shares) Exercised Stock-based compensation expense Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Treasury Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Statement of Comprehensive Income [Abstract] Depreciation and amortization Provision for doubtful accounts Stock-based compensation Amortization and write-off of financing costs Provision for deferred income taxes Accounts receivable Prepaid expenses and other current assets Accounts payable and accrued expenses Deferred revenue Other current liabilities Other long-term liabilities Net cash provided by operating activities Additions to property and equipment, net Proceeds from sale of business Payment for business purchased, net of cash acquired Payments to acquire business Payment of security deposits and other assets Net cash used in investing activities Proceeds from the exercise of stock options Proceeds from Stock Options Exercised Credit Facility [Axis] Former Revolving Credit Facility [Member] Repayments of principal Former Term Loan [Member] Revolving Credit Facility [Member] Borrowings Term Loan Facility [Member] Principal payments on capital lease obligations Payments of credit facility financing costs Payments of Financing Costs Net cash provided by (used in) financing activities Net decrease in cash and cash equivalents Interest paid Income taxes paid Issuance of common stock for acquired business Due to sellers of acquired business Due To Sellers Of Acquired Business Due from stock option exercises Warrants issued in connection with website partner agreement Capital lease obligations incurred Disclosure Text Block [Abstract] Accounting Policies [Abstract] Disclosure Text Block Supplement [Abstract] Measurement Basis [Axis] Estimate of Fair Value Measurement [Member] Preliminary allocation of the assets acquired and liabilities assumed [Abstract] Total consideration paid Business Combination, Consideration Transferred Business Acquisition [Axis] Cambridge [Member] Goodwill and Intangible Assets Disclosure [Abstract] Schedule of definite-lived intangible assets [Abstract] Finite-Lived Intangible Assets by Major Class [Axis] Customer Relationships [Member] Gross carrying amount Accumulated amortization Net carrying amount Total Finite-Lived Intangible Assets, Net Weighted- average remaining useful life Trade Names [Member] Other Intangible Assets [Member] Schedule of future amortization expense of intangible assets [Abstract] 2015 (April 1st to December 31st) 2016 2017 2018 2019 Thereafter Stockholders' Equity Note [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of stock option activity [Abstract] Classification [Axis] Stock Option Activity [Member] Schedule of weighted-average assumptions [Abstract] Volatility Expected life (years) Risk-free interest rate Dividend yield (in Dollars per share) Schedule of restricted stock unit awards [Abstract] Award Type [Axis] Restricted Stock Units (RSUs) [Member] Earnings Per Share [Abstract] Basic and diluted net income (loss) [Abstract] Securities excluded from calculations of diluted net loss per common share [Abstract] Class of Stock [Axis] Common Stock Warrant [Member] Preferred Stock Warrant [Member] Redeemable Convertible Preferred Stock [Member] Options [Member] Employee Stock [Member] Income Tax Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Subsequent Events [Abstract] Assets Current assets: Liabilities and stockholders’ equity Current liabilities: Stockholders’ equity: Revenues: Operating expenses: Exercise of stock options Cash flows from operating activities Adjustments to reconcile net loss to net cash provided by operating activities: Changes in operating assets and liabilities: Cash flows from investing activities Cash flows from financing activities Supplemental disclosure of cash flow information Supplemental disclosure of non-cash investing and financing activities Business Description and Basis of Presentation [Text Block] Significant Accounting Policies [Text Block] Mergers, Acquisitions and Dispositions Disclosures [Text Block] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Accounts receivable Other current assets Deferred revenue Goodwill and Intangible Assets Disclosure [Text Block] Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Long-term Debt [Text Block] Stockholders' Equity Note Disclosure [Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Number of options Weighted-average exercise price Weighted-average remaining contractual life EX-101.PRE 15 evdy-20150331_pre.xml EXCEL 16 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`!0@H%]0$``$P8```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F=%NVC`4AN\G[1TBWU;$ MV.ZZKB+THELOMTKK'L"S#R3"L2W;[>#M=Q):-%4,A(:T[RQ"ZG7!MVG)HS8KO00NI],K;H(OX,ND##/8 M?/89%OK)E>K+&C_>DB1PF55WVX5#5L-TC*XSNB`I?_;V3.:W'8Q M7R`&XWL3ACM_#WC9]PV/)G46J@>=RE?=(P9?._XKI-7/$%;UX2%[*,-BT1FP MP3SU>`)UC@FTS2U`Z5T]7NM>=_Z5^T#^N#CS\2+.##)\OW'PB1R2"(,@G_D/]G;HL>16)[#? M2\)6^>P`?\X^PF&T,W'W9.(@R"5 M#G8%][ZB>)>(S?GI@6^::ABZ>0MV3S8?GP7,?P,``/__`P!02P,$%``&``@` M```A`+55,"/U````3`(```L`"`)?]=J>*V?5@^@8B)G M:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\(V(T'4\4"_'L)MI<3_3_MCAQ(DN)T$C@\SS?BG-` MZ^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?````__\#`%!+`P04``8`"````"$` M[M'D,`("``!/%P``&@`(`7AL+U]R96QS+W=O0MX>_=GWQ6_?(CMT)>&%DM3^+X:ZK;?E>;'T[E^;@H[G; M?/YT^^@[E_)'L6G'6.15^EB:)J7QQMI8-7[OXF(8?9_?;(>P=RD/P\Z.KGIV M.V]YN5S;<+Z&V;Q:LWBH2Q,>:A)3/!W&O/7[BP_;;5OYKT/U<^_[])\][.\A M/,?&^Y07=6'G4VFFJ6B/;T@6&;.Q;\#)]="%$TY,ARZW MVW12?\=H?Z8Y]Y\ZXP1AFOK7+$P(CJR4X<@*P;E41G.)P+`R&$9@2)M&!&G$ M685518:7J#H\*ZLG"N5_?$."^1K!6&E@;UA9AAB(LVL(G4/E$VQ0$NL)J5N6+C0N^_IY"3K/G.>)\&G'\ M0EF&+Q`8TD9#$`YKYW*&N9RUEU4?<"@8*T@X4!`.%:!N6 M0,/2]BMH5]HG!0^*M$M#L#:L;>4,K9RUK9RAE8NVY@C4'-&V3X'VJ6U7V*V4 MGY-_VU?7 MX)L7````__\#`%!+`P04``8`"````"$`JBCLHX\#``"^"P``#P```'AL+W=O MI:I%@VTO+)`:L M.C:UG0)OOY-D"9,$T'(%3N*3F3/?3'Q[MTF%\\6TX4KV7?^BXSI,QBKA#[M]NUTA\SI3X<$)"F[RZM7=UXGHF7+*7F M0JV8A#MSI5-J8:D7GEEI1A.S9,RFP@LZG9Z74B[=4N%&_X^&FL]YS!Y5G*5, MVE)$,T$MA&^6?&7

V<"_969N30U>J%IA#W1KB.H,8^)=RRI.]&L%1K5KN@ ML]4PXP+N7H>=T/4&59)C[21L3C-AIY#>3AW\"KI!T,N?S*UXXVQM]IORI;-Y MYS)1Z_Q1L'9;K4((8%W<>N>)7<+]3J=37?O-^&)I=Q=!WD/ZA8/PGN+7D45Z M.T?(O4S(D[3<;LE(ENYS!27,71]!9K[KZ!L.?_0H\?/`L>]64N8\_,VYXT2+8N!!MNFYN^J54LN9"$&A]\FJ7 M3`-/,`<6?"88P3*X`'ZGJ?.LY&+*=$H>V*/(H2Q M9G.F-7#9*!RVW&_16`@,J8%]#RJ%F62*48$#N<2!M#A\898\*V/(&!P`B2*J M)=4U^W%#^"T(1S!/4T:F=`.S<]^)7OO(.0A%$F#Z_A5\;.4-FVQ*_+48@POCY)_D#%X"?6A`8 M0_],#B&!HL/RR19A$&'8-F;;$1(.!(3)#%ID'@6B4,+Q8#*#-IDGFQLG%F"' M8-%(#+>DJ>%P(J]$.[/8?0"?"7XZP0-@KL(3C74Q%#.?. M_*_`7``#__P,`4$L#!!0`!@`(````(0!/`9C*6@0``$`/ M```8````>&PO=V]R:W-H965T&ULE)==CZ,V%(;O*_4_(.X3 M,-]$258;1M.NU$I5U6VO"7$2-(`C3"8S_[[''(.QV9E-;F9"_/KX\3F'-_;Z MRUM=6:^TY25K-C99NK9%FX(=RN:TL;__\[Q(;(MW>7/(*];0C?U.N?UE^^LO MZQMK7_B9TLZ""`W?V.>NNZP"P+^L2*:TV;#H.TM,H[X.?G\L*':'5Q3[@Z;U^N MET7!Z@N$V)=5V;WW06VK+E;?3@UK\WT%^WXC05X,L?N'6?BZ+%K&V;%;0C@' M0>=[3IW4@4C;]:&$'8BT6RT];NRO9)5YKNULUWV"_BWIC4\^6_S,;K^UY>&/ MLJ&0;:B3J,">L1 M\NZY%"%MJ[CRCM7_H8C(4!C$DT%\H)?CWKU!'`3J]_>4=_EVW;*;!4T#2_)+ M+EJ0K"#PL#'$&+?ZT4YABR+(5Q&ECP6;X%">UVT4K)U7R&@A)3N4P`LQ2HBN MR`:%*`30C8BP;Q/1APK^./<#D9BD$X4FT5SB&41S112.$HT14C=E_)Q-B#=V M,$E%%(UA^X3N4(*M)#*<3;[0%H8H]R\LQ-!ZTX5C8V&4I'T-_]$S^")<1Z[\2N@8622>],OM#R(7Z=)N_^YTTKQ'H^8N,% MWJ$$\T$"-S:KI(V3P%/S-:ST$2PA-K!42V*94"*QO-A39>C',VW<]3R53PV+ M@.?;8"IMD0PJ1G((M<@SW0!)%0)=#3#Q3^O)$&CG=J`V;H[J4&T-''- MUM;&HS!5.=7!#._^"1CZK0:F`LN0(%4"'>TA4R=S5X^-I.RD)NS]2X M1"=)I`0ZV4.^+DY(9M)4-60]43-Q*SE+L@2$J-[360P[%T>7GY\+R-S78]/7 MI68H9)H8E>3T`O#2:9ZC;CH MB-<*-6'@^DF@=H)UQHL,'O1KVIYH1JN*6P6[BDL*@0R,W^(%:@<7J/ZVX8P# M<'^YY"?Z9]Z>RH9;%3W"5'<9PSY;O`'A0\?;?_`P``__\#`%!+`P04``8`"````"$`)'96)"$$```\#P`` M&0```'AL+W=O:5=:K?;CFH"3H`*.,&W:?[]CAK0>DVUH+YI@WGGS>#QX\.K; M:U-;+[R3E6C7-G,\V^)M(_/2]>5Q8DWN73$F;=PYR"Z)N_ALCNZ\MSQO!R"FMKU M/2]VF[QJ;718=G,\Q.%0%3P3Q7/#VQY-.E[G/?#+4W665[>FF&/7Y-W3\_FA M$,T9+/957?5O@ZEM-<7RQ[$57;ZO8=ZO+,R+J_=P,;%OJJ(34AQZ!^QND5F`OQ).2_BC5$`2[D^C'807^Z*R2'_+GNO]37'[EU?'4PW)',",UL67Y MEG%90$;!QO$CY52(&@#@O]54JC0@(_GK\'FIROZTMH/8B19>P$!N[;GL'RME M:5O%L^Q%\R^*V&B%)OYH$@#]>#]R0C]:)%]Q"4<7^+RZ^(Z?1"R*[[.X.*\A M35G>YYM5)RX6U!Z0RW.N*IDMP5GE)_S?_$!B5,QW%32$@EK"HKYLPB1:N2^P M$,6HV=[2Q%2SFVH85617A5IC('['AI2:V`$4Q^UEO6*K((H=A?3WME.);TQL M=T-"3;(;B@\3,@VH"'T:G^,K,=2?;6E97]"?WJ(&*UDMUI01_H\.TIL9B-/H5;B6FW'YL[*M;U&B/'`Y@X0=)&J?F MKI9I(80-RNT+21W4]^A&D88WCL"'ZB6)$X:I_F>NOVY`856[F%T!#)N+OJ%. M4SF*=%@,HV7\L;\/'3+3PRBB:@[S$;&5W$%$D8Z((UBX;)$F1IO(F!9"\51[ MF(^'S83BF=L60Y&.AR-8C@L_9IX1D^DQE$_UBOE\V%GN\&GM9UB\'<.1L1P9 MO&49NU0V*H8Y43[5'N;S83.A?,8FLE6OJ_#$Z_G#$-@**9VP66Z9UBW%Y<>2:OI!-'EXM MA.*I#7T^'F[_=_!0I&A/>BAU/+\/4$IU0.KXR>`^*#$/WU0K79]W/OYC\` M``#__P,`4$L#!!0`!@`(````(0"<9XR1?`<``+DA```9````>&PO=V]R:W-H M965T31+;N]*NM%KM MX3H-H8D&"$K2TS-OO^4X3NPJ%IB9BZ'[R^_"?ZIL%Z2?/GX]'6=?RJ:MZO/& M<>=+9U:>M_6N.K]NG+__XA\29]9VQ7E7'.MSN7&^E:WS\?GGGY[>Z^9S>RC+ M;@81SNW&.73=9;U8M-M#>2K:>7TISW!E7S>GHH-?F]=%>VG*8M!`WG;9TVYWSB?W+7P`V?Q_-3?H'^J\KTU?IZUA_I= M--7NM^IY;7K9;N*,09NZ%,M*V/L($X/_9J9*E`7>D^+IQ/'CC:M<=-HX? MS<-XZ;L@G[V4;<?.MHF$`O.H!\3P)PR!*[DPR'D;"JQYY M>Y(+=8O[C.5%5SP_-?7[#)8!W,3V4LA%Y:XAFDZ5LCDF[_]R!TF303[)*'TL M2$L+!??E.0B3I\47*)+MH$F5!M;XJ'%M1:85LB)DV!P#IM]'*S@&P@`+L#CZ MA%K"/GTH[.LEJ6W)0;:M,+#GG"J)Z3"5?W\]4]>-%%H#XGD8V0$9'L`Q$`:P/,+V MBCW>WX+D(.P192E5FJBWZ*[PQINIRX9%2[^,T"UA6,\Q$`:P',H&#ATF]ZM4 M#L(.T6:7*HURF,0N2G*F+AL.,6`8<`R$`2Q/JQ_Q)`=A3ZB04J6!(CR%;`N`>W-U97-0Z6=]QN;F_7;JJ18#)3?M&C-N60:3J M,I!EB8O2:#2&7AL3-@29;@DG1)C$-B=/>L/YX>+!@E,=`-S0*46X=TQ=HTU0K0@A.2&,$$Z(,(GM1I[; MR,T#!:=.>RLW$3[,7-T2&)9CM(MGHTCOXCDAC!!.B#");5`>XM]O4!W]ED&Z MHI1(K:@P2`(/=6&9JQ0)G+=3VK$J'U13$3-"."'")+9C>;H;CN\L,]4+V$Z1 MC]35#8,\BKT(K<)LO#PE40_0A!$-)T28Q++D7>E+`ECZMZWUHU!?$N,V$$<()$2:QO:%6Y(ZG*RU(C%>>AYN)C)"<$$8()T28Q':! MFHG'=D5/-16W=\5!-&4@(R0GA!'""1$FL=W`4/N>>DJD MZLWW5XF'&LAL4$Q^(YW&()IJ+",D)X01P@D1)K'=7.DT'EA35SJ-F*PI)5)K*HJC M>(D4F:=[$5U?.2&,$$Z(,(GM[DJ;\`OSM)!-,T](R0GA!'""1$#&1J7_FN&\0.=[0XU&/UV'X+EV[NB M?Z732%#GEPXBNS1QCS^*QM(DA!'""1$FL1VBYN..L2O?9.!ON5-?B9*D_[YJ M.7=1WY@-@BFQ.2&,$$Z(,(EM"O4@=TP-O4?18QI^=TD$DOU`9&PXO03MH-JFF$E318:!&C*HX1?(I MN9R6&JA\JZ?>ZAGJJ6Q>RZP\'MO9MGZ33[0#**&1JJ?MJ;N&!YGPQIA[Z\R[ MPC_Y/CR>[Z>*1_B!?G"_&"_!@_-+\5K^7C2OU;F='9+W<$C\_['`_R)1`G5LYR#>%_7G?X%)KL8_^CB^3\```#__P,`4$L# M!!0`!@`(````(0!?=,P,``-\)```9````>&PO=V]R:W-H965TOA)(&X543:#;I$V:IGT\.V""5<#(=IKV MW^\:!P).FJ9Y"/CZ^/CX9#6)T"L1Z'[Y^=-BS_B3*`B1%C#4(D*%E,W<<41:D`H+FS6DAIZ< M\0I+:/*M(QI.<-8.JDK'=]W0J3"MD6:8\VLX6)[3E,0LW56DEIJ$DQ)+T"\* MVHB.K4JOH:LP?]HU-RFK&J#8T)+*UY84654Z_[:M&<>;$O)^\:8X[;C;Q@E] M15/.!,NE#72.%GJ:\YUSYP#3WR%DN6G_^4K(7@W=+ M%&S_A=/L.ZT)F`W+I!9@P]B3@G[+5`@&.R>C']L%^,FMC.1X5\I?;/^5T&TA M8;4#2$CE-<]>8R)2,!1H;#]03"DK00#\6Q55E0&&X)<(^3`QS601H4EH!S-W MX@'BV5J>+SN,-T.B'7B]R')1<@H(_4M,3@@+V>DP&9&L[&ZE<8,,M(! MG9%W/J/W(7`/JZG?8-$9Z8M6'_\5X5NR)F4IK)3MU"7J@:5]M+_?'_SVBNX[ MX'YM\);\P'Q+:V&5)(>AKCV#@N+ZAM8-R9KVU`9PS M)KN&*O[^TVSY'P``__\#`%!+`P04``8`"````"$`@S>C,FH&```0'0``&0`` M`'AL+W=OR))\1 M9[$6#UU@"Q1%#]>*+-O"6I8A*9O=M^]0I"URQHF5YB*)/_\<\R>''%I\_/2C M/'K?\[HIJM/:#T=CW\M/6;4M3ONU__=?XF'A>TV;GK;IL3KE:_]GWOB?GG[] MY?&UJK\UASQO/8AP:M;^H6W/JR!HLD->ILVH.N&=7U67:PLMZ'S3G.D^W M7:/R&$3C\2PHT^+DZPBK>DB,:KF:V^[$]5G3X?P?>/<))FE]C="Q*^++*Z M:JI=.X)P@>XH];P,E@%$>GK<%N!`#;M7Y[NU_SE@JDHM" M3:4*RVZ%C=U&_**Y-!(82`L$X/IJ'?("6X=T?B.]+DY5(]=I-'%[M+DA<14) M5J+N*5!<>0MS>S:'6?(8!780W9[)5Z&2HG7/N3\=<(G M\?P:MYOAC=;HU:NF/,&`8<`Q$!A("SB]AZ[8O>]R/7YS0[G84*U@ZW!L+)`- MK8%0EM6EJTDNFDNB,@PX!@(#:0''&7RR[>S]>5%B9&@R=CN[T9IEMY3G$5K* MB?UN%$5H4IGS]F*)!H+KM_LY%QA("S@V9ZY--8'W5ZQJA.VBG6>C-7V7$@P8 M!AP#@8&T@.,"MMGADZ7$]Q:1UEB]QX!AP#$0&$@+.+U7IRNK8+R?:DJ,QQXE MTT9K%HLNUZ+1?,H?D"31DMX@PX!C(#"0%G#\+%T_PW)*-<*^4&'::$W?Z00# MA@''0&`@+>"X"*%P#9^63GTOJXS(,D`((X03(@B1-G%=J%(].+E"7=B=G7F" M4F=C1":]QJ,QJI")$?0V&2&<$$&(M(EK2M57R]2P#`MU57;-H;YOC*CO>T(( M(X03(@B1-G'=J.)JN7E__8=*?3?1M,AV@0DS@7H-)T00(FWBNE"%U'(Q<$YT M^87.]65^@DY3F]"JT=T9)R&$$<(-F76;X'0Z'J."+$@3:1/7G"J?'S>GBZYK MKC\&ZN.:^OH%\]E/0T(((X03(@B1-G'=J#)JN;F3<+KHPAST4T0.G:%5F09230=1`OB M)1%(.Z;K4978X1YU0;8]AC')-ZMJ&X^8L!`33H@@1-K$=:%*['`7NB#?R3>K M:AL7F+`0$TZ(($3:Q'$1H?/`L`VN:X7/-7B#,R*=((LHFJ(,2AQ!3//W1JB&Z=&O#:,B+M<4(M)$;06V"$<$($(=(FKJG_=6J(;IT: M\)=5(S)'HNE(;0+63\@?T%$V,2ULM_J#>L*)1A`B;>*ZA6W`7G0#TU6UPNF* MOFUN(BTR^]G\1KIJ06^%F28]X80(0J1-7'/J1#!X1XGT^0$Z=:U@84RF4(OZ M'B:F64\8(9P008BTB>L"G2K>K\/J">O=@Y\1]7U."&&$<$($(=(FK@MTFAB8 M:/IX8,\);`KHD4F$SQ")(68744O,;<)($TZ(($3:Q#6G2O?P1-.%WC$U(1NA M%ND'0;/Y'+M.(BWHYY`1P@D1A$A#]`=-E_8R=3VJ:C_*X4,_>AKOHU'BW MQE_7CBSX9,"RL!">&$"$+43=;UJXUVJ2^F]&U)F=?[/,F/ MQ\;+JA=UZ13"5[4KU1=BFW`%=QCP?#>XO@'W4>=TG_^>UOOBU'C'?`=-Q_"0 MR_=J?:.E7[35N;M5>*Y:N(GJ_CW`S6,.C\3'(Q#OJJJ]O%`?<+W+?/H/``#_ M_P,`4$L#!!0`!@`(````(0`L=3K:(`,``"$)```9````>&PO=V]R:W-H965T MGXKALY%6&UC0XK\1$/GN#@V5RFO&K#8LY*I9V-J6U6ZNC_47)!]">M^ M\N8D/7N;EXE]Q5+!)<_5#.P>DL'7#:KC,&*]!IMP3--_:-MTH\UW:V M:Y.@/XR>9.^[)0M^^B)8]HW5%+(-^Z1W8,_Y@Y;>9WH()CN3V7=F!WX(*Z,Y M.9;J)S]]I>Q0*-CN$%:D%[;*GF^I3"&C8#/S0^V4\A(`X-.JF"X-R`AY,L\3 MRU2QL8-H%L9NX('/[%)D%K`L\7 M$W\1>F'T/HJ#RS)9NB6*;->"GRPH/0"7#=&%[*W`6:9 MJ:"6L*>/VWG@KIU'V(>TU>Q0`\>HT_A#1?**(NPD#O!UD)"W,63P+J2>-(3T MYYV]6<<.)0NS5WIA26]@``"9N1Q`3]K8\UX&YH$W(D`-%IXAZ`T,","F3_#V M_F@Q%&KOEWT_&OTR:I:X>Z$?#\,)A@W8@`.*_N,<6JPY=(7XKC=&P'!DPF$0 M!R,$#$\1HDL0M+B',%KF#L-GA.BE_DR!)!B>(L27(&AQ#V$Q7.8.PRV"%X^2 ME&!XBJ`;5._@OET06MQ#6(X0,/Q?!`Q/$9:7(&BQ1NC=!^.BVZ$&.;R%%XWN ME`3C4Q!H(!<&.A'=M1<6! M)K0LI97RH^XV/A1]-XJ=<.>MX$*"#C0:3Z!#FG&G"T"#:LB!?B?BP&IIE30' M2W<6PXD1V.+P1?'&W(![KJ`UF:\%_!6A<-6Y,Q#GG*OSBVZBW9^;[3\```#_ M_P,`4$L#!!0`!@`(````(0#Z>3UJRP4``*`7```9````>&PO=V]R:W-H965T M68P MMM$:8P$SL_OWJ:8:4UTXQI.7\;@X59RJ[NK3KL=/W\NC]9;735&=-K:8N;:5 MG[)J6YSV&_NO/Y\?EK;5M.EIFQZK4[ZQ?^2-_>GIYY\>WZOZ6W/(\]:""*=F M8Q_:]KQVG"8[Y&7:S*IS?H(GNZHNTQ:^UGNG.==YNNV5]EKF9]:#%+GQ[0%_LVA.#=]M#*[)UR9UM]>SP]959XAQ$MQ M+-H?75#;*K/UE_VIJM.7(^3]7?AIUL?NOHS"ET565TVU:V<0SD&BXYQ7SLJ! M2$^/VP(R4&6WZGRWL3^+=2(7MO/TV!7H[R)_;\C_5G.HWG^IB^W7XI1#M6&= MU`J\5-4W!?VR529P=D;>S]T*_%Y;VWR7OA[;/ZKW7_-B?VAAN>>0D4ILO?T1 MYTT&%84P,SE7D;+J"`3@KU46:FM`1=+OW>=[L6T/&]M;S.:!ZPF`6R]YTSX7 M*J1M9:]-6Y7_($CH4!A$ZB#P>27(#4=/.\*G=@R&E]_P\[4??'[LA9!3ERY\ MWO-"!ZO5%3].V_3IL:[>+=C14(_FG*K^$&N(U5<=*5_6X;^6`>JO@GQ64;I8 M4.$&]L[;DR^"1^<-UCO3F!`QT*X7C#`148]0BZO"QMR0$(,#"5RR@/7B67BP M`Z_OG9ZTH=J!9P.;Y>!;*:6/# M_KF4U1=+\X4A8K!K5&$C;HBY(2$&@R.\B'*\76$%ACXTN*T8-\2LNDVS\-T5 M*U:$SP?N,77P5TO!'!+B8#"'W7T_L&`GQ,+@O/L)=@3EWUFHA8I"[[P4!:]8(GQ/JU,%S`[$PBY$0!X-Y\!'F M"LR8\^4-$3,PB[@AYH:$&`QNZNK`SK[I4T,Y3?4;8@A';HBY(2$&@^/*Y'B[ MWQ28UX]ML1`QN/+>0@BVJR-\/G"/J8,,/)CIFYV+R5T)#^"MQG][@`N7)S(/)7JA!<%X-LB,9L4B#EK!# M"(II;'Q/J&0JE)FW$B^2]\2Z*33;>?QX"P6"AF6)1I9X9$FHQ62H1(HPO'-E M4-K@[U!.+CJA(/K7W:*BD24>61)J,9DJ22),)VJ)`F;L'<%/('6KAX+W/>`N M1SV`@*'8L>$BE@NN"HD&7.D!)4SW\T<9,_B/3R&JA0_^2K+FB`010WV1-5V\ M@!^BU,6LOQ*O^_FCU)G\1V<0@K#^8B46H[XE@JGY&RZ^]-F2)8*XF/R5L!'^ M=^YTE$,S#U;F4/2:2=J!W[4C#9HZ@ZZ%XE>0/E?Q`]16:J2FG%TH$X8\^&3"!B/1CRIXZC'[?)M3!Y/Z_ M=%:BA,([!YWEAWRH02!5!,1_`6K0Q.ES-10K2C(5RLQ;*>C]'8-ZZP7=+$P- M"$(U,U/+.)BBL2D>FQ+#9')2&D@XJ?/&A]=\<-0$,\CQ!F-WRE"#U/WKLCJ2 M+V$TH(;I#48'Q]ZDAI[JA6C"C'"(B7.T,J_W>90?CXV55:]J0#F'B<#%BL/3 M$(:GW:21V^4:)DCP*F:/)0Q;K]@_RSD\Z!J#>4#*_7S6N3R"^>@YW>>_I?6^ M.#76,=\!/7<60-5KG+#BE[8Z=X.PEZJ%R6CW[P$FX3GL!'<&X%U5M?T7-;2Z MS-:?_@4``/__`P!02P,$%``&``@````A`'GPSQ@>!0``:10``!D```!X;"]W M;W)K&ULG)AOCZ,V$,;?5^IW0+R_@/D3DBC)Z8*U M[4FM5%6]ZVN6.`G:@"-@-[O?OC.,$VQS%Y*^N=T='L_]/!X_!B\_OY='YTW4 M32&KEN4^>+KOI)U]GR$>;^S*,LON;L_!NG+(J]E(W?M!-)Y!#J< M\]R;>Y!IO=P6,`,LNU.+WP*]+T0YT;[W6D.\OQ;76S_*"H! MU89UPA5XEO(%I5^W&(+!WF#T4[<"?]7.5NRRUV/[MSS_+HK]H87ECF%&.+'% M]H.+)H>*0II)$&.F7!X!`/YUR@);`RJ2O7<_S\6V/:S<<#J)$S]D('>>1=,^ M%9C2=?+7II7EOR1B*A4E"522$.C5\^#A))%*`C_[),$L9O%T',6C:755XEF; MK9>U/#O0>@#>G#)L9+:`S)?RT&2N!?M9O:!0F.0+9NER02D:6.2W=>1/E]X; M+$RN-!O2P+ZZ:IBI2"\*7`5,RR]I<8&!]PH-];2A0^B,'Z_IA1$'F8Q!9`)L M?B`Q%>E0,8U-"1]*@EYB3`/:X?%IX*"5"TMU+6/D)R;"AC34SEC(U`YP+6`@ M05X=Z79%40S[04,)0XN$)/.N)5@4,KM:*0EZ5&Z,"!+&?E(\V'WWDZ+8)(W\ MF85*FBEU;Y@D5E%3>JZ1Z@-"/V%]PQLEG3X"BF(;=&Z!DH9`6<"LQRD]CKMY MQ%%?/=I2EZ?VEDI,2O2!\2V%@RQ:YENTI.G+EMH!K@6,PN$1;%G3.!(.&ML> MI-&0[`#7`@;2W$2ZO3U0;%5GT'2DH;6SBI?2X)^5:P`!C8'^/%ZL;92$R MRY4W2@3=WCL."\Q53J^BWKN1:.5V["8JNOK#Z\KH+-#-)F*VVRA17Z]T$.%Z MQ.1"XWZ7*NOSL"/&8ET+CO"=8W)A5ZM<=UN.D;.;M1IT'5*1&T71XFU M9U/UO.?E>L2D0[_6Z.XS#D8N;U`.&X]$(XUW$?6-IT5,5#1L#76DD&3O.F(X MM[QV@V^2ER;O_#4=1+@>,7G0BS6>.TM'#@Z3O-5PFLTK+CO"F18QN="0-:Z1 M.I%]&W4:[$O2J",KCI/^J%1TVAE`YQ33(B8=>O/]=.3D.MWPY&&L*D?]^YCTCYD__A);;^]:6_XW3[<*%$/DPXB7(^8 M/.B_6O7N7%5R[=OV'VC63HXQB'`]8G*A\VI<(]U//CVRJB12GX%S-NV72.%I M;M]%\$X(ZW_Y<@RT#QFBI1L?NLLH1;T7J3@>&R>7KWB;P^#SYQJEFZ8-6\`- M`W[W7!_`1<\IVXL_LWI?5(US%#L8ZD\26/N:KHKHCU:>NIN#9]G"%4_WZP&N M]`1\6OL3$.^D;"]_X']PO21<_P<``/__`P!02P,$%``&``@````A`(F@[J_, M`P``F@P``!@```!X;"]W;W)K$B['IXY/ M53F5_:?7LK!>6"-R7D4V<3S;8E7"T[PZ1_:W?Y\6&]L2DE8I+7C%(ON-"?O3 MX???]C?>/(L+8]("ADI$]D7*>N>Z(KFPD@J'UZR"-QEO2BKAMCF[HFX83=M% M9>'ZGK=R2YI7MF+8-7,X>);E"7ODR;5DE50D#2NH!/WBDM>B9RN3.70E;9ZO M]2+A90T4I[S(Y5M+:EMELOM\KGA#3P7L^Y6$-.FYVYL)?9DG#1<\DP[0N4KH M=,];=^L"TV&?YK`#M-UJ6!;9#V07DY7M'O:M0=]S=A.C:TM<^.V/)D__RBL& M;D.>)#W]PPJ62)9"YFP+,W+B_!F7?H9''@01+0"#B/_Z,`\^1G&',./K/N13 MF[8OC96RC%X+^97?_F3Y^2(ATA)L0#=VZ=LC$PFD`6(Y_A)9$UX`!7Q:98[U M!#;25Z4N3^4ELH.5LUQ[`0&X=6)"/N5(:5O)54A>_E`@TE$I$K\C@>^;>N][ M3N@OUYM[6(*.!;X[%N(Y)/16OU;BJEVUACU220_[AM\L*%?0+6J*Q4]VP/NQ M*V`'8A\0'-G03K!A`:EY.7A[]P7,3SK$42'@C70=Z]*-" MJ/I"P?'H@18?2,;Q?QX7P:!O%#KMF8#LEJ'A+R[II4-_L3-;F,$ZTJ(V<<*HM)U M^JC3XQYA>K.]1PF"#27&>7%4$,S7RX$$RTVX,7HK[A&F$@)].]^4%FUH>3\C MU"G38<953$PU`V8B!T^^V3DBZIP<]S8QF[O#:'+,]AXP$SEW';A$'9^:'+/% M.XPFY[U<6P?C`3.1@P?B?'<0;23+;'2B,)J,D:V:RO?(Q!;%\8&4NPYCF`4G M4LSV[C#C+/E&V^%,B3PC.6KR4X-,R9HSBUE1""OA5YSD"'@\/!U&TVYF'%[` MD%?3,_N;-N>\$E;!,ECJ.6N0TJ@Q4=U(7K=CTHE+&._:RPO\!V#P*^XY`,XX ME_T-EM'PK^+P/P```/__`P!02P,$%``&``@````A`'633Q[G`@``O0<``!D` M``!X;"]W;W)K&ULE)5=;YLP%(;O)^T_(-^7KT#` M44C5I.M6:9.F:1_7CC%@%3"RG:;]]SO&"0.R=6TN"-BO7S_G''-87S\UM?/( MI.*BS5#@^LAA+14Y;\L,_?A^=Y4B1VG2YJ06+O/^W?HHY(.J&-,. M.+0J0Y76WC>494X?I0\_\Q;!LF&,ID"[(5X,-+[W`S!8N]B M]5U?@*_2R5E!#K7^)HZ?&"\K#=6.(2`3URI_OF6*0D+!Q@UCXT1%#0!P=1IN M3@8DA#SU_T>>ZRI#BZ4;)_XB`+FS9TK?<6.)''I06C2_K"@X65F3\&2R`/K3 M?.RF<1PMT^2_+IXEZ@.\)9ILUE(<'3@TL*?JB#F"P0J<360+R(_E&&+]5Z@0 MHS&Y,2X9@M,.RQ64YW$3X>7:>X2ZD)IHK=66%*`7@#(T0^9OQ[UL\H M1FQ03!4,V]8.@/?`%L[VO50LXT$R(8$,C4G.V7J9R"S*4#0"B'`R^%M(J[%G MQU#O1@,3`K`9$[R\LQ%#/4<[AXD_V]EJTK2OFN]&48C]T6^>J[D<)TL\^J6# M^X0:SN?KJ8UX3CW#V%H-7(>B1OC/WGU.=R]K)GS+M_`9\9QO,<1MZVDUIZP& M;A)^N)J%L)M)<#!*(\;I>,&$-7D+JQ%/62.,9ZQ6@^T!F,Y!4S7KYW.6Q[9+ MVTT:)DNV8W6M'"H.IA6&X#>,#EWZ)C0OYFQ\"]V[[W7>,`'=LR,E^T)DR5OE MU*P`2]\UC4[:_FL?M.CZ'K87&OIF?UO!9Y+!*^2[("Z$T.<'TU:&#^_F-P`` M`/__`P!02P,$%``&``@````A`'!B*ZMI`P``NPH``!D```!X;"]W;W)K&ULE%;;CILP$'VOU']`O"]@[?=P8'%ILTS;Z$8,XV92<5$N?1)$OL?*1*2\ MW"_]7S\?[Z:^IS0M4YJ+DBW]5Z;\^]7'#XN3D$_JP)CV@*%42_^@=34/0Y4< M6$%5("I6PI=,R()J>)7[4%62T;0.*O(PCJ)Q6%!>^H9A+F_A$%G&$_8@DF/! M2FU(),NI!OWJP"O5L!7)+70%E4_'ZBX11044.YYS_5J3^EZ1S+_L2R'I+H>\ M7\B0)@UW_=*C+W@BA1*9#H`N-$+[.<_"60A,JT7*(0.TW9,L6_IK,M^2V`]7 MB]J@WYR=5.>_IP[B]$GR]"LO&;@-=<(*[(1X0NB7%(<@..Q%/]85^"Z]E&7T MF.L?XO29\?U!0[E'D!$F-D]?'YA*P%&@">(1,B4B!P'PZQ4<6P,\E1:5'\,2!RIC(D\9D$GA=(K@0.SH'P/`>2 M83`AT6PP@=G[@:%17YOQ0#5=+:0X>=!AH$]5%/N5S($,71BV#*TO_[(%_$"2 M-;(L?5@:$*Z@EL^K410MPF?P/SEC-GT,L1';!H%E`WFM1G#'U8B5,EG>K!%9 M4".6$D5OFH$WT;$CJ$&X@L"HKJ#++=-X@V!HCHXWPXDST<9@3)NAMFUGP+)B M:,_WC M/Z(PSA7EN+`QF"LV&MKS^T-8:LIH$3E\K;5Q@8[#BG?MN36/[T>U+LQ>?0:2[3<;3 MJ5T\O`]@A0'5.F/.=W.D%4SNV9;EN?(2<<2S&_UM1]M[Q;J^5CCC&[QO(*\[ M'L^WE_!K@@$7(PB$@%34V)+!U:&B>_:-RCTOE9>S#.1%`9[6TEP^S(L657TH M[X2&2T/]]P"71`:'0A0`.!-"-R\X07OM7/T%``#__P,`4$L#!!0`!@`(```` M(0![ZQ[$U`(``'P'```9````>&PO=V]R:W-H965TK.Y>FQJ],*FX:#,<>@%&K*4BYVV9X>_?'B=SC)0F;4YJT;(, MOS&%[];OWZT.0CZKBC&-@*%5&:ZT[I:^KVC%&J(\T;$6=@HA&Z)A*4M?=9*1 MW!YJ:G\:!(G?$-YBQ["4MW"(HN"4/0BZ;UBK'8ED-=&@7U6\4R>VAMY"UQ#Y MO.\F5#0=4.QXS?6;)<6HHR_SM@2D* MA@*--XT-$Q4U"(!?U'#3&6`(>;7_!Y[K*L-1XL5I$(4`1SNF]",WE!C1O=*B M^>E`X9'*D4R/)!&H/^Y/;R7QG2";WP/19+V2XH"@9R"DZHCIP'`)Q*?$G(P^ MU3]E"BD:DGO#8KD@"075>5G'0;+R7\!2>L1L'`8N1(\)QXCM"6$J`?)ZC9#X MI<8(2OA[\T^2S*$+2;-QO,TU9#I&;*\12=Q#1AK!NZ'&OVLSX`S/!E9$P47H MC<.X9C(>;P9#,^X1MK;>C_32-%_W^ M2!;T]>VR#/C2D+/1-N[&80:&#%Z,(B?CR*:E_]TNYM#8F.BJ@QTFLG_B#2'+D6FO?W.)H<)`U<_F$=G`4[B&!!ZL_.U M<`K=%'13HF&R9%M6UPI1L3<3+@3B_JT;OAL8OG94^?T&#+^.E.PSD25O%:I9 M`4<#+X6:23<^W4*+SE[2G=`P]NQC!5\Y!@T?>``NA-"GA1D+_7=S_0L``/__ M`P!02P,$%``&``@````A`&#MU"-:!0``_10``!@```!X;"]W;W)K*7$2 MU(`CH+=_OV./&[!IFO#2%.;S^//,^!OCU;>W^NB\\+:K1+-VR<)W'=Z48ELU M^[7[S]\/=XGK='W1;(NC:/C:?>>=^VWSZR^K5]$^=0?.>P<\--W:/?3]:>EY M77G@==$MQ(DW8-F)MBYZ>&SW7G=J>;%5@^JC1WT_\NJB:ESTL&QO\2%VNZKD M]Z)\KGG3HY.6'XL>^'>'ZM1]>*O+6]S51?OT?+HK17T"%X_5L>K?E5/7J#%UVO:'M1M$"Q;[`0&X\\B[_J&2+EVG?.YZ4?^'(*)= MH1.JG<"O=D+H;">!=@*_@Q.:,,*BZU0\7):*TGW1%YM5*UX=*#T@WIT*6TSMP@ M7&-N,G4!%,#7'.4@BV-X=J^6D2$D42F2Z\I'+PP"$)`Q@:\GEN"U&XY7'ED3 M(P3+3$T\>F%,#%YNGUB"(3+CB6-K8H2D*F5AP@+?M.=C._-CFI[M!BVH^#$M MF9#H:D+D((M>Y3X_K`\@UYDTOLZ71)LT1I6C;00 MPA2MB%G)S"]9#4JQ2>FV$I:#3&IVPC*$8,32(!X"HICG8S-CE](I>]S->U^" M+5)6FC*$("E"(A);&R\W`#1,Z>#!B%HZAY@$6\2H63\90I`894EHA\NT,W\8 M;]`B4.NW!TRA+6(3M90>81.I$B-A0*)!"C&3VHM&T)B0`6&2FZ?DJ,)CT0BL M;&4$,3AU"$5FA\T`!'Y,ABUB4K.$_.N-25"-#6K#FG%G:@Q28\E$,$P[#0;F M)C&IOS?O`"+15D*'%6MBB$%B01#&DSV@O6@$"<+TPB8@LYJ`0IOM9[1J30YE M?M1_]"CUQHS,)U)_O??*@Y4=(5OK-0;73YD?V;W(``0DII=VXRRY)U.]#VR] MUQBDEB0C==)[$7V@/8K#@;D9.TOTKY3[5.U'CG7BQGI.X;AGZEM.QO;`]R\1 MFR7X9*KXX5"JFMA8T9-TJA!HQQ::CL3-#-@LO2=3P0^'$M&\QHH>LC"QA#?7 M3C"5(0WI!86@LR1?H4V%"*V9,XW!F0GQX3O"RJ:!2.*+Z:2S%%^A+6ZVXFN, M+O"46&'-37L4#VLS\DEGZ;U"6\2LD&0:H]/ECQH-[DS33OQAO$G,TGMY'(M! ML[[>H72J^Z&M^QJ#A3YL/\T.'=A&DYJE]I):>O5L35'1P3_`\8O,/MQD&H.S M!Z/C@R;WT13DYUQ`AI(PZ5G]X$K$IGT@M/N`_&:%7H&T[MB0,4WKDMFD-:L' MT&D/".T>H#%8:31E)+!2G5L(2L@E[9C5!^BT#S"KD#*-07)W!$Z#S`IK;D%( MZJ>#%S-VL[H!G78#9G<#C4%Z)$IH,&$W[AW7_*]=S;`Y=.IV/.?1;NOFLXY\AVX]!=2IEJ\OL*'7IS4-<>CZ.': M2?U[@&M&#O<9_@+`.R'ZCPL@=>8RP<<.CXRJV%Z!>^SXL:MXA[M,<=M%24M4C`+=OZO&<8 ME:I3V_A1$"1^BTCG:H<%^X@'K2I2X%M:[%K<"6W"<(,$\/.:]/S%K2T^8MH>/%6-Z_L6U(PRFDE/+#S M->CKFE,_]<%IO2P)5"!C=QBN5NY-N,C#T/772Q70'X+W_.2WPVNZ_\)(^8UT M&-*&<9(CL*'T04KO2_D(.ONO>M^I$?C!G!)7:->(GW3_%9-M+6"X8ZA(%K8H MGV\Q+R!1L/&B6#H5M`$`^'9:(J<&)(*>U'5/2E&OW$GBQ;-@$H+, M[AV8>@#.>R0G`-M^C]HLI.%E@SV&DU+PD"Q!5X0FNWY MV^T&'KPCI\F-3RLIMK".56LL+4D451CHCT4V*C'@DDO@I-B"FYO_G&E)K",S MV_+S;0;.[!(<*;9P4O,O,RTYCW.^S<"1.^#%*X/L9&(E@86E)6_/K+?;#;S4 MQ!N?65)L85D3.M,2/;,FGQM##BHS@AOG$ZI+3QKMUF&UQCIN& M.P7=R5TZ@I=K>*I/$%FX@)4<=F[K>0XG"_7<'QI@8^_1%G]';$LZ[C2X`LO` MF\&2P?310-$VJNM8T,%;.GJ9PU'.`Q[1."!N*)4O-S(P\=P*%S_`P``__\# M`%!+`P04``8`"````"$`HVSZ19A)``#Z]@``%````'AL+W-H87)E9%-T&ULW)W;;AQ)MI[O#?@=$@(;9@-%-H^B--/3&Q0EM;5W=TM;9$]C,/!% ML2HIUJA8Q:F#),[5P/`C^&8#-F#L:S^%_2;])/[^M2(B(R.KBM1,CSW>P!S$ MRL@XK%CK7\>(_/H?/MV,JP_U;#Z:3G[S:']W[U%53P;3X6CR[C>/?KQXN?/D M435?]"?#_G@ZJ7_SZ*Z>/_J';_[]O_MZ/E]4O#N9_^;1]6)Q^ZNOOIH/KNN; M_GQW>EM/>'(UG=WT%_PY>_?5_'96]X?SZ[I>W(R_.MC;>_S537\T>50-ILO) M@G'W3HX?5_3-U_/1-U\OOGD^'2QOZLFB.IT,JQ>3Q6AQ M5[V:^`#,^^NO%M]\_96:>O/#ZOOI9'$]I^FP'I9/O^_/=JO#_5YUL+=_7#Y, M(['B%2-5OS^]G"]F_<'B/Y5OAFF]K=^-U(+)_M"_J3NM(/7=L']7_<>Z/UY< M]UC&8+=LE"9Q<7?;Z6%_;^>?RQ?.EK.9R/-R-!_TQ]7OZOY,:Z^>]Q>=]\,\ MSZ8W-]-)=;Z8#M[WJO/K_JR>5Z^7"]MK-K\Q4R8Q8P*O MH/NGZI_JN[*7V"[,]VU].YTM&(UY]!?+>=G\=W7GI]##;Z?CY631G]VQYC'< M6[[YP[3$;QHS:LS"/-N.NO,[X?I9*<_&-1T28NA=[ZFIY_J\7CG_63Z$2K6 M_3G2,:Q>S>?+>E:^D/;S33T;3<57J[V3)TO++M/^^7\SF; M3N;3\6AH2WS6'_*ZGGTMJ?EL/1E>CKK`]KP=)V([*3D_G'-L[6X\.3JF^_@0V#ZP0.]I05U#>7]2S^>M1C/*UW,?I0CSL< M]+R^JA'&8;7H?Z)3%EBN[\VLONV/AE7]"9R<(W5:JY&R&@2YL/S$#?&?"H3D6[6\FLD:6C:"FSY_]AJAEJ]?: M^]"@?.837;V([T;]R]%XM!B%A<\%0-?3\1`A_M__^O-__I\__Y=_M8DO.J1- M^WW;O]-FVQK9T=D2W:T/#[S:.EQ8@AMK0BV](,_<-3>'`P*1&_5ZUM;>[MU_= MHC40M67]JVI_K[>W9_^MYJX:^LO%]70V^A.D[B^JA\C)KZO)-+X]$B[RICB] MT3$/[:FD;-!=ZR;_]!>9/!;"\>.#WM[!$YLV?QX]>=K;?_KXEUG39A2YP%R: M+]%NML9R_:?#(0(TG8`&0I*=T02LO!V!#IV6`PRGY=B`?EA?C0:C#C\[FWZ& M&/H+&7L9?3ZC@XWJYPV&"+9;O1AARVSJ2P?*4M M79^[H/;;&^>VLNF#)W8OH5IL)ONREBHT-?^:#>E+@M;:.[F3<%12Z*VKDOFO MR@>G0\S[Q6@NBU98-[^5I36;7X]NJZ!_.EJ=_;P9+6^J>3W[,!J@%=#)>#!8H1VV=JMD5) M@V_K"<3%U&+]_>'-:&+ND(RELJ4O2/8*>Y%-O&SWW11;\VHVO:E"6XA:ML%H MJ3'+%G'U&VR60)^RAU6C5)?87O/,#QNN8U99SB[\;D#"D/#?C_YW+_GPT,%H/1^.E7):'XC= M-6WG^H7F";8J8^R-WHP'M) MGX`D-D+U^^_-7N\XZ`A:L'HVMTNZ=W.S3`F_"4KXS)7PVAF\K1<$/=BC%_W9 M!(Z?KVUIHE&N,GIJV%\;W:K83IP0MDF6UL9W7GRJ9P-YL-`?OSCL;.-0\SYG5E?CI:C3!$Q?"#]!`'7`KYA2%=!.VGEWCH:*K8/!& M?;B_:<-GQFF'7LF+;*(&Y7($MP_:C/+%DCU&DP_H)*U\$WNX,6]LP.X_U'V' M;(.Z'@;-.$=WB]:72XP/8C/ES-[T[RQX)ZT5VU2W2Z(=$LH4-K%5]P=@,R&, M=7T((FH<8.'WD`C>?(159:[=AIA`HNE2(,#&/80V)3T;3EI/SS9=F!$@\T!L M>S.#Z4:WYE89N5"$R;6JQKADT/AR/'IGLK6.QF9A#J`?!L-5'TD7G9J9KY2! M1!T8X,,HB/]V(!6V1I*@]>M6%\.:<35+Z.M;B1%F_]@01C,B:_O*ACWLGG>C MB3256`O&)'A9,L6&MPD8KW_O?'E[.S:+''(/B5N#A$M,+0:R>0AD60;\2A)A M18P_&7SR@,M)$51/=IFYR&6##:-/"`';##(&92$/V0)%?RWFJ$4$>\ITJ:0N M2E42OW).SY=8DD1,""L3"Q,A'O2*Z:%<92=^[S#H3_V9$A/@IH=CQ"73R42A M3/C\XVAQ77VL+Q'G6K&@!79\U7\WJVV7RME&6Z.K,9>1EE)%UAAM9`DVBFP7 MO,\I$6*BNP`$02!WTQ?7V((!'.?BVCD)P=F\%WH;$#72XRLZ@Y>)'/5P/MT9 MES`)W@)+,Y@8G2X6T,B>Q)9L<#!2HS.^2]:CKL*JJH\D"626S%B/A=00("W< M@@M:VO-ZW/^HJ?#@'_N3I?)3)#L/E%TX)=_4K[Y'+?0MZ<<$A;EFR:`0D3F_Z$SV]ZM^,QG>A!_WPE76\*)FM,_3?9MC5C%]=@IW# MD*MEV5F^^1RZD?T:*.D;S$OAVQLX?D">HRU:BV]6--D@[O=T7FV2[X/=ZI[7 MR[D%$TB!(/CY3.$K2Q2NT,"2#+(O+O%:KZ326V/A!7V)C'$-O",]X.83) MPZO+$(_3WY%S)17BP?D2382PS*"@BR$8M!SSA(DU@2!S9'P2EE(*MFOE4FC# MF;FI(>Z?H"E3-:VOKCS#IW"R624^9RQC]"/4V*V(&U?S;.='"D$%$1Z+0-),3KV7^V+FSNB&A+3Y4I"UB6B6;2\" M=0V*M3$V,UY>3OI+K%)SPN_;JF::8#_0Z4:[]GLV-!O'`.''W?/=ZIU'_)!@ M'A.'IZG:L7P-'O2U.&H;#?'MZ>D;5P^.G7.!GJ)8@#0ND*;^X#G*K-(;=ZIW MP-IDX$ZV5BC;$WBJX?26<*0G^8`>PEZ>'(UL2=(8K=%XZS!:GR06%NBXPELD M.:L%L6,R5+5?H*,(@P6%WA'8`Z:F*@&"J_YH!DDT;&#MG__\+WAK:0/-<6(V ME@E:P=CBG&0*\V)8;-Q,-\?G8=TK$G*4MZ`E+AA_O>!H=HMK3+R*D*(J9IR* M96\L=S)=I'4*K$>3H2EGF!DRJ9\XBJGJ&TI<+N5Z*5$.B>+LXU:)D.5>'5AN5ETMC<7'ZQ%%&*L`/!>DTPGVU;C".<"XE)_^DGTD<;WS3ZQU3,_)8H%0 M>NY,?>QU7QV`_=%CGR\(U\`L7:5]`1U\_]VL#GMU/XUA01J)!\6Q-BGCE9E< MJF`I9=8&=W'N?^B/QE;CD8DO*G>PT)Y'I$''P+W#$>0`+I0@HD:!?4R3 MV*U>3^B5W7\WU=Q-S[0-Y5H5#]KP8OK&R0WAI4*$#NK%!YEAZXOP[%F@'O\_ MF&()2IAM+63H\/($7_"HXE\JB\L*0CC:8_%-AS7#)K)BDP9^)$&>?KR^EL@BW8 MLIE8`V4MZFKK2>_)T1,P@'<#`D3+P^B6;T9)H^/>XY/'O2-H$XA8;H5`%;K9 M_J=9L=D#LVZV,*3V]IHJ#I/C.'A@`#/N,`:)EAENP8\0=6%E='`?+"!+,<3I MFNPJNG6!&VS5+I@@X2TC.4P-=/7?$8$CX&P3V7_2.SH^Z1T<'J]92,X^QR1"9A[&1&H(^2R1S>XB&9HSZ;+=]@-ZVLPYFP<8L-VM"HN.)EE/,2S[BI/!E@BI0N5SP/0)^\9?;-Z)TG*OY(41E$2-A M-73?A59.,X_OWLJWMD(2\*75O63789)MH[@XEP.M!F07&D$AY5SG%.FZJH/5 MK)!="C5+:L@+"Z9)RV!-):^MHI84'L;@_ND:GS;OU:+-[F-9R,[,<:K1%B,B M_WB_MFKV)".;,(B0'U2#^^L^9F!H9B:&@9T0UA@60IF390H/D[X&A_"G>5>! M5G,\54Z#\3Q[QX\?-;TXJ%F7!I]SF?2,.+ZSB-IH(H+I/=KC]LC-(2$C(H6] MD73#&<$E*OKHR=RWD1;7H]EPA[XQ^FJE=%1CSK_DCT MDMG`-^:5F;%M]A,QI:S3N'M=10#HH0M`#;`K$9/W)X+IS!'H#OODL"FC%2L\I,$E-'X]%52S#'FS#*@!)"]X4OET0'C$_DY\3>2<0:B&9^'_CQ`C_$_C]$?PQ^85>"4W`N,Q*D*%R2<"LE'5:?UJ:&I M?G,^37CZ@YD52S0ZP01"SDS*+02S6#R6S'5MU6QZQW$;)#'6W(O^#:G$`\2Y M;5<&(6X0N[*Y10Q/8XG4ZD/SU`QD\K.^?(LB<7-`)I%EI-9O'!P)>;XXI/L^ M&P?.V.'&4@G!)2A)B:?B1`OF@[DD&&A>HD)TI*@%Q#.93P/1!)JH(-+7I%58 M)FK/^ M,.UT8HAAMAOGRY023YMW)T@ZZ2*DXPG/LQ=BUW#-;^3M2HC9$OKO8JNR71467OJN-?BF^)>[<64QWG$O! MH!C!EF\8L84M;/D@Q!:\%D`C'!P?!JU\'Y5;P3U)9TKX9&%%NBP2-"+S?7'F MHPZ?B+%F-7;;7+;>*XM(K&"7Y(.["F4#ZQO/$AF=)/Y-+U":N(;+L18S4T@' M(V,"7E@Q'KJ0R%Q_+,EJOVJ/!6EHLVA^R)E09&&%TGQ)`J#ZK<[3B*M>IOCK M*TS,V=+J`06W[W7 M";%D`P8R:7?D2@Q1H;$G3'<(-T)-H3P)6)+Z^CB=O3=#XL8._.BMO"\HG.+$ MBJ5XD11O7U*AG;?TU]VC4@@E#65<`MFH\D87*K9BA11$U."G/S$1T=N7)8[W M:*BLA44]N+;SV'/\*5DW!J[!=9^*M`)/[W;@Y$U>7/D"!EIY?J'52E)AK4QQ&\0Q8PPC MS*== MC0%;R=>S4E3!1Z31XOE5_R]M6E*5#E=4([&,X0QOY79\]14,A MM'68DY=[R4N56ZA9KEA#XUQEPW>VXX*7`V"Y_M/LY#.PN!#6;J+@@MT4&X=8 MSGCQ]636"YE#)^)S]]C4H6:*S>;%C`(NLJ^+':87:A#-@+]5,:R1/P^KPYC0 ML#SV$ET)-Z45]`T:/)@C6?527(UAF(U!#L0-6VTK:.-5IW)U*;/LW\UP%6BBW?Z^AI$*6.>]5LN(RO9+)JGVZZQ6#_=O<^#QJ)0XB5 M6;VF"!%Y(5C$L`(_VF:;T,`YO&%>;!8)@_,E_X2?I'`\H:[S!V2D!_C[=JKI MWP13X4.-:LYML%H"K:$TH$%O@P]LHQ$EJ/CYBM"AT6%O)(AM98$)B2A/@NY58,!/0RE8QCD<#HU80^ M">A*XD&A.+&`L@'7/+ZQ>D59;O8^P]I=#"L'*>7RO'YG!-EPF4I+=&$Y2:C< MPUB;99#$'2]XV"':330/7--Y!+:"F+,L(1\'P\FX43\%QSU4@^)'+(5?@KC` MUQ'<#2]DVF/L051%6\S\#'UZ.%)RXE%NJ8`59$RA*2'AD%"Y4J*F4:V&:3[E M+,2*\/Y;2GM@F-.FGND\&'6=(-BKF(AK/,27I^?/T+I^]AU"R]YYA^%JX5;Q MI"]'Y+!,F2JF=$Z^\9X`^%0T,J%F,KY-H'F"OE`D8LK9#]E.IN]NW1T)$54N M.4'..7YZM5!N5>,0X<6PFBG?*;X;+.@(DE/XLZ`^P3BN&=WV(OBOO$#?5JL$^.160=H5[(:KD\QQU7A8K:(GR427=+"(0*+#>_^ MJ0D=6[*#<:E,$G-36X"@XKS&T\P2-ZM_#-$'.N$^&W*>"BUA*\%Z[@%$#K8( MA/L"(JM*[+R:P3B<:?BN,9CO!5/"1>5/YQ75?W1F85ECL\\F"Z3&)5*F4HO] MU'>+\ZY@:=C>3!JV/9Z%66=[NHD*!/J M1WYC"F),7O22,=\:J2+YD>%W)PY&L-BS1KI09-HK2JR(D(>;:;0)X>X'"9(O MS'<"QP^9=U_$!XA0&W,0=Q8\C0&W[ENV4N;:D#24T4@H-94X7%29XK^T"A-S M2XQ$[^X^\;'QH@&4(TBISQ"K?URB)E;+U?)6Q;P9!#.^9^0E+>E0:N;!N_/M MJP)?J1&@,E_U@LKF4F`G@`C]$CU`[J71L?QL"&L]2('&[#)H53_"8PXE.P-2J]C[8&7A?,PZI[ MF&6(00ALQL:=-L5XWO9.41N'(^&ZC6QV<3=$(2'P!1D+%J3HR1ZH_'-#<<4?F^!@B5>*U/!ZFE'I([H[Q%@?*\#ZM"5%:JTZW4[R8 M59(["&L:K0_`)`^@SV M-4:`1A";-B6I6\?&,VG+8LU2ZLWV.I@_%F@0&X4"B^B/2#+\C@PF^>+9JXOG MI\&T9CY@CA;"N.0A#+IABT*-1FW`M(!'>J5]]D/*E@0^U M[#B7C01QOB-2KQ@0MNV*282S*7!QY&&U7*EFG$WC'.10S7"9Q).FD5/O:$\Q M0;)*@_8S*#`>\>.QN@?1_8QVQV[\!&:V]@VDXI++T9Y-*;+V`Y\-7#48Y2;L MS0VW\L93N`ULP0I@%H;PH"9N(R_)CD5KCZ M$JX$P]*?5CQ/GV92(4P\C@K%*DMT5(!YP8!2!.%H'R?"W()(F2J-@4D6G;0F MUS?W[8LA%G@S"\.T!+0I*-!H08=L?[PXTLP MV^AU7]6%]B$9'3O1:G3+CV5M[3]^:I"3KR7D%(S([2O$S/FW2U.#);<>*5/P M18MN:+F2SZ@?X[H),6T(+2YOX,J4'LWW,W!,IGX\37<_:^0\0&8EVWIQC8B9 M4&*2V50Y,JOJ0X)(60B@I9[MB1A=$.AF0.^ M@JYV:"]9_JMGN:*/%(W2VB+@)13V:V#MR*17K!@)\L4RAT;>7/XD]O)QLE-! MO(9E@"*87H;;M3PYWH[B6Z/ZDVJ3($DR23IK*0,*6^4/7KL4=;?O?=GFSO!3;I M\]5F,SVU?=CX3J=U9OAO<"):XV[N8X/OP(G75D%E*S))2@]T=[;B$<><_"`"?;AOI2`I9O"*S+C7/=#7 M^B1XJMQJK3>`HUG+:;]L$_>/#GO[C\G@V81<54CU83+4S?`=!6F)51O1OD`8]=:,U]]ZRR6H)[$^(6OUA.?3DI.87 M[2*V/WOALI;4BK')B%CVT3W"U50VL,:"\#-LRF,VVF877D5@[4Q[-RT;\K:B M;Q`>J(P3K2!PH]ML^SC12&*I4<&Y!**G,K)+)DA>$IW@:N$@NU%-6E?WPHGI M4FXH(%K77?$6G'-R&-=011N(;KDVB!% MIT[M$B/D[S>/YDL<8S_-ITN%_C:7!7VSO1\LLO:=0&=+3W*V]4U[C8MO+AJ% M4SYRRZ71A)V`[?_Z'QWC]`+FP1&TMS&_8!7JSI_PUN[$LO[FJ1,I(IL$'#2]@`^O**)MR8 M,="0^!6&AL-/]W;SWQ&;(I$T%%>D$HO#_0Y(09[C:MOS7_MH0SK.FL\7'0\& MMB77J=QHN>OV:8P+59L^7_$ICN;#&7JZ,:=`!'%S7\PA*E\ERYB0&?"R8MO% MQX2%XYV(X=A:-;]SPX%7+ON3]RX*VML86A&[N/%(D'M,S(R^(3\<-]DQIU0D M+89Q$UG.;O'`PCSNR+*Q.@O_@0L5,>5TG\#;\(==L13L@YL^Y?C<,,_Y>K_% MD,@5*1'S1@X]@FM2BPD)H<>Z.E%=&=EUD:+UQ5!;1_9A#8LZMRQ[G2I8:97G M[C4=/)]B=,Z>6TZ1CR_M$K+S#V!Y?*Y77]%AVF:@27WKJ:9/\ M2+_)JD5S[?(P=?C82&<=TB/7/")')OKA:`>E7"PM`G8SB-:MJ2K`'%ND@N$8 M-VJO(S'=4TE>OE%/?VTPM3WZP!2LTB4%P"D$:B[LB'"J^D6N&X-3;1IP!WD4 M5`%H24E7P*YRUY)T&)^DR83`HA5[L86M_2R[R#=^\5%)KFWY7,X*SBOPYYF? M48SW;AJ7;N(,&5G*$D`44;3@S>1JBXWNV_3CI[V#8W)E]VWZ2>_D>"]N^E_! MF,J![LGQU^(<;E!Y0OJ2,AG MF?T0(MYYX$/RF8HH.51+W1\9>+H<">YU-P;1-281<*=<1<(=M\58"($P#)Q^ MM;=[S-@H&Y2>)2$Y0!QIL9S@?$!F%90RI\#.D4TVY7X?1%HAV>'N\<$7&WIB MFA;J>6QHT0*50*6&8\026T>NLW/T"0WCO`/;;AUR5PPXE>Z;T$9@3NP,*4&!B/38\80@H*7#CIO5:R3W!6_D<%M(Q%"2;_9/9 M0:6%^`.\P]`)2U_P<4X#0"H24I%+CV2*%`DSM1[JQF/]I5I! MHT0/@XP\K[T2"Q+,=J?,;\GP-(XU8#!H;.&5BR*[A#:7I"RU`FI0Q&7WC\3# MD>6>(B-VG3^$!F8Y)F*UU@"/C@B2E8Y7_2>&9[MT`(#46;+9;%S$,LU1HJ8EO[%J]5V:](S1^Q^ MF`/69J1U#K2$M667&*[H>3!2];=;*G&5J'\_XMWT%TZJI1NN.`_^U)Q2<8<$ MH9,02!,C(AR'A3TR!N#-->-`C:V3`V[L,FG@KQC.ICS8+AT!8/V6*JTC.)(P M17-8K*F.3KQ@B!^.->(\VPU,FHT6.8Z:70ERQK-9MHTVG:$,@Y9D4=XRI2P@ MA]L?T7&]SV]NU MI#/[]EO)O/9C^'1F^J#2#\H+K;\\?OT[377>1D?ZL0X\?MX\3U=(HLE2%A7( MKM23/I3N;KX>">_<)E+,C3SQ4`U4RO1@M+L>^.T\ MY.UB)!X/HZ"_U_FYU$AC9P/'XC0K$HJL[B5<%LJW&^ID*N97O*'_P+RF#&Z- MS/-N1S>_:L<6,OFWX9Y-=5J`>41?VW6+D2XPC)_(MJ)TM&_$$NGDLK/@=]F. M)1=<2M`=1G-:`9UP*[ZLJ(`30LQJ?P=O<6=_]QAAQJ2;ZTBTOF_`#2H>@BB' M6[VS62EA3C/?\-OXX=*(,GD34R\3W;IEE0\`&EM7WB"X8F[N]:R936L`B2J1 M9I^B@',IZR:82HP7$.(LXX>6M1(0![Q,-2N^7S&7RNSA4PAEE^@V]3]6JVR7 MR\"US?K80Z1%IS=X!_A:L3CS>U:6-$<1ZNZ56-YWEC6QRZZ+%-I:F?2`15,) M/&W6,'=5J1E:.Q6(4OT/'$\O"1LIF:?*W<2[K8A2M^("7L687\NAT1J-% M6ZR408A-.9N-.4#-EWOA#&-HB7GSE5PL@G@3O96Y&]3JYB$ST=6;'#P^_JU3 M74&7WQ9X;`,;;//D@QJ+(YN1^4);O#Y7Q)')C_>[@$=U.BD4#W$Y?JWKJ)V@ M]PZJHFM$C[6D@4+14O?SQ>SV$I[1I4GLN?SJ:'Q1DW@N>K.H3 M4-3_.Q=9W(-!::E@6)AM+MU=^$WA7]UQ)VP(9WP(2.EN6WKS2X57B$$.-1T] M<"XLQ4>7#ZL9Q&K1TE3(E#M#Y"T)@HZ-(F!)/J6DS"5.U:1>-_I\%W#I,[DVM'4'U+KBJ)` M^H?&^UX]S/UG7+@5HM;!2\,7C(?SVWO6NAI&(,'W7PZ#3??:O]7SAF,V%M&( MV!*_GF--]=0M#1A#R!H_E?D*B01P$!7-8#.H^*F%=&-W85 M&;>5W35ETO;U"D71W3:7@,QT3["R$2F<@OIP!C$FY1JF-Z\;]#\X">CO]U`( M*Y*38!_V"5VG2?*E.<2UJ2`/M&YT&HN.!WKB+MJ\#&,3@5Q+I5Z%)?)QO6!< ML[!WM;#6IEO2SISYUHZSO0*2X&'X[J=,J'K+A7NC/)ZN,'5[U>'AT]Z3@Z?1 MAFD6"Z3KJTJA:B?Z^/EZV7[MK:]WE3K(I\-6/;`_Z86\*!2=&N\AE@/I&11T M?/R(T;Y(:7ZCU8)&3R\]%A=PY"2"(3>D,A&]L]W_LCKZ(G+87ZC5I9EDT/H2HP[)>M*IMW;[\$GNO0[OLEHP`X5W87HVWE]8A%V8]WCRS$1BQL]_AQ+.=[D`3:"J5SVBMT;,ZFE6U1 M'!JX;0HM@#"-UYYP$V5[1H'`^YWS`8ZZ+'ZW&22D@C>[L"'8+DW5HQWUUMG8 MYFJQ>!#=SP9%G(PD:49CAN9*A3M)Y;Z'FP%*#M9NE/`&[BJG:LYI=ZL(UJ4/ MEUB:!1,BDL%(<`_1G$[W(F/:EPY$_G:*Z6(?8"T7\T7YPPN["P15O`G>WH[F M[W>N=`%;"@,J`%KV]3P$W*N[$?Y,^?3G/__7\B>15O'$S!(U5*ZH[/`%V!DC MY#:2#R\I'K;#Q8]?64%OCZT.MO4>_(B50)#$P,>_^,WN2P9#R8:% MZW#_49H9\\C_D:T!ERTMZ)MV9&!;,^]<0%(S(S"YT9QUBH$D MO6[(2E`BTT9A4F0X]>:.6&8A^&AG857.=G0RIVR8D4?L<`A7:Y!H!$BT4I]&*R2079,AY\0(%^@343G9`SY[ MSIVNXC-9;6G;11F[NBA]K]ZX38-A[VN>3E20)T_NIE5V=XMM=XDS0AL^=0P@ M/T5BILR*;\$8#05#F<^0FSTL'@*@+YX>/W%]P=VV'``SJK*>AXMZ`<&E0)V6 M&M9R)/"-QL]N*$4,*/\_V3\4WRXG626YQ")ZTZN6M;3T77(C`H]&/U]X'^79 M.33K.@A71[,U0J!PJ9\AL%L=W&QN@V6;K$)[YO(7E2O[GG#6""K(7MYZJMN` MX8*W#!?\YG.+YOXHO_G4/*=R*X1M01HM-D;'\5U?0^YS6PG;^8]\IH8/ MR$K.DQMJ_K@'KQYXJES*QD[_ZOYRXDT2&,]"]C(7&'B=ZYMQ(?L?@U-1?6(' M^UTK^(B.2(,^F*+.^-J4!X&:D^626W$2_'S%>7ARMT%5^Y)M"@:)'H0W>F3) M6GW*0=45YHA^Y.RYW[Q#@LS/!K^%,G`I&DT]\<%42,DAD/CYQ58>T/KF!?>$ M_6*::!U(@1E[-==Y-"*?^X7R`OQ&LNP<=0")<,&ERCXBL631D&O3CI>&`H;` M37:B4A/[!5P@$:3DMY]"L7/Y^RDJC8*2\N=OY3I4SU=H\9?I_N;V.^LKTZTO MQ-#;9\7I#/UW4YC^6X.*]I(6WQAK&1-\+HQX8!<1DWPY&R$!7BH*LRH$QM]@ M&T)A]R8%O6$C>H@=,?'*(.G4=(@_JO`;;J,QSS[&C9NN*(WEN!W%1QV$^GP] M9?,Q]73P^.#A&LD*>_Q=^54Q=BPS06)@M106/`:!W.G#@_!B2)IK/.4Y+<[I MJOT^Q6-CT9D>[AW]Y7I/\XB8^%>KN\>':\[,68CO18#Q$$9] MPU6-&%(>!RT96>!S[TM6W_SB_(U]B38NXO]VS!3G.>9'7'C$.U;^@KP<[UG! M<`P9\HO8*=>C\$F3.N8\9OKD6SJ;.?-D0Y3J7!\Z2'=B8@S3ZE8F^J;XI$CH MX=H4/B2IJ(_#;@HAM;?&0HR#+,08?0J`=&U@D042!$)L%"G5'\3S64H(5^K2 M3WO0&`(/Z50'^S*>B&'TR`\>9<8-Y+Z.T2UVCWR>9"`Q'=TBH&)KL#KDLEN> M`SUP;IN85']0T7RF$C MKU)J9Q=W$TY9>K6@[$P9B?N)6+I1F^MC(+WL6=G+UG>*,4S-F MM@Q`I%1'^;P,2N]>+PY&M8I..R[E17'MA3)3;KI"@+8.3L(!9;^N+KP6ZH,6 M*C"3^N?C;,L''^#GT.VI4:X=@^U5^D;DR=Y)AKDMJMB@+40,-8T)M]N+Z-"' M(Y345B/O;Y"C,Q?51!910VNQH:)K5>,-656^H/G@>3SC]KM!\V44 MX4*DB`DW^,7?_LD#H&ZHL)=01<<%[6,I`?\ZGNZ]BB>'Z!@<8'B^;]BAZO,1 M-T?#*FG0OXMIHMQCN1%2%\MQ;JEXP*,R'3G4O)7-#06V1/AVJS>;&PAWXH4& MIF,5A8+[#6MUG`\C0`Y9LJ$M`@MQ4IP)@&E%#LS1[_KC6':".@!*[I&^`*)] M%7@H^$4$,&;3/9;FK2,P6(1+'FZ`N80AB7LL9E!(2_6\":;%O<2KB+M_+ZC8 MA&7YM=Q@R@%([&;II"90$]:VF0+!PEE7,B9%8;TN2(566]$YD%Z"IOM<)K0$BU6W&L#>*6BR\8F-%% M:D/[.U?=0"1ZX\6[\.E^?4Q"U59T8NT7G9N@2EA+>%L^().I2YZGLTZGVUQ* M^/A)V9YTW$GW8ISGM3YK0'G/BGYB4&`G'$W/TL'K2;*C8&N;MN5,!*6&=!W0 M><#+VWN[!X_+'K?W=X^.RA\OV)AF+QK`\%Q>:QM5\T=X''8(YEEGY]#JF'+& M,0V7<2N&7T^8,H[%.?+(7%$TS4K,:4>W*306BD!DX+;8M]A?15*^^2EB##@9 MC8T64#@Q_BZC*>L70)G[`[X$_?>^M+?_OZ]B\8W'IT.ZQ:N-2NDBDA%JOLHG M+V+@P75F8L];2G+*MAYQ:K%[IMK+UC_>X@45Q:^ALBI4S<:*>#DI093//*EE MH=UHJ'#L975%.[8CZ_L@X#51?]3W8DE-\\>=H?9FO8;S/&GHC`+ MJU=/0,"?[WI**DG?Q\0O&&O7.PF:%_U/7@QG7R0%?YOO,S$*_KTJ16$GKO:. M!;#M5U`7JLXU\A!,$^YA2?9\G70,+V7BK&T]0;^-O5E(N2]'$]YMMN;5^U5JQC6I1Q.4"VY4D1 M?J0(8B:G+#((%GN404T\BD;[_6B*F\#`*7[?!9LJJC4]K:61,4E&87.((G*8 M(M`&4M:/=%M9O(:72>M)TY@/C=MGN,'A,/IAVTLJ:K[B4 MF&R2'4V/P*6I^8UF.@!B-0H*C7$1((,N/M:Z#-G7I.5IPJIEV`XRX.'9]MI9 M@IG_C%KP2$?/7!18X5CC5XVH3`L\=21:G2F%M<(YZIQP6TTN_`+QD!+ M#F5A^QF(:G[#?A*C<9`,?K[SGK`_53/H!:]U-G1I%\RH0B544TO^%2!T9Y:^ M"5A"2G+R*`CB[ZM6P(1%Y3`%_3."BCK.X-(VEZ(!$(2;G:1)WJLVG9\GYE?; M5JQ`W!UI71W0'/E"71CRFW]RL,EK0E)VOD5]GGB]$&C>+LW!`* MSFQDD-9=TUP"9_=1!"8QE^T>3=T9,+*/&X[_T.?.1`6Z8+=@6X18+,)D M#UR.8VH/4>;XAE<[4*B^!YOY4>6#O]95)L3;E;,KC_](D^ M6P6&^(FZ+A-"_9+X*[8YB`MRM'72.SH\5-\9DF)*A(R(@R[MV#C=\\G9N18T M&3^+#-F`L.PLA?;8-@"=H(E;C9X@-T',O?;I'TAFS+F* MU!(W!FANH'IT$X#L`TWHSVY2V`9[Z0.X;5E3A<0M-3)7F(Q9$>+:84=6]RWH M8F;`N@0)QZE21B_`NONB=$W_Z#$,`X;C'!]Q-G0J"O7_L'=VNU$=21Q_E7,1 M:1UI#!@P;*0(R7A@%PF#99MP@?9B&!MBK<-8/C8)TCY,GB5/MK]_57>?/GT^ MY@PQ=UQ$"I[3W]7U\:_JJK,_%H!RC(D///"RGYINPXAV!JA>B!3)5_>TJX*Z[85'/R%GM2\K:?WW[E3_QL&) M26QFAS8K"+%\:+NR9E=4/3<#NG4.V;:D%"4,\5\.)J@-[S6D_@T> M83GILE.T3\Q1C0N`!`=7Q,$&1)ZOVB()M>!4[F(F(6)#6R!NEVY]IUT+80@I M.G5MP;-L#/%`O(!QD:LGPE'F7LJ]W^BE-E?3KRZE>;H_4]2O62Q^;^]1<.@B M7'RL$)GDLUO:NU^M,]L9.7,A1DA?Y,&U52Z'J],F$\G>\7[U^"$4LLJ\E[]3E)4OGO^@F7 M.^1*\LGLYSNTT+<[SL M)I6,I/N+57'A M9U->"'V*!^,&3B(BL+>K)M5U49+W$."0>;FUQ.75:7([D&70[0W'KX_3=567 M<94B4UL'AB-JTCF5WCPJA(_H+_\T6*-CKJY+;FYB.`DM8!1A*Q?QX=C,)VCIS3!+A=R7:BO^ ML?.P<3^1&'KVS!M_J=Z%=B-G:;HWH.%S/),(&.CY6+"D2<`)S=^X!O$L0&+, M-@PYH>W1&7RBKE->STW:'A-^(W9F[I,9RJ+GT6;Q^BMIJS_5B"K^63+5%T3\ M:I6'-_"7I6<.9+M??XK90/H,0YTRA.)RV=O[,R4&`WG6<3$J%-Y$/.JE``X3 M/11P^<\_+4J];CW?5Q]F9NE1 M/#P(9H-62D2S0ZIF^F7GZ=]H9SR)&[:=9H9`N;9,H>'*' MNH)RD%M[%BW=L&N[3/0;Y?ZGMN\'=L!1B`.Z-$2X1JFB\7;^.7NX2T+$![L# M"\G)9__.GE\!N2GJ&]Y MHZ+1SG6.A;\WNLYPKT&\(S[41_\.S`(O.$W,>S1VR;3;UYA:!$-%WT!`GE%W`@2:9/N#D-I)MK@PY6J1,U!@(A+];1) M1\=G7ISDJ$$7PU>K3W"YI8G$ MCNI4F)5EYF1B2_B-JR)2B6&D/RZ7E$^4&(@NW7]I9H]S$`HEAJNMG,KVS6?7?&WO\J'7/=2@SP(R)TPH._"\ M_Y!GR1]0=@;X);E@[+A]W+\Q6GLU1YB"G:><)$64;VF3M8FE-2%JLBZ%1GV+ M1W^OD)8O^\*H)]%O-UQZ)DL]A/G-0S#Q9F>YQWVU^#B%\X*_WZ`NBHL_:P75 M:=]O'+T2:^I.9,J9$KY@^CRB*^>AP9:IMN;@8^<78H-OCN?5#QT&MU,=@.7\ MRMP$`I<7`%WX3A55X?+'X\ECCS$]5>K`M#LZ"^+-P4]CD+/J+1MWMHT.J0V: M1^=X$/K(-\M19ES0"GY(!3$%N9RJ_7J(7`LYX)_S!+C\9G]QB2_O@JX92<6/EW^\>T9*@>`[1YBY6"%6Y/_ M]4S]#K$.S4B!:O&WZG_29&27.5^,?R_'\E]?N/TUYX9PG(>H#"N@?B,)PQ]J%$8S!4O8WW$D(N_'N+AQKIM5A34N.+ M$=*ZR_7E[4;KFW*T19$8=D@/P\V=54= M$F0A*4(L`]LZ)]7M`A=WLL@Z.WR`C%Z4G"'036R&KKE&PRL;-7)^>KYQ?:YLHD:%M,R/.GX@D0#N35TK4"`0(+U^$7D<"D MP^<`.K^;#C\@L+_QJ&,W:IK-D#9B8`$;]C(VH7';0_+CNG-H>=DX3J1CL90- M&JJ*5TL7YZ:^!@61VG+A[D>LD=,?.EPRUHXM>^R=%;1*&(=N M2YUN>=EP/A_\:<-%31EMP[/>KG)CT`);I/\-!14/$-CH;K,S(Q:XE=/T^!:Q M#G\86VXA>O;-;[P1-M=*1D[E=[)+8BG.@:[2,R1*LL!QX)9-@"RQ`M+>E'RJ M[/FGX$5_1*B-,JJ-#!ME]N,]WDC+>5$>"D+Q3A5^W"U_')SEV(4IBZP<*=XC%^II*GJ)P0^U=?7(]A1.E,1052\;VAP:NS/FZ^P][=,%_H5N M7MW!^;[Q0F1QDC.SJD.],N"+3,,N#WFP2[.7!Q?4J^D;-BV MM`/VL!>S^G3@M:&%#+>PL7OR^Z\7*L;[8WKV=J<'4*_VE&/@H[E_Y+_.ORN`\82YQT$L+"2B2*CVH$I"<@WKZ*QY`-#_ MFO$MT5MK\*C952'-'&:HW(MSB;S,A3D-?]ES(U*HUM"D!Z"?]&`5_,H"SH8Z M$"X4,UAZWD;C.(V/Y!7QMU_0:!O'5.&8*/?W]H8VCW7?^'[2%E^:.R8 M:EL-::1#._(U=."Y]!3A$8FP.>MR6FMXQ1CB2>=@?Y8\K])CY2$6>PM+DR\< M7U;F7:_<%""(ZU-,?#]SZLXNP-CL!SQ,6TH@]^/@6L(IWJ=L0I_]T.G4L%$T MRF]^,0:HLSQN"R92C,'@"ML$$=T1=H8UUZYN,J\%-V@"CD=@[-!I+1\EM39B MB8`8\8(>WG1['H!HBILTX5WE.J3!=[I!X5KFP5B]W7HPDV%@S6:TXVS9G13" MPRU:\MQ"D57?ZTZ4I]`P5W,^#S&`6SFLD/*&(*UT-J":WY/Z81C$ARS"=;O5 M0B!U0N&@<,O=9PPS3^I7GFG[JJ;<$O+R7/8FZ2/0AYBZT=OZ/6_@M\H;V#T] MJ9MD`"3`:L0XFZ!IMU%0X]PAY3U!_"&V9"M7LG&,Q)"3@,:!*?=Z^^^-`DOC M?98+OJ65C-D5C5O=@V@[J&74LE,:IQ2-:U>CG'+G\P9M70*DAOHVO9!KQ$=W M'O?CE_'W^P\>]^HGJ1".X*]@EGR6"[:<8TCT7CWH[6;C3?\]9+]..V3NI1`S M-(`_YC#H:/MAR#-NQX,!A'K>JH@QT0V]\>)10V(L4VURLI5:'I4J_FH]>^1' M5>BA0U?I=BS**P\UUAX2K>%$WPXJFG:`%ED5CO=69;JS!Y;Y>-KW$ZNL_(<;BT` M;,17I3%2'L"1S%*Y65&]]>1J@S9(@4BM_?ZO/__ZLUS\41/H[J$VO:$Y@U.( MP-&03OOF$@'[E9FR_L%Q9I@LT/>$I&R%VHND``=,KPIJ"TJ2#9PHTU+V]2C?NXR1[1;= MN9^G?"AI+L4&0NT)LPK`<,`8DYND2UAWZ_KZR?\!``#__P,`4$L#!!0`!@`( M````(0!=H`+UCPP``)]\```-````>&PO7K^KMGS]6^V.'."?RY/GC;US7;7P5KQW^8ZW^^ M,R^FNK:++']MN8%OS_47>Z=_=_/+7USOHA?7_OQHVY$&(OS=7'^,HNU5K[=; M/=J>M7L;;&T?OMD$H6=%L!D^]';;T+;6.SS(!3PP9@YO06U=/?O#5-_$[(`.8AS^[N=[]K'VQ7-@S M0'BKP`U"+8(H@WULCV]Y=OR+I>4Z]Z&#/]M8GN.^Q+N'N(,1(_F=YT"8<&5V2=-U MS(LC'S;1E<6*Z`D?[N>Z:4(-&?3[Z%8:L):4S99]T->9LLMQ9Y:-S)$YD6H9 MQ\7CN*'"D2G3E14*S7>3]YVY4[ZR(NN2,MQ5!F#"R?6B`ZE;DM\3$_]UP9.. M![1V(L:D&^\AL([0^XYY\Y_%OZOX]4-HO0R&K&43.V`7 MN,X:43PL68N#H>S(8&_,\J6?L( M9/L49O6*HTH0*(HJ0:`HJFQ6U9-0^9-,@04FQ5$E"!1%E2!0%-6)Y`H\41Y5 M@D!15`D"15%E:X$2)+M147Q>;-<(\]3X(U[#DD)XV&ES"'#'>=W/MVIL( M3`B=AT?\&P5;-"B((C@?=7.]=JR'P+=<^-A+CTC_EAP)9^S@Y-QL$E2[=EK9^\=6Y?I/LE+<"/ZMMIP MXD,_4Y+0(5^4[&$4DO`)'L%"S2(M>`!P(J6$X!$R;,P7Z$5M)$>(V4@.$+21 M'"%J(Z3.J>1*/;D.]G"R^##`ICGM]^.U4%$]Y0()\!.,.0V"''/LS\I#3GBT M\IBZMD)].[XA*451QS;67'`"2LKCA"UD>=-&EU.>+9T@>7Y!)(# M?W,_;P;CH/8E90E/S<0G9R@:`-=P&*G4UITQ:1Q:AL2%N=2[KPY0\W!7&%\6 M[*1)@9YG9;ON9^Q"_KK)&A]82[RY?MZ0"UO@:B.\\@.OF\&/L&"??(R;G'@# M+"HZ:%AXD&9MM^[+I[UW;X39;#=5C,=^' M062O(G:)%#M-5(1G5(!GD`@2P=-$OU&@'_PD[(\F^F&U[600P2]*]0.YA/7+ MY`->#):0&D)`25V&1R8"6%-)$4`05"#`B]<2'P`]52"`N6J*``B:(P`X):QH MD@<#4LV``[E*T-^62J@QJ96/O@&)0-`)3-B@:@BD$;@SN,"=H)+@1 M4A$&P*,D*_(^8<"-&!VZ@4!052$)&X:J2B3%H*I&YJ$8JBJ1!(*J"DDCH:I$ M4@RJ:B0)A:H222"`1Y142!H)52628E!5(_-0C%252`)!584DD1BU7")[=-DT M7D0EZZ>S_EGKI]KSIG(A%C\#)-,O&UP!3OL4,?;3"-G1?=\#:WMG?T,4]'X9-OSYF"ME\TNDQ5B M<8S\,FN*M5ODX,7JI>TL-!7>S#T'IYETK=)M1+FXUP3]TP`+PDJ6`N$C5]IY MDA72JM)R7!&J/*-PX/;3=#D?`R6ML,FR0;1)`4G)C35'=:Q@>%>.@88*AGJQ M%!',ULJ$H9X$+M`6C8D',.D%^+J$Z`5?N5KQ,XZC#(`-&'1:< M+M?2N<$NB.')<=**(D8C936\!R!C$5A;0IX[CJ6:MX=LRX M%H">S;@6L$AD7,OH1!D',#;I5)".U^7I6K]0"_&P*>ARGRH&+51ZX&%`W7=& MYP]^'<`5Y421>SE.=("WK<:S'6+(*:Y*W'J2M47EK((%]4O#69.2AEP&BI<2!H4I`Z9:*6"&"D3"P6I,IT*$L@+8'D)9/JQ#>+RN2ZR_ MXPNST-B6#!62SKV`>^[9*93D-C"^J`G":X*ED%HPFI2!$29_G<#1,97SS."_ M$PU-NX8M".\N&/*E!*\)LXJ:;UD5H0UL5:V;,.M;`2!??4(VR"A7!>^FJ:MJ$)+6Y!HI0H>3?WX+DFX1-=J3`HS5A8: M6E+DTNWU)\3_C@];28@V`BRU&VT#H-0XX.24&9?C M^*E$*P6V4/U1:%I17[S0**O?J<.+8C2R6HIB_WR1O5U_03# M$"R7FK&GR@6[Y7=V:7ARUC@Y7']7VL7VKL5CMQ9'4-^W>\= M%QX:C"N@>-?=:K^#YU4NXIW)%>%ELC(B8CF@LL`+=65ERXQ#O!.3X(*I4EU9 M&?U&8"V1!0\%JRTK&X3AI1^<++BCI"XN."0>T$>\[\>"OC=.Q9'=44[\!2:+ MX**R\CB"YXB_T.2ZLO(X0N"H+#"YKJP\CH"0R#)`25U9>1PA"E06T*VNK"R. M!@2.R!H+^O[R9!QYKN+MGR*XJ*P\CCQ71X)>S@$_$17I`AXJ-82AXU MGN4C09;'4O)X\?PV!/D=2\DC!?*(109\(6Y1%J,1[UU#T+L+:YU679XP.,Z( MP(#7C*[V+KS^-<"7Q[+;F[%U)`;A9%)(TJ.]>M*6\+3*3!"?#SB,B@BZ?=ZZ MEF]%0?BBX2W-F3@^Z&-!<;\/@LQ'O(0A;(H`^@.\:A?>XJN!7V(/\1S&^X+K MB,ER@7)K*0[=(B(^ M.OZ3O>:9PWL8^TX129_L?11:&?_XE!H*.N83/N,TD\&7B/C-=ND#69/^\Q,\ MTC1U(JYJD-S!!EX$^)_V$7$C'D6$#`7KTIT3P?.WTR3F1"`L$1QW`3QF(!-Q M4%$$9?S%"GW,%BYU#SA:8%'^T`;H_M?/^?-NF=\C?!DU>Q)N-A\`1ZWMC;5W MH[OLR[F>?_XC>[(]D"GYU??.ER!B(N9Z_ODCOC(`LABN-H9R\W$'CZ&'O]H^ M=.;ZOVX7D]G[6W-X,>TOIA?&R!Y?S,:+]Q=C8[EX_]Z<]8?]Y;_!9?CF[BMX M]7.#-V.S-WC#8QL&QM7.A?=GAXFQ"?C/^;ZY3C9B^.PYX0`;[LQ,C>CMLC>+ MW_P'``#__P,`4$L#!!0`!@`(````(0#[8J5ME`8``*<;```3````>&PO=&AE M;64O=&AE;64Q+GAM;.Q93V_;-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYI MF9984Z)`TDE]&]KC@`'#NF&7`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](& M&];5AT0B?WS_W^,C=?7:@XBA0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K' M8\QX3-K>G$COVM;[[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH!GXF! M)DV<%08[GM8T0LYEEPETB%G;`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U M8FUA7=_\TG7I@O%TS?`4P2AG6NO76U=VJ^>?__J^5/TZOF3XX?/CA_^=/SH MT?'#'RTM9^$NCH/BPI???O;GUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@A MT8LOG_SV[,F+KS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT,X9Q)2"M.69EN`YQC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<= M+DH-<$/S*EAX.(N#UO5D"53,+2L?VW9`X8NXS'"L< MD)@HI.?XE)`2[>Y1ZMAUC_J"2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV M;+-W%W4X*]-ZAQRZ2$@(S$J$'Q+FF/$ZGBD".S1P1%H$B)Z9 MB1)?7B?-AOZ'&(KA\1JCX_M\+H>SHX;.1DC M56#.M!FC=4W@K,S6KZ1$0;?785;30IV96\V(9HJBPRU769O8G,O!Y+EJ,)A; M$SH;!/T06+D)QW[-&LX[F)&QMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q>Q,O91&\\!)0.YF.+"XF)XO1 M4=MK-=8:'O)QTO8F<%2&QR@!KTO=3&(6P'V3KX0-^U.3V63YPINM3#$W"6IP M^V'MOJ2P4P<2(=4.EJ$-#3.5A@"+-2[\JIB4 MOR!5BF'\/U-%[R=P!;$^UA[PX7988*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\ M,`U!!7?4YK\@A_J_S3E+PZ0UG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4 MD(FH@K@RL6*/R"%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63Y MWFMSX)_N?&PR@U)N'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG60',"EM! M*TW[UQ3AG%NMK5A+&J\U,N'`B\L:PV#>$"5PD83T']C_J/"9_>"A-]0A/X#: MBN#[A28&80-1?F#R`Y+<2`@``@08``!D```!X;"]W;W)K&ULE%7; MCMHP%'ROU'^P_+YQ$@@!1%@M76V[4BM552_/QG$2BSB.;+/L_GV/;8BX5"Q] M(;IY!U\JI26U\*AK8GK-:>F+ M9$O2.)X0246'`\-*-:B%?;-DV(DV?RY[I2FZQ9\OR9CR@[<_N&"7@JFE5&5C8".A$8O/<_( MC`#3F4;O/6I1?1<C!.!HS8U]$HX2([8U5LD_`93L MJ0))NB>!ZYXD2:-TFB79Y'T6$CKR!A^II@NN MZ+2%=#S0^RY7`3+U$SW6&YWJ7==QX`*/CVQD27XF%#!^X"?&H.K8V'4A!P;C M)T+3,Z&`F?G$DSB/XW@`G`C#8CH6OBU15W3>P&S@#Y$&S*73R:G@=:<._%ZD M`7,IE/^/D`.?.SJ/-&!"I/EX-!H,AT##41!VBN2ZYI]XVQK$U-9M\P0F,;P- M)]`*3J#4+[GA`YP`/:WY-ZIKT1G4\@I*XRB','4X0\*#5;U?T6ME8>_[VP:. M>@X[+HX`7"EE#P_NE!K^/)9_`0``__\#`%!+`P04``8`"````"$`-%AE?ET% M``"2%0``&0```'AL+W=OU%7>PL?ZX#27 MFN>[SJ@Z.9[K1DZ5EV=;>EC6]_@0^WU9\%04+Q4_M]))S4]Y"_J;8WEI!F]5 M<8^[*J^?7R[?"E%=P,53>2K;C\ZI;57%\L?A+.K\Z01QO[,@+P;?W0?#?546 MM6C$OIV!.T<*-6->.`L'/&U6NQ(BP+1;-=^O[0>VS+S`=C:K+D'_E/RM(?]; MS5&\_5*7N]_*,X=L0YVP`D]"/"/UQPXA,'8,Z\>N`G_4UH[O\Y=3^Z=X^Y67 MAV,+Y0XA(@QLN?M(>5-`1L'-S`O14R%.(`#^6E6)K0$9R=^[YUNY:X]KVX]F M8>SZ#.C6$V_:QQ)=VE;QTK2B^E>26.]*.O%Z)_#\Q,D-0[\WA&=OR/P9"]P( M%[]A%_1V\/S:@N"V"Q>>PX+>+/#">-[%:R[IR'QUZ4_S-M^L:O%F04]#1II+ MCCN$+<$;YMV'ZDD/UTK\7R&@`NCD`;VL;=B,8-Y`][QN0C=>.:]0\:+G;$T. M4QG)P,#RHMM4!S(".!#`-0JHF!X%=L\7HT`O&,6P_G8`QK`\3?+`&$S2`1A- MHE"UR08*V"A!0/?H0000Q.=;8,@\&JUM:""2^;FZX%9RY+;!O"8ZD.I`1@!% M(RQ$-=[6AF1H)T7;0M,F.5'7,['/6!P&*B.1C%%]2DW\P/=#S]-Z+2,VBGQ( MY_WRD:S)9ZXJ;BLYH[A$!U(=R`B@:(M4;;@3I\N/1E/EEQRB40=2'<@(H&B, M38TLQA-YHDO13DNEJW>"Y,A.8($?S_6])@GS!>FGP-.Z):5>HH47NMHADTUX M4<+%MPMR.-[N=B1K,3)M\:WDD%+H0*H#&0$4;9`&JNV^=D&CJ7:1'*)1!U(= MR`B@:&0P2721=_5+9Z@ETVB8G@3--YY]3&^:GC31-3UK:+YY%&H;/9ORH\:- M\J*YYWJQ MT4T3GM3(<9J1R">Z2,X^6&"L#=-.R2TC`[)[U4H,)#60C"*J0IQI1.%]AQ&^ MH4V>1CUI[)G$0%(#R2BB*L7)1I1.Y%+.02679NM(DJQW%/J+4#_V$T;F:?]F MJQA%L3]W(W6G9]1(C0%'V/TQR(%'8PAB[93<,DFB6=:1U.!D%%$5XM`B"N_L M!SGJ)DX5,@_[SM61E.E(1A%5*8XNHG2B'^2@H[D,S7Z0)-D/83`WWE$21N9E MWPXZDE&.HMC39NIMQ1U;':3!7#N-MCV)5-]`4@/)**(J_&3Z3<\43TZ_V]7O M252I-!N1U.!D%%&5:M-O(I=R?-VNOB=)LOISU_6UGR9)3Z""];&848XJ&!:_ MOUT]9$/Q8_*+UH`2DY6:4*9`JB:<)60+X6:/OGZ%`+=+^ONSL7.V/8DI-6#: M#^QD9(T_RZ5W,!P@O,["!24D(Y+74_)^I.+U@2?\=&JL0KS@U1/6](I>K\4> M/'2IX5NX+NONEG3<6R:?\5,/KM<^\?/@^?!%)]KP%`PW M'\IS8YWX'F2[LQ@&;2WOU.2'5ERZFY\GT<)=6/?O$>X^.=P-N#,@[X5HAP]X M2W&]3=W\!P``__\#`%!+`P04``8`"````"$`R]ET:A@6_A(/E M.4W)`TM?*E)+0\))B27$+PK:B#U;E5Y"5V'^_-+"Y=(#.M\$.LYY[L]]8%HO,PH9J+([G.0K M]PXM[M',]==+7:`_E.S$P7='%&SWA=/L&ZT)5!OZI#JP8>Q909\R]1,L]D>K M'W4'?G`G(SE^*>5/MOM*Z+:0T.X$,E*)+;+W!R)2J"C0>&&BF%)60@#PZ514 MC094!+_IYXYFLEBYT<1+ID&$`.YLB)"/5%&Z3OHB)*O^&A!JJ0Q)V)+`>$L0%%!@J,1"*+"&#F>L.W(3Q-)YV M@($P#-?EP@IL"]NU-9B)%IX%07!<=C*4O:RS:I$MGW3\IL`&8^23_\I/KY%7 MBVSYB25O,(G.'DWFW;^#FBO//]A0ER6O%MGJ?4]-\@8SGJ[Y4/#T="GPN3$V MF+$0@MUYF-II)8VV<[('N069CH9Q..T!@Z(BRZ8NJZI>98&PO=V]R:W-H M965T^U+,MC.3I*7).#CP_&]QP=G^>6M;9Q7.O":=2N7>('K MT*YD5=WM5^Y__SX]S%V'BZ*KBH9U=.6^4^Y^6?_^V_+(AF=^H%0XP-#QE7L0 MHE_X/B\/M"VXQWK:P$#GHU![S9F?^<"T7E8UK$"6W1GH M;N5^)8N<9*Z_7JH"_:CID4]^._S`CG\,=?57W5&H-O1)=F#+V+.$?JOD+9CL M6[.?5`?^'IR*[HJ71OS#CG_2>G\0T.X$5B07MJC>'RDOH:)`XX6)9"I9`P+@ MTVEK:0VH2/&FOH]U)0XK-YIY21I$!.#.EG+Q5$M*URE?N&#M3P21D0I)PI$$ MOD<2DGAQF*3S>UBBD06^3RRA%\X3DLRN:_%Q7:I,CX4HULN!'1WP'BCG?2&= M3!;`+.L3_[(^4!@YYZNZ^-)$)[' M-5U@GMMU2;"N*S)E(62F9)$X(C.C8KD&"%-"/@":L-D]PB18%T8RTT^(065Q ME*9FP:;C49"2V>6"I;HNN0.OVUU.TO5%\S,]]A,A*"],@EF@C^?3\8BDX2_Z M*=^$DX#XW&<2K,N*C5V_00C*FF=6T7`X4>W.)KW66IG=HTF"=4U1ENFUV"!F MLNLF-[0G$PBB:3ENS$LYZ]K.5]0K=R)B>D=78:3VYTTA&+3:[@],MXR@T6SEW8A!30_A+#$V>3X"+F@R(OB*A2]DK_&H M#4$,VN:!9):%3^.6;^Z*6W)#WHZ844IB.?@4N):2NT(6SO"V:ZRJ(`B/&%$8 MII88*W;Q8(\GUK[8T^_%L*\[[C1T!^_)P$O!K0,>Z_%"L%X=`[=,P'%<_3S` MWR\*1ZG``_".,7&ZD$L^_Z%;_P\``/__`P!02P,$%``&``@````A`'.0,#\2 M"0``DB4``!D```!X;"]W;W)K&ULK)I;;^)*$L?? M5]KO@'B?X`LV!H47[NF/:^G[H,SG=3G7;MOSJ_KZ7__DWV)II.NWY[W MVV-[KM?3GW4W_>/I[W][?&^OW[I#7?<3\'#NUM-#WU]6LUFW.]2G;??07NHS M7'EIKZ=M#W]>7V?=Y5IO]]SH=)QYCA/.3MOF/!4>5M=[?+0O+\VN3MK=VZD^ M]\+)M3YN>VA_=V@N'7H[[>YQ=]I>O[U=ONS:TP5^W:%O_@=Q?VIVU[9K7_H'<#<3#:5]7LZ6,_#T]+AOH`/KNKRHNFLZ=''J#_-?5[I_U_TAW:]_S:[/_1G&N(-HP3&X&O;?N-2`'S MM&N/T`#X=W)J6&I`1+8_UE,/;MSL^\-ZZH^OZ M]O1_(7*E*^'$ET[@5SH)'A:NL_07X..&W5S:P>_OWQQNP7L`O]*)YS_,O6`1 M\2[%76D)#;N@74@^_>*?Y7?V$R<:;"+_2\'9^NF!-,*!&7(<5^E6&06LS+ M,W.SGD*'(7DZF!;?G_PP>)Q]AU3>23V%N#;G@+>U<$!I_,00E)B0A)"4D(R0GI""D)*32B=%U MZ(;1=38_U#)W]_Q@;F"*P6V&H/AA:([Z1H@@*$KD+9>F*!Y$0VX0DA*2$9(3 M4A!2$E+IQ(@3K'!&G&ZG"%/S<&`G-H+H"4%(0DA*2$9(3DA!2$E(I1.CH[![ M?**C3&UV5)!([*ALD8L)200)H0TJ6QS'3(1T$&$,,T)R0@I"2D(J0>8^FYQ& MWR$SC;Z+S>*!S8?^T.R^;5IH+ZRF(X/OPZ8@M@KFQ`R)(.)^7!,3D@@2P`JE MA<3:/])!-(2$D)R0@I"2D$J0D9"PPIKNGY\,"7-BAD02+4L(202)0K[=>HYK MK;'I<'V(AB3>L.KFA!2#%=O$P>O<3+MRN(Y>*T%,6(SDA90=6)> M,+49!$$B8]%T[*U2FJD^)8+XHOQE,RR5)!SZG1%-3OP41%,2/Y6N,?K.:JE/ M=)[+S=Y+Y.DI'UD9'Z.(SU59,[$[0X4/2_4P5=RE99BBH;G&^.9@9Z@R?5G[ M5HXJU8@"D6EH-:)$E=D(*^,J5)F^5"/,N+-B3I^0MY,.LM;..HG\^9`M,:JT M)$.5EF6(M#1#I%0Y]55058E(^:H0<5]FGUG=]HD^BS(/BA&]8 M"THL5>YR,$PD\OBIE>=?BDBM71DBIP@/+8C:4L/M[1FGZ@(C=GG.RKIQ#XE#3T5R@212I\4T4((TVPAK6 M"GW!HCPTU5VJ1IB#`?$R!N.#Q8O)K8BJ%$HGT+1*16G`R1&IX M;-;Z$*[//H$052O+]"'0?FBEW,85*N.,Y;M6 M:1TK%:Z0"44I11E%.44%125%E8',-&'5J!ZR#])$%*\0&>S-QA5(/VY1E%"4 M4I11E%-44%125!G([#.K,C_19UF4ZGT6*-*>.;@2J>TED>B#LY=284@SBG** M"HI*BBJ)1HX;L/>:8?BM(QCW8BTJ M@J*2HDJBD>A`&?(71(=[,:.#2/4H1J1%1Z)?G\B4`*.0(5*>]#"7**D>DIGJ!2*E*1,)WN/0"QVIDA1):)+'>&8L/KRR7=U26 MW-**F"R_8>U1&Y5K=31&0ZW6E@C&%<;4?4%5)2*1 M=NX\"@-KJZQ00LMQ&&P:-/>>+!.EM[Y?<5]0S$/HAG[ZKG5:C5&E,B%!I#(A M1039/O@:B9FL_Y5ACH;*?8%(J4I$(M&\,/(<;T&BIGLWYR:K*N_?Y]@IWRH! M$9GY92T8,:KT_)(%K4J35*H\D0!AX"\#>VYGJ%%F.75>4%6)2#H/%WYD'[`J MU(RD%RMK/Q$H606KP=NP(82994C M4KX+1$I5(KJ9L!6JN*&94F,5M@NO;)G#NQ_;0@Z03)/(S#1UMA%G9#34,TT8 MBA?EXJF!5,U%,D2.XUNE>R85VO*74]<%JM3KMA(1E""_GO`5JD8RS2ZW?ZOF M\F@5+A$[[`P-\UVKWS&J]$)#EN^J:$A1Q9ZS?W]:^*Z["$@&$K,>9[6SDB*8L:3>8&6V/E5Y`+W%'04'L[2V3X$"=2J-V=,"4"TB MWOR,M@H8=9/2T0DT5\C9_JZVL=U\=C-]FU;^QS"JC(GQX'++[U M2#QGE8ITM*Y`O;9B)1D$PKH"WX<\\\!:?`/?C?`QL+D'WY.,^-GX*WAG.>)_ MOGJ&LS:]L)FOX.7="`]6\*Z+\F'1"EY% M4%Y$*WB90#DN\';-!B/X(N:R?:W_ MN;V^-N=NQ3*3@L>5_: MML<_H+FSX6NJIS\!``#__P,`4$L#!!0`!@`(````(0`AAKH.[0(``($(```9 M````>&PO=V]R:W-H965TOD*2 M!H54Z:INDS9IFO;Q[(`)5@$CVVG:?[][;4+CT*;9"X3+\3GWW'NQL[QY:FKO MD4G%19N1R`^)Q]I<%+S=9N3WK_NK:^(I3=N"UJ)E&7EFBMRL/GY8[H5\4!5C MV@.&5F6DTKI+@T#E%6NH\D7'6GA3"ME0#8]R&ZA.,EJ814T=Q&$X"QK*6V(9 M4GD)ARA+GK,[D>\:UFI+(EE-->2O*MZI`UN37T+74/FPZZYRT71`L>$UU\^& ME'A-GG[=MD+230V^GZ*$Y@=N\S"B;W@NA1*E]H$NL(F./2^"10!,JV7!P0&6 MW9.LS,@Z2F^CF`2KI2G0'\[VZNBWIRJQ_RQY\8VW#*H-?<(.;(1X0.C7`D.P M.!BMOC<=^"&]@I5T5^N?8O^%\6VEH=U3<(3&TN+YCJD<*@HT?CQ%IES4D`!< MO8;C:$!%Z).Y[WFAJXS$"S^^GD;3&>"]#5/ZGB,G\?*=TJ+Y:U%1SV59XIX% M[CW+9.9/Y^$D>I\DL!D9@W=4T]52BKT'4P.2JJ,X@U$*Q*\[`BN(72,X(S#5 MD*N"-CRNXOAZ&3Q"Z?(>#8"@Y<`UEBN/%B5(/SCF;B!%IPGA]7N?Q]Q+7RQO@M7,WS4@AVI6QD;"6"/6SD)9K[T,?S M$F:AJW$(N7XFPS`Z&PO M=V]R:W-H965TJ M]WW?WQAHV\0`[:"Q/?/O3ZI4*I7T:=IPSGDQ^%-F:LF42J6E^/BOOYX>3W[N M7@X/^^=/I]'9Q>G)[OEN?__P_/73Z6+>_'!]>G)XO7V^OWWGH\+UQ<7)X_W3X\GVH+E9>WV-A_^?)PMZOO[WX\ M[9Y?M9&7W>/MJY3_\.WA^\%8>[I[B[FGVY<_?WS_<+=_^BXF_GAX?'C].S%Z M>O)T5^E\?=Z_W/[Q*/7^*RK=WAG;R7]@_NGA[F5_V']Y/1-SY[J@K//-^1E]^73:1Q5XG;QZO3\\\>DA98/NU^'W.\GAV_[7ZV7A_O^ MP_-.FEL%.FE3,G!7*RM+=_E$*(/^>/#VHV)`FN?TK^?GKX?[UVZ?3 MXN59^>JB&(GXR1^[PVOS09D\/;G[<7C=/ZVT4)2:TD8*J1'Y&3!R1+&8*LK/ M5+%P=32G4JH@/P,YO;&X4K&DSO(S-1)=GEV7RZ7+ZRMA1\I[F6I*(=]67NEG M25;R,U7(M>Z1C&Y2/?EIBGA]5BJ4KZX3OQS1C"2$M$?%9V\K9&3\IWY)5MR5+Y447`L-^/!R+KPK8T9&6=&TJQO+*DTO*Z<]4`DD?VFHAI?1+91?Q-M M!=.6ZI?W-4S!="SU2ZKZUH8I&'\4;*/^KJ2F+0NV9[S1AYL*"<8/ZY9UM:GI%P7KPK6U:-*XLVAC_39L636RK7TS#O#'8BL8? MZI>C#7.N!^1D?*_?OMY^_OBR_W4B3TV)F\/W6_4,CBK*BAG9=6_,QOI_&NIE MC%=68F7FTZFTM8SB!WE`_?PLC^B/YS_EF7*7RE0I$[D2-2.A'B#*;-T'#1\T M?=#R0=L''1]T?=#S0=\'`Q\,?3#RP=@'$Q],?3#SP=P'"Q\L?;#RP=H'&Q]L M?1!G[C6.B3-G9@3.B^&]&.Z+X;\8#HSS'CR7L,UB5_K8_R)VE1D5NZ8J50-R MP>P%JI$P*G4?-'S0]$'+!VT?='S0]4'/!WT?#'PP],'(!V,?3'PP]<',!W,? M+'RP],'*!VL?;'RP]4$<@V3.-*Z*:Y"!]V*X+X;_8C@PSGO0"509V1&HZE$1 MGCZ;,55I?3J5,3DWIGHC9E7+Z*E_,F360.H@#9`F2`ND#=(!Z8+T0/H@`Y`A MR`AD##(!F8+,0.8@"Y`ER`ID#;(!V8+$,1&]&M.M,?T:T[$Q/1O3M?+RF,2: MCB,G="7\G-`]'K)*6F828BT7LP5W\*QJH:([62BZ0K5,R/3;.D@#I`G2`FF# M=$"Z(#V0/L@`9`@R`AF#3$"F(#.0.<@"9`FR`EF#;$"V('%,9!UM?!C3K3'] M&M.Q,3T;T[6QXULGC.6EXQUAK*23,#8%KVJ2'V=!ZB`-D"9("Z0-T@'I@O1` M^B`#D"'("&0,,@&9@LQ`YB`+D"7("F0-L@'9@L0Q$;T:URA%O\9T;$S/QG1M M[/C6"5!YQ7U'@"II-T`U*D!]('&8`,048@8Y`)R!1D M!C('68`L058@:Y`-R!8DCHFJ1#4B^C6F8V-Z-J9K8\>W3H#*%-,)4+6X52B? MR1C_SN4M994#;>@C1`FB`MD#9(!Z0+T@/I@PQ`AB`CD#'( M!&0*,@.9@RQ`EB`KD#7(!F0+$L=$5:(:49V(CHWIV9BNC1W?.N$L#W[OZL[F5B(4*!`;DHFV'I%IG>5I'%,1.TU4BC_(A,5"=J$#6)6D1MH@Y1 MEZA'U"<:$`V)1D1CH@G1E&A&-"=:$"V)5D1KH@W1EDA"&[Z5T":K!5C`X[)U M1MV`SV7[C'*NU]W05ILA_WUHZRT5)[0U*NDC/&HSMZ;.?4AG+Q6R#E`WZ"K9 M,BX5+FZ\)8N&E3"]IDG4(FH3=8BZ1#VB/M&`:$@T(AH338BF!MFVFA'-#<7"X>3'$E\&DO$`(2 M^)0S02!]0NRY@:]V//*!'QB[Y:A*-GCK#1(GPM,]$_OLJJF-#_4XLWO)]125 MI5?F%N:NW`E-PTJ9>C<-LH^+%E';(,=\Y)V\Z%@I8[YKD#7?(^H;Y)KW-G0& M5LJ8'QIDS8^(Q@:YYKVMH(F5,N:G*>HT.G7*.50US,_!:/S91)R%FN M_;Z521GS3=IJ$;53Y)J/O!WXCI4RYKNTU2/J6\4CI1]8*6-^2%LCHK%5S)F/ MO.?#Q$H9\U/:FA'-K6+._(77]@LK94N_$2AGS4]J:$H[;( MWM%K](Z:TVNPR593!\K]7J-1+JP;J50.-:G8(FI3L4/4I6*/J$_%`=&0BB.B ML57,Q4#D+=%-K)0)@2EMS8CF5%P0+:FX(EI3<4.TI:($/WPKP0_G2J23U0.Z M)@IR$U99F,ITCS2D1'HF9EI2UJHT"T6ZVFO+1[H^T)VL56'3ZQV+5WH+S^D1 M&I7L4[46I!,K9?PXI:T9T9R*"Z(E%5=$:RINB+94E!X!WTJ/T"SG7.D19"8(2C8NY+6> M]DP8B+TC#2D]@EF8V`CU"+4WE^\1OWG3UUMY3J1KI.[)V/>,R)OKUJ),ROBW M;I%5C&Z\-XB&D=*K.,7+R']_;QH)^X;4(FI;="2WCI'2N7V(HJLK;R[3-2(V MNQY1WZ(CV0V,E,ZN4"H6O=R&1L+F-B(:$TT,4JLT/S_?G'F&IR;=&IX1S2TZ M4HV%D4JK<57T;[F8CK'Z/*B[*\!Y(+9Q+=TXLQZQ@+!*CTVE?L'5\D#+6_(74Q0FYGOZ+YZ M[]/IOBF2'[GNZ[T?U-1]/9G-R0]3E3I1(T5R(RVYXU2ZN/:BKDFE%E&;J..: M_E"Z*7@K/5TJ]8CZ1`/7M(Q`EYYWAU0:$8V))L9TE#3(U9EG>$J5&=&<:&$, MZY:.KB_]=X`EE59$:Z*-:_I#J7CE+=IMJ22]"P$BO8O,!%(:(E&I4/)"1-Z% MJ&8B2Y),_,D,D7(FF`JZP>6>K_M*+ETIK^1T)76_U.E*N;GAVZ>"B15WUSY% M[@.RX#5JS4J9&M935+3KB@V#U,;IS\_%&W^@;1H!J],B:A-U#-*6/Q0O"]Z3 MN&LDK.D>49]HD*)220\+5][@,J3*B&A,-'$-7_C>GE)E1C0G6ACT3\V\-`*V M+59$:Z*-0::92]?>.+8U$M:T7-Q*=]]SK!I@)HC2EB[YL[`X$%)RFXO&`V$D M-[JT7&K\XLQ[Z,H%+RT@@2XA[/8M64'_'_0M9<7K6QJ59+TC>WKY4\B:C`9* M3X1LU\J0U>/4FA'-+3I2 M\H612DM^H29M?CBGN[UZ-O/!FR754HVR'0OJ%MEN7\B]O[AE51M>^;+^IH!Z?RS_ M1E=(=^#LT9$:49VH0=0D:A&UB3I$7:(>49]H0#0D&A&-B29$4Z(9T9QH0;0D M6A&MB39$6R+I;_"M]#>R@,/EF4&Y@,OE+C_E`DZ79T9>SHUAM?WTCAC6NU5. M#&ODGG0N>*_/-3F"I'IG;K.V3M0@:A*UB-I$':(N48^H3S0@&A*-B,9$$Z(I MT8QH3K0@6A*MB-9$&Z(MD80U'"EA319PN(0UY0(NE["F7,#I$M9Y.3>LU;[2 M.\):;T,Y89WN3.6'9J"Z+(XD86VE&D1-HA91FZA#U"7J$?6)!D1#HA'1F&A" M-"6:$MV-8;4[ M](X8UIM)3@QKY`W-WL&=FOJNES\T`S4HU21J$;6).D1=HAY1GVA`-"0:$8V) M)D13HAG1G&A!M"1:$:V)-D1;(@EK>$W"FBS@H1]8D&1$.B$=&8:$(T M)9H1S8D61$NB%=&::$.T)9(8AB,EALD"#I<8IES`Y1+#E`LX76(X+^?&L-J: MR,?P?[8!D6YPV*W/JJSTJ+&X+`^*;)&T4/"6,FM&RLXZZ@;90RP-HF:*Y(:! MO^RKON+EU.CXNVPB[J[OIDB]0>>*[AVGJEDIL]96M\@J8@VT8:3TQFZI7/"6 M0)M&@$O:LBOSKKJE"VPYMR06DCU5_45(?Y6O9@5LM?+K=,GUD48J)=,`9:9< MO/+>DIJ.&2?BU'B2'S43"_+9`+V=4;B(O`:L60%;!VU&=`QJ&"GM MAW+QT@O.IA$(^,%?V_E-C'%!1WU:5*WQW.CMJ0M_U;UF!4R!ZT2-%!D_1%=> ME#8='=F?!W^H]&KJ%^^G*JE2`:QW!"`.,NDK(\TRFW[-%+S)=U7HFLYRN%N$#=- M`9*M"[>":I[]WU=0S]:="J83>.G:606QAU7,A&S],F3U`D-<*J5[:&";IYF: MUJ'A5EG-M_)5_DU^0]0E MZA'UB09$0Z(1T9AH0C0EFA'-B19$2Z(5T9IH0[0EDD\SHJ7C:H`%'"Y?9Z1N MP.7R?4;*!9R>?-[?>EW'L/YNNMGM\/)S<[7^H3_%?7\AHGV'] MAP)D)57^4H`L:TH70U)9)26+^DBZ5$F70:TKE91$.K2N55(RL_*3BDI+:AXH MADH))BAK06,WDI`,9GXNT86DR+7^0"Z1^HL)^EJHKU4H2)+LOE!+-(I*+50\ MF4E6U-0QH"59A:Q5DR($%*I)`4()*O=D?N"5.1:OAEM3N3OH;>7LH*^5JT.> M5G<**_)/J/)R$%#2U)'>0/7ECF%%3@`&RRUWI%1:J(1R^DG*J.YY!&U*,=7) M^&":A)`Z(\PTN7E948>;F2+'NZ24ZI!S($TN8E;DB&2P!G*13*4%:R#7951: ML`9RFT"E!6L@YZI56J@L7.@:2$2B`WNROJ#@1+(!>\*^HJ!%/DGG=%W>(. MI90D)51JN78G*:%2RVTC20F56FY=2$JH!#(^5,)]5HVYZ@([R]:6KJ>NWX92 MRI(2*IO44-GDJP32UJ$A7#[`H(::4)(:,]3]"!9.!I)*N'.K M$5;=TJ:.W#F5E%!5Y5Z=I(2J*O>0)"5451G$)254-C56JUL84H+S[!DC?\CG M^^W7W>#VY>O#\^'D/E[TGP+2_WG=?Y=W3/ES/OM7^1,^R:_? MY&\V[>3;'W)P\?3DRW[_:OZC,LC^"M3G?PL```#__P,`4$L#!!0`!@`(```` M(0";>F\I]`4``)86```8````>&PO=V]R:W-H965T&ULK%A; MCZI($'[?9/\#X?V(7!0EZLDHL'N2L\EFLY=G!ELE([8!9ISS[[>J+]`7QCC9 M?1G&CZJ/^JJZN[I[]?6]/CMOI&DK>EF[_F3J.N12TGUU.:[=O_[,ORQNNR:>UY8G4A?MA%[)!=X< M:%,7'?QLCEY[;4BQ9T[UV0NFT[E7%]7%Y0Q)\P@'/1RJDJ2T?*W)I>,D#3D7 M'<3?GJIK*]GJ\A&ZNFA>7J]?2EI?@>*Y.E?=#T;J.G69?#M>:%,\GT'WNQ\5 MI>1F/RSZNBH;VM)#-P$ZCP=J:UYZ2P^8-JM]!0HP[4Y##FOWR4_R('"]S8HE MZ.^*W%KE?Z<]T=LO3;7_7ET(9!OJA!5XIO0%3;_M$0)GS_+.605^;YP].12O MY^X/>ON55,=3!^6>@2(4ENQ_I*0M(:-`,PEFR%32,P0`?YVZPJ$!&2G>V?-6 M[;O3V@WGDUD\#7TP=YY)V^454KI.^=IVM/Z'&_F"BI,$@@2>(R1W'$/A"$_A M&,23Q6P6S1F%I_#SXTD4S.(%$WS'*0>3S2K6UITQ6;5T)L#DP%2V5X+G%I^`ERR8/S+?0D_JB"4#DF> MD&7MPBR&XK0P[-XV_B):>6\P5$IALQVQT2UVT@+'!=*F)I"90*X`'BCJ94'M M_P=9R(*R9$!;"0PZ`T.#M)`NJ0ED)I`K@*8!AJ&I(809.3Z79"70:>W".%0J M,=-CW'*;,.YU[2PDM9#,0G(5T2*'SZN1WX\8C6'T`9D2\MP(F1N%^@B+=:-= M;]0GWT(R"\E51%,!D_)Q%6C,5,AO;SFB9ME"4@O)+"17$2T^F*YJ?&SJQHL) MV']R]B*1'CM'PJ56DX61[MY(2DXM)+.07$4T.;$NY_Z@06,]9(ZHZ;:0U$(R M"\E51(L/]RC&2AE#<_ITMI%'#YTC1K:71K9[HS[;%I)92*XBFAHHK:KF?K;1 M6`^9(VJV+22UD,Q"/: M^AR*V.Z,6>UL*+6AS(9R#=*CQTZE1#\2)6S3^C!Y7]/"%!`LN4/>I^:ZX@LK MOD'D&P$!P>(Q."Y]O6"9=(S9#B2*ID87R:7!'#.G2\->]K@TWODT:0*"":=$ M:.X.L,OA6%SVI4L%%`RERR3D\YU4:/2Y7+[G>W%UV^-C,WMJ)WK'/K-U@<$PE%/5JDZ\!F][@.WAHU'1PRRF'LK'>^L%++ M(2"U'`+BL\./@H6QX.629Z0@V!4?%\)[J"9$0%I!K(DOC-39P2&M(`*")4^9 M:<8>-_=[1]5J*)U>)VR3C\M#:Z.A<$BK4VAV<%\8J642D%HF`<&@4N192T#O MJ%I])`^[K"*/'_(^VW5XJ]:**B"(I0\U,A;E':QUUBSC4#`YQM'$O\P;;8XSV`&JMM/&TIM*+,AO`X;N'B8_'J+7Y/4 MI#F2'3F?6Z>DKWAU!6UKL^IA?J^V72:PE84N:N+^-,'MX-@;N(J#K=;(FR"0 MEW0&&]S>/;$R&/@6J4:9@&@,#Q,XN]M??HJ`?]0A2N"8;#ML9PD<3T?P>0+G MO!$\3N!\-8(O$CBI`.[URN!6\%HH62 MP-T@[>`^D/U[@OM?`M='4SR<'2CMY`_\0'^CO/D7``#__P,`4$L#!!0`!@`( M````(0!3+)<37P8```HB```8````>&PO=V]R:W-H965T&UL ME%K;;MM&$'TOT'\@^!Y1O-N"YZOCANBD-S5&O_A^K\CX\___3PUK0OW5ZIWH,,QV[M[_O^M`J"KMRKNN@6 MS4D=X2?;IJV+'CZVNZ`[M:K8T*+Z$$3+91;4177TAPRK=DZ.9KNM2O6Y*5]K M=>R')*TZ%#T\?[>O3MTY6UW.25<7[^<'C`VW0OY5ZZT;?>]V^>?NUK3:_5T<%NPUUP@H\-\T+0K]N,`2+ M@\GJ+U2!/UMOH[;%ZZ'_JWG[356[?0_E3D$1"EMM?GQ670D["FD648J9RN8` M#P!?O;K"HP$[4GQ?^Q$05YM^O_;C;)'FRS@$N/>LNOY+A2E]KWSM^J;^;P"% M]%!#+GJTST5?/#ZTS9L']09T=RKP](0K2&Q_%G@(Q#XA>.W#>02:#C;PVV.8 M)`_!-Q!=:LRG`0-?WS$71`"D%V9@F\^,8&3&7<%'^30$QC21G29VH4'PVD_& M#Y^DE[P#\X"A`AEZ8-5\/0B&+8=<[]N49(Q)@\8BPR2_@`QV.`'SV1%,[)?M M'")349E+6@2;:77$5'!G5Y"[4"'8I!HB4P7HGJ,#3DT7I@L0?/VLXSJ304?@ MY(UJ=F\70EM)CZ'C(JD2[N($%`.;(AF;$/( MHH,U/U8E6=XM\IME"77CQ^]6<`X9A4E#09.3'V"#.IP1KWU(;UO-8FR@!U3<.V[3[0QTR"Q,+A7'J_W!J`#ID M$<0LX(:.:>.'.F0VS?N+SS#BT*GU"6?,-'8AFF77(K,O[6]34X=3XT;3Q=6AZOB+6^#,; MAI8Q0=H!S,((;WP<^ARV;^H`E,#F`!%S@!N%F38^)0!I9F&$]W[DU/B$9KLF MO?HCUOA8F#2<\9*AA8Q$>X!9&N'M'SEY`*$9F^0!L<4#HF4R0Q.M-%G.(4-3 M)@P#L9,/$)JQ23X08QN/?`#+%"ZC.9IP)6/1(5.3,`S$3IY`:,8VV,34$V*+ M)^0Y_EYWPZYI(2.QN4(FS`6QDRL0FK$-1F&1Y.0*\=05SB'#%3)A'(B=7('0 M3(?D"K'%%<+\?DYMM`>,IBA*!L3F<1-&`WQ9CP_Z=5\E--,DV4)BL84P@8V^ M3D'+3(ISR!0DS`;(,%\0H1F;Y`D)MO'($V[H0#3+K$/F81-F`YQN'=BFLP$E ML+U*$XL/A&D\P]MH)=-D-0)A/$B)DQ$0 MFK%)1I!8C>$`+&8EM/,B$\2!Q\@%",S;)!U+F`]?;AM!FYG/(*$TNC`0I M=N_L)B4T8\,$MK9)6?O32)VF,]J&5C(6;07P#TP6^O\MWWTKJ$$0&;61I@#4J?V)S33(;5_RMI__KA&*QF+M@*S-L),D#I9 M`:$9FV0%J<4*YMDTK60L-B_(A9D@=?("0C,VR0LRY@54IUES#JTT6ZOJQHV6,0CN" M*4B8%/#.9>RI-]B&]A_?)%`"VQ0'E^E&YKF"=/./*V3S@SL^)@PW[\/U=JW: MG?I%'0Z=5S:O>*L>P87U)7JY\7^*\$J$QY/5T_"7`,'E)W`3?RIVZH^BW57' MSCNH+>1^.4$QX#Z^Z>$.GK[=P]]<*+BT7N+IW#9-?_X`S,'E MKS@>_P<``/__`P!02P,$%``&``@````A`"@DUX=H`@``R@4``!@```!X;"]W M;W)KGHTS22SB.++-[>\[CB$+RU:E+U$\.3YGSEPR?3JHBNS`6*GKE,:]B!*H MAV93XAXZQ26&TU;GK(1T+B=YZGK`)0Z;9-)/HP)>=&,A3.H^3Q9BRV;2MSR\) M>WOQ3FRI]Y^,S+[(&K#8V";?@+76&P]]SGP(+[.;VZNV`=\,R2#GV\I]U_O/ M((O28;=':,C[2K+C$JS`@B)-KS_R3$)7F``^B9)^,K`@_)#2/@K+S)4I'8Q[ MH\=H$"..SJ=%[@NU&M&VX'YXX0>*W M<\$D/';NP2G%<409B_7;S>+!9,IV:%J<,(N`P><+ID,P%.V44>U^90_VRKXJ M/I5%"%S*]-^6&?R/C`>G='B9_##J>(-RP+0-NO*#M^[WX\%8-0 MRK`[84`5F`(^0E59(O36[T4?1ZZ+=BL[[_NI>!T?)O-VE5GW`5>IX05\Y::0 MM245Y$@9]1[1BPG+&`Y.-Y@Y+I1VN$3M:XG_3,"IB[SQ7&MW/J`PZ_["LS\` M``#__P,`4$L#!!0`!@`(````(0#%?J5&E`<``,PB```8````>&PO=V]R:W-H M965T&ULG%K;;N,V$'TOT'\P].Y8)'6Q@SA%I<6V!5J@*'IY M5FPY%M:V#$G9[/Y]20XES8QD6\[+;D(>#@_GW]\_?G^=*;U4UVVF:'\I2OO>]Y[?WT_.,/3^]E]:7>YWDS MTQ9.]=K;-\WY<;&H-_O\F-4/Y3D_Z9E=61VS1O]:O2[J%A(WX\6 MQZPX>6#AL9IBH]SMBDW^J=R\'?-3`T:J_)`UFG^]+\YU:^VXF6+NF%5?WL[S M37D\:Q,OQ:%HOENCWNRX>?SM]516V[YD&; M6P#1X9E7B]5"6WI^VA;Z!,;MLRK?K;V?Q6,:AM[B^]'9J_RO=?\^)U MW^APA_I$YF"/V^^?\GJC/:K-/$A+8U,>-`'][^Q8F-30'LF^V?_?BVVS7WLJ M>@AC7PD-G[WD=?.Y,":]V>:M;LKC?P`2AE1G1#HC2K-W\W*JD040LN?[E#79 M\U-5OL]TTN@MZW-F4E`\:L/MP8!&=]1+)]7LC)&?C15K2Q^BUN'Y^KQ:/2V^ M:H]N'"0!B"Z(#B(H(FT1)A":74=1GYM35#J"X[YO&9E%E)$,Z'[)"(0BTB$B M"CL(X:A=ASE>YV;`:R_`KO#]SJ[U:`(8R"7CXA0-D)VUF>D[&[#./;3SDD4A M``B:QG@BABTRF>5F'8^XVPBN]A9<"%GYT(6E6E)5)FMN5;A9Q=OVIH9H` M$]K0"3^F+DQAU@567"(GM.9,]YE%J#SOE9K03 M9?NTO!*@N)BCXBKM,$!QKJ)A",&(`\@HN$21R?A$BD,]5P,O`L8Q6"G)=4L0 MP#(2_2&I%XW0(B_>B##(,O%>7_4NP(!Q`5XNF::DYH:E2QO*(T2=B/*Z2^C% M4.EYT!*'@7W5P%]@83!+2=VE\V(H]"A1G+.PK@M6J:FSX$@AA:.LF.Q/S+(Q M_1_$$BN\DGZ?YY9^*O"\])>7DHRU@!M)!LJM$[B_5*+T=8YKQ=_U52J`1 MXA_))'Z:?^PJ)O6":7GB0*U2^`,',4`0]\V"LN0WY+HMXQC'M^4(I02??%2 M76G0>-0<:P`_INQS1=Y0B+I``@M2?QX-; MA#/2%JR4?;U2BDS@)SH1%)L4@F1A3"2`@(*4BE\H4P=P9Y"J%QU"T5R><8U. MHVA7L2X@>1=PH-9+@C\E22E`!)=R4;$N,)'C2#?@D4RLZ;4''$,_EKU:0#(2 M@(AD<*%>U(?:@UW%_=A'"K+1@8!CL`SYQ3PE`.W&N$\6&FNCZ$B/)_H1^@"1 MOL'C)04@U%7Q"&5A)!RQN-X5%`@^+0;>%1P(/*2?,C(/IF1>2O0T@S*[JR4H M4'O*C+<$!X(JY+>UE,[V:RFK#[4*!3)/H];+E,NLME5T#XC"@\ MK^I$`SQJJ8X2@#`E-$)9&+V<+((!J"LI9M'+ MA=L=0'AW-$)WOTN"@Q$)5ORO!0?"N\,R2(VYTL5TH2V91^5W^&)$=M&S,.<+ M`&$V:(3Z@LGKC=00R>;U2%@T MERA>$P[D_"Y(!=@\31W">H>RN4LPPY&KKN+-WH&`C0QQ.3HR8`4`2O])<:%> M0Z:@-SPUIIS\"F!-FH>?79SP"/6,$;7)RAF"!%[/$@?"NU]2SM"(VO3=00*O MUZLUV3[XG<=A[W47%C`RDB-WZ:;^8F#PZFB8(P""%Z)+G2/T'8[Y[,`8@?F` M)#0$"3XJ@)?NQ[QZS=/\<*AGF_+-?#`@]#NI;A0^9DCTQPSVS?^BF]#?$IRS MU_R/K'HM3O7LD._T4O\AUGM7\#4"_-*49_O2^Z5L]%<$]L>]_FHDUR^0_0<- MWI5ET_YB+DG==RC/_P,``/__`P!02P,$%``&``@````A`#!9RY`D!```-@X` M`!@```!X;"]W;W)KQLO[R7 MA?9&:YZS:J>3I:EKM,K8*:\N._WOO^*%JVN\2:M36K"*[O0/RO4O^U]_V=Y9 M_<*OE#8:*%1\IU^;YN8;!L^NM$SYDMUH!2-G5I=I`Z_UQ>"WFJ8G.:DL#,LT MUT:9YI6N%/QZC@8[G_.,ABQ[+6G5*)&:%FD#Z^?7_,8[M3*;(U>F]K-.NTY`TGY[RL&!"+M6T_-._TK\A)BZL=_*`/V3TSL?_*_Q*[LG=7[ZGE<4H@UY M$ADX,O8BJ-].`H+)QF1V+#/P1ZV=Z#E]+9H_V?TWFE^N#:3;`4?"F'_Z""G/ M(*(@L[0GYKK3K?72V=CV@3HVI'R)LZ%I*YE MK[QAY;^*1%HI)6*U(O!L1:S5DJS,]2O9F_D%4K`L].Q%Y^ M5@0^)T,"SU;$!KV9H5BWD^'9K6`S>S(PY9?AV4[V_F^NH?(IRR-,FW2_K=E= M@ST'&>.W5.Q@XH.>J`L;JNMY74!!B#E?Q20Y%=@4X`EE,Z:$3RCNF!(]H7AC2CRE>.:8DCRAD`?%@%@]`@;%.PS8SP,E MR"A0SD-6QO*@**[<*"*X`09"#$08B#&0#(#1XF'7S%^\($,U#%+H66CQBN+) M$K`)JH%@.(H"'@['%@X*2C0L1K_^R3'F@**K-BI2'&(@P$&,@&0`C.]"-YML19&0' MY?"@*(ZTT^\(Y:,;$\>%](&!J`-$BW`LM'7C;K2;GW2`HO?;>.006N9\AX*, M'*):.RB*2MC&F%U*K:5M+[0@!8%US+V*J[(8E$/5%W?#\2'@QSZ M&,(#XL-Y/L5#XL.Q/L4CXL/I/L5CXL,A/\43^-D@<>/Q8;BUW](+_3VM+WG% MM8*>8-QR^^ M_7\```#__P,`4$L#!!0`!@`(````(0"(O+_G:`4``/H6```9````>&PO=V]R M:W-H965T')\QCYCO/GZ6N3."Z_J3)1; MUY],78>7J3ADY6GK_O/WPY>EZ]1-4AZ27)1\Z_[DM?MU]^LOFZNHGNHSYXT# M&+)00TJD62E MBQG6U3TYQ/&8I9R)]+G@98-)*IXG#?"OS]FE;K,5Z3WIBJ1Z>KY\245Q@12/ M69XU/U52URG2]?=3*:KD,8=YO_KS)&USJR^#]$665J(6QV8"Z3PD.ISSREMY MD&FW.60P`RF[4_'CUOWFK]G,=[W=1@GT;\:O-?G?J<_B^EN5'?[(2@YJ0YUD M!1Z%>)+0[P<9@L'>8/2#JL"?E7/@Q^0Y;_X2U]]Y=CHW4.X09B0GMC[\9+Q. M05%(,PE"F2D5.1"`OTZ1R:4!BB2OZO.:'9KSUITM)F$TG?D`=QYYW3QD,J7K MI,]U(XK_$*1FU"4)=)(9L-?/@]%)YCH)?+9)PLD\"*/E'50\G)92B25-LMM4 MXNK`T@/B]261"]E?0^96'IQ,)]A[>H%0,LDWF47E`BEJ*/++;K98;KP7*$RJ M,7O$P+[J,+Z)B%N$K(),R]Y*N^H&>3"%;AX@L3V/&2R6M\OT` M(P&#$N2U*.C*^JC^YL6TKL_[E0-(@(.(HQ&3%[2E\?S0C<',R+J MV&[K(XCRLB.,8DQ>THG'\T+_-O4:E!9!-TK;@OK2DHA)57KR>*KHY`;59=\0 M=6F)W:M([-L11B,F+VG)XWFAD#PO-'!3 MK\&2(RZO];(CS,<(-K)P$2WF?M]:3*+2G<<314\WB=IMWR?&KXG:$:8QNN/" M42`*9GVS,9E*TQ[/%*W>9&KUS;U/^H%F:D<8Q9B\I'./YX5^?V,)DJ:@>=D1 MYI.(P2OX5.-0HZS&L;0KJT%D:PPB3$?T$HRB:?A.70.K:WQ\.E%HFU^_MI5* M>PVB_+#)]!%&,:9NG^H6P3W=0H-Z%O$@PFC$Y`5K>/PZ"^0H6Z^^$EHO!%%> M=H3I1%C/:+H(^D5ATI3F3;;#C7*BU<.O]4Z\M,]S`8(H/3O"-`;I+9?S_AAC MLI.&3=C==U275P`#$>V6JT&4)>D.2FC68>3Y_3U+#J1Y$XXW%$2K-Q7L9Z\+ M;'>(6/V([ER:&\&8FGVJ103H]5"HOK*#EU4-HIH-6@3%F+P^U1""-QI"-*AE M:_^4O"5JK#/UY!F-F%2E2=]?4K1TLZ3VB3@@OJ\*&`\BC$8,/O(]B_*Y;QNH M4;?>=#2H5R4>1!B-F+RL7G`GK[?>(.R2PN4C'M5(25?6633N0-V)F$:0*EY! MXN5:P:L3CWF>UTXJGN7UH@_OQ%T4KS[W_AJNO""CUSV`F\=+D$P$&ULE%7;;J,P$'U?:?_!\GLQEUP:%%*E6W6WTE9: MK?;R[!@#5C%&MM.T?[]CG*`0HHI]03` M6$^B>4TMY&\JT9H3FV13Z"35+_OVABG9`L5.U,*^=Z08298^E8W2=%>#[[=H M1MF)NWL8T4O!M#*JL`'0$9_HV/.*K`@P;=:Y``>N[$CS(L/;*+V/0DPVZZY` M?P0_F+-[9"IU^*I%_ETT'*H-?7(=V"GUXJ!/N0O!83(Z_=AUX(=&.2_HOK8_ MU>$;%V5EH=US<.2,I?G[`S<,*@HT03QW3$S5D`!&=2F*SNP M4W95<:G<^\"Y3'Q=)OD?&0?.\.PL^3A9]+Q>V6.Z!@W\P*GI?AP82@Y0.&T]9 MV'+=;05_-0YK(0Q@,`NE[.D!E$G_G]S\`P``__\#`%!+`P04``8`"````"$` MKLBR2BH*``!'+0``&0```'AL+W=OT*ZU6>[CVV"1&8QO+D,G,O_^JZ2[Z4(P3 MS^[->/+P5M%55#?5P,,?/T['R??JVM;-^7'JSISII#KOFGU]?GV<_OM?Z9=P M.FF[[7F_/3;GZG'ZLVJG?SS]]2\/[\WU6WNHJFX"'L[MX_30=9?U?-[N#M5I MV\Z:2W6&(R_-];3MX,_KZ[R]7*OMOC>>XRSFIVU]G@H/Z^MG?#0O+_6N MBIO=VZDZ=\+)M3IN.QA_>Z@O+7H[[3[C[K2]?GN[?-DUIPNX^%H?Z^YG[W0Z M.>W6Q>NYN6Z_'B'N'ZZ_W:'O_@_B_E3OKDW;O'0S<#<7`Z4QK^:K.7AZ>MC7 M$`%/^^1:O3Q.G]UUR8+I_.FA3]!_ZNJ]U?X_:0_->W:M]W^KSQ5D&ZX3OP)? MF^8;EQ9[CL!X3JS3_@K\XSK95R_;MV/WS^8]K^K70P>7.X"(>&#K_<^X:G>0 M47`S\_IA[)HC#`#^G9QJ7AJ0D>V/_O>]WG>'QZD7SI:NLV)+\/*U:KNTYBZG MD]U;VS6G_PJ1RP>H\*_$7S^C.PB#P%R'/^`U+ MF++]6.%76OHSUW<6/,..0+G:#%00!DN[5@FA=9$'$>8G)B0A)"4D(R0G MI""DU(D1.]P`[XB=J\W8!=$O,B$Q(0DA*2$9(3DA!2&E3HQ`80H:@?*;WX+- MU-W^T_<_[LE,@B!6`:RL`AA$0P$0DA"2$I(1DA-2$%+JQ,@+5*V1E]OK/5>; ML0NB%P`A,2$)(2DA&2$Y(04AI4Z,0'G'DO=P,5:)0M-V\:8DHBB5:P'(S M+`?,<0*&(HEBB`-H/+3M6.]T1QI$JP7^,,4; M5R`/KN$P'4)K-D0H4G8Q(C`?[-R599B@RER*F)GD%%6F+ZN3S5"E!I$C,@VM M012H,@=AE5^)*M.7&H29=][*W9%W+K>6_PQ, M3CFA\M1REE)51GWE5%4@4KY*1.*IFW'[X@V>G@;>QWD+_EAM[(ZE+T*B-30R M(I`Q^YBCBJZ/-7*E2E5^C$B53X)HV2_=S`V$`BL'C!%D;++$"GO.2*E*A`) M[X'OL-"WQEFBIC#=ZCZQ?C@WBD:6B/Q$JF[8N02%$MDW"B%REB$%*7)Z.^;"[9$^CZ#HIBBA**4HHRBG**"HM)`9LQCC;87S&"ZW/G`%599 M^_XED;'E9*ZUR8B4"AN.F**$HI2BC**YZ*2-U!8XD^V(4J M%19(2E%&44Y105$IT<@^RX,FQ$B#>!=QYRZT]V*M$]RQL6.(4*5G1Z@^V(5* M0U"I[`R&B#*JRBDJ*"HE&LL.[SOU(OF]['`O5G8D4A%%O''B*CT[`OUZ%RIM M0(!92!$ISQE%.:)?[D*5`#V7$HWL0CW>A)(TP3O/CUK!WM#*C&QH]8T8#+ M6UI;DQ15RC"C[G.J*A")LG/]D>]<^M]P7[% MK#)K0QZA2E5"C$A50H((JOU6SF0#JPPS-%3N8M0L_QEB1KNG?S M/L=[0;W4;G>YO,NWURJ)X!1#?,RUGAM$:*C7ES`TZDLB40"+@*T">VZGTI-F MEE'G.545B*3SQ9*%]AZR1`TM+W9?:]S+S8DHD554UN2)4*6N>HQ(7?4$$>XS M0]^S,IZB1%EEB)3O')%2%8AN%FR)JM[0*"DVUE"[P9T]0^_%2J#LK\U*4]LW M\1@`#;5*DPBFRK"22>2+8@@=AUD;XA2-M%6,NLY1I5P7B*"6APE!%LD252.5 MQCMC?4K^5E?!1'^MKVH2\2LW#(RY5MP1JK1&`Y%J&A)$_%7#]Z)E85> M6NHAD#E6WK?J!7[[G@-/1L@`!3*N#T&Q--14"44I11E%.44%1?S;13Y4<481 ML_@647S?=:JNKU54'8_M9->\\>\,H7J?'@8L/H+<,`9?0?9K-#D2X/>1]I'E M&EZIPT2P>;B&5\HC?+6&-[`CW'/6_%G)V!'X-A.>$8P=\>!(/WVML\=>L$Y@ M7T!M8(>Q+D:/P">@SV.^-G#Z\;/#R4?.L.%)'.'/_OH9+A,=TL9?PS*:_[.D-K`"T&P&3L"CPX@A6,AQIX/ M1\2Z.%P1^(SULGVM_KZ]OM;G=G*L7J#\X--&J-BK^!!6_-$U%[CKPG>H30&PO=V]R:W-H965T0>7[DRH2]T6D5&>Y5F0Y5L6V7)*2S+S]-`@T0>!G MG"@SN8CLC]T_`32V!BG?_O['R_/5U]WQM#^\WO6<_DWO:O>Z/3SL7S_=]?[[ MG_"W:>_J=-Z\/FR>#Z^[N]Z?NU/O]_M__^OVV^'X^?2TVYVO2.'U=-=[.I_? MO.OKT_9I][(Y]0]ONU>Z\G@XOFS.].OQT_7I[;C;/-1.+\_7[LW-^/IELW_M M207O^#,:A\?'_7;G'[9?7G:O9RERW#UOSE3^T]/^[<1J+]N?D7O9'#]_>?MM M>WAY(XF/^^?]^<]:M'?ULO623Z^'X^;C,]7[#V>XV;)V_0O(O^RWQ\/I\'CN MD]RU+"C6>78]NR:E^]N'/=5`-/O5.O!J'=]?ULWT/_VNV^GUL]7 MIZ?#M^BX?\CWKSMJ;8J3B,#'P^&S,$T>!"+G:_`.ZPA4QZN'W>/FR_-Y??@6 M[_:?GLX4[A'52%3,>_C3WYVVU*(DTW?K8FP/SU0`^O_J92^Z!K7(YH_Z\]O^ MX?QTUQN,^Z/)S<`A\ZN/N],YW`O)WM7VR^E\>/F_-')$H1H15XG0IQ)Q)_VA M.YI,+U$9*!7Z9)6^,[P97U"0H9*@SU^O#=6[;A+Z5"*3_G0T&HZGDY]ODK$2 MH<^F,I7-_ M>SQ\NZ)YBWK]Z6TC9D''+6G3/007.M@+`%N_@V"&P0VB"R06R# MQ`:I#3(;Y#8H;+"T06F#R@8K&ZQ;P`@(#7H(R)#&7?>*Q&-$>-WU:-YNQH@[ M')@-/IU8LVG2&+%T"D(9D+SQ>D>Z:(Q8 M>@E")9"J\6I)C\;FS+%JC%AZK4C=LD80:0JZ((C"V@RB).,Z_ZIW7`M%!DW; M^Y*,:+O<"J(U)0:-$9I58\32:R54MZP11-HU7Q!$86T&49)V$!5I!5$2"B(7 M)P`2*J]6Q(#$C5>[[M:N,6F,^&8I"&5`\L:K)>V,S&8M&B.67H)0":1JO%K2 MHZDIO6J,6'JMA#!BE'1>$#%A;49,DG;$%&E%3))VQ("$RJL5,2!QX]6NNSU1 M-D9<]Q2$,B!YX]66MH9OT1BQ]!*$2B`5>*V`K)47AD?D^$9\9%+;%ZGQ^6F_ M_3P_T%1&V5;'9F-`R:M*:86*&;=:^*XWED=#(D-=,!HV(\M7:*07P@!1R(XZ M'XL0Q>B8($K1,4.4:\=VO.P1IJV:@*%6B:A"QQ6B-3O6[65,@XY(?]M'$1W1 MH7.R)CPR6Z:M.I=S7BO<]=SV[MT=V1MS;<6./J*`T:0^S!A-9X/QS)HQ0K;1 M18@0Q1KI9G=FU@*:L)6HX-?[67]FC:.4#?3-,D0YHH*15![WAU8UEFR@E4M$ ME4:Z&JYK56/%5K+9W!GD16NVJ.]F=@"1;E_0`61V;G0`A6AFT'L5^QQJX316 MN@,`"I25.ZX#,G''SHVU1.;PM9/OA8ZN5 M0[8BR::_.#-K/QYI*[YCC"AA)(?9I.]:.\*4#73!,T0YHH*1?+8A5ITE(ZU5 M(JH0K1AIK36CC@$ILO9V2']M'96Y/]V&FV_N*&2.4VM3LM!6[.@K1&=MC`*% M7%/+FCU#K?5NI)MRL7RL'1DE?,=F]$ZMNZ7HE"'*$15:FN^V1*L2485HA5IK MP\H**U!6`[%'^WH_'@UFHY&U M`(6H%"&*-6IW!TLK82LYI!UZO&AUT90M=-_.$.6("D:\*(^M%EFR@58N$54: MO5./%5NI19D>$EDU7;-%QQP@SA[^?L>0)QC&'""1.#9OYEYW;,V]"_%DC#I& M:\#[B`)&3&?CF6LU:,@V>NJ($,4:Z5)U;-9DJ6C.$1UQVA\.9^U_T$N@ M$IF^#P_T'%&AD+K/J']CQ6V)/B6B2J-W*K5B*]F(SF0VM5:P-5O436A.'^)P M`WO)Q9E8:>!"6_&LXB,*&,D5?SCLN]:$%;)%>_)S)]:4'VDKOEN, M*&&D[C;K3ZS)/&6+[]W-;,K+SF9^S*/<$'TB1#&B1"'ZZ%9.#1^SB<010GM0_J"WJ1,'W=7GKD16;[,V$PMM MI9NH<604L)7:NO;ME@[9X'OAK\]`(VW%RC&BA!'?;&:%-66#[]W,;$BR,AKR ME[).T8K6[*:0N>.<6//)0EMQE7U$@4)FUCF!?B@+T=J]1J@5(TI^2CXU',TV M[,[<+]Z/N4WNKD?M8&QUR;FR,EZ(&(RA8:56>['7CMS6`:(0480H1I0@2A%E MB')$!:(EHA)1A6B%:&T@,Y0B#V[/*[\V'&0VW=Z/B7=.S.B9%8\-GY%^,2)`%"**$,6($D0IH@Q1KM"(5GV]MMOO>13:BBNT1*T24:4= M6_)3:XU9:2N67[-6_7S4C)B=K_X@8DU:RMIS5Z+V,UQ&>DGW&>DGM`&B$%&$ M*$:4($H198ARAA:(ENA8(JH4LJ)O MK=;+IH9QWJR]!GIA^D!HA!1 MA"A&E"!*$66(E3(7-\ MV@?["VW%L)I'UXP,H:AG8DOM)4.I-+2(S-05L8P!*L(M6)$"6JE M:)4ARA5JG8T4K&74$2=:*&J)\A6B%C M9"^-*HUT8W4LEU*+FD&W#9;?R9X[4T\\0:+J6E<^N$/O@_RZMG6%SO$\<1"%/G-W M1%?J6ED^E&/3E7INL:[0M\(_U$][+#ZG;XO7$;:Y2T)=]Q[0M\L[^`>J!CV0 M[B@LU:*S$E2'KBI\<"94TJY;T(-F*FN=XUF%I03:$^DQWIT2-;K2U?"4#-"5 MKJ:BF<7;S.G`LP[7>CHREMT7J$3+$\D9JA&IU:>R,_P"AU>>2)-PRMTAN6)U`RO MT+F5)S(TO$+'5YY(U/`*G6)1>+H:=$G1Z6R"DH+3>:&BV'0I5129SL!07#K# M0E'I*BN]:^V)EZNQ%BE5O/-"1O7NO)!3M;O*FE,/[RIK3OV[JZPY]>ZNLM)K MYU[1>>>00MYY(:*(=UZ(*>!=98TG'GU-"%LCGGKT990./O.2KK+2Z_:>>+\> M/>;4V3LO+*BO=U[PJ:MWE=6?>/1M*;R#/_7H.SD=?.8%766EKQEXXGL%Y''= MS$[T9R_>-I]VQ>;X:?]ZNGK>/=+Z<%,O9D?YAS/D+^?#&ZU<],&ULK)S) M@/F8DE,U$`"N27/_Y\?;GZN3N>]H>WNTQPD\U<[=X>#H_[MV]WF?FL<5W* M7)W.V[?'[7^6MWROQQ_]__?/EU.'X_/>]VYRNR\':ZRSR?S^_Q[>WI MX7GWNCW='-YW;U3R=#B^;L_TW^.WV]/[<;=]3)1>7V[#;+9X^[K=OV6$A?CX M$1N'IZ?]PZYV>/CQNGL["R/'W_?3\K:Z\-'S+UNC]]_O%\_'%[? MR<37_=Q3#_BP7QUW3W<9%L2L%18SM_=?DA%:['>_3JG/5Z?G MPZ_FAX];A[VOYX.4\.OUJ[ M_;?G,_F[0%WB/8L?_ZKM3@\TI&3F)BQP2P^'%VH`_7OUNN>Q04.R_3/Y^VO_ M>'Z^R^2*-X4HFPM(_.KK[G1N[+G)S-7#C]/Y\+H40H$T)8R$T@C]E4;"XDT4 M9,NYZ.-&\M((_?WG+:'JDN[07VFD\.F&4&XD-NBOZLU-J5#(%TN\-Q>&H2P5 MZ:]4)!,7Y`,U;OR#U`@^5E60DW7Q#]C32Y5&2I,^2,WJI#C'S[5]%"%"/\@-<.;?%B(2DFT7N@U#V;17A,9I0^JJG@(34!\T$NA MB@C^X5-=S2G_\@]2\\->NA4YGDP9M>UY>__E>/AU11,Q#?CI?3_OI$P%90);HJHD M^)S$S=9<4'=!PP5-%[1ARS<3GUP?<#.TQ*"^ZF#.%4KVK%H10A3,1BC, M%FVAJA92"5T#4@?2`-($T@+2!M(!T@72`](',@`R!#(",@8R`3(%,@,R![(` ML@2R`K(&L@'"&"+C:.5#AFYEZ%>&CF7H68:N999OK?BF4/;$]PW?UIV?]P_? M*P>QU?5,U3E:YXK5+S>21+?J3T60]+P,I`:D#J0!I`FD!:0-I`.D"Z0'I`]D M`&0(9`1D#&0"9`ID!F0.9`%D"60%9`UD`X0Q1.A55D4I]"M#QS+T+$/7,LNW M5MP6_Q]QRXW8<2M(7ISE\"U859)0KS!JDD3)-B\?9LMY>XJN:P&5#@T@32`M M(&T@'2!=(#T@?2`#($,@(R!C(!-)S.!,@&::P$U7`L@2R`K M(&L@&R",(:H@4DXWRTIFO*Y:R=#/#!W-T--,NCI(HLR*:GKT6[.Q9]:E8QLU M[7)I.WP%R95UL%8E,;N[FB`%VN3JI4B8=BGC;KM954LIZTP&5VHV83*4TDC&DAV"[H@S&5\DI@*&ID!F6BMEVAW8N192 MIA=@:`ED!5IK(!O08@Q11>M=:"2K:BG52E9#6S)(K)30BBGS[O`R&3E62J3- M6RD1T`S_B9Q(Q.VDD"B=%0JETD*B5*/JB!JHV$340L4VH@XJ=A'U4+&/:("* M0T0CHYAVCW.F-392ROL3M#5%-$/%.:(%*BX1K5!QC6B#BO1VB`<,W1(POJ7W M0X*EG,NJ'E;SZ*HH2-M386!/HH$SD/3R"*M5L>&9_&D'8D>Z>/N9G/[``>?' MCX,2LTY&B'=J>3-$52F5-YN5FD0%LY^L(VJ@8A-1"Q7;B#JHV$740\4^H@$J M#A&-C&(Z(YS]U]A(F8R00VC&:XKF9Z@X1[1`Q26B%2JN$6U0D3("VDH9(5C* MN901R%00I.*"WINB/14&9._"0%)&8!4J-GP9P5]AI>\#7-Z!\ULJSH)(HC!] MU!\&SH*[:J24?VL&F?X$96<34%=2XO0I5PSKZ2DI4%^9S.:>V@9(PM0T1C1"-%>*G)S_ORS>. MX8DJ-X:GB&8&7>C&7$G);D2YK',&LE`2IK8EHI5!%VI;*RGMHS#OS"8;)6*J MHQ05H4MQJB*04E2S"Q52UDHQ46-0S!;7;OQEXB?25[Q[I-=RJI45_HJ.9S2M#LTN/W!V`E4CI11KB.H2T5U' M'G-A/EMRHJZ!2DU$+41MV_1UOAPZIS,=5.HBZB'JVZ9I!BHZWAV@TA#1"-%8 MF0Z2`8EN',,35)DBFB&:*\-BI(-2T=T!+%!IB6B%:&V;OL[G(B>9-ZA$V:7# M2`4(91HCZ$N7S8EJ(G,EE@"I#1"-$ M8]MPUO7V!%6FB&:(Y@K]W3`OE(`9BR6B%:*U0FJ8\R5G'MLH"6.:LDN^4T\Q M%5:IZ*`'E9"3(YUW5V&46VA(QU3*N">,*+)F)YT$?4,,M5!Y_I*2E1'TWSD.'2@)$QM M0T0C1&.)Z,:S&O`)2DT1S0RZT/*YDI(M+Y?PX:?=JQJP5$JF,RN#+M2V5E+2 M+4$Y6W8FL(T2,;8I9:$)]$#4[$*%E,56V.6R$1Q[U)1(JL:ZAWGBD_)8F$]Y MAU)7,/%\M5.7ORUV4[>82XY,?K-7%.^9K705J"">!-?.$Z8:R&+3JYI!9LC" MU-K/;BM_C>>VE7<-SG9^TW+Q.I"O%?2LDBLX7J\$0HKN_!BI,'1>!U6-E`K% M&J(ZH@:B)J(6HC:B#J(NHAZB/J(!HB&B$:(QH@FB*:(9HCFB!:(EHA6B-:(- M(DIH[6[E2$IH9!Z'TV,7Y3PNI\OQ*.=Q.J5K6LY.`?ZJ+9T"OXET\6;.RE&! M**Q5/ZL!H!JB.J(&HB:B%J(VH@ZB+J(>HCZB`:(AHA&B,:()HBFB&:(YH@6B M):(5HC6B#2**87`DQ3`RC\,IAE'.XW**893S.)UB."UGQS!_4Y6.X7^V$Q/O MNZS0%JA`CQD]KX>ALZ:K\J,06BX63`+4%#*G^75$#8GHM(8RQ^H1_X:Y4C8#IEM91J"ZEY-%"(1LH5)=2R@]!Y$1IPS)C^X'O(#_1!['AM/R@]Z"R M#\ZJK1IJ`=7@&J*Z0M(/GCZDS=A]X$OI=!_^T>Q%MQX37Z3=H]?H)I-#-U&K M2M'LO6H2I?:_=87$IB8HT9FV?5+6L.S8'>2K]'_?0;'6MWPG$)UHF`["9I[" MB@],ZMBC9I#1\TQQ4E&3E8@X1:R5:"5',$X1/7QB_K1! M>_R'!9)GC:-1X3\XX#-5"?DO$7@L57)4D'3;,<7R,:,M&-9=H0+ZDH6GH$`% MR0;.-<4'AH885>@694SK"U^+Z39EG+P-]6@UJ(CN3/I*:)SI4IBOI$PEWK&D M"P=41-<)?%H!C2A_L8IEFRCF+X2Q@*Z9QK3@\A95J(@NDWJ4*M3RJK?E%6HY M71KRZ?"6\[L6WC)J.7_KC&6+*.:OQ;%@&<7\Y3@6K**8+MAZ>"FF^X,>7H[I M$I6'4X/Y51-?24`EOKHG43SQ%DRCF%\+0%NS**:;QAY>BNDBI8>78[HZYN'4 M6G[)QE<24(FO[D$4\]L1J#*,8GY'`@M&43SVM794BL>^UH[*\=C76KJ`%//K M19X:*(CY-0LLZ40QOQ>"!=THYK=#L*`7Q73WW,-+,5VM]?!R3)<)/9Q:R^]: M^4H"*O'5W8QB?RK2%$IW[=%4JQ3356(/+\=T>=+#J5'\,IFO)*`27Z-JQ7CL MF]IF19HX?`4T!?`+(EA'-8K]^4J3)%TM1X5:*::;LQY.CPU?]^@&%CU/?-VC M*9A*?(VBJ99?/Z%*;O6L3K\@\[[]MNMOC]_V;Z>KE]T3/1'IK0"M4H[B-VC$ M?\Z'=]K*T._(',[TVS')QV?ZL:`=?=>(WMADKIX.A[/Z#Z]`__S0_?\```#_ M_P,`4$L#!!0`!@`(````(0"FHVH'L14``)Y]```9````>&PO=V]R:W-H965T M'RZ/WY] M>SF[>G-Y7OY]>+K\U[O_ M_J^?_SP^_O;T^7!XOI`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`A3)?`A M]"'R(?8A\2'U(?,A]Z'PH?2A\J'VH?&A]:$;@9,0.;0@(4LY:$R?-$T?4;7> M7LI!9M1'%NX&?Z]C%IM3DO:0`!)"(D@,22`I)(/DD`)20BI(#6D@+:0;BY,2 MV:Q.2EY.A8J6(YZT-LK%TLN%#EJX![65&[0_!9VZ""2$1)`8DD!22`;)(06D MA%20&M)`6D@W%B<]TCG.2(^*[M-C-NI[+>-^`0D@(22"Q)`$DD(R2`XI("6D M@M20!M)"NK$X&UXN1YP-K\[O\]65Q)]YAE<-N3G1LI`+PU$G6GO]XQ1D4AE` M0D@$B2$))(5DD!Q20$I(!:DA#:2%=&-QTB07?$Z:7CY\J6@W%UK&_0,20$)( M!(DA"22%9)`<4D!*2`6I(0VDA71C<3:\'-V=#?_#_4,UY.9$B]<_-E[_.`6= M^@3F0@T7S\B%'EW*(,3L\>]GFKQ3 MQM;O*JGD]HHTWQFR#:?DPI#+S9?VBC3?&7(-E^3&D-.\RMO`-?:*--\9ZC? MT&Y>I:US\JK"O:L%3>O^KE4_";Q7T_$2M;;9#P9:R<7)**_>=')HH\RJ1Z8M M.\$6DQ);<=3\S)L?2FV4:3YC6SFIL!5?:+ZT4:;YBFW5I,96'#6_\@8>K8TR MS7>FK7Y#NWE5`]YSK]59.3UX'&>=4D>34K%:H;*JJC6XH&6H^3.+1E M*;$5QYO!NRF1VBBSQ(S-YZ3"5APU/_.F!TL;99JOV%9-:FS%4?,K[ZJYM5&F M^NU)W7Y\_W M=[^]/\KA3Z[I)Z[Z%W(7;K@WIT?53B(UK?5M>'6K;:]N_JFC[/+4]8*!5O:$ M&I(B4]'>6(I)"2NFI(P5DQ))=J]G6.^FF)DI]P#_>;:^V7F_*3(!=6$XJ2*4AW?+Z:NE] MC,H$V)9K4F/)?HSYW/L8K8G2FVV^G2^]S=^9"';;^7ES)GVX>Q5D2-)I=X"U M=]VZMU&G'8`4#C1?]PG9S->S-UY#$6O%I(24FK9G?=NS^=7<.[]FK)23"E)I MFS8?KF)436I(+=OJG"BG^\[/FU+IP[WLZ5D6M_NNO3UL/U24*/,!`U)H2!WQ M3X]6K+VM')FH\0%CMO4NY6,;99:8D%)#NIO)8S?>E6-F`NR*YZ2"5!K2SY&I MLTYER+95DQI2:\BVU1F:Z)#^S,P/G4?GG+`QY/93[_)D;Z/,=@\&DH<&#(4# MS=VVO*-G9-NR^\-$IH=5M:/CQ%8T2TS-$D^]]\9;6L9*.:D@E;9IL[2*436I M(;5LJW.BW-ZK)F3&)]\?2[6>UAF?DU5OENLCKU-[%QU[&V4^=S#0PEYKA8;4 M-=H?[]:KQ7:U\@X/$5N*28FE\>[@M96:*-VE9_(HI[>+9B;"]L.<5)!*0^:D MO/:V2&4";,LUJ;'TPN=H3=1P4I9G$+U/VIF(B6.`/^7T8SL&9Z+FFM3S/Z,C MM'?LW=LHNV.<*AH*390^5R]NMNOMW-N@D8FQAXZ8E%BR:\6+M2%*CCEJ1[RY M6BZWX_]A+\$:YW8YYD,4I-)=SNKJC9>WBG5J4F/IA0_5FBB]$6>;[8UW!NM, M1+\)W<.'FFL:'SY>OG973QG+0<$Y3FBZL?,5^R%J1`$I)$6DF)204E)&RDD% MJ215I)K4D%I2YY";"S6G5W%&V'OYZ<7"S.FYSIP]U<#.1U%6]Z:&^C3EV% M%)(B4DQ*2"DI(^6D@E22*E)-:D@MJ7/(38\_^_)#E^DRV/)[T$"COK$G!:20 M%)%B4D)*21DI)Q6DDE21:E)#:DF=0VZ*_B.S*0O.I@RTMA=B^X&6=O`<#+2Q M%]BA(3V1,7_CWX:+3("]DQ&3$D-VJ)H:.K7LSY"8@'YMW,WDST2\/)18<,IA M(#6FM2/+C3=YN[=1]D!SFJLP%)HH/4Y?+J_FW@$K,A'NTKR!6FRC3-,)*34T M+&U[M?$NNC,3\4]+E&G>^_ORYT,/4\>6-(3E!CC:E-XVZMU'FPP6D<""9 M;NQG;^1[L>[S)!'KQ*2$E'ZOYEHY,P#^EO[]S&=LHTW)"2@V9A6V]A64FX)\6YFY(?]3Y8R<@ M#D87FMQYHHUW/-G;*/.1`U(XD+K*&>W.V`]/2S1MQ6PK(:6O:CYS*KK;\+RA MH9R3<;;&.'`_1(U.X`$I)$6DF)204E)&RDD%J215I)K4D%I2YY";"S4^&Q\[ MU?[\0]\`4D]P>\.2@=Q+X8T_]VFCS'X8D$)21(I)"2DE9:2<5)!*4D6J20VI M)74.N9E3H[EQYKYS`:$'?\Y93Y/L'&;#[U6JW"%B0`I)$2DF):24E)%R4D$J M216I)C6DEM0YY.1B>=ZHL0]W1XT#J46,#MG>9='>1IF,!:20%)%B4D)*21DI M)Q6DDE21:E)#:DF=0VYZ_%'CRUU%AA/^D6R@<5!2D]=5_+E(&V6[RJFBH9!1$2DF):24E)%R M4D$J216I)C6DEM0YY*9'KH+/.*LL5;AW)-/D=!50,%0<186DB!23$E)*RD@Y MJ2"5I(I4DQI22^H<QME^D5`"DD1*28EI)24 MD7)202I)%:DF-:26U#GDIN>\,;4:V?E=1=.H$^R'J!$%I)`4D6)20DI)&2DG M%:225)%J4D-J29U#;BZFAN4_-(Q9V!OR#ZG%!BRWTL+21$I M)B6DE)21M0_GAL8:/Q='D-V(CYU]T#CC!D:9761IW2,]!4>OP9A!\Z M2ZDCB'<).-#XJU:&[,$R,&2_1!62(E),2D@I*2/EI&(@F7DQV[`D5:Q8DYJ! MY`M9XZQY-RU:&V66V`TTE34UX'_]85`MVD^/)O>NU\H?0`T51[>X`E)HR)[Q M(D.V@\:DA)0:LFUEAFQ;.:D@E89D,&*[R\;;\)6)LLW7I,:2;0O/%;EOYDQ1];Y07"T]^U5$>(35?INLK>H?-80;#F7B]\>]1F(KV2CX@ MA0/)K5^S?5\F8Y]VXL5JQ5DQI2:]H>OB4R MN]IZO:-S*KEY/&^"8\4)CH'<_ND_T+VW428O`2DT9/M49,CN]#$I(:6&;%N9 M(=M63BI(I:$7>TMEHFSS-:DAM8;LJG:&)GJ>K(1S1/VQ\Z!JQ>N&`SG=<.U= M4NU7IRB;2%`X1#G=$%$QVTI(*=O*&)63BH%DRL*L:FG:IN6?KKOSN^XF3)0.KY,'LV\;_VL[=19NL$I'`@F8(S M41&C8E)"2ME6QJB<5)!*0_H+6M/'TV'JQR:C-K4L-9;LQIHX7>JV9#.H)XIF M4X=8':$O0-P\^],K+X_=5YQ'&6AT9;XG!:20%)%B4D)*21DI)Q6DDE21:E)# M:DF=0VXN_'D4=?!<+_H^]YVT<$IEI4EZN.D;^X$V-_U^\I,WW`UL#;NSS6_L M?3-W7=64P!F7SBK<.Z)K%)!"4D2*20DI)66DG%202E)%JDD- MJ25U#KFY.&_$+R^#0RXTN5UEZ]_L&2J.[NP$I)`4D6)20DI)&2DG%:225)%J M4D-J29U#;GK\@?MWNLHP-K=CFO?RFC?O?+$G!:20%)%B4D)*21DI)Q6DDE21 M:E)#:DF=0VXNSAM\RYN?T%4TN4\7^&_\V0\5)54X5#86,BD@Q*2&EI(R4 MDPI22:I(-:DAM:3.(3<]:ACX^@LP]0Y+[P)L(.>LHJ-&%#`J)$6DF)204E)& MRDD%J215I)K4D%I2YY";"S6\&N="7;BK:>=S?R1!#]/&]]G6FKS3C7?S;V^C M3(<)2"$I(L6DA)22,E).*D@EJ2+5I(;4DCJ'W+R=-_B5-PNB#VD:=9C]$#6B M@!22(E),2D@I*2/EI()4DBI236I(+:ESR,V%/_C]SJF?(U[YG'P^.FP/WSY\G1Q=_Q=_:SC=BYS"2?6OSGY?KV4'YWLY^10LI*2?D8" M)6LIZ1_L0,E&2OK;T2BYD9+^LL$O64D=F6>1#X&2K93T=VG\DO4;::V_48D2 M]2.:_:P<2N92TG\K%"4+*>FO2_V2I=21YVLGUFTI=>1ISZD2V:)ZEA.MR1;5 M<\@HD2TJCU5-M29;1Y[FF2A9R">5F=FI$JFC#VG^5%XU,E6-"U,ELM;R MS;B)DH6LM7SU?*)$&IML2YJ:;&DF+%CVUQ_ZRW/TRW375GCRU`,GN M9'+5<6$J7C([E5AYM&>G'MSA9I)'2';JF9&IDIF43'UL>4)KIQY/8!UY4&NG MGE)@B3ROM5-/8TV5;*5D:MWDD92=>N!DHLYJ)B53RY'WJ$NNII;S7M;@_60= M>:INMY\LD8?K=NJ9$:Z!/%"W4X^.L$2>J]NI)TA8(H_7[=13(RR11^IVZN$1 MELB3=3OU#`E+Y`$[R>G4)Y57U>_4:WE91]Y8OU-OYV6)O+A^IUY+/U6RDI*I MO5#>IRTE4_NAO*192J;V1'D1L)1,K8&\OW^GWE7,-9#7^._4*XM9(F_SWZEW M]4^5K*1D:JWE)>-2,K76\N9J*9E::WD[LI1,K8'\J,%.O:V9:R"_;;!3+VUF M22(EZ@<,IDI64C*UUO+F=2F96FMYG;>43*VUO!]:2J;60'[I8?=^LF0O)>JU MU5PW^=V'G?I5AZF2E91,K74@:ZU>-C]59R,E4VLM;\B6DGX-KD]';OEU[&^W MGP[E[>.G^Z]/%U\.'^4RZTU_#^A1_[ZV_H_GXS>9PY??R#X^R^]B]__\++^# M?I#7HKY1#[I\/!Z?S7_(2EV??EG]W;\%````__\#`%!+`P04``8`"````"$` M7J([.Q8%``"R$0``&0```'AL+W=O&9OEU_>ZMT?=[L M\XHU=.5^T,[]NO[YI^6%M2_=B=+>@0A-MW)/?7]./*\K3K3.NPD[TP:^.;"V MSGOXV!Z][MS2?,^=ZLKSI].95^=EXXH(2?M(#'8XE`7=L>*UIDTO@K2TRGO( MOSN5YTY%JXM'PM5Y^_)Z_E*P^@PAGLNJ[#]X4->IB^3;L6%M_EP![W<2YH6* MS3^,PM=ET;*.'?H)A/-$HF/.L1=[$&F]W)?``)?=:>EAY3Z1)",SUULO^0+] M7=)+I_WO="=V^:4M]]_+AL)J@TZHP#-C+VCZ;8\0.'LC[XPK\'OK[.DA?ZWZ M/]CE5UH>3SW('0$C));L/W:T*V!%(<.%UX2C\23D@XG2';.^^;23]X*H:3112%L\7\IJ,G MEIFKMLO[?+ULV<6!4H"%[,XY%A9)()B22[QZ$/!'^H%P&.0)HZQD(R73$R!B*1L\8 MRR"&M?YD&6`4*"18%XW+S.(BC(#+U8C$4]-H.Q@-^VB$I",DTQ&#'E2V38]$ M$VP5_:DL7C8,\H52NB%4`-4L:AQC<'(JI8U`0CX0N,UVA.Q&2#I",ATQTH8U MTM.^D1ZT294?&IOY201$'^0@TX6UTM)(S"+>=20"65W=8JM7I=)HSIM="`W; M#)L-06"U#$YXT-$:[GU.:&QRDHC>:DEL-R%I%`\%OA.(?Y4JE0CA!$@PM_+7 M'8S\X\_DC\9F_@+QH>=IBVN-BJTT"J[Y2R0KZP0F2Z@Y$_@;)^ M7`!N;3)0$*S00"&P7K]51IH$$M(U4-!,B!!%HJG4D/I^3C],1,->@)R-`IB,UR MW>+,@4HS9)*0+I.$L.^K@QJ)[=)7L8R^&?^('HY4C9XX0'YRM!`QEPW6$M)% M#:TFO%5^NJC"S[\>VE)IY4-+T%A;&R135H^)BI/V/[,6X]I@+2`\YFFICL26 M5N+2(T[*$H+]JSE:ZY7B10QV28!#'8[HOC^W^E:F+'PL+W,?XY36*-\?7'#% MM#N_A(+K?MPJ*_XV>>07CL%U'J?*D=]:N17>8#D1;B72%#=2<;>I:7ND6UI5 MG5.P5[QM+H#Q@`XWX2?^8@O?X`T9Z=NXG\!1_08>)'`2OH&'"9PWQ_A3E#Q! M_N,O-E$")[@;^"R!(Q+@WI`1W)C/^9'^EK?'LNFS'JX*_-_3_#;"(7+U70"F^'`6*\^X`N&7UO6_P(``/__`P!02P,$%``& M``@````A`#O##P-_`@``$08``!D```!X;"]W;W)K&ULE%1=;]L@%'V?M/^`>*_Q1Y*U5IPJ7=6MTB9-TSZ>";ZV48VQ@#3MO]\% M4B]IIBU[L0T^G'//_6!Y_:1Z\@C&2CU4-$M22F`0NI9#6]'OW^XN+BFQC@\U M[_4`%7T&2Z]7;]\L=]H\V`[`$608;$4[Y\:2,2LZ4-PF>H0!_S3:*.YP:5IF M1P.\#H=4S_(T73#%Y4`C0VG.X=!-(P7<:K%5,+A(8J#G#N.WG1SM"YL2Y]`I M;AZVXX70:D2*C>RE>PZDE"A1WK>#-GS3H^^G;,;%"W=8G-`K*8RVNG$)TK$8 MZ*GG*W;%D&FUK"4Z\&DG!IJ*KK/R9D'9:AGR\T/"SAY\$]OIW0UWX+#[.3TW>A`%\,J:'AV]Y]U;N/(-O.8;7G:,C[*NOG6[`" M$XHT23[W3$+W&``^B9*^,S`A_"F\=[)V747SJR2_G&?S!>+)!JR[DYZ3$K&U M3JN?$97MN2)+OF?!]YZE6"3S=VF1_9N$Q8B"P5ON^&II](Y@TZ"D';EOP:Q$ MXC\[0BL>N_;@BF)38ZP6J_"X*HI\R1XQ=6*/N8D8?$Z8;$(P%)V44>U\90_V MRCZW/I2;N'$H\SN0(YGB?V0\N**S@^"+HIC"C\H1$\I\)(2GSO?CP9ARY)K2 M5!2S5TI[T*')HIA/H"-U;*/SU3TXJ$_IC#NGIA;'M*'QTSQYA_B_MXH_>"RQ MW\'"'5A>O'(31S!VJ`+3PGOH>TN$WOKQRK'GIMUI\M>Y;XO7^[-R'6X$-OW` MB1QY"Y^Y:>5@20\-4J;!BXDS'1=.CQ@YCJ5V.(KAL\.K%[#MT@2--UJ[EP4* ML^DR7_T"``#__P,`4$L#!!0`!@`(````(0`XA@A9Z0(``(`(```9````>&PO M=V]R:W-H965T;=\0SEC49JU0C4O(B#+E=O7VSW"G]:$HAK`<,C4E) M:6V;4&IX*6IF?-6*!M[D2M?,PJ,NJ&FU8%FWJ*YH%`0S6C/9$,>0Z&LX5)Y+ M+NX5W]:BL8Y$BXI9V+\I96L.;#6_AJYF^G';WG!5MT"QD96T+QTI\6J>?"H: MI=FF`M_/X83Q`W?W<$)?2ZZ54;GU@8ZZC9YZ7M`%!:;5,I/@`-/N:9&G9!TF M=V%$Z&K9)>BG%#LS^.V94NT^:)E]EHV`;$.=L`(;I1X1^BG#$"RF)ZL?N@I\ MU5XFU^RAD45HH]Q0[D7AD-&@<:/ILC$504;@*M72VP-R`A[ M[NX[F=DR)7'DAY-@!FAO(XQ]D,A(/+XU5M6_'";<,SF.:,\!]P/'S)_.@SA\ MG82Z_73V[IEEJZ56.P]Z!B1-R[`#PP2(S_L!(XA=(S@ET-.P5P-%>%K%X6)) MGR!Q?(^YI^PP79%'?F#5]7X0#"D'KCY-`X[G,[2N5\K'I9"L%C*1-#K M:"8*YSYXOZR`Z\8*^\C8S.2\F<58];(4@L=2+G)J)H09]E]NNH5CC4-H[&=Z MWD^(7_@@C9<-=>@C-21(R1E+^%$/F+%`\3QXO4`P^8_3=@B-+&ULC%3);MLP$+T7Z#\0O,?4XCBQ8#FP:Z0-T`!%T>5,4R.) ML"@*)+WD[SL4$]5+T/HBB*/']^;-HMG#035D!\9*W>8T'D640"MT(=LJIS]_ M/-[<4V(=;PO>Z!9R^@*6/LP_?ICMM=G8&L`19&AM3FOGNHPQ*VI0W(YT!RU^ M*;51W.'15,QV!GC17U(-2Z)HPA27+0T,F;F&0Y>E%+#28JN@=8'$0,,=YF]K MV=DW-B6NH5/<;+;=C="J0XJU;*1[Z4DI42)[JEIM^+I!WX=XS,4;=W^XH%=2 M&&UUZ49(QT*BEYZG;,J0:3XK)#KP92<&RIPNXFPYH6P^Z^OS2\+>'KT36^O] M9R.+K[(%+#:VR3=@K?7&0Y\*'\++[.+V8]^`;X844/)MX[[K_1>05>VPV[=H MR/O*BI<56($%19I1V5?%I[(,@6.9 MY'V9]%3&%SW%UOW;J+^4T_&1B32Y'_A#!@'3-^K$%]ZZWI<'8^F1:RA7FDS/ ME%Y!QV;3-!I`)^HX"=>K>W"O/I0U1"Y-34YI^]&=X/3]KY#^WJG":P3[]]=Q M>CXB88?"H"HP%7R"IK%$Z*W?CP1';X@.J[M(_'2IX!<_< M5+*UI($2*:/1'7HQ82G#P>D.,\?%T@Z7J7^M\=\).'V1-UYJ[=X.*,R&O_'\ M#P```/__`P!02P,$%``&``@````A`#X2*8%K!@``0!X``!D```!X;"]W;W)K M&ULE)E=CZLV$(;O*_4_(.Y/"-@DFRC)T9X>;7ND M5JJJ?ERSQ$G0AA`!^_7O.QX[P-@FP,UJ,XQG/*_'CYVP^?J1G[TW4599<=GZ MX6SN>^*2%OOLR3<@FL\709YD M%U]%6)=C8A2'0Y:*[T7ZFHM+K8*4XIS4,/_JE%VK6[0\'1,N3\J7U^N7M,BO M$.(Y.V?U)P;UO3Q=_SA>BC)Y/D/='R%/TEML_&"%S[.T+*KB4,\@7*`F:M>\ M"E8!1-IM]AE4(&7W2G'8^H_A^MMB[@>[#0KT;R;>J\[_7G4JWG\ML_WOV46` MVK!.<@6>B^)%NO[82Q,,#JS13[@"?Y;>7AR2UW/]5_'^F\B.IQJ6.X:*9&'K M_>=W4:6@*(291;&,E!9GF`#\]?),M@8HDGQL_0@29_OZM/798A8OYRP$=^]9 M5/53)D/Z7OI:U47^GW(*<5(J%D[M>U(GNTU9O'NPWN!=71/9/>$:`KOG`I.0 MOH_2>>M#/T*:"@1\VS&VW`1O4'2J?;XI'_C;^(2-1P!)F\R0;7QFZ2PS2U7D M5+XI0S=-Y$[#IJ21SEN?=R?/XR:NRJQ\<(%(/3!J?#W2&22'6(U,C#T8F;13 MM\B0MTXD.W3`^.S2&;,W,9N-_O%#F.9M`66+>FXI"OFHI) M,4N:]7XJZ6Q)V096BZ:=B)3QW)U=\G;TEI#.M%!EL:5]335Y*Y12\^9%Y>S9@"%X39B`]*;58H"M;RL:2@AT M5DI*&G'84_<;!H<9*31.J*+,W1]RUW;3#F13O*!;G;>+I1757E11WC.!2:@) M&]8TNUV;'(I*#AB*,NBV@1(5/:#$-H,V44%;E)+M'CHHP^`D'DJKD`+*-41A MO&U"+:QR@NETG/H6=A)W0A=X>+MD.K^3/#T0#R>A![V-/NZ#3^B@3QR.@`\. M-)(X\=,2EZQM-`D_Z$VS:9/=JY'!%=S]32FI@8SS1Z,M(G6U)*'UC2)*9'-%&URU.1@RG(I MK[@#^UMZF,)I$RVIW?.T)`,K`\ND0&%PNB66VLZ1]B*<7O3P))K$$_0V^D3! MPZ&I`0KLD^5JC*B*$%U61]I$16U!1D4U0#(@JD9%YV2(E,FNB1FDP)HX"'T_ M!0ZCLMU,M*!V*4E!S,#(0#;-"7KH+)IS6G4)QH0YT2YIO>@$8)KC:<*DMU&N M,CD4==$D9B-HPFR:W$Q4U/;;'ZUI$DU80Y/N(=V&UJ)J+RIJSTG*#.@,K*I- M&@S@NG0R@RJR34>=I#C06#E-$ZIISTG*)M$$O3%;5]-6+:VIZW:R[#GVF`&= M`4UMT&``IZ8&5*2F41R/:50;,/*^*G<($779<^QQ`SKW:T)O2]1VO92H-R_2 MJ,N>0TH";OSN1V_:0]ID[WXNL="YI2!/1]TE<*2110:S1.TY]^17L&[F`5%M MUF``5Z-P@RM8TRBBX4BC)@T4VB@]YQZ?!!3T-K(IQCC6R0&4<-19SC4^.J?K MS41KZCGZ^"2BH+=14]_]A!NHF-![-C8PF-5[/:T M]J(;NCV?R-$73R(*>E-1MF+J`LX&?UH6MGK.'1V7LW$]E[#SV' M:3R))^AMK&`?3V('3Z+%PXB2;)Q@+*--PH>>LS2>A!/T-DKJPTGLPLD*=![H M1)LE&,DJJ&U.VG:36!(W+&F^@6N3W7;RQZWN"8E\'"X(AU'-;B;:=.;!K-Y) MJ1<_N2B/XA=Q/E=>6KS*]TWP97"W:BJ&\?9(+FW>_N?P```/__`P!02P,$ M%``&``@````A`(L*(:TR`0``0`(``!$`"`%D;V-07B^CVJ^ MTVWR""ENC)@1+,?:B`*=;P$7A%QA#8%+ M'C@^`%,[$=&(E&)"V@_7#@`I,+2@P02/\RS'W]T`3OL_+PS)65.KL+=QIE'W MG"W%,9S:.Z^F8M_W65\.&M$_Q^OEP],P:JK,85<"$#OLI^4^+.,J-PKD[9[M MWER;>-]4^'=623'84>&`!Y!)?(\>[4[)2WEWOUH@5I!\EI)9FA>K@M"2T-G- M:X5/K?$^FX!Z%/@W\01@@_?//V=?````__\#`%!+`P04``8`"````"$`'(0: M_I4```"I````$````'AL+V-A;&-#:&%I;BYX;6P\CD$*`C$0!.^"?PAS=V?U ML(@D65#P!?J`D!U-()DLF2#Z>^/%2T/14-UZ?N>D7E0E%C:P'T90Q+XLD9\& M[K?K[@A*FN/%I<)DX$,"L]UNM'?)7X*+K+J!Q4!H;3TAB@^4G0QE)>[-H]3L M6L?Z1%DKN44"4X"L-JK:N`\@8K]`ZCT2[0:_R/V"P``__\#`%!+ M`P04``8`"````"$`9N@;*/("``"^"0``$``(`61O8U!R;W!S+V%P<"YX;6P@ MH@0!**```0`````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````````"<5M]/VS`0 M?I^T_Z'*.Z10-":4!I66#22V1DIACY;K7%H+QPZVT[7[ZW=.U)(,-T.\V;Y? MWWUW9SNZWA9BL`%MN)+CX.QT&`Q`,I5QN1H'CXMO)U^#@;%49E0H">-@!R:X MCC]_BA*M2M"6@QF@"VG&P=K:\BH,#5M#0'`:-QZN-_:C33#&'SSPM=B4"CJ-)60K.J,4LXQ^< M:654;@>W6P8B"MO""-&EP"K-[2X>1F%[&Z6,"IBBXSBGPD`4OAY$=T`=:0GE MVL31QEYM@%FE!X;_0=K.@\&2&G!PQL&&:DZE15A.K=G4:U$:J^-?2C^;-8`U M48@*S6&];.NVU_PB'EW6&KCJ:CH/#1(4=#$NN!5@YGE"M?5`'EVV,=)EX4'*U`%V0&2RM5V.JBD))@KRPY]IQHB$'K;&>Q[BJ=6^P]S."UG@GF'H* MO>Y_@B4/RAB2(-I]K#75?@KN\9XJ@"SH%OP4.`_<-@W@6,!*.U[Q?L-;RPL@ MK98&7BIL&7*[<8WCU7I;(D.6NZ9<.S^U[7(A8BR!WW5_U M^+[)_0/E9_58O9LX7D#])A\)XR>X/XZ?X..]Z!+RIM-OXD^G?5OX2M)Y*/]Y M&A^X?#:/Y4+-\$'9O_W=PRAU]U2&K^)>_GH0W>&SKX5S,EWC#0S97N>MP/U4 MGIKO6'QV<3H<#?$3TCJ+PM>/5_P7``#__P,`4$L!`BT`%``&``@````A``%" M"@7U`0``3!@``!,``````````````````````%M#;VYT96YT7U1Y<&5S72YX M;6Q02P$"+0`4``8`"````"$`M54P(_4```!,`@``"P`````````````````N M!```7W)E;',O+G)E;'-02P$"+0`4``8`"````"$`[M'D,`("``!/%P``&@`` M``````````````!4!P``>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$" M+0`4``8`"````"$`JBCLHX\#``"^"P``#P````````````````"6"@``>&PO M=V]R:V)O;VLN>&UL4$L!`BT`%``&``@````A`$\!F,I:!```0`\``!@````` M````````````4@X``'AL+W=O&UL4$L!`BT`%``&``@````A`)QGC)%\!P``N2$` M`!D`````````````````.A<``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"QU.MH@`P``(0D``!D````````````` M````^"@``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A`(F@[J_,`P``F@P``!@`````````````````IC<``'AL+W=O MYP(``+T' M```9`````````````````*@[``!X;"]W;W)K&UL M4$L!`BT`%``&``@````A`'!B*ZMI`P``NPH``!D`````````````````QCX` M`'AL+W=O^L> MQ-0"``!\!P``&0````````````````!F0@``>&PO=V]R:W-H965T&PO=V]R:W-H965T M&UL4$L!`BT`%``&``@````A`*-L^D6820``^O8``!0````` M````````````9TX``'AL+W-H87)E9%-T&UL4$L!`BT`%``&``@` M```A`%V@`O6/#```GWP```T`````````````````,9@``'AL+W-T>6QE&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`(````(0#V2>WWD@(` M`($&```9`````````````````+"K``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`#1897Y=!0``DA4``!D````````````````` M>:X``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`'.0,#\2"0``DB4``!D`````````````````J;L``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,5^I4:4!P``S"(``!@````````` M````````DNL``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*[(LDHJ"@`` M1RT``!D`````````````````/``!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*:C:@>Q%0``GGT``!D````````` M````````NR@!`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`#B&"%GI`@``@`@``!D`````````````````ID8!`'AL M+W=O&PO=V]R:W-H965T```9```````````````` M`&],`0!X;"]W;W)K&UL4$L!`BT`%``&``@````A M`(L*(:TR`0``0`(``!$`````````````````$5,!`&1O8U!R;W!S+V-O&UL4$L!`BT`%``&``@````A`!R$&OZ5````J0```!`````````````````` M>E4!`'AL+V-A;&-#:&%I;BYX;6Q02P$"+0`4``8`"````"$`9N@;*/("``"^ M"0``$``````````````````]5@$`9&]C4')O<',O87!P+GAM;%!+!08````` ..+P`O`+(,``!E6@$````` ` end XML 17 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9

Stock-Based Compensation (Details) - Schedule of weighted-average assumptions (USD $)
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Schedule of weighted-average assumptions [Abstract]

Volatility 44.29% 49.77%

Expected life (years) 6 years 3 months 6 years 3 months

Risk-free interest rate 1.72% 1.92%

Dividend yield (in Dollars per share) $ 0 $ 0

X

- Details

Name: evdy_ScheduleOfWeightedAverageAssumptionsAbstract

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssumptionsExpectedTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Risk-free interest rate assumption used in valuing an instrument.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssumptionsWeightedAverageExpectedDividend

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average expected volatility of stock price.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssumptionsWeightedAverageVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

XML 18 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 19 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9

Acquisitions (Details) - Preliminary allocation of the assets acquired and liabilities assumed (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Dec. 31, 2014

Acquisitions (Details) - Preliminary allocation of the assets acquired and liabilities assumed [Line Items]

Property and equipment $ 25,847us-gaap_PropertyPlantAndEquipmentNet $ 25,502us-gaap_PropertyPlantAndEquipmentNet

Goodwill 143,165us-gaap_Goodwill 127,115us-gaap_Goodwill

Intangible assets 43,777 30,716

Accounts payable and accrued expenses 25,060 31,722

Other current liabilities 8,977us-gaap_OtherLiabilitiesCurrent 965us-gaap_OtherLiabilitiesCurrent

Cambridge [Member]

Acquisitions (Details) - Preliminary allocation of the assets acquired and liabilities assumed [Line Items]

Accounts receivable 4,406

Other current assets 137

Property and equipment 783

Goodwill 15,576

Intangible assets 14,280

Accounts payable and accrued expenses (2,659)

Deferred revenue (197)

Other current liabilities (53)

Total consideration paid $ 32,273

X

- Details

Name: evdy_AcquisitionsDetailsPreliminaryallocationoftheassetsacquiredandliabilitiesassumedLineItems

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

For an unclassified balance sheet, the amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business, reduced to their estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.9)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.5)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name: us-gaap_AccountsReceivableNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477

+ Details

Name: us-gaap_BusinessCombinationConsiderationTransferred1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1 Response)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

+ Details

Name: us-gaap_DeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph ((a)(1),(b))

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.8)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6904-107765

+ Details

Name: us-gaap_OtherLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=evdy_CambridgeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 20 R37.htm IDEA: XBRL DOCUMENT v2.4.1.9

Income Taxes (Details) (USD $)
In Thousands, unless otherwise specified

Dec. 31, 2014

Income Taxes (Details) [Line Items]

Operating Loss Carryforwards $ 107,000us-gaap_OperatingLossCarryforwards

Deferred Compensation, Share-based Payments [Member]

Income Taxes (Details) [Line Items]

Operating Loss Carryforwards $ 7,433

X

- Details

Name: evdy_IncomeTaxesDetailsLineItems

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

+ Details

Name: us-gaap_OperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: evdy_ClassificationAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 21 R9.htm IDEA: XBRL DOCUMENT v2.4.1.9

Acquisitions
3 Months Ended

Mar. 31, 2015

Disclosure Text Block Supplement [Abstract]

Mergers, Acquisitions and Dispositions Disclosures [Text Block]
3. Acquisitions

In March 2015, the Company acquired 100% of the limited liability company membership interests of Cambridge BioMarketing Group, LLC (“Cambridge”), a provider of strategic launch and marketing solutions for orphan and rare disease products, for a total purchase price of $32,273, of which $24,273 was paid in cash at closing. The remaining $8,000 obligation is comprised of convertible notes, which will either convert into shares of the Company’s common stock or be repaid in cash by May 15, 2015, at the discretion of the Company. The total purchase price is subject to any working capital adjustments that may arise. As of March 31, 2015, the $8,000 unpaid purchase price obligation is included in other current liabilities in the accompanying consolidated balance sheet. In addition to the purchase price described above, the former members of Cambridge are eligible to receive up to an additional $5,000 in cash based on Cambridge’s achievement of certain revenue and Adjusted EBITDA targets for 2015. This earn-out payment is contingent upon the continued employment with the Company of certain former members of Cambridge at the time the earn-out payment is due to be paid in the first quarter of 2016. The Company records any such earn-out as compensation expense for the applicable period. The Company expects that the acquisition will broaden its strategic marketing and communications solutions to pharmaceutical brands targeting orphan and rare disease segments in the market.

The acquisition was accounted for as a business combination and, accordingly, the purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed on a preliminary basis based on the respective fair values. The results of operations of Cambridge have been included in the consolidated financial statements of the Company from March 20, 2015, the closing date of the acquisition. For the three months ended March 31, 2015, acquisition-related costs of $169 are included in general and administrative expenses in the accompanying consolidated statement of operations.

The following table summarizes the preliminary allocation of the assets acquired and liabilities assumed based on their fair values on the acquisition date. The fair values presented are based on a preliminary valuation and are subject to adjustment during a measurement period of up to one year from the acquisition date. The measurement period provides the Company with the ability to adjust the fair values of acquired assets for new information that is obtained about circumstances that existed as of the acquisition date.

Accounts receivable $ 4,406

Other current assets 137

Property and equipment 783

Goodwill 15,576

Intangible assets 14,280

Accounts payable and accrued expenses (2,659 )

Deferred revenue (197 )

Other current liabilities (53 )

Total consideration paid $ 32,273

X

- Details

Name: us-gaap_DisclosureTextBlockSupplementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.

+ References

No definition available.

+ Details

Name: us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

EXCEL 22 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`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`@/'@Z5V]R:W-H965T4V]U M#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C M8V]U;G1I;F=?4&]L:6-I97-?8GE?4&]L:6-Y7SPO>#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D%C<75I#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C M<75I#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D=O;V1W:6QL7V%N9%]/=&AE#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K0F%S961?0V]M<&5N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O M#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DYE=%],;W-S7U!E#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DYE=%],;W-S7U!E#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T'1087)T7S0X,3(T-V,Y7S8T,3%?-#DY,U]B M9C%F7S,T961E-C,V9#1D,0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]# M.B\T.#$R-#=C.5\V-#$Q7S0Y.3-?8F8Q9E\S-&5D938S-F0T9#$O5V]R:W-H M965T'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$61A>2!(96%L=&@L($EN8RX\2!#;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$"!+97D\+W1D/@T*("`@ M("`@("`\=&0@8VQA2!#=7)R M96YT(%)E<&]R=&EN9R!3=&%T=7,\+W1D/@T*("`@("`@("`\=&0@8VQA2!&:6QE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T* M("`@("`@("`\=&0@8VQAF5D M(&%T($UA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&-E<'0@4VAAF5D/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XY,"PP,#`L,#`P/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T.#$R-#=C.5\V-#$Q7S0Y M.3-?8F8Q9E\S-&5D938S-F0T9#$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-#@Q,C0W8SE?-C0Q,5\T.3DS7V)F,69?,S1E9&4V,S9D-&0Q+U=O M'0O:'1M M;#L@8VAA2!3=&]C M:R!;365M8F5R73QB'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES92!O M9B!S=&]C:R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XQ/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5R8VES92!O9B!S=&]C:R!O<'1I;VYS("AI;B!3:&%R M97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW,BPX,S(\'!E;G-E/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S&5S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$;G5M<#XR-#$\2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@ M("`@("`\=&0@8VQA6UE;G0@9F]R(&)U6UE;G0@;V8@'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0@0FQO8VL@ M6T%B'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'`@61A>2!(96%L=&@L($EN8RX@*'1H92`F(S@R,C`[0V]M<&%N>28C.#(R,3LI M(&]P97)A=&5S(&$@<&]R=&9O;&EO(&]F(&AE86QT:"!A;F0@=V5L;&YE2`R,#`T+B!);B!*86YU M87)Y(#(P,3`L('1H92!#;VUP86YY(&-H86YG960@:71S(&YA;64@=&\@179E M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2!A;F0@:71S('-U8G-I9&EA2!A8V-O=6YT6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@(%1H92!A8V-O;7!A M;GEI;F<@:6YT97)I;2!U;F%U9&ET960@8V]N28C.#(Q-SMS($%N;G5A;"!297!O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2!B87-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M:6YD96YT M.B`S-G!T)SX@("`-"B`@("`@($]N($%P2!I2!C;VYV97)T960@:6YT;R!A;B!A9V=R96=A=&4@ M;V8@,3@L-#4W+#(S-2!S:&%R97,@;V8@8V]M;6]N('-T;V-K+"!I;F-L=61I M;F<@-32!G96YE MF5D(&EN('1H92!P97)I;V0@:6X@=VAI8V@@=&AE(&%D=F5R M=&ES96UE;G0@:7,@9&5L:79E2P@;W(@=VAE;B!T:&ER9"UP87)T>2!E=FED96YC92!I6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@(%-U8G-C2!P86ED(&EN(&%D=F%N8V4@;VX@82!M;VYT M:&QY+"!Q=6%R=&5R;'D@;W(@86YN=6%L(&)A2!O=F5R('1H92!S=6)S8W)I<'1I;VX@<&5R:6]D6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@ M($1E9F5RF5D M+"!A;F0@*&EI*2!A9'9E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@($-O6%L='D@97AP96YS97,@9F]R M(&QI8V5N2!P87ES('1O('1H92!O=VYE28C.#(Q-SMS('!R96UI=6T@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M:6YD96YT.B`S M-G!T)SX@("`-"B`@("`@($UE9&EA(&-O2!O<&5R871E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@ M(%1H97)E('=E2!W M6EN9R!C;VYS;VQI9&%T960@2!L:7%U:60@;6]N97D@;6%R:V5T(&9U;F1S+B!4:&4@9F%I M&EM871E2!A M;F0@17%U:7!M96YT/"]B/B`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@(%!R M;W!E65AF5D+B!5<&]N(&-O;7!L971I;VXL('1H92!C87!I M=&%L:7IE9"!C;W-TF5D('5S:6YG('1H92!S=')A:6=H M="UL:6YE(&UE=&AO9"!O=F5R('1H96ER(&5S=&EM871E9"!U2!T:')E92!Y96%R2!A;'-O(&EN8W5R6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`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`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E2!A8W%U:7)E M9"`Q,#`E(&]F('1H92!L:6UI=&5D(&QI86)I;&ET>2!C;VUP86YY(&UE;6)E M2!A6UE;G0@:7,@8V]N M=&EN9V5N="!U<&]N('1H92!C;VYT:6YU960@96UP;&]Y;65N="!W:71H('1H M92!#;VUP86YY(&]F(&-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@(%1H92!A8W%U:7-I=&EO;B!W M87,@86-C;W5N=&5D(&9O2!B87-IF5S('1H92!P2!A;&QO8V%T:6]N(&]F('1H92!A M65A6QE/3-$)V)O6QE M/3-$)W9E6QE/3-$ M)W=I9'1H.B`X-24[('1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M,3!P=#L@<&%D9&EN9RUL969T.B`Q,'!T.R!B;W)D97(M=&]P.B!";&%C:R`Q M<'@@6QE M/3-$)W=I9'1H.B`S)3L@8F]R9&5R+71O<#H@0FQA8VL@,7!X('-O;&ED)SX@ M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@ M("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[('1E>'0M86QI9VXZ(&QE9G0[ M(&)O"!S;VQI9"<^("`@(`T*("`@("`@("`@ M("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS M1"=W:61T:#H@,3`E.R!T97AT+6%L:6=N.B!R:6=H=#L@8F]R9&5R+71O<#H@ M0FQA8VL@,7!X('-O;&ED)SX@#0H@("`@("`@("`@-"PT,#8@#0H@("`@("`@ M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F]R9&5R+71O<#H@0FQA8VL@,7!X('-O;&ED M)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@ M#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M M:6YD96YT.B`M,3!P=#L@<&%D9&EN9RUL969T.B`Q,'!T)SX@("`@#0H@("`@ M("`@("`@3W1H97(@8W5R6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SX@("`@(`T*("`@("`@("`@(#$S-R`@("`-"B`@("`@("`@/"]T9#X@ M("`@(`T*("`@("`@("`\=&0@6QE M/3-$)W9E6QE/3-$)W1E>'0M:6YD96YT M.B`M,3!P=#L@<&%D9&EN9RUL969T.B`Q,'!T)SX@#0H@("`@("`@("`@1V]O M9'=I;&P@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@ M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@ M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@ M("`@(#$U+#4W-B`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@ M("`@("`\='(@6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M M,3!P=#L@<&%D9&EN9RUL969T.B`Q,'!T)SX@("`@#0H@("`@("`@("`@06-C M;W5N=',@<&%Y86)L92!A;F0@86-C'!E;G-E6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`I("`-"B`@("`@("`@ M/"]T9#X@("`@(`T*("`@("`@/"]T6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)O"!S;VQI9"<^(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T M9#X@("`@(`T*("`@("`@("`\=&0@"!S;VQI9"<^("`-"B`@("`@ M("`@("`H-3,@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`I M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)O"!S;VQI9"<^(`T*("`@("`@("`@("0@(`T*("`@("`@("`\ M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!X('-O;&ED)SX@(`T*("`@ M("`@("`@(#,R+#(W,R`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)O"!S;VQI9"<^(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@ M("`@/"]T9#X@("`@(`T*("`@("`@/"]T6QE/3-$)W1E>'0M:6YD96YT.B`M,3!P=#L@<&%D9&EN9RUL969T.B`Q M,'!T)SX@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@ M#0H@("`@("`@(#QT9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@ M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!L969T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@ M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@ M("`@(#PO='(^("`@#0H@("`@/"]T86)L93X\8G(O/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@($1UF5D(&EF('1H92!C87)R>6EN9R!V86QU92!O9B!T M:&4@87-S970@97AC965D28C M.#(Q-SMS(&1E9FEN:71E+6QI=F5D(&EN=&%N9VEB;&4@87-S971S('=I=&@@ M82!N970@8V%R2!O9B!T6EN9R!V86QU92!O9B!T M:&4@87-S970@;6%Y(&YO="!B92!R96-O=F5R86)L92X@5&AE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@ M#0H@("`@("`@("`@/&9O;G0@6QE/3-$ M)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@ M,"XX<'0G/B`@#0H@("`@("`@("`@/&9O;G0@"!S;VQI9#L@=&5X="UA M;&EG;CH@8V5N=&5R)SX@("`@(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@ M("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G M/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S M;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX@("`@(`T*("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE M/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR M:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S M;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@ M/&9O;G0@6QE/3-$ M)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@ M8V5N=&5R)SX@("`@(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6EN9SPO8CX\+V9O;G0^ M/&)R("\^("`@(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6EN9SPO8CX\+V9O M;G0^/&)R("\^("`@(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UEF%T:6]N/"]B/CPO9F]N=#X@#0H@ M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX M<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D M9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX@ M("`@(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W=I9'1H.B`Q)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@ M("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUR M:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`X)3L@<&%D9&EN9RUR:6=H M=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I9VAT)SX@("`-"B`@("`@("`@("`\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W=I9'1H.B`V)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ M(')I9VAT)SX@("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q)3L@ M<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@("`@("`\9F]N="!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H M.B`Q)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@("`@("`\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`R)3L@<&%D9&EN9RUR M:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@ M("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN M9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@("`@("`\9F]N="!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`U)3L@ M<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I9VAT)SX@("`- M"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q)3L@ M<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@("`@("`\9F]N="!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT M)SX@(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I M;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX@(`T*("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX@(`T* M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE M/3-$)W!A9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX@(`T*("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@ M("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[ M('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@ M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'@@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O"!S;VQI9#L@<&%D M9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S M;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@ M/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@ M("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[ M('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@ M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'@@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O"!S;VQI9#L@ M<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@ M("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G M/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$ M)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H M=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$ M)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H M=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`W)3L@=&5X="UA;&EG;CH@ M6QE/3-$)W=I9'1H.B`Y,24[('!A9&1I;F6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'!E;G-E(')E;&%T:6YG('1O('1H92!D969I;FET92UL:79E M9"!I;G1A;F=I8FQE(&%S6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@($9U='5R92!A;6]R=&EZ871I;VX@ M97AP96YS92!O9B!T:&4@:6YT86YG:6)L92!A6QE/3-$)V)O"!S M;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[(&)O6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@ M("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(')I9VAT)SX@(`T*("`@("`@("`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`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$ M)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H M=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$ M)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H M=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'1087)T7S0X,3(T-V,Y7S8T,3%?-#DY,U]B9C%F7S,T961E-C,V9#1D,0T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\T.#$R-#=C.5\V-#$Q7S0Y M.3-?8F8Q9E\S-&5D938S-F0T9#$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0@0FQO8VL@6T%B'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2!E;G1E6YD:6-A=&5D(&)A;FL@9W)O=7`@:6X@36%R M8V@@,C`Q-"P@=VAI8V@@&EM=6T@8F]R&EM=6T@ M8F]R2!D871E(&]F('1H92!497)M M($QO86X@86YD('1H92!D=64@9&%T92!O9B!P2!W87,@86UE;F1E9"!T=VEC92`H M87,@86UE;F1E9"P@=&AE("8C.#(R,#M#2!T:&4@36%R M8V@@,C`Q-2!A;65N9&UE;G1S+B`@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E2!D871E(&]F($YO=F5M8F5R(#(P,3DN(%1H92!I M;G1E28C.#(Q-SMS(&-O;G-O M;&ED871E9"!L979E6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@ M(%1H92!#&5D(&-H87)G92!C;W9E'!E;F1I='5R97,L(&ES2!T;R!P87D@9&EV:61E;F1S+B!4:&4@0W)E9&ET($9A8VEL:71Y(&ES M('-E8W5R960@8GD@82!F:7)S="!P2!S96-U2!I;G1E28C.#(Q-SMS M(&5X:7-T:6YG(&%N9"!F=71U2!W87,@ M:6X@8V]M<&QI86YC92!W:71H('1H92!F:6YA;F-I86P@86YD(&]P97)A=&EO M;F%L(&-O=F5N86YT2!I;F-UF5D('5S:6YG('1H92!E9F9E8W1I=F4@:6YT97)EF%T:6]N M(&5X<&5N6EN9R!C;VYS;VQI9&%T960@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!.;W1E(%M!8G-T'0^/'`@2P@=&AE("8C.#(R,#M02!C;VYV97)T M960@=&\@8V]M;6]N('-T;V-K(&EN(&-O;FYE8W1I;VX@=VET:"!T:&4@25!/ M+B`@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E28C.#(Q-SMS($)O87)D(&]F($1I28C.#(Q-SMS(&%M96YD960@86YD(')E28C.#(Q-SMS(&-O M;G-O;&ED871E9"!F:6YA;F-I86P@2!T:&4@0V]M<&%N>28C.#(Q-SMS M(&-E2!IF5D('1O(&ES2!T:&4@=F%R:6]U7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M:6YD96YT.B`S M-G!T)SX@("`-"B`@("`@(%1H92!#;VUP86YY(&AAF5S('-T;V-K M(&]P=&EO;B!A8W1I=FET>2!F;W(@=&AE('1H6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE3H@5&EM97,@3F5W(%)O;6%N M+"!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@ M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!B;W)D97(M=&]P.B!";&%C:R`P+C5P="!S;VQI9#L@ M8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!X('-O;&ED.R!T97AT+6%L:6=N.B!R M:6=H=#L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M"!S;VQI9#L@=&5X="UA;&EG;CH@8V5N M=&5R.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z M(#$P<'0G/CQB/DYU;6)EF4Z(#$P<'0G/B8C,38P.SPO9F]N M=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M=&]P.B!";&%C M:R`P+C5P="!S;VQI9#L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!X('-O;&ED M.R!T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@ M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M=&]P.B!";&%C M:R`P+C5P="!S;VQI9#L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!X('-O;&ED M.R!T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0MF4Z(#$P<'0G/CQB/F%V97)A9V4\+V(^/"]F;VYT/CQB"!S M;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE"!S;VQI9#L@=&5X="UA M;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE"!S;VQI9#L@=&5X="UA M;&EG;CH@8V5N=&5R.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4 M:6UEF4Z(#$P<'0G/CQB/E=E:6=H=&5D+3PO8CX\+V9O;G0^/&)R("\^ M("`@("`-"B`@("`@("`@("`@/&9O;G0@6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0MF4Z(#$P<'0G/CQB/FQI9F4@*'EE87)S*3PO8CX\+V9O;G0^("`-"B`@("`@ M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@"!S;VQI9#L@=&5X="UA;&EG;CH@ M8V5N=&5R.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE"!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT M+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE"!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!F;VYT M+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/CQB M/D%G9W)E9V%T93PO8CX\+V9O;G0^/&)R("\^("`@("`-"B`@("`@("`@("`@ M/&9O;G0@"!S;VQI9#L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`T,R4[ M(&9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G M/D]U='-T86YD:6YG(&%T($1E8V5M8F5R(#,Q+"`R,#$T/"]F;VYT/B`@#0H@ M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H M.B`R)3L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M3H@ M5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@ M("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS M1"=W:61T:#H@.24[('1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`R)3L@ M9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3H@5&EM97,@ M3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/B0\+V9O;G0^(`T*("`@("`@("`\ M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@.24[('1E M>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/B8C M,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@ M(#QT9"!S='EL93TS1"=W:61T:#H@,B4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H M.B`T)3L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)3L@9F]N="UF86UI;'DZ M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E3H@5&EM97,@3F5W(%)O;6%N+"!4 M:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,B4[(&9O;G0M M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@=&5X="UA;&EG;CH@F4Z(#$P<'0G/C(Y+#(T M.3PO9F]N=#X@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T M>6QE/3-$)W=I9'1H.B`Q)3L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)V9O;G0M3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4 M:6UEF4Z(#$P<'0G/C6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z M(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@ M#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@ M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P M.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT M9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W M(%)O;6%N+"!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T* M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT M+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@ M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@ M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V9O;G0M6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P M<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@ M("`@("`@(#QT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N M=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL M93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N M+"!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@ M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+69A;6EL M>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$ M)V)O"!S;VQI9#L@9F]N="UF86UI;'DZ M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0M6QE M/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\ M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G M/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@ M("`@(#QT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@5&EM M97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@ M("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS M1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M3H@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B0\+V9O;G0^(`T*("`@("`@("`\+W1D M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\ M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C M,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@ M(#QT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O M;G0M6QE/3-$)V)O"!S;VQI9#L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6QE/3-$)V9O M;G0MF4Z(#$P<'0G/B8C,38P M.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'@@F4Z(#$P<'0G/B8C M,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'@@'0M86QI9VXZ(')I9VAT.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O M;6%N+"!4:6UEF4Z(#$P<'0G/C,L.#DV+#DR-3PO9F]N=#X@("`@#0H@("`@ M("`@(#PO=&0^("`@("`-"B`@("`@("`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`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\ M+W1R/B`@(`T*("`@(#PO=&%B;&4^/&)R+SX\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'!E;G-E(&]V97(@=&AE('9E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)W9E6QE M/3-$)W9E6QE/3-$)W9E M'0M86QI9VXZ(&-E;G1E"!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R M)SX@(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE"!S;VQI9#LG/B`@("`@#0H@("`@("`@ M("`@/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W9E'!E8W1E9"!L:69E("AY96%R6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX@(`T*("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE M/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE M/3-$)V)O"!S;VQI9"<^("`@#0H@("`@ M("`@("`@/&9O;G0@6EE;&0\+V9O;G0^("`@(`T* M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q<'@@6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'!E8W1E9"!S=&]C M:R!PF5D('9O;&%T:6QI=&EE2!U&5R8VES M92!A8W1I=FET>2X@5&AE(')I'!E8W1E9"!T97)M(&]F('1H92!O<'1I;VYS M(&]N('1H92!G6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@ M(%1O=&%L('-T;V-K+6)A'!E;G-E(')E;&%T M960@=&\@2X@("`-"B`@("`\+W`^/&)R+SX\<"!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E&EM871E;'D@)#@L M-S$S(&]F('5N28C.#(Q-SMS(&-O;6UO;B!S=&]C M:R!T;R!E;7!L;WEE97,@:6X@=&AE(&9U='5R92P@=7!O;B!T:&4@2P@=&AE($-O;7!A;GDF(S@R,3<[6QE/3-$)W9E"!S;VQI9#L@8F]R M9&5R+6)O='1O;3H@8FQA8VL@,7!X('-O;&ED)SX@("`-"B`@("`@("`@("`\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE M/3-$)W9E"!S;VQI9#L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,7!X('-O;&ED.R!P M861D:6YG+7)I9VAT.B`Q+CAP=#L@=&5X="UA;&EG;CH@8V5N=&5R)SX@("`@ M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@ M("`@("`\=&0@"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M M86QI9VXZ(&-E;G1E"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@ M,"XX<'0[('1E>'0M86QI9VXZ(&-E;G1E"!S;VQI9"<^("`@#0H@("`@("`@("`@/'`@"!S;VQI9#L@=&5X="UA;&EG M;CH@8V5N=&5R)SX@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)W9E"!S;VQI9#L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,7!X('-O;&ED M.R!T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@("`@("`\9F]N="!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@/&9O;G0@ M6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W=I9'1H.B`R)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@ M("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G M/B`@("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`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`T*("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE M/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR M:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@ M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q<'@@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$ M)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H M=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\ M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`Q<'@@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@ M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'@@6QE/3-$)V)O M"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@ M,"XX<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`Q<'@@6QE/3-$ M)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H M=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W=I9'1H.B`S-G!T)SX@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@ M("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q.'!T)SX@("`@#0H@("`@("`@("`@ M/'-U<#XH,2D\+W-U<#X@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@ M(#QT9#X@("`@#0H@("`@("`@("`@4E-52!M965T M:6YG(&-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M:6YD96YT.B`S-G!T)SX@ M(`T*("`@("`@5&]T86P@'!E8W1E9"!T;R!B92!R M96-O9VYI>F5D(&]V97(@82!W96EG:'1E9"UA=F5R86=E('!EF5S('1H92!I28C.#(Q-SMS(&-O;6UO;B!S=&]C:R!P=7)S=6%N="!T;R!P M=7)C:&%S92!R:6=H=',@9W)A;G1E9"!T;R!E;7!L;WEE97,N(%1H92!N=6UB M97(@;V8@2!T:&4@0F]A65E2!C;VYT7)O;&P@9&5D=6-T:6]N6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@($9O M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'`@2!D:79I9&EN9R!N M970@;&]S2!T:&4@=V5I9VAT960M879E&5R8VES92!O9B!S=&]C:R!O<'1I;VYS+"!R97-T65E('=I=&AH;VQD:6YG6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!B;W)D97(M=&]P M.B!";&%C:R`P+C5P="!S;VQI9"<^(`T*("`@("`@("`@("8C,38P.R`-"B`@ M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@6QE/3-$)V9O;G0M=V5I9VAT M.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/B`@("`@#0H@("`@("`@("`@ M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL M93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@<&%D9&EN9RUB;W1T;VTZ(#%P>#L@ M=&5X="UA;&EG;CH@8V5N=&5R.R<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@ M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0V('-T M>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!B;W)D97(M8F]T=&]M.B!";&%C M:R`Q<'@@'0M86QI9VXZ(&-E;G1E'0M86QI M9VXZ(&-E;G1E6QE M/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!P861D:6YG+6)O='1O;3H@,7!X)SX@ M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@ M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L M9#L@=&5X="UA;&EG;CH@8V5N=&5R.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q M<'@@6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!B;W)D97(M8F]T=&]M M.B!";&%C:R`Q<'@@#L@9F]N="UW96EG:'0Z(&)O M;&0G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`- M"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@ M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@ M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P.R`- M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@ M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Y M)3L@=&5X="UA;&EG;CH@'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@*2`@ M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I M9'1H.B`R)2<^("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^ M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@=&5X="UA M;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`D("`-"B`@("`@("`@/"]T M9#X@("`@(`T*("`@("`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)3L@ M=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`I("`-"B`@("`@ M("`@/"]T9#X@("`@(`T*("`@("`@/"]T6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M,3!P M=#L@<&%D9&EN9RUL969T.B`Q,'!T)SX@("`@#0H@("`@("`@("`@)B,Q-C`[ M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9#X@("`@#0H@("`@ M("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@ M)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@("`@("`@("`F(S$V M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@ M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@ M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P.R`- M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@ M(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B;W)D97(M8F]T=&]M.B!";&%C M:R`Q<'@@6QE/3-$)W1E>'0M86QI9VXZ(&QE M9G0[(&)O"!S;VQI9"<^(`T*("`@("`@ M("`@("D@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'@@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'@@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`I M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@ M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@ M/"]T9#X@("`@(`T*("`@("`@("`\=&0@6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C M96YT97([(&)O6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD M.R!T97AT+6%L:6=N.B!C96YT97(G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[ M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@ M/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT M97([(&)O"!S;VQI9"<^("`@(`T*("`@ M("`@("`@($UA6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L M:6=N.B!C96YT97([)SX@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\ M+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$ M)W9E6QE/3-$)V9O M;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O"!S;VQI9"<^("`@(`T*("`@("`@("`@(#(P,34@ M("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'@@"!S;VQI9"<^("`-"B`@("`@("`@ M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D(&-O M;'-P86X],T0R('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L M:6=N.B!C96YT97([(&)O"!S;VQI9"<^ M("`@(`T*("`@("`@("`@(#(P,30@("`@(`T*("`@("`@("`\+W1D/B`@("`@ M#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!X.R!F M;VYT+7=E:6=H=#H@8F]L9"<^(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@ M("`@/"]T9#X@("`@(`T*("`@("`@/"]T6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`- M"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@ M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@ M("`@("`@(#$T."PV-3`@("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@ M("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M,3!P=#L@ M<&%D9&EN9RUL969T.B`Q,'!T)SX@("`@#0H@("`@("`@("`@4E-5(&%W87)D M'0M86QI M9VXZ(')I9VAT)SX@(`T*("`@("`@("`@(#@P+#`S-R`@#0H@("`@("`@(#PO M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q M-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@,7!X)SX@(`T*("`@("`@("`@("8C,38P.R`- M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX@(`T*("`@("`@("`@("8C.#(Q M,CL@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS M1"=P861D:6YG+6)O='1O;3H@,7!X.R!T97AT+6%L:6=N.B!L969T)SX@("`@ M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@ M("`@/"]T#L@8F]R9&5R+6)O='1O;3H@0FQA8VL@ M,7!X('-O;&ED)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\ M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!";&%C:R`Q<'@@'0M86QI9VXZ(&QE9G0G/B`-"B`@("`@ M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D M('-T>6QE/3-$)V)O"!S;VQI9#L@=&5X M="UA;&EG;CH@#L@=&5X="UA;&EG;CH@;&5F=#L@8F]R9&5R+6)O M='1O;3H@0FQA8VL@,7!X('-O;&ED)SX@(`T*("`@("`@("`@("8C,38P.R`- M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@#L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!X('-O M;&ED)SX@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@ M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C M:R`Q<'@@'0M86QI9VXZ(&QE9G0G/B`-"B`@("`@("`@("`F M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE M/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG M;CH@#L@=&5X="UA;&EG;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@ M("`@/"]T86)L93X\8G(O/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P M86-I;F<],T0P('=I9'1H/3-$,3`P)2!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$ M)W9E28C.#(Q M-SMS(&]U='-T86YD:6YG(')E9&5E;6%B;&4@8V]N=F5R=&EB;&4@<')E9F5R M'1087)T7S0X,3(T-V,Y7S8T,3%?-#DY,U]B9C%F7S,T961E-C,V9#1D M,0T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\T.#$R-#=C.5\V-#$Q M7S0Y.3-?8F8Q9E\S-&5D938S-F0T9#$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&5S/&)R/CPO"!$:7-C;&]S=7)E(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'`@&5S/"]B/B`-"B`@("`\+W`^/&)R+SX\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E28C.#(Q-SMS(&5X<&5C=&5D(&%N9"!H:7-T M;W)I8R!A;FYU86P@;F5T('1A>"!P"!P2!C=7)R M96YT('EE87(@9&5F97)R960@=&%X(&%S'1E;G0L(&$@8W5R"!P"!R M871E('1H92!#;VUP86YY(')E8V]R9&5D(&$@8F5N969I="!F;W(@=&AE('%U M87)T97(L('=H:6-H(&ES(&5X<&5C=&5D('1O(')E=F5R"!R871E('=O=6QD M(')E2!R96QA=&EO;G-H:7`@8F5T=V5E;B!I;F-O;64@=&%X(&5X<&5N6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@(%1H92!#;VUP M86YY)B,X,C$W.W,@9&5F97)R960@=&%X(&%S'1E;G0@=&AE($-O;7!A;GD@:&%S(&1E=&5R;6EN960@=&AA M="!I="!I2!T:&%N(&YO="!T:&%T('-U8V@@;F5T(&1E M9F5R"!A2P@=&AE($-O;7!A;GD@8V]N2!A;F0@2!D:69F97)E;F-E M2!F65A&EM871E;'D@)#$P-RPP,#`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`@#0H@("`@("!I M;B!A8V-O2!A9&IU7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^ M/'`@2!P;W1E;G1I86P@8VQA:6TL(&%N9"!T86MI;F<@:6YT;R!A8V-O M=6YT(&%N>2!A8V-R=6%L2!M87D@:&%V92!E2!O3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\T.#$R-#=C.5\V-#$Q7S0Y.3-?8F8Q9E\S-&5D938S M-F0T9#$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#@Q,C0W8SE? M-C0Q,5\T.3DS7V)F,69?,S1E9&4V,S9D-&0Q+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M:6YD96YT.B`S-G!T M)SX@("`-"B`@("`@(%1H92!#;VUP86YY(&AA'1087)T7S0X,3(T-V,Y7S8T,3%?-#DY,U]B9C%F7S,T961E-C,V9#1D,0T* M0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\T.#$R-#=C.5\V-#$Q7S0Y M.3-?8F8Q9E\S-&5D938S-F0T9#$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!0;VQI8WD@*%!O;&EC:65S*3QB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'`@6EN9R!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E M;65N=',@:6YC;'5D92!T:&4@86-C;W5N=',@;V8@=&AE($-O;7!A;GD@86YD M(&ET6EN9R!I M;G1E2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,@ M*"8C.#(R,#M'04%0)B,X,C(Q.RD@;VX@=&AE('-A;64@8F%S:7,@87,@=&AE M(&%U9&ET960@8V]N65A2!A;F0@;W1H97(@8G5S:6YE2!I;F-L=61E9"!I;B!F:6YA;F-I86P@6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2!B87-E2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M:6YD96YT.B`S M-G!T)SX@("`-"B`@("`@($-E2!T:&4@0V]M<&%N M>2!T;W1A;&EN9R`D."PX-#@N($%S(&$@2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@(%1H92!#;VUP M86YY(&=E;F5R871E2!S871I2X@26X@ M:6YS=&%N8V5S('=H97)E(&EN9&EV:61U86P@9&5L:79E2!OF5D(&]N(&$@2!497AT($)L;V-K73PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`- M"B`@("`@($-O6%L='D@ M97AP96YS97,@9F]R(&QI8V5N2!P87ES('1O M('1H92!O=VYE28C.#(Q-SMS('!R96UI=6T@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@($UE9&EA(&-O2!O<&5R871E'!E;G-E($1I'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#X\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'!E;G-E M/"]B/B`@(`T*("`@(#PO<#X\8G(O/CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@(%1H97)E('=E2!W6EN9R!C;VYS;VQI9&%T960@2!497AT M($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'`@2!H87,@ M;F\@:71E;7,@;V8@;W1H97(@8V]M<')E:&5N2!N970@;&]S6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!L:7%U:60@;6]N M97D@;6%R:V5T(&9U;F1S+B!4:&4@9F%I&EM871EF%T:6]N(&]F(&QE87-E:&]L9"!I;7!R;W9E;65N=',@:7,@8V]M<'5T M960@=7-I;F<@=&AE('-T2!I;F-U2!E>'!E;G-E M2!O9B!P87ER;VQL(&%N9"!R96QA=&5D(&)E;F5F:71S M+"!AF5D(&-O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M:6YD96YT.B`S M-G!T)SX@("`-"B`@("`@(%1H92!#;VUP86YY(&%L2!E>'!E;G-E2!O9B!T:&ER M9"UP87)T>2!C;VYS=6QT86YT65A2!A;F0@97%U:7!M96YT(&9O2!N;W0@8F4@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M:6YD96YT.B`S-G!T M)SX@("`-"B`@("`@(%1H92!#;VUP86YY(&%N9"!I=',@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@($EN($%P6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M:6YD96YT.B`S M-G!T)SX@("`-"B`@("`@($EN($UA>2`R,#$T+"!T:&4@1D%30B!I65A2!A9&]P=&EO;B!I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M M:6YD96YT.B`S-G!T)SX@("`-"B`@("`@($EN($IU;F4@,C`Q-"P@=&AE($9! M4T(@:7-S=65D('5P9&%T960@9W5I9&%N8V4@;VX@2!A9&]P=&EO;B!I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M:6YD96YT.B`S-G!T)SX@ M("`-"B`@("`@($EN($%P7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA2!V86QU871I;VX@86YD(&%R M92!S=6)J96-T('1O(&%D:G5S=&UE;G0@9'5R:6YG(&$@;65A2!T;R!A9&IU6QE/3-$)V)O"!S;VQI9"<^("`@("`-"B`@("`@("`@("!! M8V-O=6YT6QE/3-$)W=I9'1H.B`Q)3L@ M=&5X="UA;&EG;CH@;&5F=#L@8F]R9&5R+71O<#H@0FQA8VL@,7!X('-O;&ED M)SX@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@ M("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q,"4[('1E>'0M86QI9VXZ(')I M9VAT.R!B;W)D97(M=&]P.B!";&%C:R`Q<'@@6QE/3-$)W9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M,3!P=#L@<&%D M9&EN9RUL969T.B`Q,'!T)SX@("`@#0H@("`@("`@("`@4')O<&5R='D@86YD M(&5Q=6EP;65N="`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT M9#X@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@ M#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@ M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@ M("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^("`@("`-"B`@ M("`@("`@("`W.#,@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@ M#0H@("`@("`\='(@6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@ M("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@(#$T+#(X,"`@#0H@("`@ M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO M=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@ M("`@("@R+#8U.2`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`I M("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T6QE/3-$)W9E6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M,3!P=#L@<&%D M9&EN9RUL969T.B`Q,'!T)SX@("`@#0H@("`@("`@("`@3W1H97(@8W5R6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M('1E>'0M:6YD96YT.B`M,3!P=#L@<&%D9&EN9RUL969T.B`Q,'!T.R!B;W)D M97(M8F]T=&]M.B!";&%C:R`Q<'@@6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q M<'@@6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V M,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P.R`- M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$ M)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@ M,"XX<'0G/B`@#0H@("`@("`@("`@/&9O;G0@6QE M/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H M=#H@,"XX<'0G/B`@#0H@("`@("`@("`@/&9O;G0@"!S;VQI9#L@=&5X M="UA;&EG;CH@8V5N=&5R)SX@("`@(`T*("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O"!S;VQI9#L@ M8F]R9&5R+6)O='1O;3H@8FQA8VL@,7!X('-O;&ED.R!T97AT+6%L:6=N.B!C M96YT97(G/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6EN9SPO8CX\+V9O;G0^/&)R("\^("`@(`T*("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UEF%T:6]N/"]B/CPO9F]N=#X@#0H@("`@("`@(#PO=&0^("`@("`- M"B`@("`@("`@/'1D('-T>6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@ M("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G M/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S M;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX@("`@(`T*("`@("`@("`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`@("`@#0H@("`@("`@("`@/&9O M;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@ M#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@ M=&5X="UA;&EG;CH@8V5N=&5R)SX@("`@(`T*("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`- M"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`R M)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@("`@("`\9F]N M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUR:6=H=#H@,"XX M<'0G/B`@("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H M.B`Q)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@("`@("`\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W=I9'1H.B`U)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ M(')I9VAT)SX@("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$ M)W=I9'1H.B`Q)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@ M("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I M9'1H.B`U)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I M9VAT)SX@("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q)3L@<&%D M9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@("`@("`\9F]N="!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W=I9'1H.B`Q)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@ M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D M('-T>6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@ M("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H M.B`S)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@("`@("`\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX@ M(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX@(`T*("`@ M("`@("`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`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@ M<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR M:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@ M<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)V)O"!S;VQI9"<^("`@#0H@("`@("`@("`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`@("`@#0H@("`@("`@ M("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@ M#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX M<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX M<'0[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@ M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'@@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX M<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE M/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR M:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@ M<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@/&9O;G0@6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`R)3L@<&%D9&EN9RUR:6=H=#H@,"XX M<'0G/B`@("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'!E;G-E(%M4 M86)L92!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^1G5T=7)E(&%M;W)T:7IA=&EO;B!E>'!E;G-E(&]F('1H92!I;G1A;F=I M8FQE(&%S6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX M<'0[(&)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@<&%D M9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@("`@("`\9F]N="!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX@(`T*("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A M9&1I;F6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O"!S;VQI9#L@ M<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@ M6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@ M("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T.#$R-#=C.5\V-#$Q7S0Y.3-?8F8Q M9E\S-&5D938S-F0T9#$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M-#@Q,C0W8SE?-C0Q,5\T.3DS7V)F,69?,S1E9&4V,S9D-&0Q+U=O'0O:'1M;#L@8VAA M2!;5&%B M;&4@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!F;VYT M+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/B8C,38P M.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT M9"!C;VQS<&%N/3-$,B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!B;W)D97(M=&]P.B!";&%C:R`P+C5P="!S;VQI9#L@8F]R9&5R+6)O='1O M;3H@0FQA8VL@,7!X('-O;&ED.R!T97AT+6%L:6=N.B!C96YT97([(&9O;G0M M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0MF4Z(#$P<'0G/CQB/F]P=&EO;G,\+V(^ M/"]F;VYT/B`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T M>6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI M9VXZ(&-E;G1E6QE/3-$)V9O;G0M M6QE/3-$)W9E'0M86QI M9VXZ(&-E;G1E6QE/3-$)V9O;G0MF4Z(#$P<'0G/CQB/F5X97)C:7-E M/"]B/CPO9F]N=#X\8G(@+SX@("`@(`T*("`@("`@("`@("`\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/G!R:6-E/"]B/CPO9F]N=#X@("`@ M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M=&]P.B!";&%C:R`P+C5P M="!S;VQI9#L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!X('-O;&ED.R!T97AT M+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\ M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!B;W)D97(M=&]P.B!";&%C:R`P+C5P="!S;VQI9#L@8F]R M9&5R+6)O='1O;3H@0FQA8VL@,7!X('-O;&ED.R!T97AT+6%L:6=N.B!C96YT M97([(&9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P M<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@ M("`@("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!B;W)D97(M=&]P.B!";&%C:R`P+C5P="!S;VQI9#L@8F]R M9&5R+6)O='1O;3H@0FQA8VL@,7!X('-O;&ED.R!T97AT+6%L:6=N.B!C96YT M97([(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0MF4Z(#$P<'0G/CQB/F%V M97)A9V4\+V(^/"]F;VYT/CQB6QE/3-$)V9O;G0M65AF4Z(#$P<'0G/B8C M,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@ M(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M M=&]P.B!";&%C:R`P+C5P="!S;VQI9#L@8F]R9&5R+6)O='1O;3H@0FQA8VL@ M,7!X('-O;&ED.R!T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B!4 M:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@ M("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!C;VQS<&%N M/3-$,B!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M M=&]P.B!";&%C:R`P+C5P="!S;VQI9#L@8F]R9&5R+6)O='1O;3H@0FQA8VL@ M,7!X('-O;&ED.R!T97AT+6%L:6=N.B!C96YT97([(&9O;G0M9F%M:6QY.B!4 M:6UE6QE/3-$)V9O;G0MF4Z(#$P<'0G/CQB/FEN=')I;G-I8SPO8CX\+V9O;G0^ M/&)R("\^(`T*("`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/CQB/G9A;'5E/"]B/CPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!B;W)D97(M=&]P.B!";&%C:R`P+C5P="!S;VQI9#L@8F]R9&5R M+6)O='1O;3H@0FQA8VL@,7!X('-O;&ED.R!T97AT+6%L:6=N.B!R:6=H=#L@ M9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0M3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/B8C,38P M.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT M9"!S='EL93TS1"=W:61T:#H@,24[(&9O;G0M9F%M:6QY.B!4:6UE6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y M)3L@=&5X="UA;&EG;CH@F4Z(#$P<'0G/C4L.#DS+#8Y.#PO9F]N=#X@("`@ M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I M9'1H.B`Q)3L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N M=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL M93TS1"=W:61T:#H@,B4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O M;G0M6QE/3-$)W=I9'1H.B`Y)3L@=&5X="UA;&EG;CH@ MF4Z(#$P<'0G/CDN.30\+V9O;G0^("`@(`T*("`@("`@("`\+W1D/B`@("`@ M#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&9O;G0M9F%M:6QY M.B!4:6UE6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`R)3L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/B8C,38P M.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT M9"!S='EL93TS1"=W:61T:#H@.24[('1E>'0M86QI9VXZ(')I9VAT.R!F;VYT M+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE3H@5&EM97,@3F5W M(%)O;6%N+"!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@ M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=W:61T:#H@ M,B4[(&9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`R)3L@9F]N="UF86UI;'DZ(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0M3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z M(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@ M#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P M.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT M9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\ M+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R M:6=H=#L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@ M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H=#L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)V9O;G0M6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P M<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@ M("`@("`@(#QT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4 M:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N M=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T* M("`@("`@/'1R('-T>6QE/3-$)W9E&5R8VES960\+V9O;G0^("`@(`T*("`@("`@ M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+69A;6EL M>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P M<'0G/B@W,BPX,S(\+V9O;G0^("`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@ M("`@("`\=&0@6QE/3-$)V9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M.R!F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P M<'0G/C6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H M=#L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C M,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@ M(#QT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@ M(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@ M/'1R('-T>6QE/3-$)W9E3H@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3H@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@ M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L M:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T* M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT M+6%L:6=N.B!R:6=H=#L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@ M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P M.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\+W1R M/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@ M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`Q<'@@F4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@ M("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!B;&%C:R`Q<'@@'0M86QI9VXZ(')I9VAT.R!F M;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/C8L M-3,Y+#4U,3PO9F]N=#X@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@ M("`@/'1D('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@ M("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+69A;6EL M>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT+69A M;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/C$P+C(S M/"]F;VYT/B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z(#$P<'0G/B8C,38P.SPO9F]N=#X@("`@(`T*("`@("`@("`\+W1D M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT.R!F;VYT M+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#$P<'0G/C8N M-C4\+V9O;G0^("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT M9"!S='EL93TS1"=F;VYT+69A;6EL>3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UEF4Z M(#$P<'0G/B0\+V9O;G0^(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`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`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE"!S;VQI9#LG/B`@("`@#0H@("`@("`@ M("`@/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W9E'!E8W1E9"!L:69E("AY96%R6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX@(`T*("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE M/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE M/3-$)V)O"!S;VQI9"<^("`@#0H@("`@ M("`@("`@/&9O;G0@6EE;&0\+V9O;G0^("`@(`T* M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q<'@@6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#Y4:&4@9F]L;&]W:6YG('1A8FQE('-U;6UA2!F;W(@=&AE('1H6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"!S;VQI M9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I9VAT)SX@ M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@ M("`@("`\=&0@8V]L"!S;VQI9#L@<&%D9&EN M9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(&-E;G1E"!S M;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(&-E;G1E M"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@ M,2XX<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE M/3-$)W9E"!S;VQI9#L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,7!X('-O;&ED.R!P M861D:6YG+7)I9VAT.B`P+CAP=#L@=&5X="UA;&EG;CH@8V5N=&5R)SX@("`- M"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@ M("`@/'1D('-T>6QE/3-$)W9E"!S;VQI9#L@8F]R9&5R+6)O='1O;3H@8FQA8VL@ M,7!X('-O;&ED.R!P861D:6YG+7)I9VAT.B`P+CAP=#L@=&5X="UA;&EG;CH@ M8V5N=&5R)SX@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^ M("`@("`-"B`@("`@("`@/'1D(&-O;'-P86X],T0R('-T>6QE/3-$)W9E"!S;VQI M9#L@8F]R9&5R+6)O='1O;3H@8FQA8VL@,7!X('-O;&ED)SX@("`-"B`@("`@ M("`@("`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6QE/3-$)W9E"!S;VQI9#L@8F]R9&5R+6)O='1O;3H@ M8FQA8VL@,7!X('-O;&ED.R!T97AT+6%L:6=N.B!C96YT97(G/B`-"B`@("`@ M("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE"!S M;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R)SX@("`-"B`@("`@("`@("`\9F]N M="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)W=I9'1H M.B`Q)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`-"B`@("`@("`@("`\ M9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Y M)3L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I9VAT)SX@ M("`-"B`@("`@("`@("`\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@ M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX@(`T*("`@("`@("`@("8C,38P M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX@(`T*("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX@(`T*("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX@(`T* M("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@ M("`\=&0@'0M86QI9VXZ(')I9VAT M)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T* M("`@("`@("`\=&0@'0M86QI9VXZ M(')I9VAT)SX@(`T*("`@("`@("`@(#QF;VYT('-T>6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F'0M86QI M9VXZ(')I9VAT)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T M9#X@("`@(`T*("`@("`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@ M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@6QE/3-$)V)O"!S;VQI M9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)W!A9&1I M;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)V)O"!S;VQI9"<^("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@ M<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@ M("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'@@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@ M("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@ M("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'@@ M6QE/3-$)V)O"!S;VQI9#L@<&%D M9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T* M("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q<'@@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN M9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI M9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@("`@("`@/&9O M;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0G/B`@("`@#0H@("`@ M("`@("`@/&9O;G0@6QE/3-$)V)O"!S;VQI9#L@<&%D9&EN9RUR:6=H=#H@,"XX<'0[('1E>'0M86QI9VXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A2!D:79I9&EN9R!N970@;&]S M2!T:&4@=V5I9VAT960M879E2!D:6QU=&EV92!S96-U2!D:6QU=&EV92!S96-U2!S=&]C M:R!M971H;V0L(&%N9"!E;7!L;WEE92!W:71H:&]L9&EN9W,@=&\@<'5R8VAA M2P@=&AE(&)A6QE/3-$)V)O6QE/3-$)V9O;G0M=V5I9VAT M.B!B;VQD.R!B;W)D97(M=&]P.B!";&%C:R`P+C5P="!S;VQI9"<^(`T*("`@ M("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\ M=&0@8V]L'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C M96YT97(G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D M/B`@("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E M'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O"!S;VQI9#L@9F]N="UW96EG:'0Z(&)O;&0G/B`@#0H@("`@("`@ M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S M='EL93TS1"=F;VYT+7=E:6=H=#H@8F]L9#L@8F]R9&5R+6)O='1O;3H@0FQA M8VL@,7!X('-O;&ED)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@ M/"]T9#X@("`@(`T*("`@("`@("`\=&0@8V]L6QE M/3-$)W!A9&1I;F6QE/3-$)W9E'0M:6YD96YT.B`M,3!P=#L@<&%D9&EN M9RUL969T.B`Q,'!T)SX@("`@#0H@("`@("`@("`@3G5M97)A=&]R.B`-"B`@ M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0^("`@(`T*("`@("`@("`@ M("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO M=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@'0M86QI9VXZ(')I9VAT)SX@#0H@("`@("`@("`@*#@L,#8X("`-"B`@("`@ M("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@'0M86QI9VXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@)"`@#0H@("`@("`@(#PO=&0^("`@ M("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Y)3L@=&5X="UA;&EG M;CH@'0M M86QI9VXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@*2`@#0H@("`@("`@(#PO M=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO M=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@'0M:6YD96YT.B`M,3!P=#L@<&%D9&EN9RUL969T M.B`Q,'!T)SX@("`@#0H@("`@("`@("`@1&5N;VUI;F%T;W(Z("`@#0H@("`@ M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@ M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@ M("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@6QE/3-$)W9E M6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[('1E>'0M:6YD96YT.B`M,3!P=#L@<&%D9&EN9RUL969T M.B`Q,'!T)SX@("`@#0H@("`@("`@("`@5V5I9VAT960M879E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@ M("`@(#,Q+#4R-2PU-3D@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@ M("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@ M("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@ M("`@(#4L-#`S+#@T-B`@("`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@ M("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^ M("`@#0H@("`@("`\='(@"!S;VQI9"<^(`T*("`@("`@("`@($YE="!L;W-S('!E6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[ M(&)O"!S;VQI9"<^(`T*("`@("`@("`@ M("0@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H=#L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!X M('-O;&ED)SX@(`T*("`@("`@("`@("@P+C(V(`T*("`@("`@("`\+W1D/B`@ M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!L969T.R!B M;W)D97(M8F]T=&]M.B!";&%C:R`Q<'@@6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&)O"!S;VQI9"<^(`T*("`@("`@("`@("0@(`T*("`@("`@("`\+W1D/B`@ M("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H=#L@ M8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!X('-O;&ED)SX@(`T*("`@("`@("`@ M("@Q+C0T(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!L969T)SX@("`@#0H@("`@("`@("`@*2`@#0H@ M("`@("`@(#PO=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@("`\='(@ M6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`- M"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@ M(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO=&0^ M("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT M)SX@("`@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@ M(`T*("`@("`@("`\=&0@'0@0FQO8VM=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y4:&4@9F]L;&]W:6YG('-E8W5R M:71I97,@=V5R92!O=71S=&%N9&EN9R!A="!T:&4@96YD(&]F('1H92!P97)I M;V1S('!R97-E;G1E9"!B96QO=R!A;F0@:&%V92!B965N(&5X8VQU9&5D(&9R M;VT@=&AE(&-A;&-U;&%T:6]N(&]F(&1I;'5T960@;F5T(&QO6QE/3-$)W9E6QE/3-$)V9O;G0M M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT M97(G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@ M("`@#0H@("`@("`\+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M=V5I M9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O"!S;VQI9"<^("`@(`T*("`@("`@("`@($UA6QE/3-$ M)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([)SX@#0H@ M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`\ M+W1R/B`@(`T*("`@("`@/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!T M97AT+6%L:6=N.B!C96YT97([(&)O"!S M;VQI9"<^("`@(`T*("`@("`@("`@(#(P,34@("`@(`T*("`@("`@("`\+W1D M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!" M;&%C:R`Q<'@@6QE/3-$ M)V9O;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97([(&)O"!S;VQI9"<^("`@(`T*("`@("`@("`@(#(P M,30@("`@(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,7!X.R!F;VYT+7=E:6=H=#H@8F]L9"<^ M(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@ M("`@/"]T6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@ M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D/B`@("`-"B`@("`@("`@("`F M(S$V,#L@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`F(S$V,#L@ M#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)W1E M>'0M86QI9VXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@(#$T."PV-3`@("`- M"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@("`\=&0@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ M(&QE9G0[('1E>'0M:6YD96YT.B`M,3!P=#L@<&%D9&EN9RUL969T.B`Q,'!T M)SX@("`@#0H@("`@("`@("`@4E-5(&%W87)D'0M86QI9VXZ(')I9VAT)SX@(`T*("`@ M("`@("`@(#@P+#`S-R`@#0H@("`@("`@(#PO=&0^("`@("`-"B`@("`@("`@ M/'1D('-T>6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(&QE9G0G/B`@("`@#0H@("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,7!X)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@ M(`T*("`@("`@("`\=&0@'0M86QI9VXZ M(')I9VAT)SX@(`T*("`@("`@("`@("8C.#(Q,CL@(`T*("`@("`@("`\+W1D M/B`@("`@#0H@("`@("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,7!X.R!T97AT+6%L:6=N.B!L969T)SX@("`@(`T*("`@("`@("`@("8C,38P M.R`-"B`@("`@("`@/"]T9#X@("`@(`T*("`@("`@/"]T#L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!X('-O;&ED)SX@("`@#0H@ M("`@("`@("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'@@'0M86QI9VXZ(&QE9G0G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@ M("`@(#PO=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@#L@ M=&5X="UA;&EG;CH@;&5F=#L@8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!X('-O M;&ED)SX@(`T*("`@("`@("`@("8C,38P.R`-"B`@("`@("`@/"]T9#X@("`@ M(`T*("`@("`@("`\=&0@#L@ M8F]R9&5R+6)O='1O;3H@0FQA8VL@,7!X('-O;&ED)SX@("`@#0H@("`@("`@ M("`@)B,Q-C`[(`T*("`@("`@("`\+W1D/B`@("`@#0H@("`@("`@(#QT9"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'@@'0M M86QI9VXZ(&QE9G0G/B`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO M=&0^("`@("`-"B`@("`@("`@/'1D('-T>6QE/3-$)V)O"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=&5X="UA;&EG M;CH@;&5F="<^("`@("`-"B`@("`@("`@("`F(S$V,#L@#0H@("`@("`@(#PO M=&0^("`@("`-"B`@("`@(#PO='(^("`@#0H@("`@/"]T86)L93X\=&%B;&4@ M8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@ M6QE/3-$)W9E28C.#(Q-SMS(&]U='-T86YD:6YG(')E9&5E;6%B M;&4@8V]N=F5R=&EB;&4@<')E9F5R3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T.#$R-#=C.5\V-#$Q7S0Y.3-? M8F8Q9E\S-&5D938S-F0T9#$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-#@Q,C0W8SE?-C0Q,5\T.3DS7V)F,69?,S1E9&4V,S9D-&0Q+U=O'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2P@4&QA M;G0@86YD($5Q=6EP;65N="P@17-T:6UA=&5D(%5S969U;"!,:79E'0^=&AR964\'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2P@4&QA;G0@86YD($5Q=6EP;65N="P@ M17-T:6UA=&5D(%5S969U;"!,:79E'0^=&AR964\&EM=6T@6TUE;6)E'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^0V%M8G)I M9&=E($)I;TUA'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@ M97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(U M+#@T-SQS<&%N/CPO6%B;&4@86YD(&%C8W)U960@97AP96YS97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A;&QO8V%T:6]N(&]F('1H92!A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW.#,\6%B;&4@86YD(&%C8W)U960@97AP96YS97,\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO M8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T.#$R-#=C.5\V M-#$Q7S0Y.3-?8F8Q9E\S-&5D938S-F0T9#$-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-#@Q,C0W8SE?-C0Q,5\T.3DS7V)F,69?,S1E9&4V,S9D M-&0Q+U=O'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6EN9R!A;6]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA6EN9R!A;6]U M;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S6EN9R!A;6]U;G0\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S6EN9R!A;6]U;G0\+W1D/@T* M("`@("`@("`\=&0@8VQAF%T:6]N/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M/B@T+#DR,BD\6EN9R!A;6]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S6EN9R!A;6]U;G0\+W1D/@T* M("`@("`@("`\=&0@8VQAF%T:6]N('!E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF%T:6]N(&5X<&5N'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T.#$R-#=C M.5\V-#$Q7S0Y.3-?8F8Q9E\S-&5D938S-F0T9#$-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-#@Q,C0W8SE?-C0Q,5\T.3DS7V)F,69?,S1E9&4V M,S9D-&0Q+U=O'0O:'1M;#L@8VAA28C.#(Q-SMS(&-O;G-O;&ED871E9"!L M979E6UE;G1S(&]F($9I;F%N8VEN9R!#;W-T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S&EM=6T@6TUE;6)E2!2 M871E($UO;G1H;'D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!;365M8F5R73PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!;365M8F5R73PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&EM=6T@0F]R M2P@3W5T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S28C.#(Q-SMS($)O87)D(&]F($1I28C.#(Q-SMS(&%M96YD960@86YD(')E28C.#(Q M-SMS(&-O;G-O;&ED871E9"!F:6YA;F-I86P@'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T M.#$R-#=C.5\V-#$Q7S0Y.3-?8F8Q9E\S-&5D938S-F0T9#$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#@Q,C0W8SE?-C0Q,5\T.3DS7V)F,69? M,S1E9&4V,S9D-&0Q+U=O'0O:'1M;#L@8VAA&5R8VES960\+W1D/@T*("`@("`@ M("`\=&0@8VQA6UE;G0@07=A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65E(%-EF5D+"!3=&]C:R!/<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M<#XX+#'0^,2!Y96%R(#8@;6]N=&AS/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G0@07=A2!);G-T M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ MF5D+"!097)I;V0@9F]R(%)E8V]G;FET:6]N/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XQ('EE87(@,C(Y(&1A>7,\2!3:&%R92UB87-E9"!087EM96YT($%W87)D+"!%<75I='D@ M26YS=')U;65N=',@3W1H97(@=&AA;B!/<'1I;VYS+"!''!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR-C(\65E(%-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65E(%-T;V-K(%M-96UB97)=/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^5&AE(&YU;6)E2`Q(&]F(&5A8V@@8V%L M96YD87(@>65A2!T:&4@;&5A65E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!;3&EN92!) M=&5M&5R8VES92!P'0^-B!Y96%R65A7,\65A'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5R8VES86)L M92!A="!-87)C:"`S,2P@,C`Q-3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA3PO=&0^#0H@("`@ M("`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`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA&-L=61E9"!F'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S65E(%-T;V-K(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!C;VYV97)T M960@:6YT;R!S:&%R97,@;V8@8V]M;6]N('-T;V-K+B!);B!A9&1I=&EO;BP@ M=&AE(&]U='-T86YD:6YG('=A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T M.#$R-#=C.5\V-#$Q7S0Y.3-?8F8Q9E\S-&5D938S-F0T9#$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-#@Q,C0W8SE?-C0Q,5\T.3DS7V)F,69? M,S1E9&4V,S9D-&0Q+U=O'0O:'1M;#L@8VAA&5S("A$ M971A:6QS*2`H55-$("0I/&)R/DEN(%1H;W5S86YD'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'1087)T7S0X,3(T-V,Y7S8T,3%? :-#DY,U]B9C%F7S,T961E-C,V9#1D,2TM#0H` ` end XML 23 R29.htm IDEA: XBRL DOCUMENT v2.4.1.9

Long-Term Debt (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Dec. 31, 2014

Nov. 30, 2014

Nov. 01, 2014

Mar. 01, 2015

Long-Term Debt (Details) [Line Items]

Credit Facility Rate Description The interest rate on the Credit Facility is equal to the London Inter-Bank Offered Rate, or LIBOR, plus a variable rate ranging from 2.75% to 4.0% depending on the Company’s consolidated leverage ratio, as defined in the Credit Facility agreement, and there is a 0.50% commitment fee on the unused portion of the Revolver.

Payments of Financing Costs $ 722us-gaap_PaymentsOfFinancingCosts $ 2,227us-gaap_PaymentsOfFinancingCosts $ 2,899us-gaap_PaymentsOfFinancingCosts

Minimum [Member] | Credit Facility [Member]

Long-Term Debt (Details) [Line Items]

Credit Facility Rate Monthly 2.75%

Maximum [Member] | Credit Facility [Member]

Long-Term Debt (Details) [Line Items]

Credit Facility Rate Monthly 4.00%

DD [Member] | Revolving Credit Facility [Member]

Long-Term Debt (Details) [Line Items]

Line of Credit Facility, Maximum Borrowing Capacity 55,000

DD [Member] | Term Loan Facility [Member]

Long-Term Debt (Details) [Line Items]

Credit Facility, Outstanding Balance 60,000 39,000

Revolving Credit Facility [Member]

Long-Term Debt (Details) [Line Items]

Line of Credit Facility, Maximum Borrowing Capacity 82,250 35,000

Credit Facility, Outstanding Balance 45,000

Line of Credit Facility, Unused Capacity, Commitment Fee Percentage 0.50%

Line of Credit Facility, Remaining Borrowing Capacity 37,250

Term Loan Facility [Member]

Long-Term Debt (Details) [Line Items]

Credit Facility Maximum Borrowing Capacity 40,000

Credit Facility, Outstanding Balance $ 67,750 $ 59,250

Credit Facility [Member]

Long-Term Debt (Details) [Line Items]

Credit Facility Rate Monthly 3.52%

X

- Definition

Credit facility maximum borrowing capacity.

+ References

No definition available.

+ Details

Name: evdy_CreditFacilityMaximumBorrowingCapacity

Namespace Prefix: evdy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The outstanding balance under the credit facility.

+ References

No definition available.

+ Details

Name: evdy_CreditFacilityOutstandingBalance

Namespace Prefix: evdy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Description of the effective interest rate on credit facility.

+ References

No definition available.

+ Details

Name: evdy_CreditFacilityRateDescription

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Effective interest rate on credit facility.

+ References

No definition available.

+ Details

Name: evdy_CreditFacilityRateMonthly

Namespace Prefix: evdy_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: evdy_LongTermDebtDetailsLineItems

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(b),22(b))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.

+ References

No definition available.

+ Details

Name: us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition

The cash outflow for loan and debt issuance costs.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentsOfFinancingCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=evdy_DDMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=evdy_CreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=evdy_TermLoanFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 24 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9

Goodwill and Other Intangible Assets (Details) - Schedule of future amortization expense of intangible assets (USD $)
In Thousands, unless otherwise specified

Mar. 31, 2015

Dec. 31, 2014

Schedule of future amortization expense of intangible assets [Abstract]

2015 (April 1st to December 31st) $ 4,527

2016 5,373

2017 5,365

2018 5,176

2019 5,176

Thereafter 18,160

Total $ 43,777us-gaap_FiniteLivedIntangibleAssetsNet $ 30,716us-gaap_FiniteLivedIntangibleAssetsNet

X

- Details

Name: evdy_ScheduleOfFutureAmortizationExpenseOfIntangibleAssetsAbstract

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

+ References

No definition available.

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

+ References

No definition available.

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 25 R30.htm IDEA: XBRL DOCUMENT v2.4.1.9

Common Stock and Preferred Stock (Details)
3 Months Ended

Mar. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Apr. 30, 2014

Stockholders' Equity Note [Abstract]

Preferred Stock, Shares Outstanding 0us-gaap_PreferredStockSharesOutstanding 0us-gaap_PreferredStockSharesOutstanding

Preferred Stock, Shares Issued 0us-gaap_PreferredStockSharesIssued 0us-gaap_PreferredStockSharesIssued

Stockholders' Equity, Reverse Stock Split In March 2014, the Company’s Board of Directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation effecting a 1-for-1.5 reverse stock split of the Company’s issued and outstanding shares of common stock. The par value of the common stock was not adjusted as a result of the reverse stock split. All issued and outstanding common stock and per share amounts contained in the Company’s consolidated financial statements and related notes thereto have been retroactively adjusted to reflect this reverse stock split for all periods presented. The reverse stock split was effected on March 14, 2014.

Common Stock, Shares Authorized 90,000,000us-gaap_CommonStockSharesAuthorized 90,000,000us-gaap_CommonStockSharesAuthorized 90,000,000us-gaap_CommonStockSharesAuthorized

Preferred Stock, Shares Authorized 10,000,000us-gaap_PreferredStockSharesAuthorized 10,000,000us-gaap_PreferredStockSharesAuthorized 10,000,000us-gaap_PreferredStockSharesAuthorized

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

+ Details

Name: us-gaap_StockholdersEquityReverseStockSplit

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 26 R31.htm IDEA: XBRL DOCUMENT v2.4.1.9

Stock-Based Compensation (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Dec. 31, 2014

Apr. 30, 2014

Mar. 27, 2014

Stock-Based Compensation (Details) [Line Items]

Proceeds from Stock Options Exercised $ 460 $ 1,172

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 484 910

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share) $ 5.49 $ 7.56

Allocated Share-based Compensation Expense 1,958 1,069

Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options 8,713

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 1 year 6 months

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 2,613 953

Common Stock, Shares Authorized (in Shares) 90,000,000us-gaap_CommonStockSharesAuthorized 90,000,000us-gaap_CommonStockSharesAuthorized 90,000,000us-gaap_CommonStockSharesAuthorized

Performance RSU [Member]

Stock-Based Compensation (Details) [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) 40,000

Restricted Stock Units (RSUs) [Member]

Stock-Based Compensation (Details) [Line Items]

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 1 year 229 days

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) 548,424 ^[1]

Restricted Stock or Unit Expense 262

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized 5,904

2014 Plan [Member]

Stock-Based Compensation (Details) [Line Items]

Common Stock, Capital Shares Reserved for Future Issuance (in Shares) 339,829

Common stock, number of shares reserved for issuance, description The number of shares of common stock reserved for issuance under the 2014 Plan is subject to an automatic increase on January 1 of each year through January 1, 2024, by the lesser of (a) 4% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year and (b) a number of shares determined by the Board of Directors.

Employee Stock [Member]

Stock-Based Compensation (Details) [Line Items]

Common Stock, Capital Shares Reserved for Future Issuance (in Shares) 676,707

Common stock, number of shares reserved for issuance, description The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1 of each calendar year from January 1, 2015 through January 1, 2024 by the least of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, (b) 400,000 shares and (c) a number determined by the Board of Directors that is less than (a) and (b).

Allocated Share-based Compensation Expense $ 271

Common Stock, Shares Authorized (in Shares) 500,000

Common stock, purchase for participating employee price, description Unless otherwise determined by the Board of Directors, common stock will be purchased for participating employees at a price per share equal to the lower of (a) 85% of the fair market value of a share of the common stock on the first date of an offering, or (b) 85% of the fair market value of a share of the common stock on the date of purchase.

Contribution Percentage 15.00%

[1] RSUs granted during the three months ended March 31, 2015 includes the grant of 40,000 units of performance-based RSUs that are dependent upon the Company meeting certain performance criteria.

X

- Definition

Common stock, number of shares reserved for issuance, description

+ References

No definition available.

+ Details

Name: evdy_CommonStockNumberOfSharesReservedForIssuanceDescription

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Common stock, purchase for participating employee price, description

+ References

No definition available.

+ Details

Name: evdy_CommonStockPurchaseForParticipatingEmployeePriceDescription

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The employees maximum payroll percentage deduction allowable towards the purchase of common stock under the Employee Stock Option Plan.

+ References

No definition available.

+ Details

Name: evdy_ContributionPercentage

Namespace Prefix: evdy_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: evdy_StockBasedCompensationDetailsLineItems

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.F)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section F

+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Aggregate number of common shares reserved for future issuance.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_CommonStockCapitalSharesReservedForFutureIssuance

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Unrecognized cost of unvested share-based compensation awards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Unrecognized cost of unvested options awarded to employees as compensation.

+ References

No definition available.

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The noncash expense that represents the cost of restricted stock or unit distributed to employees as compensation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_RestrictedStockExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=evdy_PerformanceRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=evdy_Plan2014Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=us-gaap_EmployeeStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 27 R8.htm IDEA: XBRL DOCUMENT v2.4.1.9

Significant Accounting Policies
3 Months Ended

Mar. 31, 2015

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]
2. Significant Accounting Policies

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The results of operations for companies acquired are included in the consolidated financial statements from the effective date of the acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation.

Interim Financial Statements

The accompanying interim unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) on the same basis as the audited consolidated financial statements for the year ended December 31, 2014 and, in the opinion of management, include all adjustments of a normal recurring nature considered necessary to present fairly the Company’s financial position, results of operations and cash flows for the interim periods ended March 31, 2015 and 2014. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015 or any other future periods, due to seasonality and other business factors. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted under the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto for the year ended December 31, 2014, which are included in the Company’s Annual Report on Form 10-K filed with the SEC on March 5, 2015.

Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, current business factors and other available information. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition and deferred revenue, allowance for doubtful accounts, internal software development costs and website development costs, valuation of long-lived assets, goodwill and other intangible assets, income taxes and stock-based compensation.

Reclassifications

Certain reclassifications have been made to the prior period financial statements to conform to the March 31, 2015 presentation.

Initial Public Offering

On April 2, 2014, the Company closed its initial public offering of common stock (“IPO”). The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters’ exercise of their over-allotment option, resulted in net proceeds of $70,622, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling $8,848. As a result of the IPO, the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, all of the Company’s redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision.

Revenue Recognition and Deferred Revenue

The Company generates its revenue primarily through advertising and sponsorships, and premium services, including subscriptions and licensing fees.

Advertising revenue is recognized in the period in which the advertisement is delivered. Revenue from sponsorships is recognized over the period the Company substantially satisfies its contractual obligations as required under the respective sponsorship agreements. When contractual arrangements contain multiple elements, revenue is allocated to each element based on its relative fair value determined using prices charged when elements are sold separately. In instances where individual deliverables are not sold separately, or when third-party evidence is not available, fair value is determined based on management’s best estimate of selling price.

Subscriptions are generally paid in advance on a monthly, quarterly or annual basis. Subscription revenue, after deducting refunds and charge-backs, is recognized on a straight-line basis ratably over the subscription periods. Licensing revenue is generally recognized over the life of the contract.

Deferred revenue relates to: (i) subscription fees for which amounts have been collected but for which revenue has not been recognized, and (ii) advertising and sponsorship fees and licensing fees billed in advance of when the revenue is to be earned.

Cost of Revenues

Cost of revenues consists principally of the expenses associated with aggregating the total audience across the Company’s portfolio of websites, including (i) royalty expenses for licensing content for certain websites within the portfolio and for the portion of advertising revenue the Company pays to the owners of certain other websites within the portfolio, and (ii) media costs associated with audience aggregation activities. Cost of revenues also includes credit card fees and service charges associated with subscription fees for the Company’s premium services.

Media costs consist primarily of fees paid to online publishers, internet search companies and other media channels for search engine and database marketing, and display and television advertising. These media activities are attributable to revenue-generating and audience aggregation events, designed to increase the audience to the websites the Company operates, increase the number of subscribers to premium services and grow the Company’s registered user base.

Other Expense

There were no charges reflected as other expense in the three months ended March 31, 2015. In connection with the refinancing of its credit facilities in March 2014, the Company wrote-off unamortized deferred financing costs totaling $2,845 and incurred prepayment fees of $1,016, which, together with the mark-to-market adjustment on certain preferred stock warrants of $253, is reflected as other expense in the accompanying consolidated statements of operations for the three months ended March 31, 2014.

Comprehensive Income

The Company has no items of other comprehensive income, and accordingly net loss is equal to comprehensive loss for all periods presented.

Fair Value of Financial Instruments

Due to their short-term maturities, the carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value. Cash equivalents principally consist of the Company’s investment in highly liquid money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value of the Company’s debt approximates the recorded amounts as the interest rates on the credit facilities are based on market interest rates.

Property and Equipment

Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from three to five years. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the improvement.

The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of payroll and related benefits, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.

The Company also incurs costs to develop its websites and mobile applications. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of third-party consultants and related charges, and the costs of content determined to provide a future economic benefit, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.

The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s property and equipment during the three months ended March 31, 2015 and 2014.

Segment Information

The Company and its subsidiaries are organized in a single operating segment, providing online health solutions, and the Company also has one reportable segment. Substantially all of the Company’s revenues are derived from U.S. sources.

Recent Accounting Standards

In April 2014, the FASB issued amended guidance for reporting discontinued operations. Under the new guidance, only disposals that represent a strategic shift having a material impact on an entity’s operations and financial results shall be reported as discontinued operations, with expanded disclosures. This amendment will be effective for the first annual reporting period beginning after December 15, 2015. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

In May 2014, the FASB issued amended guidance for revenue recognition. This amendment provides a comprehensive new revenue recognition model. The core principle of the guidance is to recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. As currently issued, this amendment is effective for fiscal years beginning after December 15, 2016, and for interim periods within those fiscal years. Early adoption is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company has not yet selected a transition method and is currently evaluating the effect that the new standard will have on the consolidated financial statements and related disclosures.

In June 2014, the FASB issued updated guidance on stock compensation accounting requiring that a performance target that affects vesting and could be achieved after the requisite service period should be treated as a performance condition. Current GAAP does not contain explicit guidance on how to account for such share-based payments. This updated guidance is effective for fiscal years beginning after December 15, 2015, and for interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

In April 2015, the FASB issued updated guidance on the presentation of debt issuance costs in financial statements. The new guidance requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs will continue to be reported as interest expense. This guidance will be effective for the Company beginning in the first quarter of 2016 on a retrospective basis for all periods presented, with early adoption optional. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

X

- Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18861-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18854-107790

+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 28 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9

Stock-Based Compensation (Details) - Schedule of stock option activity (Stock Option Activity [Member], USD $)
In Thousands, except Share data, unless otherwise specified
0 Months Ended 3 Months Ended

Dec. 31, 2014

Mar. 31, 2015

Dec. 31, 2014

Stock Option Activity [Member]

Stock-Based Compensation (Details) - Schedule of stock option activity [Line Items]

Number of options 5,893,698 6,539,551 5,893,698

Weighted-average exercise price $ 9.94 $ 10.23 $ 9.94

Weighted-average remaining contractual life 6 years 175 days 6 years 237 days

Aggregate intrinsic value $ 29,249 $ 20,931 $ 29,249

Exercisable at March 31, 2015 3,896,925

Exercisable at March 31, 2015 $ 8.45

Exercisable at March 31, 2015 5 years 3 days

Exercisable at March 31, 2015 $ 17,987

Granted 726,100

Granted $ 12.22

Exercised (72,832)

Exercised $ 7.27

Cancelled (7,415)

Cancelled $ 12.84

X

- Details

Name: evdy_StockBasedCompensationDetailsScheduleofstockoptionactivityLineItems

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Gross number of share options (or share units) granted during the period.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average price at which option holders acquired shares when converting their stock options into shares.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(iii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of share options (or share units) exercised during the current period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 29 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9

Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified

Mar. 31, 2015

Dec. 31, 2014

Assets

Cash and cash equivalents $ 48,530 $ 50,729

Accounts receivable, net of allowance for doubtful accounts of $523 and $637 as of March 31, 2015 and December 31, 2014, respectively 57,611us-gaap_AccountsReceivableNetCurrent 68,007us-gaap_AccountsReceivableNetCurrent

Deferred tax asset 656 656

Prepaid expenses and other current assets 9,377 5,529

Total current assets 116,174us-gaap_AssetsCurrent 124,921us-gaap_AssetsCurrent

Property and equipment, net 25,847us-gaap_PropertyPlantAndEquipmentNet 25,502us-gaap_PropertyPlantAndEquipmentNet

Goodwill 143,165us-gaap_Goodwill 127,115us-gaap_Goodwill

Intangible assets, net 43,777 30,716

Other assets 5,811us-gaap_OtherAssetsNoncurrent 5,237us-gaap_OtherAssetsNoncurrent

Total assets 334,774us-gaap_Assets 313,491us-gaap_Assets

Liabilities and stockholders’ equity

Accounts payable and accrued expenses 25,060 31,722

Deferred revenue 8,821us-gaap_DeferredRevenueCurrent 6,740us-gaap_DeferredRevenueCurrent

Current portion of long-term debt 2,625us-gaap_LongTermDebtCurrent 3,000us-gaap_LongTermDebtCurrent

Other current liabilities 8,977us-gaap_OtherLiabilitiesCurrent 965us-gaap_OtherLiabilitiesCurrent

Total current liabilities 45,483us-gaap_LiabilitiesCurrent 42,427us-gaap_LiabilitiesCurrent

Long-term debt 110,125us-gaap_LongTermDebtNoncurrent 87,000us-gaap_LongTermDebtNoncurrent

Deferred tax liabilities 6,912 6,673

Other long-term liabilities 4,016us-gaap_OtherLiabilitiesNoncurrent 4,105us-gaap_OtherLiabilitiesNoncurrent

Preferred stock, $0.01 par value: 10,000,000 shares authorized at March 31, 2015 and December 31, 2014; no shares issued and outstanding at March 31, 2015 and December 31, 2014 0us-gaap_PreferredStockValue 0us-gaap_PreferredStockValue

Common stock, $0.01 par value: 90,000,000 shares authorized at March 31, 2015 and December 31, 2014; 31,562,028 and 31,489,196 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively 315us-gaap_CommonStockValue 314us-gaap_CommonStockValue

Treasury stock (55)us-gaap_TreasuryStockValue (55)us-gaap_TreasuryStockValue

Additional paid-in capital 295,136us-gaap_AdditionalPaidInCapital 292,117us-gaap_AdditionalPaidInCapital

Accumulated deficit (127,158) (119,090)

Total stockholders’ equity 168,238us-gaap_StockholdersEquity 173,286us-gaap_StockholdersEquity

Total liabilities and stockholders’ equity $ 334,774 $ 313,491

X

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, netted by jurisdiction and classified as current.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

+ Details

Name: us-gaap_DeferredTaxAssetsLiabilitiesNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, netted by jurisdiction and classified as noncurrent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31917-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31931-109318

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e31958-109318

+ Details

Name: us-gaap_DeferredTaxLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph ((a)(1),(b))

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesAndStockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of long-term debt, after unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19,20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6904-107765

+ Details

Name: us-gaap_OtherLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.24)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656

+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 30 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9

Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Cash flows from operating activities

Net loss $ (8,068)us-gaap_NetIncomeLoss $ (7,759)us-gaap_NetIncomeLoss

Adjustments to reconcile net loss to net cash provided by operating activities:

Depreciation and amortization 4,662 3,558

Provision for doubtful accounts 215us-gaap_ProvisionForDoubtfulAccounts

Stock-based compensation 2,491us-gaap_ShareBasedCompensation 1,069us-gaap_ShareBasedCompensation

Amortization and write-off of financing costs 107 4,169

Provision for deferred income taxes 241us-gaap_DeferredIncomeTaxExpenseBenefit 241us-gaap_DeferredIncomeTaxExpenseBenefit

Changes in operating assets and liabilities:

Accounts receivable 14,802 10,935

Prepaid expenses and other current assets (3,641) (2,645)

Accounts payable and accrued expenses (9,322) (8,610)

Deferred revenue 1,884 568

Other current liabilities 32 32

Other long-term liabilities 17 307

Net cash provided by operating activities 3,205 2,080

Cash flows from investing activities

Additions to property and equipment, net (3,005) (3,476)

Proceeds from sale of business 152

Payment for business purchased, net of cash acquired (24,747)evdy_PaymentsToAcquireBusiness

Payment of security deposits and other assets 40us-gaap_PaymentsForOtherDeposits 5us-gaap_PaymentsForOtherDeposits

Net cash used in investing activities (27,712) (3,319)

Cash flows from financing activities

Proceeds from the exercise of stock options 460 1,172

Principal payments on capital lease obligations (180) (145)

Payments of credit facility financing costs (722)us-gaap_PaymentsOfFinancingCosts (2,227)us-gaap_PaymentsOfFinancingCosts

Net cash provided by (used in) financing activities 22,308 (233)

Net decrease in cash and cash equivalents (2,199) (1,472)

Cash and cash equivalents, beginning of period 50,729 16,242

Cash and cash equivalents, end of period 48,530 14,770

Supplemental disclosure of cash flow information

Interest paid 1,253us-gaap_InterestPaid 2,262us-gaap_InterestPaid

Income taxes paid 10us-gaap_IncomeTaxesPaid 16us-gaap_IncomeTaxesPaid

Supplemental disclosure of non-cash investing and financing activities

Issuance of common stock for acquired business 919

Due to sellers of acquired business 8,000evdy_DueToSellersOfAcquiredBusiness

Due from stock option exercises 111evdy_DueFromStockOptionExercises

Warrants issued in connection with website partner agreement 1,131

Capital lease obligations incurred 193us-gaap_CapitalLeaseObligationsIncurred

Former Revolving Credit Facility [Member]

Cash flows from financing activities

Repayments of principal (30,000)

Former Term Loan [Member]

Cash flows from financing activities

Repayments of principal (41,333)

Revolving Credit Facility [Member]

Cash flows from financing activities

Repayments of principal (10,000)

Borrowings 25,000 32,300

Term Loan Facility [Member]

Cash flows from financing activities

Repayments of principal (750)

Borrowings $ 8,500 $ 40,000

X

- Details

Name: evdy_AdjustmentsToReconcileNetLossToNetCashProvidedByOperatingActivitiesAbstract

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amortization and write off of deferred financing costs

+ References

No definition available.

+ Details

Name: evdy_AmortizationAndWriteoffOfDeferredFinancingCosts

Namespace Prefix: evdy_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: evdy_CashFlowsFromFinancingActivitiesAbstract

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: evdy_CashFlowsFromInvestingActivitiesAbstract

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: evdy_CashFlowsFromOperatingActivitiesAbstract

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: evdy_ChangesInOperatingAssetsAndLiabilitiesAbstract

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

No authoritative reference available.

+ References

No definition available.

+ Details

Name: evdy_DueFromStockOptionExercises

Namespace Prefix: evdy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount due to Sellers of acquired businesses for assets and liabilities acquired.

+ References

No definition available.

+ Details

Name: evdy_DueToSellersOfAcquiredBusiness

Namespace Prefix: evdy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Payments to acquire business

+ References

No definition available.

+ Details

Name: evdy_PaymentsToAcquireBusiness

Namespace Prefix: evdy_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: evdy_SupplementalDisclosureOfCashFlowInformationAbstract

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: evdy_SupplementalDisclosureOfNonCashInvestingAndFinancingActivitiesAbstract

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Warrant issued in connection with website partner agreement

+ References

No definition available.

+ Details

Name: evdy_WarrantsIssuedInConnectionWithWebsitePartnerAgreement

Namespace Prefix: evdy_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase during the period in capital lease obligations due to entering into new capital leases.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

+ Details

Name: us-gaap_CapitalLeaseObligationsIncurred

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 6.I.7)

-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 6

-Section I

-Subsection 7

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Deferred Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6510177

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_IncomeTaxesPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other current operating liabilities not separately disclosed in the statement of cash flows.

+ References

No definition available.

+ Details

Name: us-gaap_IncreaseDecreaseInOtherCurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other noncurrent operating liabilities not separately disclosed in the statement of cash flows.

+ References

No definition available.

+ Details

Name: us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the value of prepaid expenses and other assets not separately disclosed in the statement of cash flows, for example, deferred expenses, intangible assets, or income taxes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of cash paid for interest during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_InterestPaid

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Cash outflow related to other deposits not otherwise defined in the taxonomy.

+ References

No definition available.

+ Details

Name: us-gaap_PaymentsForOtherDeposits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for loan and debt issuance costs.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentsOfFinancingCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.

+ References

No definition available.

+ Details

Name: us-gaap_ProceedsFromDebtNetOfIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

+ Details

Name: us-gaap_ProceedsFromDivestitureOfBusinesses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (j)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.

+ References

No definition available.

+ Details

Name: us-gaap_PropertyPlantAndEquipmentAdditions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.5)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_ProvisionForDoubtfulAccounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.

+ References

No definition available.

+ Details

Name: us-gaap_RepaymentsOfDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow during the period from the repayment of aggregate short-term and long-term debt and payment of capital lease obligations.

+ References

No definition available.

+ Details

Name: us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Value of stock issued pursuant to acquisitions during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_CreditFacilityAxis=evdy_FormerRevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=evdy_FormerTermLoanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=evdy_TermLoanFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 31 R35.htm IDEA: XBRL DOCUMENT v2.4.1.9

Net Loss Per Common Share (Details) - Basic and diluted net income (loss) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Numerator:

Net loss $ (8,068)us-gaap_NetIncomeLoss $ (7,759)us-gaap_NetIncomeLoss

Denominator:

Weighted-average number of common shares outstanding - basic and diluted 31,525,559 5,403,846

Net loss per common share - basic and diluted $ (0.26)us-gaap_EarningsPerShareBasicAndDiluted $ (1.44)us-gaap_EarningsPerShareBasicAndDiluted

X

- Details

Name: evdy_DenominatorAbstract

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: evdy_NumeratorAbstract

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).

+ References

No definition available.

+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 32 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9

Net Loss Per Common Share (Tables)
3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Diluted net loss per common share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding for the period, adjusted to reflect potentially dilutive securities. Potentially dilutive securities consist of incremental shares issuable upon the assumed exercise of stock options, restricted stock units, and warrants using the treasury stock method, and employee withholdings to purchase common stock under the ESPP. Due to the net losses for the three months ended March 31, 2015 and 2014, the Company had outstanding options, warrants, restricted stock units, and ESPP withholdings which were not included in the computation of diluted net loss per common share, as the effects would have been anti-dilutive. Accordingly, the basic and diluted weighted-average number of common shares outstanding are the same for the following periods presented:

Three months ended

March 31,

2015 2014

Numerator:

Net loss $ (8,068 ) $ (7,759 )

Denominator:

Weighted-average number of common shares outstanding - basic and diluted 31,525,559 5,403,846

Net loss per common share - basic and diluted $ (0.26 ) $ (1.44 )

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] The following securities were outstanding at the end of the periods presented below and have been excluded from the calculation of diluted net loss per common share because the effect is anti-dilutive:

Three months ended

March 31,

2015 2014

Warrants to purchase common stock⁽¹⁾ 143,782 692,501

Warrants to purchase redeemable convertible preferred stock⁽¹⁾ — 148,650

Redeemable convertible preferred stock⁽¹⁾ — 26,820,270

Stock option awards 6,539,511 6,673,806

RSU awards 548,424 —

Employee stock purchase plan 80,037 —

Total anti-dilutive securities 7,311,754 34,335,227

⁽¹⁾ Upon closing of the IPO on April 2, 2014, all of the Company’s outstanding redeemable convertible preferred stock automatically converted into shares of common stock. In addition, the outstanding warrants to purchase redeemable convertible preferred stock automatically converted into warrants to purchase common stock, or were automatically exercised upon closing of the IPO.

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R36.htm IDEA: XBRL DOCUMENT v2.4.1.9

Net Loss Per Common Share (Details) - Securities excluded from calculations of diluted net loss per common share
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Anti-dilutive securities 7,311,754 34,335,227

Common Stock Warrant [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Anti-dilutive securities 143,782 ^[1] 692,501 ^[1]

Preferred Stock Warrant [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Anti-dilutive securities ^[1] 148,650 ^[1]

Redeemable Convertible Preferred Stock [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Anti-dilutive securities ^[1] 26,820,270 ^[1]

Options [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Anti-dilutive securities 6,539,511 6,673,806

Restricted Stock Units (RSUs) [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Anti-dilutive securities 548,424

Employee Stock [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Anti-dilutive securities 80,037

[1] Upon closing of the IPO on April 2, 2014, all of the Company's outstanding redeemable convertible preferred stock automatically converted into shares of common stock. In addition, the outstanding warrants to purchase redeemable convertible preferred stock automatically converted into warrants to purchase common stock, or were automatically exercised upon closing of the IPO.

X

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Antidilution

-URI http://asc.fasb.org/extlink&oid=6505113

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Diluted Earnings Per Share

-URI http://asc.fasb.org/extlink&oid=6510752

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingent Stock Agreement

-URI http://asc.fasb.org/extlink&oid=6508534

+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=evdy_CommonStockWarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=evdy_OptionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=evdy_PreferredStockWarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_EmployeeStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 34 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9

Acquisitions (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Acquisitions (Details) [Line Items]

Payments to acquire business $ (24,747)evdy_PaymentsToAcquireBusiness

Due To Sellers Of Acquired Business 8,000evdy_DueToSellersOfAcquiredBusiness

Contingent Earn-out Provisions, Eligibility 5,000

Business Combination, Acquisition Related Costs 169

Closing [Member] | Cambridge [Member]

Acquisitions (Details) [Line Items]

Payments to acquire business 24,273

Remainder [Member] | Cambridge [Member]

Acquisitions (Details) [Line Items]

Due To Sellers Of Acquired Business 8,000

Cambridge [Member]

Acquisitions (Details) [Line Items]

Business Acquisition, Percentage of Voting Interests Acquired 100.00%

Business Acquisition, Name of Acquired Entity Cambridge BioMarketing Group, LLC

Business Combination, Consideration Transferred $ 32,273

X

- Details

Name: evdy_AcquisitionsDetailsLineItems

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of eligible earn out, contingent upon reaching pre-determined performance metrics.

+ References

No definition available.

+ Details

Name: evdy_ContingentEarnOutProvisionsEligibility

Namespace Prefix: evdy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount due to Sellers of acquired businesses for assets and liabilities acquired.

+ References

No definition available.

+ Details

Name: evdy_DueToSellersOfAcquiredBusiness

Namespace Prefix: evdy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Payments to acquire business

+ References

No definition available.

+ Details

Name: evdy_PaymentsToAcquireBusiness

Namespace Prefix: evdy_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Name of the acquired entity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessAcquisitionNameOfAcquiredEntity

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Percentage of voting equity interests acquired at the acquisition date in the business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

+ Details

Name: us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition

This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 25

-Paragraph 23

-URI http://asc.fasb.org/extlink&oid=34752592&loc=d3e1043-128460

+ Details

Name: us-gaap_BusinessCombinationAcquisitionRelatedCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477

+ Details

Name: us-gaap_BusinessCombinationConsiderationTransferred1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=evdy_CambridgeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementScenarioAxis=evdy_ClosingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementScenarioAxis=evdy_RemainderMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 35 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 36 R7.htm IDEA: XBRL DOCUMENT v2.4.1.9

Business
3 Months Ended

Mar. 31, 2015

Disclosure Text Block [Abstract]

Business Description and Basis of Presentation [Text Block]
1. Business

Everyday Health, Inc. (the “Company”) operates a portfolio of health and wellness websites and mobile applications that provides consumers, healthcare professionals, advertisers and partners with content and advertising-based services. The Company was incorporated in the State of Delaware in January 2002 as Agora Media Inc., and changed its name to Waterfront Media Inc. in January 2004. In January 2010, the Company changed its name to Everyday Health, Inc. to better align its corporate identity with the Everyday Health brand.

X

- Definition

The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).

+ References

No definition available.

+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 37 R3.htm IDEA: XBRL DOCUMENT v2.4.1.9

Consolidated Balance Sheets (Parentheticals) (USD $)
In Thousands, except Share data, unless otherwise specified

Mar. 31, 2015

Dec. 31, 2014

Allowance for doubtful accounts (in Dollars) $ 523 $ 637

Preferred stock, par value (in Dollars per share) $ 0.01 $ 0.01

Preferred stock, shares authorized 10,000,000us-gaap_PreferredStockSharesAuthorized 10,000,000us-gaap_PreferredStockSharesAuthorized

Preferred stock, shares issued 0us-gaap_PreferredStockSharesIssued 0us-gaap_PreferredStockSharesIssued

Preferred stock, shares outstanding 0us-gaap_PreferredStockSharesOutstanding 0us-gaap_PreferredStockSharesOutstanding

Common stock, par value (in Dollars per share) $ 0.01 $ 0.01

Common stock, shares issued 31,562,028us-gaap_CommonStockSharesIssued 31,489,196us-gaap_CommonStockSharesIssued

Common stock, shares outstanding 31,562,028us-gaap_CommonStockSharesOutstanding 31,489,196us-gaap_CommonStockSharesOutstanding

Common stock, shares authorized 90,000,000us-gaap_CommonStockSharesAuthorized 90,000,000us-gaap_CommonStockSharesAuthorized

X

- Definition

A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=49124121&loc=d3e5074-111524

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 38 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9

Subsequent Events
3 Months Ended

Mar. 31, 2015

Subsequent Events [Abstract]

Subsequent Events [Text Block]
11. Subsequent Events

The Company has completed an evaluation of all subsequent events through the issuance date of these financial statements and concluded that no subsequent events occurred that required recognition to the financial statements or disclosures in the notes to the consolidated financial statements.

X

- Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

+ References

No definition available.

+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R1.htm IDEA: XBRL DOCUMENT v2.4.1.9

Document And Entity Information
3 Months Ended

Mar. 31, 2015

May 08, 2015

Document and Entity Information [Abstract]

Entity Registrant Name Everyday Health, Inc.

Document Type 10-Q

Current Fiscal Year End Date --12-31

Entity Common Stock, Shares Outstanding 31,674,117dei_EntityCommonStockSharesOutstanding

Amendment Flag false

Entity Central Index Key 0001358483

Entity Current Reporting Status Yes

Entity Voluntary Filers No

Entity Filer Category Non-accelerated Filer

Entity Well-known Seasoned Issuer No

Document Period End Date Mar. 31, 2015

Document Fiscal Year Focus 2015

Document Fiscal Period Focus Q1

X

- Definition

If the value is true, then the document is an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

+ References

No definition available.

+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.

+ References

No definition available.

+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Details

Name: evdy_DocumentAndEntityInformationAbstract

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

ZIP 40 0000930413-15-002456-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000930413-15-002456-xbrl.zip M4$L#!!0````(`)N#K$8$W89&1(4``'8Q!P`1`!P`979D>2TR,#$U,#,S,2YX M;6Q55`D``X5B4E6%8E)5=7@+``$$)0X```0Y`0``[%WK;^.ZH/^#F@)% M+[".];3D-&O`&R>GZ7`X'`Y'Y_\R&'!_0!NZP(<&][SBS(M_]Q=_X0;79\/A^_O[J8X>]733A9X3N#KT\`?<8##A\#__ M_$_GF,B%"S&),^XQ@-QWL.($D1.T,U$^X\?I`CACT\=]V4H\KPT-&W/![8.3Z(GS_"W9L/GC<_AP\LT0XQ_PPD`2DA\9D!C<@_KIB_,V1%_@Q^7LXVBD%P"6A23P M%P44+-/^7<(P_OH9>!N&K9*'_W:#GDZ>-#U'%@6U3)C1$\D/X)NQ6C\-D9&L M#+!ZA<#R7[$UA-AY:8,\-IGU3XI,:`.;9/-="H$(X_%X&'Z[?M0K>@X!%H9_ M^W[SH+_"!1BL[2"T-8X[QR.<>>&7]W#.A2.>8:U^/?',Q=+"`@P_>W7A_.L) MYG60,'3ZX1DGPTDTD.Z@R?+A[5P2O@,7/WPRB68#_N\YM'W3 M7TW6'Z"/3`-_.#?1Y`JAP`PGB>E<7/_U9,(C?B1%DS7I?+CY67K\X89`\M$2 MNJ9C9$F&@O`GD6%)R+#.A\EGZY$VOXMX',9,)B-EF19BIF=0QQ:^WTS+`T%D MP;3X=.4Z"^&_@(TE^>CLL\X1HZX_0ZYXDK@3'@E@\RG'I9^&MI%Z-K*0Y+.6 MPI+2PI(WPMI'6\D(2VX@+)F1L.3L='I"B_+"L1]\1__]'2Z>H9OXL.V+#(L# MOBS@9IJ$GT7KY!G\6%JF;OH1*LXPT8.>Z=A?3^+5Z^S!1W+`/[_\OP#AQ.&% M8Z._>M,/TSN9)(_E.#P?%I+8@$`*27#MW!,HA+[NT((!71<:A,H^S=`_26M% M?%(5EP:W1[H;$;I[1!&K%[BKG.H.2G,%7)8H;A_UIA)ZFQJ&Z2-1`.L.F,:U M?0&6I@^L@]5@*;\]TZ5&Z/(>^L"TH7$)7-NT7[P#7?2*V>S5RC>FQ<#'F(6E MYG8>O@L\5=$U'.]AZ7UGGG?W5B!0K8#NL@]+^9_MLW>OEY-WL M1IDEXR1"8Y3MZ$&I;)=;46:*DPG%4?>BAZ6[W6U&F6E.(31W#(IVL!UEILT1 MH&)H%58P"-T%S<.L`]+Y5FN#EW']+Q3U?Q.<=9#A6\\=:L) MWO_MJ,A39_=1\Y^F^5W,>9&>?$I\7X'*^ZOPT+<7<;9G1KDR,\B/:=[#:TP*Y[%84_:MU9WH4>;+I MTHT]&1__\>GZ[K9'84GHHA#D;""RYN'3CKR0-H]L%]@5E\9 M7@XY-2%1;_P\?0 M%27?N0X2C[^ZLY!+0WSAQ3KDYMOJ<;4D;*`V_P=<^2;)5//X!9\]T\?2^>X\ MFQ:<+C'S`!=`>#V*X1N91A@G5#-^R`9!5OE<@,6S:QHOL&='R=\"S[2AYTUU MI&@OK-M)Z9C@:KM'R5LH`9%&]$L)1X7U?Q:J==7[=&$Y2&XO/?3([!7>:I/V MH$,;(.6D::=E>LC.7JMM9O=P`4S;@&[?0L+]M3)"I`=]JT:B%S-=>KZY0$/? MSJ^`Z?X/L`*X_L/,]'0T%P,7]M"_K;GXMOH>%G^'AO`->":1-&PB@0-?^&2B MM+@+/=\*Z7"O:*[V:2^_0E+?M]>+*M-'6 M\\9\@\:UC=3U8CZC#:CG0=]#7@3\W7'#G#)QZ$"7?.\V-G+N*AYA9H\N,.`/ ML(#]NZ'00],BI=VWZV8R/?UY]%_[8F0[\U^[#W?HZ=>CW_O3^+W=FV$NZ5OA M"_MA=_UR1MM8_4JRQ$<-_PF7&[*AV-$*=CK/676HDN,\[JWN)_=)CAK>DWF. M=,S7+[N-[:'K/!_GFFSD@\<#UGS?=ZT*O1/949,''(JSJXC4 M=?BHR4^:M[M8;Q6R&]FM_PI=4EI_CJBKA/7>[9\5>GKNJ.'/U_#NUV>R"?[1 M"G8ZSYFMVR/JNGW4\([G^4[6#8=N<3KZ6Q6;DU0H/'OBI[K:[D:O(/ MYRU45U(D56?F]4-_S(K"#FJV"P*+2ZBCJ&I0R%D/==8?;:9OCD:(HOVNEB+0 M'`U]@3C:2@]MA857B4H1:W3@ZX>%[*6RPJTYBXE-IN".`=_6U,7BC73D:P". M.ZR^:5"AUQ85,%?4#:3'"HTJ%]LV'F]"_<_X M50P>OX?K"8:.RR]2\S[+3<]NGZKT-G-'+?74*ZOT5G-WT)T[[@+8.KQ_^-FS ME7?Z#ER#Z"E5Q-"!+[HJ_>KE/?1\U]3]N._E3]OTO;2>^S.#"5UO]ODE#!YR M-*WF\SI'5?YJ MHF=%C@H[`!>J$B[TJ-2]=)8:40L:,G*[#`]>==]\ZT_**.YY!SP/C1@U.DV% MKE2^/NTTETF-IQIU(%OK*UWD6::ZH^ZZI:]B[7UB^DJCWYX[SM$#VFMH9$>R MHW;W>GNAT?,]J=>F_`*NBXCT,,XI>>U'I%\*DP<.FE M1K\SEWW;35[KAZ'S$BX/^_:ZIE`G^U'SGWC_>0=SGIZ1NH<&A`OP;,$+QWZ# MKH^ODM'>(M9[,]@DA6MR?CV`>CV(FGH+]Q(-K@]+#C:M6RD&'L MP`]]M3%UTA_U>P#S=TS/K1W.26\M7][JU/<0IOB87HK5]Y.J&HIO`9Z=WW(GI)S<3T'%D4U+.?#[/S8?(AMQD/_S[U]_1P=]#UL&"\5.!NF&]( M71D^\$]^!`OH`M])9ZOK@-@(D1PE._X,VL["M)/OBFA@39EG$>`"3C=4R+'6 MLM[P5B&;M50(65,@E`^V1,]D`JCL:/CKO,QRPUFF_?ML[CB^[>#6,/9O[B/\ MR%\MT2Q$!H,TX$[1U@F\P)\>G`?6C3F'@[9]KF,, MKV@+]O7D7W>#83C)B"O11T9FR#:(RO8L47[SD;3CFM`]^N)@"UM%U.S76MJME.S'0;* MU-QWR^DD\#VRG"9-D)F:2Q/"P_0RW"6DXG@3.UG$TV)YWCF>(# M_)?HK;VK7,(GO`]TB03@KZYMSW>#,`L4(G]\!79\*O`'K@'PKNV[<&\R:'TK M[BG.(!#FUA_@Y&KP*3M=H6"GBY#A+2?B#NU7C0)#@#+O'HZ,?!$FU:\5A8=\!><0L(PXVS#ET?;7#30W&ZBZ:8:X+\]G9G M849_C(_T&4+69^RQQR#\9_@E3N>O7Q#>03B9A.V.',NG\3?\$TR4SS86VGPB M!5TW?K-]TS"M`.?X'J".7+-O0N_R(_2Z!H:-Q1?XH?1NYY?`Q3E`#\$*I3== M.('M#]K4F5-6U]T#VLFJ*1:LFC_Q6J5;CH?7IS@Y?'UWBQ.^TZ5K6IP8+I+R M%PY85O)`O*[]&U@ZWG^@Q3'P\5F5@8=PU\50G+ZIAN*623D4YV&9<"#PG042 MKXY&725/HF]-VW>X2$:8F!Z*,?K-*7=M<\`PPA:H7T(<:<+OD9@]G%9>(JF] MHCG'!$WAP&E@7]`V1+9L>0X0[R]7NGR@JC7*'-LG@\LJ6;9(APK[; M)'MEE=LDL1^[07_95%!]SJU#?P_G,5Y`Q;.WTS]"^2><853F(\)L\;W MV"YP+2875VJ&'^A$-](3SH"ZN0"6]_5D()U,9$V1>/3/^;`1Q4T](#.@Q$N+ M2:`*KXIC%D"GNH[U[=U#':(?(47^@/Y%@!2)<^FM!:FH(T'(X"LC-&&#J4)F M(XWGU;:8DG+E1_`1'9S=F.`9-WM&S$"BW MHULA!4&4QZ)0G^Z=ZRS1FK/"'=!$"/L[98XCX^,K0/[HJ+)I,70"4W88*H0 MC:@HO-@6TQ^.8[R;EM7%)&1)&"D9`,FHI%;J4*LT!%40ZE$CJQ@0]U&`@Q8Z M!GS+R'ED;:$.0=8@*\0E\:HPZ@PRY6%^.+;>?>'7B'6_D,"D(X@JQRI*:F,0 MT=<=6)X%21X7^VX.Y,:Q7_`;U6;PF4%H+([$[+)0,#SIUQHBJ/2U/-\40>ASF,XR;:P6N+4B M\\P%B2W`5(AD3`0&95BRFF$I$EF1-2FKF:K9RE0*LBB+:D/Z*=-ALN2B!5$YG)/!%=TJD417.LI20+?+F_H<+))B:[9@BSNW5RX&ZD*T30B'3J2+XK MRQ*Q*2.'+G`K3:A7!FIR4^J/;GA->\6$>R7+?'[LW'1L1KXR1]24_#2NT@+6 M'3"-:_L"+$T?=-D.BV-%D++.@$(DER-JCJ4J)3(6!4%M@^4>XO)O:"0''BBZ M#Q;X9C8TD,?%724ZB&B`DQ>*EL%53;#`=KNAK!#>0!#&_)COCC(TOU?',J#K M1>6T7>*7D29*6='EQR>UV0Q!5>9)E41MU!!!:NU!>T6F$BG()%11*XKM.@!L MGG]H`7!J6EUI2VB*.44]U)J1K;`-ACB+9'SMO"&3WG3 MP']U7/,?N`@YP=E4HM<_KI!_XLE-53FYPH.L]O!*!+A%>->>%W267`6FB`9# M/%6B8HCG-E5_OU4AI0BQ1M917*7(4AN%3W-W-6AN#V@3/]<5*,,IBK:7(Y$7 MM4)PN6G!`E&5U:$MIS86QB,FB-A-TQJ"(B<$,VP,1-80&[/%US5"0KU$DD,BCL9B M,R0/P()>_-4#=-],/:Q`8B(862,R(!1B19OEYK!J2TG6!*DEK/BATF/H^N(1 MR-JA9/A)J%X_FW0#^D90 MZGME;3S66D.YMG5G`6\8(#"G:R7*B=: MX$LWZHYNY-CH1P'Z76P/CNU]@W/'A=%SC^`#>C/T!\\W=4;S8JR1U:.M$158 M[%:XJZ\@-:SEWBIWZ)E8O=^0_Y^7'\PUF(Z"5@`\1XQJ4HU@U1:HJ(UKH\J` M0C.4O4R$D>3E04 M9;S!WP[0I[!52R,A6XK,2YH\ZLY5=GM7/RTK$^]$2:7#DBZ5E5G';':V0\5` M(S!%=4JL2Q@4`E#AF_WH%6.U#N2;(1H1B#*U2<6`!D0Y$P55!U`J`8I2'%0, MKZ"XB+4:-0(?67Y#D5M!X4X1LCRP:"K,PHZ<43^[:(JD7G_N76YZ995.T#'- M1=:8JJJH22(!OA$VBF'DQP@/L2K8R^NE)6]1*B6GEB:H"NV)%5L"O2-]HYFA MB`4%6GO#9>W8D;QPVX(-XNSC[X'GATTD'QV*0$.;?B;[5-Y#-&4]TT^2]!'A M>Z@[+W8X2G7A*"/5BKF;9%MF*E\DNCLAUK:<'4BIW3Y&H+])L.9:4[6_RCOB M!D?O8O:TME:01QY[$T?P7>I"&\$I*H8OCF"Z0)((2`P"O2YP9`(.NRBO$RR% M@-4PSLL5M+/7XXA`6#?2RQ>25\>@,[ATT3"A>T%_MF#8"MDVINDW>3$Y9AB- MR)M4U91SUV6[@:U_$*$0@FP!]LYUWDS\2LN"JELVF37"H901+(B!"YM@;V?% M*Z:5GR:-(34XM!R-FT`*CS;3RD6Z_H5;_COS^>T\N6=W9=K`UM&4Q"?H;'*4 M0GP6UP;`9#O8ZY>4"+&0VX$OOC>YS92Y*!=?EJ^?.>^`LOX\[XP2/8G77CB# MT?^O[7SY/Z/:%HUH.U.'=/Y\L!OCLSE)K#LORL!\`D_U]:2-A-Q)Z79X(GJ' ML'%5FB97H"?(UG*L#:#6EK0RRAWLUD!:`32<*?&=+];F+E79.H7XEG`WJ!S> M,NY-JP'6(A?(KF/UZ=>RZW;PZTN>[X*?S'?A5J;A;LB`QK?53P_'2NMRJ2E^ M:3536U?(G%=-^CG/QP9Z_<"2UWA6T*GM!9/T"JN`A^=SN]X*PHRQUE\@)9DH M]&Z'58?0"&N/9N8;+BOR`Q?>SK\%GFE#CU7II:#DVD56T$I- M2$4U5T4.X-H.#8"Y[QR(JDKT5ZJ/8&OP&TQP2REW2(\%TQ:M5X,6MTVX<8%,`RH)$U+?7`)A9%G!;-NC?SO%Y&FXO M49E)%.BU$HV$&UX9HB]7A;C*[;@Y+R)/%7\C7B118L!+(\-AI(5!OGM#H06Q M%#K]B#JQ]G+,FM)"V"P9$*E64X\!N:!C1@US:6TLG24^4)7.;C!\.T5X*GN# M-X.WSY;Y`AAN*@2M'"*=?BY>9P.]R;4@\AIK:^AWZQ]NX5R+[)E,(T:)DYM@ MJK__%8D.K'10M>+,]8\8A\DB6B)R=34U`13>JV``OD$ZGX@RFF'/7H8N?%-- M5`5%9HP8;5"$<9V7Y11#V!K^)NZ!B**W@+_!NXE$*5/$+.4;^HER';Q%+R=B M#35;OI3?G\@J<5&L+=3D?B(N/V)T4YQR,1-3H-X1K2+?P*V.R#QZ*?GUM3EV M`BBZP;VC3`)DB!9$[';%DF@\KXJ*PN69WS!U`LN MYT3G'7SCF?9'9\1^_),]K;P"R*S1;/=:O68*K_3;+N=%57`$,CALG'/N<;)> MZ*^\[._,3ZV7^[9<'?F7:X=.8'I/'RRTKBNO^-E-+IAY2^Y*]-4[D+)[UUN= MH)]=Y\(<#IF-VY!@6^@MR:53K\U=^#=P'/]TW$?G*Q@/UP'#A^;/VQ#5@K== MSAN!6+T^P">KDQ;_?]H>9-Y4N!;WWNNM]E]&WEJ)-Z6D5?Z*?[^N$<+_?U%O M1G8H]VUS4:+T\]?,'WK63/24X@%BL"\W8"7@#>0-[@"&MS88CY4!^@\[>#/3 M_.#)9C__QU^A&[P9PY.O-:,^"[0[:PHQPV?VJ-VZ4]/1^0>Z]A6@';_1IJ9W M;SFO-?QIG3_\'_?!&X(=_X?O'N`G1DV3*.!G/]&'FO@=?3+#3^CWWD_RGZ6` M]49#,EQ88'CP^69G%B0@U2)8]C*8,.T_S.GLS?_I-1KU-]@M;3I/T2?& MFU<:'UT"`)D:&INQ:UNNYHZU";U(`]NM/8+&4&#XR`,,GSZ=N@/07,V'N#&WS;$F:;P]1A>1HAH:/'@%5LC4/K&191(-=5IZ.#&=>WQ3X&L.AB*! MJ_T&;_/&'@"8^'GFE:T:?)KXP*CK!(H$->^]^:R$+P8L@!4U$V(GAYZ(4-0L M%`\\F4)$(ZZ#!%HH))G7D;C2%]H``J!1;:$)TZYL>#0A:!;67882"XD=HH.)BV\. M.;P3$UXZ8,S1F&U-`0AA\(9)IM>J()142+*FVH>(4E\C2J55J-)B:0DT0L<, M1Q92>[D^[QUF$K_5&N-''S?:WVM>:=L^'"MK$6@R>^0+B!^.8]O4>/E!1P`@\>'9[&GYF:XWJ048(J8A$`$03Y M#3VN6N#3D%`.+.K[Z#[!!A0&L*7GT`QN7'#(P+\C'#,B1HEF=M#7Z$)L7%;C)M M'!*]!9ZZ-@HI!O$I-3)Q8YC0Y#\>R`+A&*R/ZX$=?0+41<400\BN*'-\HPU\D+=;['SPL0]&:6A2IIK3MZ_MW264C]M.6 MCU0N*3W+E,>!W.K:RW%R4ESA9P@U?<8\'45I=:U MQXD%DIGG\O*4[*T"+0\V,(%!OO@G@&C#LQ$:0#C\G@M^FXMCK1H1 MTS>?5.R]'UA3S(:JFN>AI>$:PI5-2/,JL1+^"+4T2A-(FSQ&$8Z?L-EH`*;F MGV!8)#6X6/F0S,T2>9Y)08TP2\A\]%73*`HS^:DR?-1.'#B@"*;@$4]."<*T/,C<;Y(_D!'7\SO ME"*#,!+'S:,H4^<6S$$)^H`Z#A+$6Z*<9`G,9APS5V"& MVCBD71JN2JG(YN/-E[G(1H,/TV8'M#.:NJ+QK2/-XE.`2$-=L(:N!+-9%ZG" M+/2PJS&0TD%QVB/.%?#\1#P!)IKOOPK79D%D]\"\"S19E#E`=)T,Z'ELXC`J M.U(K)3[XO%O7.PT@D3G&DAE$,.$PX%M>8E7\`P/4.*T>1M&><`&28MS<#5S/ M`<5()1V`2V#BK0+:\Y[>:_7`-6`=E4,F?3/1+_E0EE9MO=/MZ"V@D2!FED7H M:^?X"-0=$I&>0P92KZ-N\N?)O&?*(*F`#5P!8U-R:Z"Q5%/%?X-^"C_!5W43 M.X5F&+CH_884PXNG>*3KHF'I>`"/I1SMEU71@8!I.&&B.NU7R0;)T\:W&;\MSP5KX@<)HU0EBY2, MP'CU0H8Q,B`!49WRA!;28#>\GR1+^5P/9AC`>O[$FOF\X@[LFUKA-"KQ)V4& M:WFR""T#S"$$`OC=F&&\53&CG;C"*"**Y&S$,)("P:A)R>!19Y*(F=>C"4TND#1'2$W09Q0(54FTQ#WDH7V><+%["?:S[$<)!@^]XAY-95I'JP1HB-X@];( MCTHZF7?H6*Z@E8*)Y8TN<,<+,P#S;5[1'(1!XI?R[1.3JPC].*88=QPO M+5AO@7_AR\\[#6T`R2A+B]A8JBE+#E$#(>E0`@@35Q?%]LI8HHTV9CE`43D52,J#FT,-AJ47A M;ZK+078T),,+%%C/?3)MM,H2!I3"6&!D6P+M%HI4.FJ.0!BE/X_60H&3U5>J M8?'"B)D3&22=\\Q\\F7$ZSY27P3&Q6))7C99N'!"*:;4I2"*-UF21L23M$5# M%QWFJ,USSK1]5]:'@8]TY%`;FMXH5C`1NPE[.K]HOE4HY%LF(JR6"?R4(*X0 MZD3<"X0C_,B)`3M=ASP'Y73^A#ID>,D-$A2?4=TDL0D=%<@$!R?@X)C-J25^ MS9Q[?"&5^]`1X1F4J;SGCLL`9+LSV^3[.1"&,)X%)250[F3P96+NDRX='KA9XKQ*M,%!3PE1CT0ZJ0NR4TE/ M/^O0!144W7!Y&J"6\,W"E,`0?/>>^[@@,\:^8-IV#'W<\((U*E%8I-$/FIB4 M5MWBU!V%PX^,XMY([2&T$NX<_#879&%69=JS='>4PNYAU.P>;RG!N^71,Y0` MREFX*1KS@ZV4R<@]I_F"V:/G!NS"'8]Q^X[/O&2)BGG\F&T4JA(OKT/INBRLPH(=N<`D'5X6 MB"X#;G:&XC1A1.+%>.?C%.I;R5J8&'QJ44][A?SHL&GB0]G?*"CE"0< MZ1@%NCHV]'KN#UXRB"L/$`%F5DF%[#+D68"/17-T>!$+-V7O(7&'D!I>B+W$ M#GL2`8M&B3C?>TA4/OB;R9I%[^$I.\A]5`A!YL"_Q)MX=2?9T/`K;E1J!KQD M%B*ALKL2B043;5=4!X?05KX)UC=YY(;E_K%G3MFCZ_U)*C:E.?F452;>14TH M8J<]V1=C#MPP2/Z2/RZ,\>`I7HJD!L@&MAD,[Y-LM;9>PE%DFQ-Y?A-@4@_>*8&! M!78FH9_"MB1@<^I&`.P>P%@?+T+0K"ENW\B6E@U`)-O,LP4JK?$L`DVU6XA# M7'U+++\G8=PDF*"`U(\B5MF<$?=RH)F*.CQ"GZ6[:.*R"P0+XB5H:WA-+VH( ML"$)E4G?#'YU`<3AA7/.M]F$NG&`XT(WP[F'>Z?+"<`*P!0%<`6:)/LL5VM6C MYO[-Z/>`%-#A;29%ETTK_D<95T8 M!2J`\:JR.+GINW8HFD:E>4F9;:PY0-HE>FHI(13OY'NF<4_`TGXBN25`?:(> MM7E2=$W42/9E&OH M/63245-OW"E-76YT[SWF5E%M#SQ#U+CA`+CR:1W%Z(EV"UP?!$5Z8'GTAN]^ M!^P>O`YDI>,`-VYY)^$2(ZKZ:"'S>)#(GT&HTE-HS(41$:-1P/DN?Q9(5S;'E^(#L'LFWF\`AP MC<<N8SO4/.C.3)W()H($S_B;8PB4O!CYO'=Y8B4(N99 MVN!?K=VPCUAQ?UI/7N>:U^>X%QTL-S/U393?O.[WJ3MB-F?-T*6CY^+XG&1# M!`+?UH]Z":*WT?X_K#NET4Q1H,?2:^@'+IYZ)\/MB'J( M5",JTOL13_&0FRC3X/=8PI6GN;@@\`)>=+@+6_[GH*"V4W&$>/MK"SA^.B;6<$+OG2FO;>Q):<2-A%:],,0]J`*L]W M%&)R`RP^Y\0)>0=᫩X734+1X,7$4!3DA6$^1:BVGRAX` M<+C+*G=+YI_B3CE)4G$\0X9'TD@657D]E).4=S@SCZ(WLH*8&`7)?DPJLNBR M11'4%$__!RF$)[BW[$HD^?Y\"%$S=32+0RMRPJNP;G-TVTY-VR6I:49%#^K8 M*AR-M5=3!'Z")C[^PDL3@X">$7+'BP\%)+C+!&GQ9D(48"6/1Y/01:_$U0>F M3<_Y$\8"+O8C>)YJ(=0"B1TX%-;D"`EZX*D28UH26S&KC3FIEOVX6]B* MH0:=;#7H)&9Q8O+D`CE.B#T-V!1#2J+>@VA$217E?_6)*M56`#5218U442-5 MU$@5-5*EG)$J22>XEE?+W-_QS6=?QM%(E$JXO$5S6BKHYM2H%C6J18UJR8YJ MR0O2T[9F[MHNR_7XC.'LB)6K*/Y)3":MA*E:/`RF6K;JT.-@\B1B7:;/7W/P MU;1!J&@:?>)W7\9W<5ZYLJ04#(I1XUC4.!8UCF52QCB61,5RN=XNN=U4WJ`H MM)8KK=39A;?(=+@)`&T1]YO4Q3^_@^#D7Y+8K7>R]^.M"DKA-7X0\']+Z(8X M^5&+B1I@]Z" MVBZ]'"D#W/Q%:?%*G]T;TYN_;0S>DX](CU\[MICR#;Q_K):Z&R=OQ1RX(G6Z MD=J4N&J%(XKMGOR'E&0O(7R_"-X5R&WTP*R`54D56M<%,'_;H60TF_5"-+G9 M^B6]4)%\=;M@&K=&-X6L&-B0&/U4Q4+S!A.JJA7?)E-/-:-*S:A2,ZK4C"HU MHTK-J#J/&55YU96E@4?V^AX\'@5)&:1F?A5#%#4!2TW`4A.PU`0L-0&K_`E8 M^4U51>Y@+L>EX55\%,^5,Z*_1$'I.FIGJ)8S*1ZW526%NU/3MLYUVE:>1JZE M9CEUMVLV"%SOEHF#IP331QQ(]1ON"GT9C[^,90S]03**SLS#:OCL=;1]4\;U MX0U@>*HT71IXV99/_/(F$J8/C)6#@`&BF+AG?FZ1PEO9O\'B?KS#^<'U/I&X MOA/'RA?M`;1XH;.0J.W<.]F7K)A;HTTD/H*B4Y:@J=FD*GIM#M>@I= MGE5CRR7=5,H9J\)T:?*<&WZG!=VKPG1I\ MIV1:#;XK??!=?L_Z:O'SW3^:/),@8'6T!<6D`-PL!_BJ""WBA_.=U;"[) MMI9$_]*0:14B\QOW6O"^3^2RKA(>JS0IRG00\YF#M_*X6'7KB(N'3%;5JI_- M@,D\>[R2<.4(Y6?:4?TROHU`%V]*E-]G$(=DZ^^%@IDHQ->?71HQA,4KY8'% M'A,C7#P(@4+PKXD20Q759M6)F]4*C-3,335S4\W<5#,W-35S4\W<5#,WU2"WR4LQU<[*YLM0G!F;7\Z_B&8G4LD:Y`/\S[M_S*Y': M)9*UQ,T*39RV$^-0T=+(QT1W:CO=G1K-P#3J]1?11JDUI3EAL4K*4953<@)T M7$>J%)]#:DX'GC6Z9]I;R_TD.]"U7SPWG.G:K[^^2\WXB'Z=G/2AHX?D@3=O MZXZR/]L$Z>+]-E%S>UR((B(&V_["6C$B6R&,T7A!$TE` MZ0.LE-Y2KJ_I;S/Z*MQS04 M(\:/&8RP=>B!<;@QH*,C&J07:55`060`N16=G:`4"SRW)D:6Q`-'GK<)_XAE MLAUG3E6(YR(8E5L_LHM;)I,)U4>-X%VN\+[W;S_>75^)F)LX% M]D3)%G/+%R[U'O\*9W&:(6HC;#JSW2=1\!#MYM&QC1BLA33BHAA84WZL(P^( M4>32I5@7^M]:9G,/&Z-\C9^F'D[BMYM^.EV0?>S2ZXN-8!KBDC/)C;M?/T[, M$L-^12SAN29895Z%CBQ9;+[DM)_0B:9.Q18-(RS0^ZDY9"$-O('7F=AOQSE' M5>D"@^?+DJV@$E^Q6@G>799@&.3Q<$+4'RANC`;?`9T&./M83�DQV_>IZF MT@N3A]%)Q*+9;72B(C/*+3$,.CL0$,?;R0/&$+7Q0DXCK(DT-T@?MXX:^ MA1.I4\H0G[1=?QIU9C(VQ=C2Z2<-K?!=Q:.J/ZPZ:E9//G<1=3G(IH;G1J<_ M-_Q3]`?P_M<1$-(BY:#2BFP'6?TL29J6%6S2&KLXR9!*#WPK*)SBT4#9,YJ4 M)B&O"6>\JF`F)1!D+B%X4BR3RH8DS+:<)K*1=#-H6N#CQE9BG\=2H4!\KDBT M%IC)CEI9&@'O-?FO-T"A43!Y38'^&VU5X5^0 M``5>:F4*;,%779@0\H"R#-P@<*=O-)S6<`]Y@#-"J%SOM>;=#UXV&GV]T6[C M_[W*O[U.+#)*+2)PZ+5?"#44B]EL'&04\P*1>Z,)8E[@+SC";S1!I,"=O=;> MV@"?9LQ^:&1@"O#%_UW-=_9K\P#_%(QRGBY&I?EB57B2L/!HT.C4WVRYO)%+ MR)4)E(3I^;:D,.H98#SL1=N$/"V]5>]4AS)K<8M_[F6\R58*]]L$TOE<)Y5+ M@$T5JY@`7U)IFK"YJ[-G:YJNA&9)_%NZ%DGU`CMC-+OS[SLT5CN0RBW<0/D2 M6G!R8ATVG)>4=GO-^?<=&JN*V,YUY#")ZR]RYOA:A#TON8.\L]WMG('@55EZMA M<\,8E5P6R:71[^:\\80$\^"F,YV1)\O*51/*J.;"J;F_"EEQ)6HY)&EQ;N\G M53HC*[NA4-Q12T.Z'YKVE+?@S^HR44U%V;QL6YJ"\.:;TC1D'Q9C2S7:4T%A M(R$[KUBCLICE21C_#%.=S`9BW)JY66=ESKF[MZ+](O&F&^;AL3;SGGT9_\O% M/I2/L@GP2FZH+CHJV&RG1O6UOT>M#_D7QJ3NB]D,GLNE2'TVI_"X_/U[WN.< M!KM3>'8XB\#ETD;(A0CEP9(]!"T?>Q=WQ;Q+.K2[^)20L7"HX^I8928J-AM@ MK>MYO%D%INPH2GG]TITK\)8O6PA\=U7@O[_C#2_YJ#1:$I7%L,S-SPS9G?N5 MV3:H6LRPE2#OK0SY+766`@T++K*JT__DL,V%$%TF8'\7]?2]-SWG2QCZW8;78;P$3VY-;;8Z(H*J9)38*1_C;.P*][;FOJ#]O=DO M%"0YA>#+.)K1%OTCMO[29*E&)=6H%./"@PKMIT0LF?SH*#J5#IW5JBZELF)K MU:6T/\J<_7:2ZE)274I5*&ZJ+J72I%1U*95?5%1=2JI+J9KF474IJ2ZEZH65 MJDM)=2D=CPU574JJ2ZDRIE-U*:T%B.I2JI:555U*JDM)=2FI+J7E:YUPEU)B M,'FYV^'SC0(RT[J-MKX^LV!A,\8:#4G8&M!JU3NIWH#<%?,O@^;XR6&?)0)E M-+LIF.97RS1!%=Y>4#*UNKUTE]"B=3,@1C7&,NG4;G?3W).KS#$L+B1Q.@*` M[W^(RQ]W`EJKT:NG0%L%@F(%N.&5!J#Q%:\S)'1I!Q)XT8`$/5[IATF=N)"Y8L4`^@:U90*G:]?-I3T&C,5BW> M0L!2&$_R$K5;C@AYD6K>DW"]QMU).HU1)V1I*!;?&$"\1WBQ/"38%S;-79\? M24:_YV5:N@`JNN?3RK^I/C%5+]'5\]('`#^[`=.:KVK:531R4,Q.\_BXM.>M M;@L7C("-%EOKHB@^93,[$C(SGBW1@26GAF$/%`#YP&=,X^3O]%"RNTP36NH& MK07#W-:B5.(F73E;GP.('8H3:\8YTM-[1IU?_N*9(Z8YYI2W:CUOZZUN7=>8 M"12)YHA.^`3CPILFX5W1)6F5$O*[PAO+\J:01G)#PF2TFKK1:8L^L[2,)+0? M+T-@OASZE[S.C%]HP"_)X'/V^*N^#`.7II#S\>-Y]['MX!*VQ(U0BAD#:]9X*6CLQY`QO'$9>P`3=P=_ M7G`IG+@U+HB5&.?$6S0,NH"-MHDSLN/^R:1%``(FR$_7P6E?02%MG%RM%[YR MJ9DCK33IZO9Y"CP'2>IVN[AXUJXNN(TQH9@T:#-7FW64/W[_W[P$'N--?TLI MO=B4)].ZHOO_*F6AKI?AF[D:/6IR?KU*1!%WN>;WLA;WOVY&@E33:V%S;$&- M8`FD>I>H)-B?#1G2)7QJ7)8AE^(*"RL>Z1='J MH"A#Y`RN`_EE"NLUD`;I`2%V!&!&*T=0%](B4ZF<^SY97,(365#N6AE$I1)4)4/5?DX@LJ' M:H?9T2#51O/%KNGX+K=%/$/`#>4B,:ISN3,YCAZ?0Z/TO)1$2+L`B9\SK MKL6PV=$-HUXF;+:5]S@WE)JGAU*%8K)^K7UP+U)U=BF4RD/I5'.;1E=OUE5N@%2*R3S(UF;Y"GC":"PQ'KNI-M9[Y50;3Y@O"HTJH;%_+7G9TON-1C97 MVPMGMD[/3E@03@2-_-3CEYV`GS1:%1)33VKR7=6C.+D6*+0J/*:!S` ME?3TCJ$2"(7&$:%QD`2BV:VK!*)B@G`B:!S`ZK?T1DM9?87&$:&Q?RWIE+8Q ME489?=A1?55#2$:/C8W(N&A4]BUL-1)=M#^\"]:;>S[;L M*?8J1!6B5578ETV]TS!*RA;+YN[6^:02-X7H8?2JT>V7%(\KUBI$SPC10RAK MO;3D6;%6(7I&B*H4\Z39JQ`]-40/E&*V>F5U-*H4\YC$[6P0/81>M8R>BEH5 MH@K18U#6>JU;DK(>W]8=_WS/A^76D))=4^_.#4Q;J?9I(%K.>?EC,5N=EE[O ME]-\54UVGHWEH"^-OE[O]U42J91)*=/6 MG4IUO6MTE+=3B"I$JZ^MZH1S]'EZJY9_9@YL1N^W\4+&G^0_Z7-MR&R\)70( MR`K`Z_P_](T@0^:;3=!\H\FQL?7ZBS>:$*VA:]OFS&>O-?FO?&$A>!?O.`?N MK%#)F:G1AJ>5K`]-G(PV>Y(_@+_`%#@M` M0=P_M0?3#AF^EIG#B6;Z/GQA.9H5^!HV5B#\?PB#T6%H2)99"B^;9`01C?F!- M"57@X0"_`6;8MOOHO]96P/$87-[Z758%<`I\H'RD7FL#\MD. MK!UY1;K?^'=F>JAB*/+7;,BF`^:!FKTF5N?>@%Q.S'L$)"K'LZY]6?PRRA@% MV<#JQ*HPM4XO55C#WNSFYN]>>^R[&1C36\WYAK,CY9/E3-,![V;!0Q.9XX.9^-FS@V-_8\.;.O- M[MST\3-BS<$#F=W:CGFW<#:P M%T9W/I@]']:<>*PQ-_/N?#A[;F@HVW$"MN.P=\Y.F,?,<<"\,V9J:2U3:;-_ MPH@>HKQJ]'3`NY3J\?&)Z,%CEC5$9M>45*,\3@C1\^I&+_%(\VG8,/Y93I_9 MWWX*_8M[TYR]_L5U1X^6;5\YHX]1)]$5-1)=6_[0=OW08W?`RK>V._SSDK_Y M;_+I#]08]BOVA66?_LP"+81O;]GXYV>A/WJ&+5@H$_3!L-G^?N5_&3>-3Z:' M^\W?WYG3@6>-[MDGVFA^IHW8T)J:MO_SLXOFLTNCU>C5X7\QY(O7SD(J\5P$ M4ZN>@>GZ.A^85K>5`D6^_%(RI`0"M8S%!/K^+O1!'9EWRWA;I3^Q9GX^O+V> ML2;MRD.CL02-.\\.[4^(?I M(,1W[F8\N+PQZK^O`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`NE!<"4R_FVK%]Y6+%XT#1%CW-&5QSNYC703K=PFNT M6E&HH69E*-51+-C*AF4 M+`E;%D+7]J<5*Y>=35UP3Q9DA>,QU;(1OWBN[Q=0(A4D[Q*(H>EY>&9Q%3AV M3`]SZH:P:K%H*+50J)^T1;@:#L,I'EQGHY7T<SDPHSQCU(]?' MSZS('>W3+RH7?7)Z<<:H'[E)^$W.D5E1&W>KCGR6S6J@[!*0:(Y-%:C"Y_D< M/("B>4+XUX()4LJ(*B-ZAD9453Y46*4L@K((JO)QVD)YQJ@?N3ZJRH=RTHU,=H6^T]&:SG)LX#\VB$Y2ZW:%T@N/$*Q23]6MSPS"5!"J4 MCL,[54B/&EV]65>YS=FAI'*;DO'"W*;1ZJK;BKO<6XH MJ=Q&Y39'.0[SL&-X<[R1<46A4:5T3B`*^GI'4,E$`J-(T+C(`E$LUM7"43%!.%$T#B`U6_IC9:R M^@J-(T)C_UK2*6UCYOC8PC\_S?M4OP03YB4N*BCIB-'Q,3D7C8J>Q:T&HH>X M7ZRI][,M>XJ]"E&%:%45]F53[S2,DK+%LKF[=3ZIQ$TA>AB]:G3[)<7CBK4* MT3-"]!#*6B\M>5:L58B>$:(JQ3QI]BI$3PW1`Z68K5Y9'8TJQ3PF<3L;1`^A M5RVCIZ)6A:A"]!B4M5[KEJ2LQ[=UQS_?\V&Y-:1DU]2[
(Z'FIZLM&76\:O;*FO*A$6ZG5^?J]5E/O=KO* M[RE$%:+5U]:*H'XV/%:(*K>ZF5OMZ[V23G!6DYUG([=G@^AY*>A+HZ_7^WV5 M1"IE4LJT=:=27>\:'>7M%*(*T>IKJSKA''V>WJKEGYD#F]'[$4W\0QLR&Z\& M'0*&`MHZ_P]](W#/?+,);F\T.2NV7G_Q1A/R-'1MVYSY[+4F_Y5+60)W\2YS MX,X*%2N'J0*8[HL<(7VC+7GY+AAN+[RRT._[RD5_Y-OF'!<[]XKN]K(7Q_R\8_/PO] MT3,P)@YJ-7TP;+6_7_E?QDWCD^DUZD;[N[SU\S9YZ>1%*R"X6>0V!UATV@UFRLC`W!/6 M1N"BU>RN[--WKW'K,Z#5:*T;I%9+XQJ%+FN9QJWQY.5-IT0/MP:_EZM<,V-C M:91;]C4%R6-__7ATE\JW!2H7S4[#*",:+4L1M\"ET>VOIY'54LA6H2-;2(,T M^39[":AI-96TG3'+1ZRD6Z!RT6SUR@A/2U/2+7!I&;UC5M).H>];0TDW>\GE M3:/=KE[L6D\;["R_.ZUZ?^U(=:>:N`3@BT:]N;J,%FI;:?3-1*9S^M3OK9\) M[)2^2P"^,/KU_LJ.>FOZ+C%E2X!MUKM&9]WZ5AHVN4?B+MHC^1`&H<>2&+[_ M,6..S]*;)VG8&T6^_MDE?U]Z1XCQ-\K=K'AH,=^`\G'CBOD!8`_$QHVF`7ZC MC5W;=A_]U[@'-/"TG]*;B8V=9]X34=`1L+R5XNUJK13BJ<"=R4?J MM38@GCW[O*.]Z0'^XW=F>AIS$#H--('\C=8TB.<_#>8WJ\OJ-CD"$I6SOPV" M"/K@"#`:.2*_)F6,@CZ=T4O?:+75,-/8_V\FKF M6;9F^-2JD+`E?E!6U_+IWB1^L-NVRVG\C7SQAA>B[^1(B]YNS(UV.5H^5:YH7$(>V%TYX/9\V'-B<<:<[?-G`]GSPT-93M. MP'8<--:XFS"/F>.`>6?,U-(.*Z?-_@DC>HCRJM'3`>]2JL?')Z('CUG6$)E= M4U(-T3XA1,]K#DR)PT1/PX;QSXI/>Y?1R;1Z`U?.JV[IR#L(%YX[]\&P4O_* MYBU_K79C]1.9*X*SUA'4^7?B*^X>W2V0:C>[*Q\)*P9@O9.F1>^9>(QMA4IG M]=/M"T!8K_,Q_T4?W'`;46M#JK8E*@C!.KWJ!6_!V1&'Q0-^NQT>5Y@CE8", MT:,FSXVQ2<$QI_B_NL[]'?.FUVP0K-_)B<9XMF%SY-3T[BWPH_C3>EX1`E]. M[7WMFH9@7B"<&@)*/F`P[Q:BR34#+^KY+`4\X?G1CN+SS4Z!Y\39+._O`+6'$PT;@'7M<6+!OSTV@W@%WQWXV"[K7+`?ED^37#++U`@D M!Y#,K@\L]N$9G`0SAM4]]N#:D`IH+[G+[C4:]3>WXL/H(^/-*PGNU/QA3<,I M=O1Y[B,N;5M36`#>]KS9UD%@^9@8H!QPS79-)_5JXN6O\&GJW?APJXX/U[2/ MCO;9?>`=6AQYH`5`[>!H&9Q>@W!@K[")1PU\2P[#N7:'@>M=6Q[#_S[5ANY4 MAY<-:SK].DN'1]/73.##""B!`'O,#T2/L8XMRH"8B^<>X&%`$N3CI?4*(('7 MF#ZC-RZ@!'XMB:B-08LBVH!,/&_3/]_`&[.OC*@C'^K30VX8`'"\$Q;`A@7\ M$,1A!/#2"SOUZ(7P1I!80$N`"'$/8DL_%8#%BYCB9Z.01;^8>0"1-3-MG!0T MCTD%B4E802*A`8U#O5=X)T1VW?F=.!9HWNFKR`/;4S"5Y"'KMYM1_*P MA="V8Z'M-7#I7?`X0^(DCZ]L6Q`4^_\]"YRC>(N`-_,LVHJA'8[D?"H<5@4P M8?>_16;9#S0/WL3A26D',(L/K0*Q")WA!-PK6N0G>D\L:%Q0$#J_IE70"X&+ M,)_(O:3H%/%UYKD/UH@A![2_0M.#7]E/,7'$PP!(9&9C@S!@2%-6@X(*6Y+2Y85-#Q:`LO;4EHAV!C!3S_B MLQ=OT1=_`1E'7WX+;]$U@/;7CV^_W.K:S`Y!A+0'$T02A8M6\3`B`P*1ZC1J MW?8+?'&K5G\!D=U,'&20H/!@09H3H_O&)SN!10BR6C:3X]Q0HW14\Q$;DW0N M4QM=VG6/QKZ9V&H/,(`_!$4GMHQ91)/0"7$JW`S#QWBHG!07T$!B'Y?_IJ$G MC.U*)$9CVZRU&R\6O`G`Q)\)JY4R;N*M:8_UO-6>\XH97R5DY7FS2_;2?#`M MFQC%#Q"-///1R3Y3JZ`V9\F)\3F8*#^RNB`1)N@)R#!2QITQ$A<'_HY,;](F M>HQ.9Y(^(2W0WM%[0*L@N4#'D)+"L?4#/>@$X.?&/!9)$>5)?[)0>,5`P74D MV-<>&1@8DZ8*!IXUY'X%>"91#YYFC$1J9/DSESM40';*`%:/&_B$JR4RC""' M8".'^?37`[Q86!;;@HR)'AF:,RL`\M&Y-(`N])"/EN^'0&>R-O(7?H`9DPRA M\A3:''"\@-!@Q`!.-'K.R*_E\M9"US@,/>YU3*"]AP;9LUPR=O0=_4[J'=#` M#P>H`@$(`!A0$[WEN!"<*%=`F,?B+!YEC[54`H/*2"'W%)PG81WY@A7$K<`S MBS@EK?ZU:FGM4LA*'!\D@E,MT@B^HDJ'GD8;)]PU= MGY029`O_?-[0>_T^OJ4P`P-#(E[$5C_^PQI'V!%,63%PD#>2Q]['8V-)O6ZQ(1FJ0Y(M%L^":'H85 M0RS>D_G@0:$\(NJ(P'K(L>:/)>S1P+1)COT)(VF_RCN!ZM$L-$3.C9'/PF'Y MPIIR,"+,Y4N6@A+)`Q$ATJ"EP61!H6='/15(5NJDK5^L[=)3Z=?G?^N(MV/3/O8AVXXLHH>Q@]O2X!F5X&&:0C MQA6+L6C5)19KP#%?UBV-)6(06QTL#V%Q?NO7$A/::^4//FI$37+7P MKW+K\G+K7-G,,&:1F<6??@*^3>R$#,X@JL\*8;MX9G..%'[_Q#/!>9EL/;NL MU^J-;KL0<@%.*5`OF#2="S57@WFHFP1U*]\4I(%>:@.^$4>EAKV+N/Z!L1OF M#>%?*%:+T#+ZA6BM;!LX'^KM)89A)6!+855W+5;-H])L-U81J;) M/]Y8*E>W\KJ$/7J79G<5[U(,V5S*<2,*M73O`L^:WE'2M`B%7E)TDE/'YN8H M]C+SF8J6FX/K*Q9J)JX]8I[__J\00/_L@I&U_*'M^B#-5=W^[M30E4W!;NZ(`C/_/<2%#ATS?Y_N0$E->:,,2 MG*A&)`J_:+3GLG3Q)4/M9JR#DM<,VO]\"SE=MS^ICN M4RA"^ZUK>M1Q(/?G>;753Z@F;M9Y[@/Q.%%&$_%C;GTU=[L7N4\;D<0'RQFZ M'D1@HM;#:U;(+LVX&+O>A5%K8P\$K,\$\?V9'>^'YBV;+XD)T4WRD@OHS/3B MZW7XQFB"W2A*CAMHYNB/D#HS<#\:,0KM")`<&/GV:`$TJ05H0PVTCD#$8EZ( M]2>QF9"(>I<%SG'Y-U'&XM2G87B(!?.Y2@/?XF(B_.FYIM"V&$_X#2@:JB%N MF/NYC,`]0BQL\ZN#?%1JW$UG(ZGZ\X\@/3FG^7U'7$!1/%%(J[;/`QK$QQ,M M;'9!7T4YSA+3DBS^CBT[H4UK*4JT[EM1]1LOND)]PW_TJ>F&_D]CV$3A(-0HJN0\&`1_41\$)K-NB!L\GI7O MWFAA\H+PS0/^&!4E7OEEO(DG-\#`6@:B`C\%_'&G2ILP.VI:6+KH*Y'-NO%" M6CC#OXT(MP0!0^"K;]T[Q-%<^*?F$VZO"I-$N3KY0Z0"_I=+%?4$\(U8[`49 M%(O#O->(.N&PEQUY%R*^^"+'`D-!Y';]A1XX;9U7+KNO'$6N$'_>+5&A.$7(Z^WD.Q']"/+^*K6*467)IR":7 MT^,01OE#+R:$+`DJ5Z,<3Z ML]##/I;HPLY&O=X4Q84O?!_@QD:T$QVR+S.9,3V"OTKGQ*YH?^!JC6W7&.N! M/<*?YKP$?CK_$N[:!VP(BR?;"Z93-K)`8+$,.1.U=0Q$$O$PQB;>(W87H+.) M6NREH11>#2+DV$`UNC(?^"9?&JV)+4+RU1&P.A8H\"R=:'D1O(C-+A#AT;*Q M3S+B,L$E7B,(QPUI]%;9#.F3Z<5?TK,4NR:%0L^7")_'<*(?@D,47?1:2@A4 MB>J1KC6;?;W7Z$N_GW1V$.!B'(/TBQJUDH07E!9G(G)2@Y3W7OE]U+$5#OX@ M?^I2&`7*/`5S-(QS$G@M6,P0$R@CNEOW"4\&R@:9Z&O$M`%>4P3$-L@@!_2E M^4IKO9#RN&6&D^F:3%3DY"O`Y0\9CVI,&ZP`P$H`4^?WX!7$2G.+CQA&]13< M".CG(]"]E:Z6.)&DO?-3;J-26H"RRJ?<4T\2%3?]<`KO`F?OIVR#1J$>VEUI M0@(ZVSC%K1/,NM&0I_7I]5)D*S\S/\M<>5YXX5GHG*O6EPPGC[XN'(*..%Z, MS:EE/[U>]7QT$G@):NZQZPL?V,TIN-,S_X73(+:C3(+.5)K;KJHFS76&5965^:WX]C!I5Y12]F( M]=557O!UL4\;8?*>KA67+&-%]H-Y0\M?=NS>#O49I%A@GR_&MX;[,(6UV'V=8>(Q5(?[Y3F>L;JPT"_DIBJPMO*9N MWX;M2[I9=JX5N!P_*C!L;(K@P0UWP6Q4)I2$>[L(.G; MS_;C`2C]7C1I9E/`\Y&6$\:B$A;I9;>A]YK9$/>0?'EUYF)Q&EA40KB[M497 M64Z%136QJ(2**.XH+"J/A=*4BG!G![G;26W8O<-I&[:M\K7UKJW?EOE'@.+A MF\9?=O66T4XCO'.I?*.)*1L198`F!>BHQ.\4L*B$KS8:M=Y\A^=Y,T9A41TL M*J$DBCL*B\ICH32E(MS90>IWLMMVF<."Z>%U*C54J6'%4L..WF[V]7;;4+*I ML"@!BW).;%3"]1OU6J-YS+PX#8E26%1923JUC@IK%!;*=:0/^-7U?M,H!9^C M$Z<=9(N[VRBL6@XBNCYIA/G.TL>J(:URRUV@>/CK:4T4:&H4*R66K9K]=**KXJA"D7E(#?%T^CJ_5ZW%&17AWQNZ&R6 M,*FTODI)/?\,4U5ZO[WW*\>.V1LY(N+F_$^1'%X$N]Q2]Y-&5]#%TTZ M3M^W*W\L7S#B5UL_;W7J](+GK5Z++C2<,7%+K;[ZW67\QL/GAFYT&_R??:.^ MZ=M:>[N6;IV+WQ[EM0%BE+\V-BUYI7'B9N%`&XE[E_F=D8BT)+V\@1)OYWW> MKK7ZG%3=6KNCC4*/+I5;A=KT&+]M.DEA?IEB`JR$B,BE+7BC'UA3,XBOHTP# M'/H2#IH1??%U.'%MH*BXUPYO.\$?3-T1L\6MJ$/WWJ'K=2T'Q`OO?X7W/8B[ M&1]P/7B`WUZGFYWE1,7T_ MG$88\\M/)1OHB25,<]:4B]?:"C0[H]L$Q=+=YHOTG/2,0UK?'ZV"^4X#JJ)* ML\!X"<)Q(SN%):`'M5Z^(SIJ*AC+J+`L@%M&I1.A4W];.LU?-+%K6;+%;0O1 M)D+N90L'$JO%Y#@5J6DH,I1B9/:O/,K`K&5@6H"I-Y9;&)I5C\+FAD5,`W+'5:K5JC?Y1L^9%*;7* M$Q:J$T'C`+K1KW7GYR<=$VO6UHT=>%3J6RM`=.=>]/T/K'FRD39W^Z. MQOX-1J=67IO7"3-&H5$E-)2:J*2U+,K<6OZ?%V/<>[*PXL+\0//D[;W;UT". MC]?GAL;^;8E1Z\[?3W%$C%'9ZWF@<0C-Z)^79APD=UVCNV_7!+NV'JP1F#[O$)Y8$2'D97F,9`[ M[/--/>>.M:$[G9D>;X0-![8UM)^T@/?STE?.4W)9GS<'F\F68,`1?SIECA]B M<4%[M(*):'@7@`?,FZ;;AS7ST?1&M31^M"?@L51#;F8A[,E^G%C#2:H567;; M$AVB15UM`#^)1Y_QU=X)K'@S+WS@6],9K&S!G[QKF189,03:FSPDG MZ!,=%C"Q1=P*1(NXEU_0P>;PB.VXP+?:5W@`P`&>//$`%!=[X.!SHOH:0_@E MG`NXYT>LTTA'%RL)8+4 MV&_H_79/GH>H=_JKGZ(H[.NO%I6NLM,;=$0/M`;1-V+4S+7`M^;`*,6ENC+4.N#/S0 M3+H!/\U5`XNP_FYD<)M!+5>`%'L,V(YU="_IMC M!=H5VE>?`!ND'ZV&)"9,<12D=-_X2%^)#6=EB-B0M_"UE_*GC?J;VZ_?_.A/ MX\TK,O[F/7!WRIV'"]+F@U#0Z1Y?&K2\-=%[@33S]?!\!S@$]XG!0^+XQC@, M0H_I6C@3=A#EWQ^C:88/T(LR+S#AQ_+$S-`%CY.2_*$)#@>?G0K!]\/!'R!( M^!<:=7P+6)LQLW`I<3J'DX)6)`I,7!O"KQ3LYH!ZTLB@,=O6T#FA2C^B[P!' M[OAC/.$4`@A(,2`G>']\XQ,!6]-^80ZHF8VGO(KH`P]RR\\52AX00D4B;8R/ MN,7^(8D?4`.H$@)+.67)0PI*@M&!H(/B#TD\?%QH>/:LCA].0=K`6O#@``&3 M_G%U6_UZN2JC1SQVP>N MQCRNR\$;(1O!;B8@YG"2\GG:?/Q5/$ZB'PN])AEQM\+9#VY;"*-^!Q.!Q#6 MN>-$SI"%D,=*%0.<$H$U8#Z\Q"]$](SCJ".ERX$\W3H6LB1Z297[391H>-:D M_33'H"M>NDE]GU7A7RA7O!;M:(F?)7_T`8L[_\+B3JSB9>VD%W%E_7"^+%K"C[HH=M?1'L,OLX/J1[RTN"G;L6?9:54Z_6E;^V6*K#4BS,J<.?\7 M]5R6DD94P(=4V&6=`KZGO9SBYBDMMW\W6799YO@Z+I>?FM$X!W]->3G&SM.7*/LI^$(!.8:;`\;E9A<91HJ&"TE,) M2K?H13WLB<9,?VKZ7&I90>Y)>+;*`;2>JU4T4P`IJ5(`'8-4E>/:2FU].,4Y M8PK1ZB&ZGTODJZ*BJNMB/A/AGQ5,^HO'P.0/>RD>$$,-T.(SG.HB/MX$>WE. MFA\3K:/HB`^DP-6+.JI72++@I85JEL-T>?0M.]9I4R&2C>)+F\+S^Y;763?O MS30224X/7&M*F.4,[7`DYA#QL4?N6&O5]7J]3C.K:.+4C'ECUYOB-H:82DU8C-&$W*BD=+R=&`4\;X*"DQ6BKQ*FWH60&(AEF;0_/X!ERN/;>/ M*,AGLW4:JT]]JFE7OG@6!][1;+!1]/C8\OR`CY@$6O,GL_/Q''=]..%E>.[T MF.<`MO5^O;7Y'$`D0VGC_SI-.?]/VQ-%BPUK=+>L]E[,BQ/S]VY"H"R(B'9C MFPY!5]D)?$O!3XW<>__UYB8Y?`H3*3881W MM^OO@.FE<'@K0^3_83JAZ3UI!KZ=F31,T`839WJD#'SZ M7O0CX9_`'KKA_23]>:.E#?@`6AM>3A[KI?E*,UY(,O&)FDNQ2@S510`3Q^SE MBV:@V(R^3\&J:R\'K\!+IEB$LPY?#E^![HN%Y>Q=G&7,P7WKFAZ9@&L+7ARX MGO"A8%!LYM,?#J%"[QJ\JFG?'/HBGH6XRDOU-)K$EP&+Y(%S<69B!&7-3)+< M>%8DNG0QG'F&(Q>87?XWA(SQJ$`=,CL9V93YX+;P0_'@[%(,UPAH0T(KH!$B!2 M:%-PVB?.Q^2B)[4W*[5IK4,1D7^C9$2F`K^4[I#':&.2&IKC;/*YLJ8O>6I. MW1"L!N(2D3(]3Q3E=`C,20D2B"!ILJ34_AS:JN[APZJ!%2@-",X]34NE>=:C MK'TCJP(?/V]TX1DD%(OB.B!Z%JA.MZ-WZ]TB M$T:+IJPS'_):9*1K2_CSMY]"_^+>-&>OKRU_:+L^O.O+^%TB2KKEGNV=ZP?^ M5P3J+4K"C4GC4/T[8,I;&R"[C"3A;_*-[PAP\L[OS!D(H4W/^[<"?!P+^ M8PR[%=RR\<_/./;/2,=@!?ILV*U_O_*_C)L&T`R)]1T]/=+R$YGQ9R#R0PC_ M;/_G9Q\_?WAVV6SV>XU^C.':\%QR?-C#Z"GY,!\Y]F4\][1\[IKYD.KP@>AI M#(SO'\#K&?\@N-MW;B$NEZ6X:8J3*!X"CY.8;`L?1'Y[B<\F5UW@E?78+?M^ M["):*_CEE8*;C?VU]*>Q;XX77\6AUO[VTS9,OTSK0:PU2;VZ\B`\NZ?H\>W3 MG&+1'.PO?!SX>S%3W__HW%!20C8K;4[5:'CE0W! M`,8+^6"\%Q67,JR5T6_W4@JXVMHY@,B*%KD[(0R+<,Y$8UE,>UVCF<)T+P!?[HE( M7#O`_8N/\'?&JH)\>6/\WOFT!\KD0GDY)TJTX&"YR1@4F`Q^=%::C,@T&*6H M>:.3D:-=09NC8X<@S.KQ1WN/="G'6;[_*[2"IX^.'W@AI8]?L%YQ-S&=7.>S M+!\LE*'O-_&NT^W7;P7Y8:ND^&U-K#(F*KX'A^S8"LZFVRS$._,RO%+'SR4` MUZQ&B@#YD,R%G#NS5@MQ;F5R_[4P;??KK?WXHOU1:P4/M+&@H(-J-/K7!W11 M194DGG]?R8V4I3:B37+3Z`HC^CU"!%]68!C:];1E6+"\A+3$&E&GD&EYL)=3 M*%+[.;O9S]FVCI0O7'*K$YZZ2>[J2/FXP=VE_>6&GWKM39` MFW]IQ]ML*S#B=S$VIY;]]'K5IM=LTV)A+^V%#\SFU-MI+_O M[N\]=B\N)-V7`;9D7^*^S.'#DMM4*ZQGQU@5XI_O=/S5QDJSRM'L%EYSNF_# MMM=[7!N;(GAPPYUWDOZ4D,$;\LK2__2:Z^+8UGO]IM[I]^905.PZ344Z`#*E MWRY9#=WIU_I9@ZW4YE35IG5*R%1'ASJUEG(]YZ)#!T7F1)T0IDNM?IFX'9W^ M["`3I=M!MD\/`/X=&*33P*)$"[0Y7MU&1S?J=25="HLJ M8E$)'3$:M49#,49A45$L*J$DBCL*B\ICH32E(MS90=*WG^W'`U!:#@XJ[;K) MHY.6$\:B$A;I9;>A]YK9$/>0?'EUYF)Q&EA40KB[M49764Z%136QJ(2**.XH M+"J/A=*4BG!G![G;26W8O<.9"[:M\K7UKB/;EOE'@.+AF\9?=O56]DK?G4ME M?-6!S=.*T@VQQ=QN%5!I=O=_KEH+LZI#/#9W-$B:5UE>?8:J*'R>N MW-WZIK'LU67YK\E55C8J-V[EKT_%O< M>N(6MVLVI$M'$VM)-(JN'NWUFYU^;]FMQ*5CM!(=5[@+6;PNL8"\'N"*3^Q/ M`96ZX>^&>252L_'L$@=WXUN^[J\Z\4W0*3$F\?G@?@H!YC3+><+[YK<2`#I MGLE^H]4OYY+Q90@4W5Z_Q5KI:\M_\5Q_F>'KU0MOY5S=!'8;':-,DN6@L0FQ M_+66V=KJ;4M*L'\TEF@-.I:'8=:;(,!XV2@;78=XJRY_`W=B21\?33+8AYQ= M=!N]9I(^:T.Y@7U:1F/Y[DH)$IZ0+E&.UL*QY,#D@^N-F867WT:K[T?66GA+ M\@ZQV($LYJQ2!6FD8QLEBN.::%8RX^@9F7NC5Q?-3KO9;[<-E7%L2TT43>P# M.T3*4;&<8R,MQY2CT>P>/N4X?,:QF0!2QE'O-XV*91Q;FHY$H\/.C6&SU^_T M&TL]=>D8E6P,$PLV[\WEQK'O6.6)[E; MF.P$(&EK8^S&7AK=?J\[;R]W@L&<;.94OY,O3.:<^`8.""2H4_Y9NA*>IDBC M2,*>7=Y-F#9V;=M]Q)-'5)779B`T&"IK`7SY*"]T%9>L:F:\IA9B=AZX&O,# M(&/`Z(FQ:7D:7="GN6--7&6OW?/!])KET(^"B<>8-@4H)[[&0"Y'F:8U#;P, M79/V&O<+,I<')C^B712"&^=H^#-S")B(78TZ_P]](Z8*9+[)[H'P[8]E6R_R M]H1Z_46T#S,$*IHSG[W6Y+]R-I=X.^,*#8;9)L?`G47+=ILOTC<29K9^UM_Y M607KG6Y=%O5T"HR7(!R/C*`-P-=:O=9+[F&="!6,9518ME6ZC$HG0J?^MG2: MO])UU[)DBWM-HW;=W&M-#R16B\EQ*E+34&0HQ;6\O^\ M&..VDX45%^8'FF>"]R^G!G)\O#XW-/9O2XQ:=_XFV"-BC,I>SP.-0VA&_[PT MXR"YZQKG:'=-L&OKP1HQ9Z0]6\CT1K%:(+$%UBOG:(>J]A--ZL M:PH4@Q6BYXZH4MEJ,C@O3.&?K3:O8?..U;FS%A],RZ-6V<0CF3[D>!OZ%IM/ MHY[@6>BQ9ZNVP"9Z@%O/+NNU5JO1CY%<&XK+76+13&+1BK%HS6/1[W9WBX7< MO<#&[Y7;C6\ZOS<_+88K^=Z5A*(8D&)R[000+#!]\!AV>E-YJ42AK!O=QF)H M\Q;?#=2K"V'=Z.\*ZKEC'YQ749JQRF&6E-2%GUVX_?I-,\4J\%MOM9,'Z0,' M*3=XAF<.MFC1.\+J6&'UI>RV^W5*;A&:ZV`%`@%RZ0B\&CFBMP]['AP4<@D!_'9@/+_$+$3WC..I(Z7(@3[>.A2R)7E+E M9`J92J22"XK<,IMHI7Y#`^:T:]&AD_A9\D>8P&J4P<8J7M;F8A%7U@_G*R>; M.]B-7J_-*[6(R&Q;C1>[EM#,+:O7;$AS(&3JG[W_?4/!21Q:7_/$]=81V)(3 M=WM8NE]XV&_QCL^IT:%QEDLK[A^ M*&VJMNCM('H^Z#G$7\1H+GR='U(]Y*7!#R**/\M*J=9KU=W:+55@N9WO\U0, MW]->3G'SE);;_[&'=JNGMQHEE1E.^$"*0J-*:!S@>)!1ZQ_WX)?*19B5.8;[ M+^:+K8$]GRP\-Y=U"OB>]G**FZ>TW/[=9-EEF>-SE`J-HT3C4*IRYOPYM<+E M.]/!+OML-+DOEIZ;TSH%?$][.<7-TI8K^W3O00`ZA6/6Q^=F%1I'B88*2D\E M*-VB%_6P)QHS_:GI&>A:N4P6AYWZQ0W;J\E.+(Y?&DC>'ZO\CKK MYKT9SXM'MQ6/0H^F"ZUT8['E#.UP)&8/T1OP`N167:_7ZS3!R<>_9\P;N]X4 MMRXNZ-IHOF(P@83/])@V8C-\.SP1S,0`WXM^7DYP"D?2$#+KS\)%`/74F9,)=*-9*!,4V5Z-7A) MH/WJ^KX&H&),#KF`1B!3Y#Q()Q/T671X$`:A*@).X:9:/?\]"S'4&3]H(A[QBAA$]`1]B!O(H&'MA8&@(QEVC:"`7!;#TSSV1"2U,!B?DV[6?P#U"C?\BDMA635(ZTW;0F>Y?LA M%3>BQ-/$L<```_O!O*'E,\*%@\XU7]>\R"");RC1!?B=D0;&@Z(S+?2C+-IC MIA]Z3^+'4Q9,"%OX-9O.;/<)*%P%E.LO=? M;VYJVC685/@Q?B`Y`SBM//670,`90'HJY9Z8HQ2;(KPE;HLI@*"E\7F<6+#J M(P/!P\1A$!-[OAO8(P`;&#QAS`(K` MNI"R4-.NAD/70TCL)X[H@"P$PBK76B#'R97]%%U04?!UOCEE$='C\`YGD8U>:RN8RLU+;3GEU_E9R9F9RNN7&^=**BMU+"SLEITS?1><'?BP/4J/ MA'M+A>1ZK0T09]L3RMUD.B@@Z?EYG8*J:0:\^>EWJX.S5N.E4ILJQ)R M=[-GM^RLV4I.]SQ1-P<"N?\@"^+&[$>N6)3;(+N1L&8VB-XN'^7X9@$U8[^F M!'495A40RAW:RKQ9H^O9R@*1+-Z7H5!J"[E;I@H+.;@OI[<"54Z#E:UM6)EK M@!?QK_KV@\@[8A!"4X3^FBK"2!S<8BM"PF]V?(M."UV+^Z MW0;F]I*?E"($?95 MY>'I2J=B1Z4PJU;.4GY<\=LFNXH7.=N3RM04R7;3T-N-MMZ&F+B:F)T7.]IZ MJ][4>ZU.SFL/C5Q%0I,-+,P:]>S<2LE<>T^>C=F066M4VG>K`AL2:?/L?4XO M-MTK>5FO-3H')L/F=1DE`-L+@%%KM79O+0]>QE%.];3B=\6.2F&6I[K\L^19 MWCTW'4O@[E*]D8G^7&H+==-#@*BY$V(32)3B_N!$)Z4V8/`B"E_BKD_V0[25 MCCUWRAM+37L8VJLWEL)[AF;HLT1S*79"I]I)7Z=)JUHX"R."Y3V'Y6J5:MA4 M#9MIK';C*P[>XK:]=*W=%[6__LHW91!."=7:0J7Z)E7?I.J;/*$^*5RMA/%" MO\GS;$6'TG"=W=Z@6=G.G]+67:<#R&@U]6ZOL34Y#X6K8B/]K]-OZ.VZ46DV M'N^.R8**R@[-HL=&C$UY]H_C`8`H^.^9Q\;,\^19V34,IJK!+11C&KA?M6W& M\V2(T>KIG79][I6'1JQ:X5YES=EMV99+Z8DR7$?!D$9'[S7J>J-;KQAFIQA\ M?4W,4=%,G+/DY]!7":?\7T=O-_MZVS#6I)(R%[OC2*?;U'OU,VEPJU2L<_OU MFS0:2CP+^B_YC0-SKZP*8N?%C0H'>U6,+HJGUZQI-%)D>2]'K/%!95&Q9F:; MSCSUM]FQV%U=K-;[G[17DN^BO];\;\,T[A7(:AZ M<+6%\=QTK_K.Q4&:J>ZX9&-?F5S==%]:J=X\V[IZTS#T;KO\#?LM.O)W;YV5 M$)4I1,V6WFR"V6ITC]9Z\\\*6J./],:C=1S3>5]Y]`WG/0]MEZ8TBS[SCS=? M-/CT:N99MM;0Q6ADT[;E#\2$Y"AXZ;Y)G]U=;0-8,T-@GDG,L)_D+VD>SJFLW:2N7KQ34U95X=V#E<,V4I.U93U-81535D_E*!6 M0"AW:"O5:2%U6DB=%BK1?J@IZSM=ZVAG.BAV5`JS:NT"JBGK1S"P6TU9/T*F MJ2GK:LKZ#M8Z6K^GV%$IS'80AJ@IZWOFX>E*IV)'I3"K5LZBIJSO7P*VEFTU M9;U2[%!3UG=A8=24]96(>;1#MM64]3,7`#5E73G5(XS?%3LJA5F>ZO+/9$MR MW(>\87_Q9;1@3J?RE1-8LN7R:]1]^UX,/\=6Y'=QF^?\PNLW,9_,Y';DDNH* M7:`Q:G"[Z@&M1&O,;MS/P;OFU.!V)52E"Y5JQ52MF*H5\X1:KW`U-;A]IZTV M:G"[8N.F;%2#VW>Y";.@2+-#LZ@&MZN1>&?*$#6X?95PK[+F3`UN5X;K/!FB M!K>OC)@:W+YOX52#VZO'$36X_5"QCAK?-?#6Y7@]O7X*J:N:T&MRLAJI`0G>3@]B.=UKZ&,U+#VM6P]N,?UIYW M,J*L\PR7?,GHQ,26[[V:0L07:-;HYV??2WG5Q;!7>,CB^SMB$E7918/")X:' MV+]S`7M&8[_II(;\('5Z8X,W/]-&;&A-3=O_^=G'SQ^>71JM9K?7B#E4"M)' MP)1FDG2MF'2MK9FR_IOGF-+I-]IUX_R8TBJ4YQMI$#?GRT8O?Z;]\%\[EOWS ML\`+V;.?CH"([4+Y*X&(&[T\Q^CT.NUZ^?)=>=YT"F4P[NAX%\E&H]-KU!O=(]&.)03J%0KA%W[I29$#;#?[;:-\ M#[A_"O0+160)!3K=9J_>.7X*].L+#)&\Y884XAO><7/[]5L!1=JM7JO1.@&" M&(4$D7M?B^Q#KUYO=G=@'`Y@'HI/GV>1[C8-H]L^`>87)@=S*#=;S6:[T=@! MJU-(?W2&[I3=F3^N+1\+`.$FLP(PW9]M53VC*IE6SZ\RX>L'^&$?2RP(KP8` M,Y^J#(-$V94^B!I<$_^8P3Y1\IC./2C7N6#-!5D1Y*/W(#`(-TW+H M8C27QE#YVL@:PV^9,\3;V."M`/T8?A(PS08YHA*2Z=Q3U<`LK M?><:K[O-O]C"`Y/6-!I-@91A\-'4 M@1O=L(=+CD"C/%A#`V)/X3'@'ZXB;F7[*S0]6)]H9LYFMC7$:+&F7<&?>/]; M:-.=>G.0C8K73]TRY^&45APL8`(3'>!Y$-VA%BW-+XZS$J))-P-"O(KW\CV( MN_`\"&2Y4(D'?:IT,A.>C5Y51*PL08N!?[1`<`9X4^#(E%J"B`PG()\X=T1\ MCXC=.]:_XPONTKS%3SEB-%*$GM;<(<@'29$`^0E1VN1O7('1T0U]R2L%I441I5U$#[5^A,5D?%#< M7@C4&7(S$;&3(!6_LKA]A6]=!$O<.9C@'!=-,08F*3?`&K`;@)F#6`T\9OX) MDN3P%PR8;3$T-V1<(J%>(`UTYZ#0`X#&!]VWQH`=$/,!5,F4!HV8#$H'YMM# MJ>?C8_R)-8-%@T<<-"-PPG)L!B`#+T.FX,[PE!OE!2`]-SWL"^>1]F\1[M.,^1"9V9,/%K@17 M!71-0%,^M0"^*JQOZVM@<@H+ZXGY.?#Y66:0+B*-X M%9&1VV'RY6PZE7[](NO7TUPH%A3;XLMC,XCIN7Y2 M6&A$TY*`8F[AK0.*FE8QA;L*M&LVI,1,.HJW.5>'7$U<@"P=#7P1$G#2\I(A97^%2*>4R23MP&%F]V!.@F0DD/I9(NRA M0-ERP&!:Y)#!.*`\24F(`R6ZXAEM+<:4$(N.P"BB.1=[U&AV3&L$8G\Q-&<6 M=8?YPJ@A@:JD>4D_`H+IAX,_<-H;^@00-**0D-YOM:\U$K?([B[-*?Z`7-H? M69Q?9.5Y+"B:"\!!A4BZ!3D!+?J!+\2#&`8ZE(GT^*"OK"09M%=/H1I%_[!* M-A)U7&=A1L(];KRLGYJR9W*O.'BB<#J648K!PF`"'BAXJF4IC,8Z065",$U) MBO5_N(_H\/>/IDTL3 MV_CJ.6H*2L3-&QMQJQSR^\7AIWA1.4:4H!<)K!*@RBO7,]"FZ2+"6#\*,28\ M>_-<0`6!\L,9:F/$]P199JYO<9H$$!D[,K8:,/$W2C`ZRP07>>A-*\$?PZ$' MP;*X?WS.7X.)'8%Y02#P!]01`]9#4)J':AAJH:'W\9)V),P4D1)QB9X(3&8F MQ&!Q#D&`4"Q,D7(@[2]!83ZF:>2Q^]`V/?!\?"W&4Q4.W?")[&3@)RF#9298 M%59"5&*=!X4VZ6YQ"@WQRG/MZNL[K=NJI]+DM`,F)T-I>/$R3RG:1;R"%PP# M[J8?B2J<`R/@N.W.D&9`)(H;@>LR+9590IHR8//9@RD2/R`1SV8CVOMBYF5: M"4G<%AC=N!2XJ&J74\S](D..7\'/OTOI3%2N#/U1IE9I?+_ROXR;!ABL;(7R MHOGL$L*:.OTO!JMXG;GMI\U`ZC?2,'V_%D'CNX2KE)-6V>C&?")JSY?2$8$N M>.W5P4]!CYT<5D#OOG)@\83\5JZ..E=%15.;0(!$,X5"HJY:L?B[.`J0-8VA M;5I389_)"6+9C47!`1@3L/<>Y6<8H*&N#K`<`8I9T]Y**\D-UH,U9+S)+W1\ M9HN*5,:$XD_!@V#`+'U32"8`89RYZ,$P2B.X1#'%_)/7`3$4&PYIUP!_'!GX MK#DC/)B/_726/Q$!(/QHFDDY>39E9]T4?I>T=V`R96["#2A"0_:(;)N@H$R! MT2V,+,C90RHL42F5T^<>`M9[BJ@XH35\J8?(`NFHA"A&\B[('#!-QE9F"I#C MF%;Z2CTJ-P%!1>)$%M8#U^]/M+'M/JYJ,]?3V3F#]34<^.#!X/'W#_B.:FCW MO'(;-2T&5>.P)A6ZJNJ,D10F/#;CI4^-Q?4AU":01C_&BQ%>48Y+[MOW0PH4 M1G&Y&60P%BH*&V.3!VP3"1QIB>/FO)_*QI[\B8?I&_XEOO%8-7<9L0G` M12M*KT&I6%3-*E"`^"4U;8D13G37%HDHN:^__?1CX-E2TR,#$U,#,S,5]C86PN>&UL550) M``.%8E)5A6)2575X"P`!!"4.```$.0$``.5<:W/B.A+]OE7['[RY7_;6%$,@ MR>112:IXA+Q(0H#,3.;6K2EA-Z");3F2S2._?B5CN$"L8(R%87:^##%&IW5. M2^IN2S[]3R:C78(-%+E@:*VAADO_=:T_M8Q6(I;3T+%V;;O\6]W%/>#7[!Y0 M_C?_ONNZSDDVV^_W/^O\5J9C"HQX5`FB4MOYL[&/V(_\+$]DL+,=`&EFFSLYTIL$&+FI\) M[63SN[M[V?&-.Z,[3P;BPLS]_3W_[MSQ\7'6_W9R*\-A-_)F<]GO=]6&W@4+ M9;#-7&3K`H#A$^9?K!(=N9C8$>S2I'>(OS+CVS+B4B:7S^SE/@^8L7,^8D[3 M3BDQH0YMS3?]Q!TZ<+;#L.68PB+_6I="^VP'>L8P(SCX\I/^Y)HQ M8F)#L%]$INA+HPO@[FBBZ:?Z]:07P+4=&FC8!62Z72%B5MR2E;:0/5=AY+7- MD:'A\L\6V#'MG&]$F*K`5C%(*'3!9GQXC##CV1O6$+":3=]ER/ M#T2+4!>_^3X,`X>#\J^PS?V\@ULF(,;`94W4,I?HS`H8V?%$P?NJ(U/W3/]7 M5=ZSF3[#P`7;`&/<:X$;WWE'Y')(D^@S,*88W82.44S4`O-LQV.9#D+.SX)O M>,FCU/?-:?X#2_QAWD:LY8_UX'=9H4L63)>-K_A*979SP9#_(QQ@BINE32TA MUBW8AOCOXM7#/63R%EG!+2%*A]CN?$6F!RJZ$`UX,B1G92_0V3XBJH]MY!]G M-'\_J09W9)EG67YK&3\NM=>3 M?&.$SO6[&.BF9_#H327MD7`W=1:*1IITSH\EU-2J!_XU-!11/Y^D^17J@;&>WBP#G_[4*^*1*DL M-EDIM:I##VP/UI!*S2&E78J()I",)DE`$F\R(':G"=0J0TME2AL&,^4^FZM! M*#_2L"7^6KB>:4P&M2U3EI0J67022Y"&2_27+C%YDTRD`NY0A18A*"L5?XEE M$=MO5%V==QXCW3A*KM-,5?<=,4GGV07#P,)49-80-J[M$G*PBY0D&C*H]`=P M-#&D5"5:NJV#B[`-Q@6B-D]B&(]K/$L0`@9?4[&.E4RN$5!37O*B:12%O617 MP"8%Q#PZ5#M[A:!LR[`)(^C]DI=)*"ODFWNZ_[??WW7'6_P;!\< M&V^'O<[ST'XJ>_W+0WI\>)O_]=0<,O.PI[_MFC?NIS=R@:]_6*Z3OSHL?7GM M59XK]U`X^H(JN\-6IXOT[]U+ZZW<*K]6][]4NY6;0;_L[.G?A\_'^IM]7R[; M=J%J%M'#D!PVCNK/1?/IY:75K==N]W_13CEKM/9JN4<]>W/?N-XO'+P2EQ[\ M.-QS^C6&*+OI.D>7G;J#[7UKZX.!CIZZOXH%[R#_@NQ/UJ>#VX-C M#Q6_ZJ_7=\5>U:LT:E?E^M7NMWSIS;HQ'Z]N:T5CT.E7#\ES:Q^,HEW)W[:R MB%S"DT&<)GM^;#P9K39VG>+CXT7G]6^MU*@'1PJVS$T^2-9S^?!L_30[MP_Z M?`V[H^>WS,=?WH*\3\D6KDG;JU5HQ3$6S/BH#=I34YQ]AY)^MCNOS>R,_9Z6 M1!_T-I`)+&BZ`;2'=7_?IY+'*1*HS59`2E"B]?`'1YSWXBH'VSJ5#-3W(/&+ MD27"W(>VPJ$Z"Y"^CT@5FHT=9UA)\AQ"`TQ^N2Q3_'5:/$\'2WS/4VB6.]2^DEQ[]"?K;A_BWM;;)/F4;'7DU1 MD#\DFIS2A]76F!'Q/;#+K)PI7A`6(J1?^DAZ`"PA.^@`( M=Q*U<^8L0/J!56B'9\?2"H)*I\H5EG8.$+!G4U@@6PM+[N2_U M$F+86RQBNXM!P_.Q$2=@?+0+GH,V\`4 M5=BBP*8>0*PLY6)FI4%@C!H+&@I'84U2T+G74!CC1"NU2'^]I3(LXB3I<&T, M52'4CQ3+X!"&U;P+0(JUW7.?E,&$]P>'OQRG!A03\211//.$,HS^5U*Q7P8_ M]LPN$6-21T@E!@E#3WMW7!QWF/;;98A>L';_1MT/'?2)/@J4`%>PC6P]+0,R_-TR]E1:+M`-T?^67-^`L``00E#@``!#D! M``#M/6MSXS:2WZ_J_H-W[LM=;7D]SYU,*KDJV;(G3CRVSO9DDKVZ2D$D)#%# MD0H?MC6__@"0E/@""8!H@IS1?MF);:(;W8U&HY\__.WX^.@]]G"`(FP?S;=' MSME_1NO_.CH^.O/7FSO+.;KT(O);*W(>,/F9]X`#\M_D]ZLHVGQ_T/7KQ\NC% M=]^_?/W]\W=''^_/CEX^?_$F^8A\X3K>YSD*\='3VO7"'Y_E@#W-`_?G\^:N3[`^?)7_Y_1/]0>'O'U^QOW[Q[MV[$_;;W9^&3MT?DF5?G/SVX>K. M6N$U.G:\,$*>10&$SOTR)_?Q5`NP_Z$_^"/X@S`U]U[$IFTZ12S=]M\(X>G9$E_YX M>[G#`Q,AV-IHN\+(C5:4VR?T3TZX*YR`(_G'#`78BU8X1&*JB9<[U:$"BO?M7$0GO\5.]'VGBSRT@]>B:/:L`;! M5#]-J>(B`+$7$I65T$:-KG4+:5@">2:E]%W>"86D:#0H=I7`KO"5QJ/QWO?MQ\=EV@-^X:H MBH#LKWUO>XV`]Q7,)C5/X2B,VY)2M?>\N\JW/ M9/,S\L'.FW M6K5)F]Z7Q5=PO1XTHBSFC:MHQ;=6P"K;(==-WI[\@ MK$6,GXC*)[GH"+]=!\T=EX@J#LGOXC6V&3KB6](`2]N9I:]O.W:QO[#QPO&< MB*#V@&UG)\YH+\X2,B:SJCZC=0]V$4=Q@-':#R+G"Z,O?J*R3GZE;6O2,/0J M@QT>(3W0_H8BP-Q'].&GNB?N6A!,>L3.?XB@A9:8"?AF?P.HX-^V),"Y M"7`8!8Y%@#+BQ43:T2,*;/5-M*R8B)&FUS$*Z5O2MATW)O`\3"P$:@&Z1.5* MXM^^E%[YQU8<,,6(GRPWMK&]"/RUA5PK=MEA#(GRV:%"D=C@P&)72+B[0B2X MHP68X@@Y,LXYH=5`[$1I5.L^UD?6-K-.&EW1!?5M(>\_D$:W[F.= M'EF^\T`:59'%=*K*>KM9_J@U+J./UKF7O#2.-=_JT=U3WXKI$W[BV>=$QT3; M2V_A!VM)ST[C*OLW`0HL44PYP:,L]D.C1F_8!FQG3=W4OG=,#%L4N]&SHQ1, M'O'=&L0./"&?G*1_,Y/MY!ED.X M;H&\V(*0F)'F>(W7F''+T@SU*Z2..$/2*`"^@A9\B[!%K M*$.,?JT>O]QSBT`E+^,"*/92]H,,DHOFV/WQ61P>+Q':_+$+RQ$4\27Y9UA+ M*[;C!0KG;-OIQR=429U@-PJSGS"U=?S\11HG_H\&*"Q`0F_88:QB)\B7P^(?S`QL&/SYZ3OV6B_+WE>Q&1M7.7_14Y M#GB9!'*SWQ.3&]L_/HN"N+!+17[<6=A#@>-/GAQ8.2H`2B\#[N1!99$W"K:GZ64&P!4NL,(.]#*G>DLWCO3_ M:)K4`W)IN'82G:$@V#K>\E?DQB"VF!C@_,8&R"Q!ZHF<)+6#E/@GPUML80*= MF"G7.$IE!^0\-<$K:H0!/GA(DK_:!3%A^"4(>/.=$ M*9CR\)5^'LX"O$&.?9X$-2>I`[N@K"$8*`(6TAS7P3PATJ6<>ZW9'`=G4!TK M!LR+>JJ_@3@O/GEF1]N9BQ+?-+D>-]0$O<9`!Z4!WN#9TDRME$O_U,^E+"`' MP9'=VH.G_IX**:7?ZJ=T.=1)&'O.8N?$2H3D@A#<03^(Q"B7^CW%UU M[7L6W$52#VC0G.'0)F7%.]VLR*H;H"[Q81,[VWWVEM3O7<[9U.0*8J'Y0@$5 MI*-&&+998U?,D29.R-8W9U=&]N!C:X!F\$#)"C.'?RI^N&ZNG!G:4L\$09K\ MA*QI5[&!].R(@#=LT'5AK1256]UVG;Q!M_@!>S'NP?M3@F34I]J%>3S*P7GN M\AF`@(RJ`V,R7M1)>=:1K-TOIVZ<]Z,?>:!&K`NYU&OUQ6FR2OJQ1L;,H@;N M\'UVG34=[$.7`VFTMQ*/NUPT)!\'`>5:*\S1\J^=FG!>P;(*[L'%Q.7> M&'G71#\!CZ!J7F2?GI%F7\@8F2;@$&GR'2K';W,E,6!9+75@QFK)UY),Q/VH MEHBTKV""RSDJPQCI":K2*F,+0++>?8!1&`=;6-;40!FQW5Y'LXQ%#6X*-<>A M;3.R('>&'/O2.T,;)T(@P40>J!%SBDN]C%VZ?1:WM(;0P_8Y"CS'6X83RXK7 MM&P:V\02=2P'Q(H0@#K6:TJ$H!DS&]*+=-F"_=B`8SYR=33+&-20B002TS01 MRQSO4[F=FAD?^5X/5D-Y4BRBS-6E]E5=6>ZT>BBV!$/X4&QY*+8\%%NV<.50 M;*F318=BRV$56[JN_TBOW@L_F/KQ/%K$;K48!S*[10J!,>2829(4)I6EZ"$D M%M5-P+"WF./D49WJTY_!4@$+:^TU@3/J"U=D4HV9UU;L9LCC71[2U2'.=?!Q'WS< M!Q_WP<=]\'$??-P''W>53VE1&FA+P0J,P3_OJU1IYX!B%AR=$>R$Q'!.88+$ M$:I0#+\S>&)7S'&KT@9*6R$7ARF0.QP\.!9KT`6BJ3B@1L`0+I6`#D>&$Z1. M&@/=]W1HCZ6HU?-LZ$QS@MP$?V!@\B`VD@NF*<>:'TCA*)"F]6Y0NQJP2WZ\G'CV!Q1\QCG<0&X'/C2#1I,45YH(IKVC+!N4 M,PM\.[:B*1$$U]^L*\D8G/DZ-9^-0?JY6Q8(M*MUV\,>0J[T7JYRLWYQ*=;4$*@]OMZ9&XEGFP[#!>5'#LSP M&_C7$@>N)?*E%V$ZG3.!EG(?Z+''A35\KO#)!'A,:%W\M>_Y18D`O&A:(([B M1=)"-)C&*_NS>D%P/O/IM-&8`$\/L^^%IWCA!S@_AI#$XP<"^:@J:,SAK/8 M@=AP#5UVX%)9.R76S@*F$)0':A3I$EPZ@:6T$#T-:VD4`8R""R6:@&6I9`6] M64(9FZE-7@#39+(T!#?:0`X^WM)*L_9\%25>?4I'S4^24?/7,=W(S8+AD,MI MZH&%BI@,_^Y2)7%[QY:>$Y08QH6ZX7NRV$L_>/6LI(L/Q*A MI!/)?8_-\X).4ZH%",8MB'RE>I(!!9E+P.`RENH!]9`((Y*JU"2E!9.@GEHP M09Y:8#"92ESFP&>2">4I=>*/:*Y2U_3O#P6S!"CI^T-IJKL)&ZM19W"RO3/B MP!R58N43'"-JX9CUQPDSHYY&8`>CT+8-CB-U8$R^/X3944L?J&@IIS,;'%N: M`8Z"02TT$X@%:>EI!\TGR.0WCI$%XR%UXZ"S#1?Q?(HAV4MU`QI1HHD,I%8RRICCXPGM;J:B85F3PH*"'.IT8=I4(G@;=GS>.4&:PS%*XN M7/^19<;O*HDF5N0$`,_:BO9.1077FS(3C!)L@@HJ(,K@LL2)1EL]TYH&U/( M\"NXLZ@ORB/GDM9R49CW/OD'W<$L\!\<&]NGVZ['2"<\,R=-F:WZZ0W46V6* M-P&V'.:T)/]V,:.J9T_6?A`Y7]C/(4ZM$%P##F*H@U(H"HA4^! M$V%_L;A99+/>+QP/D>V1]XL?EH\M[RZ67/.K8Z0:9<'ZZR=;0/YU=ZV M+936&_%/3,85\I8XO/3VN(8ACNC8R?P02JDWJ=R2IIBI;"S+D@PJ[8J("4T3 MQE.<_/^E5YU+!7$ZA>`:XZJ2/)=JWP7("E1Q504^"_`&.7:F&U*50+;#NF@D MF^N'RT*8F'"J@C%>C/9P#G.^*,[0ELHA?8I9%@&3WV._9[X1DZ]*&L1H+S(\ M3I0ON=JGA=``291Z.:\)AUC3\+D!8_= M7GH/M&&9GMAMTV+CBMTVD@7J+4PD@LA`M)VYR(N(VJ"59JS)<)8+#Q4R:(-J M3J=*BFHI)-!*3;`,10+$\=AG<4!_AF<1J'1`)#H,[`(F"'$MJ59V<[ M1?6_8I.VWVB;5:581(H"G,$44I'\KT?&BC9:`(W)R"!>^`&SAZ9XXX<.4/R4 M!VN<*I!+.;#G(,>XJ4&\1]NQ#OI`;$=)CLJ05_-KL(K[+GJGPW9L6FQ=9&<^6RMIS!?;;T)E7;-$X^!QH-6((QB/BE M)(^JA&HU_[0PA+PETF+D*^JEN9F[SA*!/<\DH`_D2NO(QB;R`EN8-XNF5!^] M%F8%UC`L3%D]R:5(]6IAUT,=Y'&7("Q1OH/"9%@A7U&GS@%PJ8DE/ MA[*/'(+'4O!'>6SE*"P2:=#(Z`D1P"#8DLV`]5H1`SS.`RQ(U/:&'-T=G^0V M)^KD9D%[`I$M8+A+M1WJ*,^I"#6U3S-A6-_%FTW2X0*Y4R>D:S)O:[:;2V_A M!^LDLU?FS:^R[F`;%ZE32F28EV*L/ID?1ILFP<3B<^N;4Y`=Q+-NVEI"+:@7 M?6X^%!Q;BB`,1A:TL:9$-+V/^T94KWV/8KOWJGIV5U^G)E"#]X3J(JF`S:F] MS2<+:(5PD79AV`,\O6I'0K0/:)'R0*U1IC&^]^F8;!R$-XLT>FE+A7);EOBJ M^"9$,XAN0@1FR>V>>=V%F<3]?G@62W<&\8DEDL8MSY]/Y"&)R),R.=BBH#\YT>H3GM-&G#,41!X.)LL`8^'1\&HKFXPQ`7%5D<1P?9,Y'OG+)#,5 MQ*1M`VDJ9`5W0[826:ATLL<.JKM[H$-A[HZ"]P2%4_+'G^OM:DU%N0W@U(W* MC`Y3'%J!LTG+G>EL17)ISL@#DPH+_>D.*,3>%+`P^YP0X'W^>*A06=B4['.B MI;/TG(5CT;34I!J+&L.^ZU@TJ-)!25=7@SQ*#="4AY`T40;T[`A"-MQYNYW! MA0>7(#7%JH![/""%UZ"R4J[1+ONKN^<[I@:P^FWS`0=+\AS+4XE-\`U9N_[]J/CNBBM`;\D]Z:W=&@Y<%(- MKBR:VX!G[LKWEK1! M*TM4U'FGC>^UE"<%Z`FI!V3P($@^>#B$$NI4V.LP=O`,5&?N M7?L1Z.71`K'+2+_:E7NZ*,2!&TVT$.%V\TQ&+DT'>!\P[*L-#C7<##>+XF0L M-YEO%$;A?G96EK;;S^6AA)'Z_2(,^#0/&/0(=D7)L-]!CW`5N@1VY9%@KDZ/ M)SKMH#C#07HA4O25AXAE4W_)$?1P\8&9=6^WL3!_'AH( M-CCW7"XS2UF\=VOTXQ9H`J.DS3-)6^< M,Y_YTK&WB]BH!=7WBTY*B_9S+.00Z%+H(0((].Q(8F#P):0D%84T`DEB#_%U M%,]#_%=,MG#^0/>A/HNUM!"H^X`'2]F,*J\(ZR;@`C.<=-S"PH)/@$^PP9E1 MU9CLZ9;]:ZLL[:-/`-B/9"9D3H@!?"LTP!M5L+^9.R'F@-@%>$<#.`T[P202LEX,I"'M,C!4G:,K3[[3S]`(Y`:O5W;7Z M0NZE1U".F:0[O<]";E?T'HZF,.PQ'4UQ@F;O M?(UU[3N[&2\IR%N\H0,W4\3[T+9B@$=T.`4IF?%2]WSP:_R8PS?P/?)/"^?T M0@\\E<9A5`\4>0IGO&[S#QFJD+JG<]Q42G"3:;"5E:[*O5V:!QTW?"_O.>,L M>5^=`BJ,SGTVR1-,1)'K%@53E+#[.S<+"=3LE, M6XN5IF6&8;S&-KMJ8=^QFE$TUFU8T.P$8XV0GAQ0K;ORZRFCX+=3\KZ7E0O* M(GSE/.`*R#Z/JC@:8RY^5R([V&#+#!N_"9N+F(YF)'<3N7N^H*0I(0M#]2<= M6O#[&L1&#Z-$!FL.HH*VLSX_%-+6:)Y]*68>@?Q@M+3#X;9/_:^,U2!:0.@J MI=7!):&6$EKD)]W1Y!$%=AXS^B))\O:H7;G9VZ^]RU('#+^Z,FW='!2X1D`T MU2TF>W2L*.U*\I&P)60;&([:DD5Q&$W4^E)BT@P4;7UMND%`SE[Y!OL$[-E> M7IMZ;BW68,^-HWX]0'*HC*?'@#*Q-5)%C4]CDC7*'K3A@'J;S)\N- MR2&C_>VI+HB3[KY5]'N2"VU8&G4DJTF,/@X-\"4Y"[#KK!T/!5OD,IDE2_N+ MB/P=>R6CU`&*/-O=.T!1S@$J7;%9\=5.<80<-^R$BGKFAE[H:O6$NO%12QK1 M!QGP8FC/.`$1I]I\%8VLTI#MTJE]?VY;4$DN/%"0+T?Y!!?MQZ^NC7^%VF`^ MZSJ(">H8+B6F'6A/61,-.3$M@M_&M1(-@G:2R#+$(Q.4FM5Y;64;C=8ZBW MX`KHH#;"^V88W$QUH"806
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`F$P:';O1Z,"FG!VGD08$G^).VTE0C:"TBWFA#\0511@(N`'$M:VX+TGXB[RS1.5R:$>L#$ALN, M.[1/4>\RWK8ACYD3^=14W"H"MWN.9%MV/VQR0RMTN*2%2C13A>%J%1/F8HX- MF)UN/Z`__>",MK,$*[:7`&\T-JE^3@J5W#+4!HM#-F"QQ^$:K0&CDK(H`*8J MB57MRQ\30;[74QPF$5X2#9B`IA+K#1?U]\I]T1BH6DO$.(S\-0Y8BC0U*U?. M)H0K[&\"9[:.74T'%IHA-I$2*`F!V.`VIF@!\JP"PV"9D@8V54D&TT.CMJP; MCDM-X,9^LAI)"10?;4#[?>"'?5N_"Z#\AA:(7QU/!1,6E".@B=>R`8%/V%FNJ$0] MX``M\<<0+V+WREF`.*0ZX3-.WG=C@>@P#"/^X`5K+X%RJ@@G[27\18-W6#[% M-.<U\5%8/) M'T,0CX0=K=9]3])QX<<#N&]VF!C+'AB`9"2L$'DV]"8N8 MXGJSN(FCD)A_M*PR;=8*85CWA;I1G[!>:Z)WKL,UK:C?PB0(*$IL%M.VOH=P MBEL.VU*XL[##_@17/^K?C.`"<%TD@Z6#X,[;MS"7WD(2ZB,_/R/6/7VCQ\B] MQ\'Z)9@0][P-D[X20'GN6QB`VI%H/)N7!&6'F*P6&QPVWKQ& MKTFK>/:J9VYX9F[_6_M63%\#0M/>U\;(.R^WI:+=!-(G!1#;;T5T];`6J`]/ MUUOF/?G#*+ST9CAP?!NL4@X"S8/-(,9-@4X_4,(72N$[..-6(_H&ZQ0,B:I. MWF?AAL80NJ(,TWU?AF&,[6E,5/8RP2>Q5_)S"3.4;!!1E,?B*[Q^%5B128;^ M49!=Y3M#,&(D7?K#`#DTEW>UDB$9B'9H'(U&, MFYGL\8-'9K1H#;*CTZ.R>SC8BIVE(!/G]JH4(VGICRGR*$$>E29=JXV!W*?] MEV@SV2^O6*PNL*!ZXQ[D!,Q)DENU!.]7GW;H7!K80^B'DL?7^OI"]>?J5UI9)(V)?:`32Y'0VJZ@H:I"3@]Z.DJR84K MM8V8/510B7U&,&869$R@(&KE[:P>L&(U+N2*W:JC;$T`FO(8S*XH:*_1:X$$ M9B=U*M,3EP?98KTVPGDT&:M2$DHTUC] MR;Q'T+-I5@5L(W@0//N8B-S0++[VL.CQ9S0Q9TRB!--:'DR8S+:?-R)/^BLX M,VQO=SJ3*=F/A)[A[=U'N%;9S0!-.&+ZT-)Y`6DA.4XP[7O)7Y;.BTW MVEYZ!/F842-7,Y"D8@\JC"2#]_"CG7(F;K],%R@?[5=DJTC3%O;W*Y1N*B3; M>R`$Q>6X`\MBF:(([Y[K@Q)IG?L:?%BJ9XG7*C/`=:D@^RMF<(U+[DNX#[VX M;VBB76;]T$I/)3?PE2EUVB_A?E#OW5C?7AL[ M,-E-$X;&*KY5]`\JNKL$"!?*]A@<)1MS+/(XMATW)LAZ.'(\\DM,,.LVRX0M M//'L:;+P-8XNV<)79&&I+#"AA92ZP5T3S@7TEU+X5+\R=S9DB+P+)-9L6Z1# MI)J*+:`$H02+`$RF6W/%*:]P2O303WB&RA1[_MKQI&6[[CMCMHN2<-?NO-W= MIR3;);L[:^[!+HR8X"6NH?D@L]LPJ@ M.=L&TE1VF>SA%":AV'C6/M/'L!4'9#T^1.4^1N2#(4-LUCA@R-XLRA2OVK]:T M&UVX=8BY[/(<.R)3DYFFZ9VF%\->>\]#"6'A$::9@SJZTJL6'6[#?88UDLU^82&ZBI=1X07$I;#1309XU03EJK9.=^;#+/BG_P]U,, MN)O6K(P8M!DA(0Z"-!]+GLI-WQMQ9TE0NG'O<(WA;[&-\9I>1F@W,E)W?,29Z7XA2$/H\3Y*.VP-37BD(3;C]B+ MI-`"!.C/UQO7WV(,K*'JP`R?*[7$@>O$W/$I-%G[L0F@T,0V MT0'H?3HWG:7'AD=YT<2R*)JT[9GO.A;98!IC5^P&(K`RQS7)JP>56E%UK)T( M%(D:5N'5H.PV3IFJ"G?VI:CB-#+GBYL%_H98EUM:W1)-/):QL4E2.B`+447` MFO3/J0EY7AL*$1;(`\>%32'#N>1$P!J;8*D@\$+LS),4IL)+`#2,+T^0GR9] M>W#<%'/[J=R=E[,;X6F\V=_">9L`56%QMP"#2LG:$A-U]W]MJ'*]COMY.L&H MD>+J@A-RB[0RX[\7(Q?(.:V$#I)$5OI^\3V:QPH>K:P%"":W/=A#+:1L=6*J M>76*L.!,GWI`/5R.(L'()N$MN'GJJ05CU=0"@[%CN,P92%RR$W_ZT7_?;J:& M1LW'S<#079!YR,`X9&`<,C"$`G2T@@E*H>T7'[/AEB,1S,18!@`P))I;WJQ! M5A&V"IEA6P7E0,"HGA*IS2H=46J#&E"Y?"F3A M@"BZ]WVE(36!&W#:F!"UH(J&+F&TB!-6^]."2=8G/`^=B,+_ MX,\=%T\V&V+8(=G\/8%E3":N2')'F#)@-_\'0I]UO(8[5$4`AA,N:VSX_"$I M$0,H[/T!/0&3O`!@X"0O$@/H_4R.I86Q'=+L+CH3$GD6OJ1D0.XLGI/3=K,@ M1@1Y;0+%IP6!&YLNH9I`I$!?F#;":3<7VJB%#8-_I%E]WI+.M/!"D#K0%H@F M6[IVYF8+,0';2S8-;;W&C^Q70%Y]( MT&BU*X=N,&Y.;AU/(B:)^'S<^%[RAWE7KEX6RJ,Q8@8KT+RUL$&)_5,\)[^\ MQ80.R'.^L%<(P_L3N00PN<9O%M,4PPO'(_<\V2I[/=*V'^3;J1,R"H`H:7W( MC5J/:^210!<[E895\XC(\28Q(RYP^<;F]JNJ?#9*-G%ID!+[K7Z[Z0QMG`BY MK`YM8O\9AQ&#Z@1LT81 MN1M"O(C=*^^$%$@]YW26T-3-]%/K31 M&E5-%,R<$"VNO1YK]R86D;20+9@OU5.Z?VO6JE"J\29N7$"YCV7-JN*U=]R/ M>QX)*4+;G1'`W[&9P8V[!*<["WN(O/W!9"%@D%%/9/ M87STP@VVB,[#-N"(12XPXR5OC=)9;#'')1A0R(8+$6AT81.3!I$AJ>]M/[8]_(K M[UEW[EH"A:Q!'J@R="U\83A+H]4&W9.SN%$08MYB"IHL+$'.\C=FQ52D'K+X?2I7*@!^_>I4B-E1,MP&)/0K4 M20:G@&51Z*7M2X,R5C@D@FROISA,YI(D&C"Z6XGU9I5YO]R'[1P4AY&_Q@%[ MO]*G\,K9`+;H:`)GM&>-H@XLE!DTD1+(WKH/D(TI6H`\J\`PV#U%`YNJ)`-H M&7Y(U(#*+9A.)4BZ^V/#Z1GRQ-QO$Z;A0F:X0BB,W=HFW?5=7%Q5(L$PH4&; M76.0T6(M$`T&O'3PJXV>`HTO-/,QJS9;@/1)$()KJ@`,EJ%YP@KTNU#CZV3M M!U%:H'VS*&\`@J,M$$=^/MOH*9`HT'/0[,KWEOH<*A'_A7 MT@_\$/J65#B'.KI#F%LG]PYA[J&'N<\";#O1!;)8)B:4=JR!,B[%6$"`YDEQF&)2FZFS!'*6%'[PW0?:$K``%_`E MTPC09+?^)H51,+N;2:;92&`ZENK7*Q]Y3>SA^%0XGYH=Z=)"Z<8]:SX(2;"Q M5?AY45:>$`^W*'"D9A%SA9D=.%%'#(AB_R+46Q3A*0ZMP-E$3GF<@A#] MRRL,7DN)4$&D[%\'Z3_X7K1R5111_FN#J14=B;[;O_XR_Z;+Z*,7D\4S74=G MG#A1VBM_WRNGK_M>#)GAZS0-!!=H*:!1"I+V5U3?FC+U&C`PE?JF@]M-A!5I M+Z`VJ2!MXG*S*`X>@>`E%];@+[]V:K5/DN@YCRTW@HJ81\4A1?N\-L6FY&2- ME>^2'8?)3.YK/\*3>1@%R`))8FZ!V$7^:Z8WY6Q*D&/0`M)@L8T89XOC-UKH M!Q:HXL_=ZHMI*;31\RNC&EAR4A7-6ZJV0IP@L2&W7S]:HPK6<--1:?X)D1(L M7+^_4Q+)F<31R@^<+S!GK@F9*HC)(PKL>_*'4+EX10#FT_#$1;-00U4D$U0;+J;<*LA-@H!&'-FK]W2[ M_YOT)QX:/8*DAR@NQ;%B;#CMC#LPPJ=](&!A3-N<(/D,;)T)NXE0D1PH'#]B^$.+.(H#3(,RU=P^ M[8YU022,1>CEG5X=*`V24[M'(YMO7\$CPT`ZI5!Q;8.9;XI.3&4JZB^7V8<& M?`MC.[P@FV.(W3"0X?D3>>0Y(51XI0VHR8QJ]<,J0,S6*!F,JXIG,940#"_I MO$#'M^]]HFDN/6(?D4>.]2MR8Q`5W@O>H](3_7)4,/#7NSR^)W\8[5#_A)WE MBICIDP<AZ)D;9_3_-BK_WH M=QS=8LM?>C1?(G^S@[X\01$?G[[IB:%@2>I@^"<*E+P=TA_1OP.9P=OS#D9I MN/7-Y?:4_0XFW+S]=I]S;O=?V?ZRVWUWBX/()1BNX[QWX5B7"MN[@;Q>D^S' M2R\DX).*%MKA^7Z%O%H3["A%","?`EP()DK_53G M.X]H&92:\_HB/;G989-),A(WN0Q[;FPY](C_\3WZ`F'A6H>>;Y75ZH0J)'Y3=\K=CBJ+BE> MJ1Q=]RY%D=-%]`QBL["L9*71B71FJ<'JI^9+[-I$:;] MX:_9L_8TQ1I(=>G30O0UW;BZ15(XA(6J-N&"*F=(2]+61-9S%\K"U5U,T^+7 M_)5:\3L`SJ&5@F_,)&PZW'D#7HZ:8/G2-T2%,H/SR@_#,Q0$VX4?L`TB+T$IP5TZ.5./4MYOB;>/:Y%S%?($O&9R$>:&QL?-'MF1N)8Z] MF.=,B*U_+/T'LG.'2LMK^@\J)*]S0M*ZNORE0)=,-GZ+EPXM[/4"'FDT/W;9S'BA82Z),,MIH!92%+Y^+N]5G.[6Y*QN*Y,E2GT^9]A1@10U3\<@)-0Z3TS>-,$;"&A%J:>[9 MNP<[B^>N8UVX/FKH,27'D_R2(]!+-700:=0K3_`)P\BU`4:WB#-*X^"L733)_63#=%?OSJ MN[$7H6![X;@XT,:(\K)C.@X5DK0F?JD?!P;BC-BX2S_0IHN*BX[*PBS10WMJ MTQ[2)^RZOWC^HW>'4>A[V&8M5!M\H'(\X"T_*FYP:=2>S-3!]9#DM6E[%=$^']02P,$%`````@`FX.L1@CPDFFV3P``C`$$`!4` M'`!E=F1Y+3(P,34P,S,Q7VQA8BYX;6Q55`D``X5B4E6%8E)5=7@+``$$)0X` M``0Y`0``Y7U[<]VXD>__M^I^!VRRE;)KI;%ESSO95!WI2(XRLJ5(\CBS4ZD4 M#XDC<8:'/,.'I#.??O'@`SP$0``D`O,@W+\$A.$DVVQL_!.=QCO[JY^$#1+^+'V"*_HW^?I_GV^]? MO7I\?/S"1TTS/TQAEA2I#S/\"W!X^%>`_]___W]_P4Q.4HA9?`]N"PC>>SMP M]`85E$#QMHCC[[S\PS)Y6:?1% MDMZ]>O/Z]=M75<,_T);?/^%?M-H_OB6MC[[[[KM7Y*]UTRSD-41DCU[]\_W% MC7\/-]YA&&>Y%_N8019^GY%?7B2^EX=)K"`7$+;`_SJLFAWB7QT>O3E\>_3% M4Q;\X:]TY@#X2YI$\!JN`1']^WRWA?_]ARS<;",L$?G=?0K7?$FB-'V%^[^* M88XY?(K"6\'H#P"W^'A]+AS,=S4-VN'57\<5[0[CHBL>^;6N MB$RG5\T<1O@7%TB@EJCP*8=Q`(-*6$Q"HE'"@>"G)HQ))WZ+:(2AD:053<+Y MO_]09(=WGK?]]TV.Y-O`.+]MB+R ME.1>X4_F%8SRK/K-(?[-X>NC$D9_U.*+)JP:%):Z-:SJT]::*ZH[XXGX=[2* MR+>*.L=W2%_QX<>;/_RU[@J2-:@[@ZHW^+GJ_Z^_4!'^RF@+_WN1ME7FI7XE M)?JQ9V1EBU=^@FS"-C]L#7*=)ALS9>>)P=R\,@?BB9?=+^(`_^?TMR)\\"+$ M+UOD)UZ:[L+X[DUKZ9<&G/A=CFXLM3,,D0.!/JX5IF+)>ZVCK`*S@71C'B``V*U06QGY\KEI\ M7:_F(^OQ-`Y&T>*1GA;1@L[3W^>IO*.6\K3L_\+WDP)1O88^1!Q6$?P`\Y,B M31&K*2+\(8[!,HLA+LY?L*ND$F"9H:"%5>\*,S>X2KB$B$]QZ3XLL@WEV M$7JK,$*N/T)&%75W:B'UE,LB4&,6S*WF50JW M7AB`-*N&5FU$]P;^+0CQ6'F M%(@:FF91J#HMYD[GU%CCH6I<6.5)[D6RC8T*BFXQ$1%@'"VB?>#@P\#4$B5H M@Y;OKM"LY`AG>)>SQ0$O9.NF,4$2?K97/)DP0JM#NQ!K`ZOV9/_A/$2AHLNV MD>D9_OBAOQRF&91]LWTR\2))?)TX-OOCJN+UD`#SNR0)'L,HFN)[KFG;_G8K MQH+OM/JS4Q3L3SRK\9;\YO;[/,[1L$.T*:*K`L++Z9,?%4$8WTVI=R6^-D^Q M5`028*7I6CH`^^;)G#T>ZV[JG`\*]_1DNM@Q]0:>KUO4[4, M`[-A^(#&,IVCSV=D\]/G2B#XUDG;>?CY4@VQ@!&/;X!30.E-M_,;'0&*VSWI M/F\6>F_/?'=C-UBS9;STRMOA8"GR)M%OT@(&3"3+PO&2"GM7ITT*LO4=/FTI M";+G\"B1.A3E?"=H``'>>9'J-)F[KU6T]1H^P+B8\IQ(P,EN=@M?B+Z0>DI; M.S9;E*&#"`<`43)3F7(VF/RF^-I?_RR$^(28GWP^C7Y_R"[]U*<>53D M]TD:_HXZ>;E2,O&?09Q4O<,LP\$CDKY4Y/B&(SX)4*7D/-8D@=!>1A-7`T-V M>FV:5UYZF9(+6P$A?P73&SS#TP-:R-E^0HN*6*K(KS'/YACC^QP4N2_=1ACT ME"^&HG26!J5X,DP(Q6Q1VXGI,=GA:#^Q4R*-*@0[!M;UH:^:6L5HXT[$Z$NA M0II5GU#\1*M*/3=4/;0C6'#5\]GHY_7(9N"<+/BV3$#)S::C+A9#\[NGKI'K M!.X>!?:!B1FYBYP;N4@ZG_EY6QO/7AW#$FQXM"\;_]W6Y\VR=/V-,[)H?NC, MQF=V7SM'J7T8VY^(N7SW>W+I?/R7'`U]1BH:9@M.DLTFB:>-H71XV/S:]YF+ M#J5),V'DY+M1(B?HIZ^^?G/P^LVWI`7ZYY???G=P]-W7XP149G3/6P2K5H4" MGF:&5*-IZ-D,J*BPM;R#51!)Z3-0#J,XAIA."$5U;HSO)S(,IMXTB5C9#MX) MY%#"&'^_Y&H3WJ,\`9#XNZ5QT#.Q8R[EYQQ'_6XY%TP\GWPVB.KQ^'KG8$1L M31O5E;&S7)I-+(D.K+BQW%E@2AXG[!O^Z/<=^C9X/0)Q:ZY1A:A$;Y^_1B:H MI_8`TU4R2"O<&FIRK1"WD?[VY6?UR0RHF7:;0B\KTMVT6VX.EU$7M&5%P;G\8FW#7-ODGO0(E;6;S;Q MY1#=8JI;`UQFYA`9&)]V<(V8'M6U;BE)AFR.G6N8>V$,@U,OQ15(LX7O%YLB MPA_H$JY#/YPDPTZ!J]5\J7YYQ/?CJH8@H"T=KUGJ"F7!I3@!0X+&Q-S=)U&` M'#U<[R/?38$L#AWB;AV(MP!4:WISQ#)GF_6,Z(T]Q32IDO#\_G[TSR,P3ST9!S M!B:=>1$'=FQA+\\)"EYIW,+BRB2UDDQ".SG,FK'55-6WX.J6>&Y,KU"%)W'T!*]NP$<@A3@O;A,4&9&5+'F"<>$=RQ;5<),F` MAT0CZ#Q,$W,H:3O9#U;L*5I,W`_I$T MPUUX6)B1)SSFLE9P5=(^W=@?U(`5`D;HUW?(RWWOI;_"'/U9)$0<[/Z M\)Q0#-%S<]C&$N=B4W5P[HGV:ZZU2LB';+"?A@_!#IS<6Y5HB0N-O4$..<%H^8Z)7!II6:,2 M3',H9-2KP$XQ(_F0C9WDQJJ=(2E/DAC1+Q"+R]I.'\-UDD+:[M9[@MD2_9#E MH3^-M3(79_R:$'V.T0!I-19*L")$T']BN`YS\&*;)@]AAO[TDCQP&=)3IQR3 M=_X$QV`T=0^BS.=WV!I=TBP_LV,Z^].!OLO*4>:L0!P!8H]U4.D.DT)%=O'& M'[EYI!*M^M-N!-H,G)Q-M$00(`6U`1'ZLU,T<)7!8J`[$KMWACK\>0EGG:E\ M)G,Y29Y9[[6?CAB\]++G.J6#4LJJ7-WJ!O*QEX7^(@Z6853DT]S.ZV-I,T3: M(TN/'2,7TOWRPA[N?KC"_4GH-*`49ED&4%'I+.I4)LK%EZT@E\Q\=C0(#D%' MAY^CLH;5;OD$P[M[1&GQ@-SP._BAP-5`+M>$&7-KV((Q,93$:NC+3$:![:F( M'7J46@N]K0OH`F.T?RO2!::'X8>%^H"YG<1-[K-7YO+RS%@'##&AAU-"A+"8 MGX6;`QI>&Y_UU%FRB$\GVWK*#&DUQG;W+DHRB3)5ZJ1I!%^V]Y^\;9+]&5`B MO(QJ-Y=`--3>OA>B.D7&B)RX^$^WXH^3RUG]]7[*"T/\8@!.0--3V8=7SL?! MC2R%>J>RJ7T.,_O:_,"$?+64TK)(T7)R10%+.)`_7FY):/KT":9^F$WT$>I+ M8?F<3E]"P6=<_1VO"^2V%DAHQQE]V,:8Z%P9U)\Q^Z70S03EV9&Z@?.S?9370F20ZV8-F^A&9!$P."[;7K3YU] M+$`28VD73^$DYX)RAE:#8%)11`L_W?$U;='F#[7^E^L;;BIJY&[YA&,?J9#V M>U*6>0HD=9DX*Z1(^A`H2U'UC!F@:`FA7;Y\.%EP^3E]- MDJ)CKU`_#R`SJ,\O!HEPJ.,4!9P.)SPV5I%%",#]$HARPO M`C]J.JS(&5I%C524_CJ!5V6=P++;;,R-DDH5R@:.A+#]NG'304O`R:XKPQ=" M@*:J,:A:S\6ID2M-5A9P!/>&.4.AN5"+F&SG4GB/=G3A0YD/;.GT34D$9^=P M*M*IG,BUNH.RT-'\#N-T\"`XEE.>,?.7[A%9/R21!_1S!/$/^);J)DGS\'?R M^RDPJ\379NA,12#AF_=-5WI7F>GC/)BLHV$6A&4OU\Z\B>&1A0D:5, M-FS'5B=+0>ARLKS([/S47*JQS?LX?J^XJ2$I]L`8-V;=/:9C#9+V^ M7"_+",=9&'NQC_Q%7#)HSRX)2K/HTK2#%A/11%M+A@I9\QXQG4-$"#MHZXH$ MPE?FSBX-46]="<9DOH9L02NR%N_\];&TZX=)95%;&*O0ZFSN_2DJM>U_]4_$ M`-<+D<41.KB$]+_G<;7R7D,?A@_>*IKDO%V)KTW`J0@D?BV!-`1IW=*YNZ^C MU[WKIFK3,"KFKE*(7S"IL%Y"')E94F9@D65PFHV`H23VTYO,!!6?.>&N=2TD M^L8N*4?A%XA8G`./])\ABG60(L>U\@0.O+$O^)RNO!W^EO!.VO?3`@9,F72[ M!ETKXT+D-[SZ,6V#"$J)GNWHD;%^+5)S5A(=Q^ID[N4O6* M)0P=EIYJ63;7=01'6:=R_/$&;Q[+Z=(GEOJ$+EG6S:>(N?471)5%DQ:BJE9^ MYC&2F=G%'FW+H2B;DE%=V:HPEN\2EGS^))T1DE\=TA8K>9.SZEFE>` MJ'AJAJS1'V!^XF7W)#P2P.!X]S'#$86ZCN3"S\.'R4"JP=U!)5EUZ22U-WQ$ M`6Q+$F"U8RK.>G5_Q_D1^B#8*_*B,TWF::)XYO+=%9KB'#FL.#^9U-VN$GZF M.A#LXVHURZM?GIY4KPSD"<8CH4(V/;`BT:E;ZNB(4%'->P>%*M,RQ%(B%CZ$ M`2GNMPP?<-V^O$CAY?JXR,(89A/5U%9A:SV)N5]*1%(S,O(OR7A7<#MNJ`UY!RWKM? M[W.=_`'7["NZ9TE*?/4EW"99.%&*DHC7>'Z(>O55D3`]WS6^'`_1;@;?F`O* M+LQ9P]X9@Y.EH$>C+?LOFX0)-F?G,5EC'&W.>-SGLSGC2->W.2LRD@B`_J_L MRM^8S6EG)D&`PLY,-$<#=F:U_V.MID@_4P?IFG*)E)QB9$``%!41<6L25=4L M\HWE54$L!R"5!./Z0"UUT8MW95_0K1#R>2EJOR*RWMUOY*2'^9GGX]CE;JHR M`APNUE_#[(@@N@!.&H*J9;=B@*,[X$)%M2Z!\T>I?XI'/'/D.VU@>@T?DN@! M9TJVB/,NV0GVNRIT;-;^515*@!#:$]1=00JNWHFI3HFI3W(-MZ57 MCO-P5Y-DQ79XV,Q*W&I%KOU:DGO9=3,X(35]0I7B[ MA>GF(O%B;8.RU]&1!6E+(3<9N"W`C1U7!>B=_3V3P!FCN0U07DW&,@A]RXY% M\Z"_V,QVE=%2Z-[K[?WKRS@G0LA`H>WVY1K7T\/51CE7@28X$.)SM7TBV2./ MJ.)MDJ;)([YE[WHU4E>D\-A'/'`3A!%[6%E"`R]8T-7B-ELBAJB63;U@B9*D/&MQM%R51%4P8<2O= M8-`XQS'PR\HW$28"DH:*:_.D#P.9&]TS6\9!X)J)[#;LN$=@'5XNC\#VA9$? M@9'MF$_=K'5E[V9R*U95I;PS,.XL6(_$2X21'FLCG=0]P$E;!\]9`^8OA@B. MD&H63HX@>=SG1[YDC$'<\\4E,\ MP`0Y\.KVW65C.%]YC+U1_4XIC#P*.;O'PU,)]@)L9U]@O]9!:_B19,9ONDH,R M[WF\RM.12X2H,A;'/C%(TC5P6G&5-NPV?]54^PK/N/!GR2P'?5G`V^0&1A%, MT?ZBS)T-M!+1>TC8S$:7BR*ZB%U`G/62^MJ\KJ4OYVA?TM%J:3B"'Y M:.E5(R:+LDZO=+<[4=4*BPWIT(T/F3YY:>JA'0U=/\[CDR2.H8\9?`KS^T]P MA1\:NO+2/(;IXBZ%I.RP$FC,*-L*%9J+*'KKNJ0%0D*,[(IK)P$`1JA)K/I;'++#C&.*?WY"?92?6QM)D!UB.+*.=4=,J%:R&2 MCLZWWHIZ;8=I^N=B0.KR,LS\*,F*%-["I_P8-?YURGK],G9VPS82241+;MT# MX"Z`].'5WG<$+@55MHIL]DR`:=2G+,"%=VM)%/HAS*8$E(2;U=<>A78.M1&OG(QS5--\5V&Y'UU;*1XC!V;JZZ,FD9KJ:[P(;-Q8B) ME=YCS@039&K8SKPP):&GX]U[\L`7(7WL9>%D+X?VL;1IXGID$6"/:0I(V[E< M!5+4)@LQE1D88.].LSS<>#F\7->,ZA\:=$^7XZW%WVHBKHYDHD=L2Q(D$0;U M!:0S8.$YCS<&35#`@E1[KHP#+%TD'`5YUO$ M;.U5]+=B@W[)7;]%I5Y&X60%LN/)*RYD7=$&7DTI%V>T3NS1 M%*94V43IKN;7GQ7;RJ:Z`O(.M MB@9@B!R`%AG`T'&[%MO6J'DR:\6).16?:D\B8N4*C7MRB*YD5;ACFL]E*]*C M/!ZB>(,VK$]PXFU6:1C<<7<6`H=LOX_U6\-[`@A/!,I6W#>?[7L\@JFN?1?> MJ$PMPKLD"1[#*$)^SGF/?PZ"(('EI+HS#'%Z$#[##4VL3J4O3 M8OJ'IFBBMRU+*G@O&)1T#B-,"(0-.LL=HOMCJR&*KBVFR;(L+7U]D7BBT#3B2%Y9V,OH3BC)2J-89DW=QU6I,Y$!2Q*ILFXPQ. M";\/<)+]=@_'^<`222.]-2XRBW-#'Z-'1:15([=_,[I?*%ZPGARS.#U3F6+Z M7[LHRMPOUI'VCN@`?&!>-?IY*N'R"X=T]-O4/,/7NX,<,KHOH M(EQ/4B]AD#R6+?80644W1\KVA\"C/4`*-QZBC\Q[03J#"/5V;>/'0$T[)7;@ M3!I[';>I%\`/W@9.N+'O\+"9A+C/7)0?@)L!TLYMJ;T^Q;"PX8YM0!(*>;%E M'WC3X4+&SNZV7"*)],'5;LB1=VSH`CX*JF21U#.]$`,#(1P/3E3'"L(F)XA M1,P#PD02J_?&S&04P_?;^1[2*FA_&'CKF9DH?4K$%K6="7RQ)'.'+VHKAN]W MSP^^C/8'PK>:&7OP7:QSF,X'PVUQ9@SDEJ"B`.\]3*&'&SXOCX*+"7-D=Z=J M"+Q)#;;[)$+;Q0R7A,YW'Y)\TCL"/1Q=%&452B.*W#&=_N1MD^S/@/8%N+/K MB[9ZJNW47I5/AK$7V]P5N%R?)!L,98)JDJ((`_*XP\V]E\*5E\&@>O[!3LD7 M(XEFY\=(41)_*V&^]=%[-_]%,YY<_V3/S3#*W1= M\&A<\!7WMG[55RB*S"$#M`-8U!;!_5/!O1II3(!TR`.7DKW4(U+YA+`R/:Q7 M(&BO](Z.6`K+RV.5P58EL'D-&>?7>HT5RUEK%&=K0#I2786*H;W']<<$7U'" M#P9>([]JDI")MA!V`R6ZX@D@W#1R'AXQU3JW\)[6M`R*]'$XXIB+CSCB)W%M M8;/%TW+N1H\XHD)[91.2V0M>[*"79B]=!YX5M=F'N<[P!Y<298A?A]FO9RF$ MU?-;-DT@E[?MPV9%N02XPTT/UZ@M3I"CKZVEJ/4,D2=3=!\"A1-B?J+<;ULK MV"]#_+AE/,GS`R9B.*E^JRZ?,-!&_PQV(8P"\"*,P3*)(F0FP1:F(,-QI#D: M3$50:*[;W$DS\#+WW-EK]&VD(29,]E(?XS!?/'II8+K'Z:=G]7D7#<$4-CEI M3:,,IQ6("O`(&=<'&*9ZY6QQU*;*V)`26K>HX53%7]H,;"U.L,R3S#D`"R[OODXW94;.4.K.U>I*"*7K;$[-&A'>H$7J%_V M&-=EL5F]'B^VD`V=_9$0U.X$Q-3$LS\[+R9,CY,"W/.>? M:M<@9F8]NTX@B.S\'B.7^H8.S^^5]=;.GY,-U^Q,OP0CIE0^2JI3LUO4>?QJ M1/($#H$<(AA0$T5!4':82SGO'G4TB1VR(9L&NZZ0LLG3`89XD/6W6""I3Q;Q M,SBT1Q\R7#QKTZ<7]K$:Z;B'K#+7,(!PXZTB>)+$#S#-<29YF^&4D0E5YC:# M^,I2"0,657_`$`#[6)Q)G5AM`+3#&#I396K#:(X3MRB-P&JU>]A//VSQ%U63 MJ?*#G-LB[OS6UJ<[%N/@]^EF&R4["",6\*589_*U`K$X?IK[=)N1E=>T422&*;-;-`6WO/-]:576M,)!L MT$/64UE]O9'R#;KO(=G+-E`IFD<;N<\Q$!:RDXQFN.I/"K03:YZVGPX!^XQL M[MBY$@A?;2&MRJJ(WSM=B:0JZD*#-\`!5RW8AXWCH'N3>TK,*/.V[`^IRB4` MUP7[B'9<)LI5U_[_^.V;HV_^#"`AY'9MTE4]BT6M*3)V?!@N%DR8A)M-.R86 MH\>8,8^WN[5H_6H30&EDVV;7FLGME\/*)#I525KFZ7O'46D]DZ1@A(R/1Y`_ M7L!)/>@.#[N''6WFPC,-VNQ[YWZT2"/M8PG.H(;4R-^2I]CCN[*@TJ1P$#.S M[`L)!1$>:)3MJSKD;;0XJ8C?I[A6/7SI>,U#.-@XG6=9`8-ED2+R5S`-DX#< M>&&N\&>G3S#UPPQ.46JQ"P9.2VA1-XWZ@[6N#]-IDQJ`^C5)%Q6 M%M)58).)I#,O1H5&%L$O149#Z+?)-<0C"2-8)E3>)N@'+,-5FN#[?L'Q;BC\ MQN1G$Z$CRBT*CS8<\/,(:<6C20%&OXW)DXL([=N2$WYFFP=W-[O/J2!5?Q!C MJ\'HFSFY1WJ#V7G<4*<1XSA@8S):5EF/I+6K&GIRBX M01,'5MI(K8VMUI\JPTLKY-T0ZLI:MTS,Z!K[_DY?>&$&18-)1"TZO_Z%2B1J:O).2P` M8:[HYOJ7X;R97HP4L/N0Q)AC8VOC8*A5'(F539LYCLCZN(Z3^)!@FUG!D<,H MM[FS@;L9=GJ_`(-)-\W9/"ZR,(99MH29GX:TPFD7Z"D$,"X=_>PN? M\F-$Z]4(+?Q(L-?`SI@<(0>=IQN9884.K MAC-I?B@0WL6DAG.<+WP_*4@*Z542A3B)=%)4*W*V73A(32R1*6\Z@Z8WJ+H+ M\.KD'$!+[ZW@O_H$F=@_3.YAFY&GZ+*2%?7%5B&R;E/]L5H1I86HHB=53 M*S,9!1@NB1T`EARQP2Q!)IU^3K`>AAL6Y@/F=%"Q!:;^FY^@+^UW&)P'R.BC M3PX&940-RY2B?[4C:[AH(0QN\27(:0WWR"+:/>`=5WB%`DOL-O&"WA*I_T.^(SLGKQDB>! MZ(XO:GN(O/$-P*U%?HR3RYMC83^%^4G\*&5G^L^9I_KGA3%0T6R'8P:*.]$;\S/QR"/!#&C1^8E4VX> M2F->':]YL%*PM]#*G*"=S6VHL51N=J6FXBKXW.RGP1(_`.S+U^2XN7K[>IZ> M]G"H\7>Q@^9^B)O$YXM_FRV*_#Y)\719ZA/4(0QG>E\)-\9Y9$MYY[9&=<@J^6=L#?+.>NLIM/SRY$6]^G M154,6`:Y4BYP7?8[DCE[O.NLP>0)N9(](U#GH4MF$/:^X?%%G\70HWT`K`H1;'$OUSFREO':_T%/HY>!'_2J7\J5MI37<..%^(TV7"86)\87 M7H1#+V\F^[@M#\/V^T#VAZCZS:<5`>`W%,@#]ZZ+:;E#=\<4.%"=>9+^>+;K M',D5QEGHDV(M,U_8]X2UFR@ZU3!$J71W=RF\\W((PJHY>,#M/Z,UFP^^B59I MSJP/2LP>*-D[_%92=A[34DGOTB2SN#4>)N9S&6,)CI1G<4<(WY M=8DF=L(-;*8ETNPVL2.*;_&1.P?#4_]`9_E]C@]3K>]V9#V00XB__,?A(?CY MT_L?O_S7S__TM\733_%7WP6_?_-P]],N_K@L'M]]DW[WS0]O?OEXN\NB;Q[\ MWU]'?\__Z_?D-#S_GTV^??.W;TZ^_NWA[*>S#W#Q[=?>V>O=ZN[>\_]Y_V[S M^W*U_.WBRZ\O[L_^_O2XW+[U_[G[Z3O_]_C#'?W#?_7W#S?G7RZ^^BW)TZ_^YYNWV\>KS$NS MO]]OOWUW=[WUCOXGS:Y_^-O;3VO_Z_WISP8__W!YGB]_B#[]\[=\\?;?YV_M_G)]M_P5.;JX/#\<.QFMH MN%+B\S6%>B-PL=NW-KJ>HJ+/WQP:H754BZBO#V>[][,D7<,09]K5PLYQY\`3 M\[GM'#AC$);!0E])%+'?XBR_1'-LC;EQ$,VKPXT#1Z1GMV3JCN$Y;B$TQZC\ MN<[R:YT(M*.NG"8*,:V_-,DI?/D7G$SSW')4.*+/8XD=?5QR%Y@DB'DY>(\^ MOGOP]N@`8"W,<2F>#*N3)ZL(=.(N6841:'8K]4BB6WT@WO+@/IC+`CNEP MZ^AD[&P50[O3M3?SRV"Q/S07!1QF,O9A!F-.&2[.OHC^K!_,PAE0B\0#_2`,/+6>S6_@]@_/7(9ZWC2[D7*")_7'HY///"='Z7DD8? MW/@Y&'-8Y7K'W;\,$FNQ3*+(2S.P1<8EPX*]G'?"ANUOPH594=/M_,S.C\C' MQS4+GZ-GO"?[9^(9MT?+YFA@GMO:,LOLN7Z_7?'GF'LY MWO">=]KE^"BU\S7SU6!])?Z0E`)U!6ZN8].TLEE]Q3IRS^V^T0AC$KW7TK0[ M`$U-L.N;CX[>F'6!SU&^7UU=V+]AU&MAT!`>B,OPF>W:-<;UN6S8U8>L8A@J M(J"D0H-_`-,!F!`Y'(;_M_;T^A^+'3=!4_.F_L.IE^*$KPRY(D302<^0Q=+%Z0!YB]\OG@`G5.><7&$&(GT>@/[?:GP!\"';_1OX@,L[H MCXM51A)GV\C&;0A>7[\MT2KH9<=MX3,7%QBF[;YW=1HHGV&L>,F`3`)EA-P2 MQLDFC+65RNMG)1(LXBY\RK%N^;VC3[]OGFO5BD8URAMXBS@/`VP/P@=X`_TB M)<\2GS[Y41'`X`Q)BEV[(B>>7=>D6%K,1I/2\LYH]`$HK(`L*]#P`A4S@.$' M&';\95.^1CI>),=&+7_]'%5IIEN4@4(L-OC!Z"F^SG$$LWI,.(K(HF*HB/9A M_=UE-77'CN6H\&D]13[:7`XYS3N/_60#;[TG2V^E2?G9OF7X&?\ M=V<6A#>1]2:?%7Z00W1U^1Y.E;;0$+?JMM=L9:JE+=P>1G0FO^6JM$8Q*(4- MIFBM>'>%-`O3M+P/-IW69>PLQU/$DHCL.ND!WH&Z3WGML(,79Z:]7YDMX]XS M!:9A!E(BHVOBQT%00]RJW:C9"L!!_KZ_*+C`0&?R68VW1S'$;KP/XW!3;*:S M%&T&MK?#+>X"E9=MN)^_"\US5<)JOSLH\QWM>^]I8OVW&%C7/\M=I'_:9C[Z MYZFDI?_.H,SU?Y4F6YCF.UP@*4=;3YR%LZ5I.K>H^U367X6MY>VA@D@"`%4] M#P#I2^(6=>\#@'MWMADN@*6A:Q9NJA-CGBN3K/-''/^-@^K')7R`44*XD"?8 M)_1DE9E;?=-<52J1CUMV(EBL_\&0`(3&;&R>-@1:_J_69!G$S@'8%;%^W^V]- MG=5!%\79&!)]S;V<9,+>^##VTC"9:I'E,[)JQG@2"/,5:),Y;+ZD*FJ9'N$` M3[W ML5D;DR>`*$)2M7(?+Y--=:U2WJAT(V(TYVZIH9KIH!4O?[O$&RUH4?D#_`KA-]RS3292!HXQ6.&%_1$;&&%-!VOI2 MX_/>ZV)YE]7F+E`E;D""2,XWYI))KK]CSI!,O=XKF*Z3=(/K+%S??-11*J^C M=9O-DT+TM39-\67T&=ALV=PWNA:-T-1F+\O#RDX5?_9BZ(1Q/RW^5H\H=203 M7F4I#[;;A78YM1$=1VF&H(%=5+3G;,B9Z56:^!`&&4YH/L^R`G\4YW&8AUYT M5:RBT+]<(VG0-G*BDQ-%YC8#/5!H1#"NCB-8ZP'8# M93_7OK624EMXZY\&\W,[G&>$00R#98$Q2ZLWT5*Y'^`C^=-$D6TESM8?N5`2 M2Q3_)CEHM#>@W> M2?-P%<%VFB5%*T7QQVT2TX89RFSK/X2;[A+P'B#S4RW6UX3H+ M8^3"D@?R,G)W"??%5Y;P5TL=]3.X[S$+ MJZITNMG"LX"_!)6@:0EP4[#ER+#*X+J*+\&$:=.H),)>,<)YP9KGA-25`20%"RW64 MR0052AGCPHDS-JRT[O#E^AINDS3'U8ENX!V)>$T!5PDWF]LLL1CBDG55_>NZ M"ZCZ.-_:]^N0!5?/X`=L>XZ++(QAEBU\A- MYQ#I,Z>MD&;=:HN6)\)9"@;6;6D]RLJG$U^;V1T4@`2YIUT/2%S2=`>E]T&S" MUZXS/724S6)1>6X&[),6&[3Q*L/EE^L]-I,8RAZ.EN-"? MZZ"/FE);U5[[I\%X7;Y`!O5RO7=1A):].$[2-'G$)S'>%OUEFEV)%G^K6Q,= MR010Q"0P!/>N#QV`JA)*30A4E)QOL4T`P8)5>]K,-RP&H%6[D";#G[T-RQ#D M[5]84P&Q%.(S:`%(>(Q0=7^F11`]$!8'J"LJO; M`V9530FP(YB)D2S2-=J-+&'FIR%Y5LT`-?L4[#WF(I5#T>;@7H#IYC0RHJ(9 M`4IXHSUMRS.52Z."B[#(G\\'1A@01[)A-`PT\7^EC M7.`G':+HXKRGU;$?G@NQ^6/3!N6?N!I4< M2_Q?[Y,H@&E&W]F]ACA7'-)$\BWB/@5V5=C:?@2B7R39_:RRYY^\;9+]&5`" M&*J$1%E&G!!Q?R=+3=V="UD*!=ME;D10JK MF[%3@%)?"*OQ/6WQE&YX51FSY%%YVD89Z$_V2U<*W+;=EDLC$GD\S`%8UCF@.$.5CM>81E`1#@` MI1`'H!8#H/6ENMA>2T$O'[N]K&$3]"V_RY:"S2L]#)3P'6J8U^)]@N'=?0Z# M!7(NT0:=_''IY?#,"Z>[GV]["%;++-L=FP5C025B+44E%2C%HDT`%@Q@R=2J M%SQ'LV+X\8QI84P`,B3!*")_AP%?[@EK&"ERMGU;4DTL4>91U1D(O]!N=2-' M24A:BF\E(ZG/D/EUR=/--DIV$-X@MSOT(9_5!UR&(<.?!_Z`,K(6LW_'B:`? MDOPGF%]#/[F+P]_+>@[EMS8%K.T(;G/)LS(BP0=5\08E<^%WA2OKE!+0%2X[ M:']WB#G8P1PT[`_*(&(I@>,`C%7`LY^S/?4.6*8F$Y(NLV>X-`7Y%6YW]*SL M`G\$EC?.=D>V&3V(R)I/5>K'&B09B87=,6;.[XV8'/(,0VH1([FQJIU*@^2;A&I%- M0S\O?8T)-ZL"3G;SGOA""-\.JAJ7;BXILQOFO`VH"_C*===Z@5D\;-,SE\E6 MK&?E.=H];9]L&*Z\P<_3Z[/JX(UV_G^%D'J/)$*^XI67YJ$?;CU2?+N4_`H9 MD"$Y`-KT+2;JFTNIE`FP+8F23<^6)0M@]8EM,6%!,H#;=`!38/!2`HRFU_B> M0((/%5<%)B1*^Y84W^!TM7G=B"N!I+1&U9B;4NVDBH9X[EM5,P2C'%(AZ'(+ M4X*KBR3+3KPTW:$OC]C4*;P+"3>;06:Q&`+4U!T`[@%:75S[MOT:9%?7GJ$/ M*Z6>)5$8D/7W"OWD[V[A4WZ,>OTZ3;ZGA)_ULJ<28<26J.ER`&@G\'/Y7]P; MD.[.WW!74>Q>87/Y7!@65";ET<)-6;'9B^HWFJ5@$RQ;RL1LYEBJ"B5`5-D= MU/U!36!.N#)29KT.:LV1Z9;]8P8OUU51TTE6PCT.5C?';=X",*%&."&W;J9H MH5P8*+ZV6)/$&?&PA^)"Y)63\"+:7D9>EH7KT*=ARKJDLW`#.%:%94T9;"^) MN@(*0XOMOFHX=%->V0P5[0K+!I-F'M.^\2+T89#])D/TG'F^5-A5X6M M[63L?I%$!T"H)[:4Y8TH;B4<'<0HJKM])J,R.4/>DLMR!'($]Z3 M7B(QA/O5+"=V#G>9[RK MRW4=$SJ/LSPMR-LAE-<4`%5C;#=I1TDF40GEYK(56N6;&"+3?]:NI1806J65 ME2?--)PH?#?)@AU5YCV71[C4[&C/^UMS]4YUD:#T^M:H]K1\=(F^PH0?[[:U MX*LQMFM/E602Q85H7U!WGB\JM73>"@\ISX^IZ?P`'Q<^>8P5DT^3&/WH0\8P M6T"FM@RVHT>Z`HI>DX./H*$#VH1FO?:;HJ3U_IS))`ZX*F0"^?D=4[G3P)1(FTI"VH&X.?:?-_N4V`E2FKE;PJ'.J0S)I6-<'ID,+E M8WM[S9%!L=!O!RFN]LP2=;7VQZ*A#M\+-Y$@_.SY8D,>,Y\..$I\K;XDI"!0 M_S;X/?1PSPW7#+G=XRHHF+O%[9L/TP1BYEVL[!:_W4K_5RD52]37ZO,7`B%$ MI3>8UN`%;?\2_$Q^<)M7U:.(.HU*-EZS9RRZ%"_"F,`L,X1!T]]B-KE$##TP MX&Z`]',5Q%55BP04[;&/_!1M^9PHG&YAZF=J>ZO6*Y'6V[-5UYDL3\HZ[GEM MEC,CACG#+**7,/?"*+M*811NPMA+=QXM+H3^F*SS>[3:XP?.O/*16R\.HM`C MCY&&,$-_*S8P,%O5QN-L,QMYDA$HV="2VTMP"!B.H&&)3R@04T"Y@HHMB0(S MC$')>78K\^A0Y)KP<96F&\&;1!QSEV)<[O9N7$XV!D=?X@S=HDF`.=D7R7/) MS*(%PB=EL_?>+TEZ@M./\;;['#"G+->Q&$,/A8/.T80=^*/@+N(/Z,/01P7 M&&ONAQS*]+X?D8D>D"#_81$ZK-1>F&($\A8KT<^_LV(": MUI,HIA-M7#E0\4-/Z\JCY),OD.?OT>*&8SM?/9SLQ;9'D7>L!:CA4JY%F`^@ MC#K.V%Q7(#40Z:Y!"@HPW8`.E6`2]TR!VQSW*?UBV_E6!(&7Y_?1#';>%#5B M?D$7QP>J^AS3Y05WN5BOK]<101;KJQ%G(=! M&!5H^P!OH%^DY#SQ],F/B@`&9TA8C.(B]VAQEU,OQ:_59UG\FF#'!K!`.RX*YQ7/`]W*Q@.H5E8,G;S*M@^(I*!^(6\XD/<_30J@&X M-Q[C>%-X%Y,#=?3=-[>]\-@*LR-1NZUQ-)M-]H^K>*`904F)"0 MTVPO,V4V\1NM63*\?*+"1#-^J4719CJ.EF3#H>?:H3;7KQ8$QW&*;WP8>VF8 M?(RS+?013QA,>%0K9&:[HK-($&&@A;8_`$R/^:R/O4ILQSUD8Q]^OU=[H11V M=GJ1QN!&FO.#P#XUR.Z=##^NXQ#56\&D!)S=^%="Q% MR+Y+DN`QC-#$!66IVG;BLK;MT")HSY[HB"7`4T6"J5[G9+FVB5NV9KG0C85)@^^:*2[$Y-)H_,Q-YD<1WMS#=+.$JUS:' MPL[V3)](!`&D+7W>X]9[,CA$ M$_6UBA^!$,*7=LFC0Z3YW#;H/:I@'M(5CW@L$.C9%5E_BYV,% MQ4A@T;4/8ZLB2'SRU@JQ2MQ8[0:_+_`[OGVY7L(U3%,8E`^W MQ'?X03_)8A0^(;CY@00)1PXEY0T@+KBACP,36'YEYSW-T0K\F\C9VJ MT*M=M"9MDIBL41\*G.%QN28I@=DUS&#Z@*1,TO,L*Y"D<._M6YZ6*3EZ,>4` MQ(0BN6%,:.*[*X0H6"/A@_W6RC9`?A51H:@&!;4B4ZW[)T`2P)@RVFS,>!B_(@YE,B M0X/9]#JQ^2<)R8A`37"J\&617Z7)0YCATZK3*+P+25F\G<34%S%YKQ22QA$$ M$)$!29$?(+->D0;%%J$DA9Y_C\&P3>%A`'.8;M":%X`M3!%@-O@K`1N(;W)E M7[@%AWL/ZV\V`QOO*=P4&_1- M[Q"S"&NL[(\^Y*#PZ4H?19GLDA:GP*$=YS#H3AA7[:)YM;_&MQZ[>$_5=IRD:?*(O0]OB_XB_IK+IS[6 MU5,?E=I7%0'@EQ2^<.BMJ8VQJR>-J7'Q>;;$0]8CRY'KC"0[]B)L&64?:M*T M!BO:G/F\_+96W7Y3/:/LT9IH6AQ_9]=>KN(L,4VJ>KYPO88^N?<4QF@]A%D. M4@_OE6*)VAQK;6^T/2KCSHT;3Z;1913FLF'-:!!9??3'=D M'6V(!N]@]5D6\#:Y@5$$T^QR73X,$51O1F"QCL3>?U!@EP^4W;$2ZOKDJY(" M4AC>$U;ER_>KEI?-G>I+.@-=W2E,F/W/Z1S;J7!3OZ]\@YI"P=NUO(^L[,\\ M2UU3*-^E=!UT5QL?)]RJ,S'V%5<6R,INDQ)*?9]>U0%_>.7G4W]L3ARR[A`XP2[R#`=U<:UHM/>/(8E^?$):^01769A#'/&+8;JX2R&4@:@D M1H+C2*](17Y-CFKYD1(DH51$$7@529=;.*,YZ"AUP$Q:/*-L%X9>/(5"]W2_ M^#5NZS*#H2MY=S,@&)R+X`=7%-ZZ%\8D5$PF>;4#?JNCT\B&Z80?63UTO[J4 MH9@4)-B#KA,_CXK9=>-8\:T'?1CN/&BB/[L[TE28L2/#M\6"!^Q$(-?LCE>_ M070!K=/+YN.B^\Q%%\V:=N!GVM+QXW6BN6Y2#;A#TC8-'R.LSN^ MI1'[&]YFE88!6X*#ZVQ4S;JHM;_NM47N+GJ\(=E+@#Z)DGZ`EHTX-L"!&Y%( M\,D9C4UON$EP*-WWGFFEQ[WT5+?:[T;$<]/1DJ&H\"YO"$;_O>-R)L5XNY7.[7,YA.BLINV<"RVD- M<_\ISE)N#9:)CYS\99A"_-_=%WZR.0#GL>\V!*@TGWN[9/7M"QWS31*1!)U, M8PO#[VG-%^2R%VQD:%M0-^;M9NSK53;SC9*%PS14^.D_-'1<-[:ZGE1<12_+ M_&,&7M+^--8*:PEO=H.%)E9/\#%>TQN?6=&@QJ(*DV<#T&CXDT0/.]-1PYFE7 M4/<%_=Z]`Z4I#+"C+>5)L7\,KR@:S\$M]>4USY#A8]7'^]"_!U'BQ?A(W(
7]A"(ILF@'5A`DJ]PC%Q+6"4YEQ_JNL[.R`[`J'PM>3LSRAF-@YA(1PH>8,M&[G9;FC-I-6?@JKF>=WWS40Y.IBU`C><`4I[X MG1D6C]%!&J)`%FX:*&J+AHK;'JY(8174)7.YL`V:;IO&%M\O1`O5ESV`QB6Q M<#.NJ^]@>EM2=R>6,R@GN^6N(`)'X4MRT=-M#JKNG%H^?KI*RS(2ZD>O=9>^ MTU<7&;_"T72GOF_DUG/`>B3BVFB^+MPY&R-JX,A>&.<:XA3W`*9RY-?-9A!# MWQ.Y,[G<(5DN#DA]RP6^Y]@;#FO=SZ^ZS&([+1Q*9\Y[!FW?W9,*Q+,G7"VX M+I8W?.YM^G[5-E\M"MQ$CN:4U<$?0V?.94.UOGJ*A>$!O3OO[DSYX-FVN%*6 MMV<6V5/8$J"N@?0';>0ZP[Q]<1RFJ\^%DHZ0F'._S MZ%&6NV]E,A5U]EU::4!$#_@5TCA'7^9Y.E M`;C`O=V_B4;E8N>8-QY;(9&*-ZV@>I%D&7WTFISEAO'=974M.CN&2.>0K;2* M?LCRT!>7/R`%9E]@HB^K5\D:AGF!!#O']=S")/@$P[O['`:+ M!S3@.WCZ!%,_S&@11^%6&?,H0_*M6N>L*/@&*]NP%`<0>0[*+1Y"%B,3SF>@ M4AV`2BY0"@8JR0`1S?6CX;95P<.N&SAH9T4&,/PW7:>86P^TE"Q3\JSMG[!O MDF30_^(N>7B%Z.#G2+[$/V#?Y4OF%1)%'K;,N)HXHM1(ZJZPMUL.Z)>4`::W MJR]`3YT8KQJS8?79F*J`]35\@'$AM'95,U"V<_MLS)[0/+O`'9=^PGFCMD\P MBGZ(D\?X!GI9$L.`%+:0O'6O]\F*R-O_6@62R#]4W.GP5]P+5-T`[>\2^5HI$@$N(?WO>5P^;IVA-0S7X$4;'_2;M(#!15-H3>+W$BKX M407ZTTOL9U0D04F3[!1+JH`AZTB'P^9"X.D:SZIN;84&5-?P+L0[TCC'+UF- M93'VJ%I!IXB[W#@T;AM>*(`<"'5C0%L[VTCWZJ4-!MX@;>YYNV:+O*QZ@NNCQKFY_:?/TI9D M!`9_+B9?,&(U*R^=+I.0""&89G\3;EW/\4DFDJW1X*]9^@EY[&P1*M?\,MEY"R38=%)(3`=%7. M;FFY<`>`>@#'&M$])E>&2CM9J@.K$R^X7<8#_<_I;$3YX$3YLH:9TWP$7 ME[G+[DG,B?S`D#FHEA3.QL5Q,$IGW#PCH3]O-G>:]+R_1)D\C>&@VCBZ/H9L MR2Q.8F@-RL42/^24\AVMI3V7\VHJSO^EHVIU!4QR2JVK?ZM+P0>88W-V1=\Z M"(YW'S-<\;U,'XGORE1P27P*4:!K0$4#`_$%)H,P]A+4E$!#RC6BU`?-`X3N ME%G5)Q,AZUD)F):S60ZZTO,4(!JCY86A5OAI^=2(N"A`]0E4+9V$VH1R\^98 M,#BC>-L"6<2`;-DC;X0\F38Y.SFB';ZBHN55&X`;.=R4<.>\VHET1V([/[1W M416MJ=COQ@G#69Z2*%!&C@=N[[VXG1.&+3)=<"<,I%!A`"-->2R3(WDZ&8+T M&1DJE..-D,7I-W*IQM:^U27X%N__BG1'TL1(#$AX=ZUL627)S2/PUI6?IT/1 M*"TOPG5><[E.'<,8KD.AT],DA5=K,7A1=GGI-B].,!#!&:EXS(:9#E54G7XU MHX49^60M9CIP!>@[&BD#6)W8HJLS$:Y2]L]#NB.T&GPJ<[&NH0_#!QP&1]LD M81"JREUK6A\`U-ZI6\P=`3A MQ,WSF5&.#W?,&FD^DCFS:D[KG@`]5Y1H8T!:`]3<<0J<0"E[=Y`X([1^B;-\&E98!8>T M.:#72`+'O@0CKS`8T1K/D!N"=/6ZAO@QYS"^PT^9CY%H)J5N+P0J$Z/G4RL= MF+H3H+UFD$8NU]G>QR<>NFW?7W`,=1;B9\;'.+FK*>5T>0>2D)%E' M^?%VG.X!*3GGFW*S65"+I:C/I_6-0R?%FKK?BR*_3]+P=QA\Q"57F5J4N,!S MUK)GU]@\,K:OM(9[)I"6;\4OHB0QJ2A5>!$N`/A&=P&L:UB,!B MBLN$S,0^*E0.49P30U^H3IM9PLQ/PRU;-7*$=":6JK7K8SSNO;E-3%MW=PAE MVN@D.NV/;J`W?(O:C><"$VJV[HNR3/M<7=S&^>$W.]?[[FP]"+NF5Q!'.(\? M<&&]$4(O-:7YAUXX@]8(O0BGS&KHI5PP0&UJTY4_=R M$GNXQ6Z0V,:MO6Q%1E%VQ(;NJU2TR,#$U,#,S,5]P&UL550)``.%8E)5A6)2 M575X"P`!!"4.```$.0$``.U]6W/CMK+N^ZDZ_\$[^^7L6C7QW+(FDTI6E6S9 M$R<>6]N7FW=^='KU\_N*'Y$OD&SX,/L^=$!P] MKOT@_.6['+''.?:_1WAY_/+Y\U?'V0>_2S[YTR/]1>'S#Z_8IU^\??OVF/UU M_]$0UGV0#/OB^(_WE[?N"JR=9S`((R=P*8$0_A2R7UXBUXD@"CCX.FK\!/W7 ML^QCS^BOGKUX^>S5B^\?0^^[?R7('1W]C)$/;L#BB+'^4[3;@%^^"^%ZXU.. MV.]6&"Q^^0YLO=TSBN'S5\D8_TE_\R?^D\@L1#[T*/HGCD_GTX\<-XYP_"_33/XY0EPJ_X66T9 M@W"J'U-JCPA!$(3$$B78R.%:-Y`VCD_B$`8@%-#4_3>.,WNI1<)P&<`%T?$@ MFK@NBH,(!LL9@<"%0("Y]F'T+9Z)2S0HA-2H"G!7^);&Y?$.(>\!^L1J>-?$ M5&"R!3K!$LY],`E#$`EPV#F21JXO4;"\`W@]!7,!BU/XED9NR"I;H^`V0NYG M,OD9^3#`&'CL%R+KMF44O0N&#GE"MF)F'XAQ8#N\P$JI_[Y&1*]`=(G"<`9P MB@HUP/P,UG]=F^%+#.F=\RAB7O)?TKAIK-.HI6?FL-G"B[;8-H7/=D)_/A&@8.WCF^GQXGT8*( MUF'R=*A^DHV.R-N'SASZ1%5!2/X6KX''V.&?D@9:VM8L/51[L0_0P@,+&,"( ML+8%'MRKLW-09P$=$QE5G]-Z(+N(HQ@#9XUP!+\P?,$CU77R)VU3$Z:AUQCL M^0CI@D8;R@"+"M&#G^R<&L'.S)3Z)CQ&.-L2BR#]"SI.=!/R;T`D`\!.H!^L3D"O+? M/91>_0=NC)EA!(^N'WO`6V"T=AW?C7VV&$-B?/:L4"8V`+ML"PGW6XB`=+20 MT[B*VN(`4Q`Y4"0XQS6:$3]1F-6Z+^N#MP72:RGJ_67RIM0ZC#^O<25Z8QYKOZK'=4^3&]`@_";PS8F.BW46P M0'@M&-EI'>5P)MB0?91\BOWZDG!5X!<\1B`@5CSCF`XLGW=)I4:($G>^0(>Y M]PAG9'QG#OQ?OHO#9TO'V?RYSR5<+\[)>2!PH>//4&+=)G/B!1`GK(AIRB'+ M7"V<<,[25^EPQQ3K8^!'8?8;AOZSYR_2+-9_"M%-[;W\I-(MUB#[Q5U5GE.B M'N""_!@:Y?9`);>:2HHZP<4).-C->"(_%K2TFL%,/W&\82FU9^X*^GL%I^Z* MG.)%J%FV"'L`__+=B^^?JZO+K0O(D1BBR2,T*X<"H0/;-L506"JU@!?1T8%[ M.N!]0%Q5EWA_P)NBM0,#(]@W$CMLT99%4*=^!4DTXY5*XWDBC2%,IEN?FUGO!Q M&F,Z+?,R*A.R:F/K%;,JI0HZ&H0ENYA.G7!%O%OZ/UK)L75\FE&:1*<.QCMR M-/_@^+$1SXJ/<-Y*#%*BG/CE=E$%"4LNR23.$MX`%Q`&B;F^`E&J@T969AL] MZ_XHQR)MQ2NWA?5J6*4C8F)4G)^412)87PU3&K_J6\0R#C0.] MLR2Y,TD#>85-PX2`>[F>\DT3ZREV^HTWT%#"VY%GHCD%T[7JDH_]FW_ MY#,\QM:`I M1(W5J_,.-X_,%>*5:8QV+5;1RF2G$A.2$MP=!DX8XYU9T=50&?6!I0ZU3(0B MD:"WB0@#L*3WI]33-A//8_=5''_F0.\B.'4VD!R&C(1V&TB-6JZ-^&7"M1`D MNJ'7#0/@G3DX@,$RG+ANO*8WK(%'/''H0B,N$`?5\6Z?/)!F$E>KP-/E[?;C MY8Y[\=:AEDE1/8QD)H]N(W\^YMA#-YZ9Q"7"3#6!PY^/RU>FLS_T=Y6ZW`[V MZ6;UT\WJIYO53S>KGVY6/]VL'L1D+-RL]GWT0#?(?/B M:/-*<)%'QE`XB:,5PO#+P;TV)^,*Q7$LY2[8-!2MZ9/G11C&_Y,F]LF4B/QAQJ1TE"XIB.QWHNM;:4W5D'665J5XC1]TC3KR[:1LYP$ MD)1DC1.KX6*QK2A_^?4T!*\4?N59%_BMT_ MQ>Z?8O=CC=VG%RB-]D6MT!C&XFWU=:JX:+DX+EE'2)]0AB%QF%.VS)005JA8 MW^2:M+-8)5A%QYZL;AT?A"D?MP!OH43*%)$S@. MX1R0D$]-:"G8N][09^;)RD[;,QK=IIJ)#<;9:=VR6L"RUN/B%(71]<+@KE4D M8'UU=2IL,9Y2`,=:"O\6^.37RTG@O7?P9Y!CW\BVU4S-JE\H)+HVR&QDZ&<8 M>;$;38DN^8AUU"R*KN$5IIJOC6,)U-AKPU#"!E.(); M8'`9=9$EV7!]*+YV$['R`DOQJ(Y//G&IHR[_E)0J3T<6:C0LN1 M&4@8B<]-S,-CJV_611`!^IILPDNJ0(;.RXVTQB"U9J!LO3K`FE-1LGY($9%Q#5(2-4Q-S0FD1$@V#K/. M49'`2,150D6^-$E3V^_L0GQ6M\@>L"?'I&GRC+L)N761'$'FKA,U+95*4@+] M".!R17B8;(F-7X*K>#T'^'K!V,Q5Q?4@9TE.QK"QRH*LH>U6W]5K;$Z%&_=W M9+"7"+_Z3J7=Q?Y^<-]]WG@(:ZA8>JIJ:Z(RG(V:1_D$:MS4Q)"0/T7K#0H` M?:?3=*E;+<&!&-_N&J5ZN,I5A\HUV^\!M>QFDHIE(D.ISV[3Q(92[0RF^FHW ME>MFY@102V(=2C55D'&EH%FI-$'9F!&")>,=0B52Z>U-KASYPXV@F. M3#`=Z.4"VPHB*G>7,R>;!DICVSJ:`,L%IJ7WCQ(/Y@K7ZPD-(WK!*X@&L'*Q MWV',I_^B]6^W(R-?"*2E$Y]$==D&8(B(#^/@2"UQ8/K&<_6:\^`%57>S6:)P MK$Y$"@$@HCT)3],8DRU@QD9G5^C9WZXW+#]U]@BP"T-#LA1F8B#.3_?"%(/6 M5F5&`ZN)QMI6@S8N!G-,E-&$5GAUU,%)'G/^BL.(SBF\0PU>.^-\[A!&J<<" M@I!A?@/(]A/"*+OCD4MC\*6RE M/C?ZG/0_G_?HI@]=4O7PR#>W25S`L\#3YZ,;DM<(FQ&549$O#:F**9N_K;8G MU.QCL"*6'V[3:C,]V>-DK$E01Z&G/#(7"T\9Y6\DHRRBD*9SRZ?$8,#HW''I M^PD[4PGE&BK#$4ACW+`.&Z6>-><(KP&^`5OD;\E1JSA^74*@X;H4[,O60,%4-7[4<%6^'M&FZ\G&OXJK0L%&;RUC6TAFV#6N' MJ)0O'K;+H3U5>>J$JW,?/;#;/?LKEQ,W@MODO:S:`U##8N8>;#!`UYZF^3'1 MTK_I*:[8)C)1!>V.,O;N+Q;"VS0V'1`+1"_%4K;N$/F!3G*&T19ZP#O9J2Y# MG?1LK509L6O%V5Y_KRD@]%S(4"8_^X#!'7B3-<(1_,)^;V+!<]&UDDTRL(#R M9H(/<(LO%Y%YA82'FA>63.A!*SUK^X!A'6@'64^K)/E$QTDY[VDLX5&E9.DH M9EC>3;!J:E9/[]:`$7)W;R%R84@P]X7>DKS19BYNRH*M.3I^OB M&.1AZ-=FM'+R]6@+'_`*O<5-:$NFVP:;57<3M1<.-J`&%41U)?(T>A',?J6O M:/=N%IJ(?S7^1".Z"@UB2YJ@4P^NR.'(IBK4T_]Z]H4VD!5:&JKO!I53\'U( MC[0UQRA#&4%>ZI8"2HK)0FYL%38(E>=&"M.["+:TRZ:>9'W;8"-*UK=B8C&( M3Y2*J%&TF_E.$!'+1"]2L-<`LLM.IA(Y750MV6Q!/2XE:CJAU%.6(2UJ%P"/ M36T*V=2B&(/KQ4D<$OT-#;7FYR$[B%R^N+B[X=2PLL5>,7%VV65%EZ@?!ADS M7(:W^=MC$E`+!OWGT/;:DC)UCC#SX:9@@T)H*$W>1&N$-K41-@E'1W<#Z#JG MK&9^/3J\==2'X/`*2ET$6UT/I:@XO/NLK0Z'MVVP$3F\K9A83(/EM^W>FG!T M$QU&%2N'(C>Y0.T=-VS4(=^`3;I[T/J*N:&'F4LT[&>N!6581O22ZZB/<$F+8&O)2][?;R-\,HL3KFA4;.OX5%V3EDCE)(<)11"B M/[[U+P:OKJ>OI!VS>G8G1)LQWI%)&^MHQD=XA*:`$U'5WDB5]ICFQ&^F]U"8KZ-MYL?!8K MS)C6]I M*U;0W;H7AQ.H+$;"&KIUZN_K3Q+=8?F*G:X:0]MXHCF-.>[S,'1P'`DR4&#`TN>0#,Z:O-A>GW&'RP`NH$L+[Y.;L]1-1SYT:?93^M&>RE`F%UH+->FG*-I@ M,;JR."E;;Z7>+>+"29`33VT-'_I<0X6CK$K;H*J%.G@(/>]4-83E]ZSW`"_) MX3&/$[&EA"HK2:?_/'!@=G5)(I$F(PMK,QB;XE8<]8&ARC8HQH!`KY2)D=)$*.[PR7!\/H2JHG9'7!"![#&J#2U;BWWX?/UFL4 ML'@LV:%F&=?L%[(AC>I+?E2>]AQ^XI9+8GCDW?[68R.J M(]U:V`RK;7^U;#+7B^++M'[R:F$8A8>W:[,[!/WL0U(<*32NYR5\DB=L=*FJ MLF0]=*)'O0J=<%6EI*_$JL^5GW82G@&<[JUTB@H/B)XY.(#!D@[(AC*YHAMI M2=\8*H]H=!$V$[,=Y^\28G[=M$`VRDADKOA.81GL1^DGLM%&3JG-7GE4HPNB ME9[U+8=#I+5%G`;]1!O'+Y@THW?H,[PL!0&"+,\EJV>Y82>E8?M9/F(,J-P^ MXB%D=(T)`3N`P MO,NTT+/NR8G57;1CU__S&NQB%\QN:CK^_N9)JUP;RGZY![-MT_ADQH^-M3Y# M]R&X7IR%$5P3UHSCV;W+E M*AM-2%*8AY&95G&,M5P^EO,M'9_H)DN4Y#BZ7MQA)P@=UY0*\)`=AVT6`E+/ M14?93G#LO1/ZV-XR@#UY3-U$1[:V.5"4[P6DNIAI-H?H(-'$L!=ON)&:U?B* MJ!_ MX!8D+"3'@-3Y M"%NZ"2TG<4XL4W&_[?WDW/C$20^+G)OVN!8Y/Z19O*2W]A+[XP)84H9NP(:^ M7IY.JP^[SD=X5"N<$\M,UCVVH\@XO`(/N2EA%)`?79"S/ST(7IB'D9W,Q#'. M%$)#',[6I<([^I*MSFOOX[Y66(7FKOH$>T/.H.F[,GY<=:S+KD+>L>^_N9/<>.)0MR@>[C#]YA$82$5TDK00_.C2_UB%N@JPD M&+F2TS3;09SNC-S^AX,*O0?K.<`FA"1$WVXNB5.%"]6I0NCFDKFR[FK-Z-0: M3=;L1?4I6CO02)Z`BZ[5:*.$]/C`;#"/P[(IK1M=+LVI$@RY=5?`BVEV)8VZ M?P'>A4=XA@L(O/3]Y[3W7.D=Z#`DAWR/,6;V4*6913L&B<-K*1R[=,MEC%YI/+&<.HC>'SF+X; M3'94',$O3M+BDN5X^E,A+?Q]';JE1U1Z7G0?R"5D78&;;_X:\L%^':ZQYAG( MOZ&9=LC<];F/2',UD%X[.7C3 MO2N<`H?68__]**"*#/5L1T9LW@T@,$`W2EO(W).]-V1S'(X!%&5Q*'WV^C*' MPB+4V+?=>J.&O7,DO4+&W:_AH!SEL6ER)<:*[8(1D5X/TG#W M?TNJRO(DB*!'V2-GJUO@QIA%V,X>73\F:Y&^\T#-2IR`7YUA3\JCC4O+V4\Y MM=(GHY&>@6<8^'`-`P?O')]I-AD:+2+R.18#<-(PL1-X_B%,[.3"Q!+77'-$ M)WNBUXN[%>"(30L]]J6'DO!VD8_73T'D0#_4`+1H?8(^RA(>L6Y&Y,LT]%*W MX^YJ73'E]*!VG1M7>R\@Q::IDI(F4M6.V4=-1]UA&!>2B#(4$>.JLYQAZ MR]KRD8:E6OZ.;?^T0_DHA)5IRKN;$<`AN%0-.]3QG"@%,%JR*0Y8" M$-977WU-ML'@IETI.5%IC!+>`!?`+67_"ICLB5(B9+V`T(@GE5\�#K,G#R MERX3/^>4/H56?F%0X\W*(I6]_?KY/YX]._J?C^\_O/[?__G#W<2/GX(?WGI? MWFR7GW;!_31^>/<&OWWS^\N_[N]VH?]FZWYY[O\6_>,+.H,7_UY'FY>_OCG] MY]_;\T_G5V#RXS^=\^>[^7+EN'^LWJV_3.?3OR]?__-R=?[;X\-T\\K]8_?I MK?LEN)I.@V!RZ9\XUSOTYO;'FT\G_OWGS_/5S>SWUW_AY?38F[^:O?AO]_BW MJ]N+UY,?_D81_N'?;UYM'F:A@\/?5IL?WRUO-LZ+?^/PYO=?7WU'^RO8S/;V>_3F]^??[QY>F7]6_^ M?__Z^^S$>UP^7+Y!G^:O@7<2G+_\?7[LH'?@C^W]\LK=?7GY\LO;]3UR_[Y^ M.SG_]_\>G=[>/'MF:1?O=;'4*6;_+ZMVWJTR9");Z7TU_G.K`K1#+A_X+WN% M2B5J)JO/OA$Y'Z"TUP^F7)U#5"R)4\)@:5+47'2_?L>(#W[Y-C(:_*3,=YLY M.^JX$7M$?H-CD`\)&72@1,A_&V9#2"#VFM-,4V)I!QTC16@E$K:"/+V*OX*K M?->:2IA(X235CS5H(O5MK/Q&H+4TK5&*$9ZB]9Q,F4Z5=AJ%A)^D[I6V0TOX M>6$R7,A%_^N(K[6JB)@\)'K>O$WT)@#1P7#T7F*]KS/WP()5FONTTASNG2GG M<(M!^.7J0QI_F@Y>6\8NE#`6'5-'H4C7]0Z[UVE4KH`W#]V0SM5T-Y6'KI4C MBZ3*RET+TG-?O(7*R>Z]\Q?"I[21JK$[_0+DK>>;Q-=TX?:Q"-(*6=J,WFD< M1F@-,*N5I7O>"FY"N@`>NG#4P*)T*#;MW M]]4$4@6L4IBBU/^SR)$YH;21&_>2:06RF"O6O6L=F*,:8K!#AB`+XQ:H,."Y M2+K=YWE-[=F7NHL?6FB]PRCLV_U*:`Y7:UM/W]U86KO2V,+:Q'7C=T:`KOGL\M M(GV/*AM6,GH-E8U"$?19.I>D61XP^A>"VDG;X0ZS;GY+M\ M*92LY9K:98W#)",;;2.)UV[5-T5-JR$Y$.'B79&&S.%'GF8E0FAH;I?0\D,R M0LI)+8"RKBA699P67_"N5*`U=9RH?LU>/$+/6XUT'O1X=DCP"X,P0Q#%]P0_Q! MIV$M(&-0U?O6!"T54[:-^069%0Q"Z+*G``=NODO,6@HQ#]Y:EV6JHS9K.(YT M^A=Z@!B;(UW#^K?A=!@0N:T4G>HZSR/I4UF% M+>T=^6`47@0S@"'RC-W(-,'FDW?"(4J)%DS]>->AT&P&YV%K9']T.3\U+=8I M^%2[WUKK3X9T59Q+KZV'5Y"#EFVP]H# M*,I+)9O,>,VDV`R^-J7M6?Z9PEMY8UC1N3E'>`$@+?W=3W:(?FH=FT]^*H7)N=KSCL4J:L4^*0>&3GM;0-5-BPW%/*6!,WI$/FGJ( MH$A@Z)$HOK5;Z'58!%!3P_0:=0IO;N_-M4QO)VCGI-:JHWD9=*!5?$J@]R#= M@?W`HQ5+9MNG&^%SX/(W(YO17(KE-UH:-_C2!=E^4S)7*$CBGO3EX&AW$1!^ M8R;HW-V%I.1[4#D:$;X'GFKD=P*U9&Z$)&XQWB8]P>J\Z%,?=RLGG7=($-@2 MS$$YKL^J5:9.!/8'TD&IO,YYC=0,FUD16A7&ZKU;([,O%G&-:TF4>!_TY<2A M:7U9[B.\6BLXQZ]L/Q"=W-.F8%1U;/6]-0?!![8ICG-G*/'^M#,HR%W#M=_! M[0QI&=!8U;O*_I-U5Q2_SHO`?:8=R>2A2X[U'O1C,J$`1#`@?P0^"N5>S6$# M3@)OF@QX!:(+-N`E&5`HS<@UD.BV=T4$BNGOA5BI?LO2>A$!ERZ%FNG::F=6 MX-6$N2P2L)8!:]2PO&DJ@=&W3*8@0&L8"*^#NN_9\8U$%T+MC+6\+,P;1;0DA\BLPQ,2W^ M+I)62L9$%S'^^$>A* M39U85_]$^^AP'QT:8XD$GE1H_++=BJA.K62M_ALGKM&?%)/%+",F*8ZV[UNR MB$(B:9V_OD=')$M./0#6='F>TL(!'-'WJ(H,FRP_Y25NQ?$7$K($H"K%=&GH M5V`5%;]A+2`E!&IIEO)923TGXJ?Z;/E5P5.K_5JQ?OYLO?'1#@##9JN.S(AD M48M2+F&D(H$\?7/5[C54QF'/VF#*]2#]^OU^?:?UXB9J(W0P6:,X,/(HJA[& M+%_CT!R7T:A%F>#T%([W'X2%RX"]Z19$$]>E4Z']YY`/70)"6K0@T0UE#VYE MS/KXJ295;Z8FNJQYLM=M!HDLJ;Z6Y\%2+]NT=%[2('JAE#[SL MQRDQGSYB]$Y1&-6>F#7%<;F)6XUF"*AW(5++#VWIYJV0)#^">0@C2N4]FD,? M3#8;/WVV5"38P3&,7;=(4`H\L&A\OEBSX:0S,G<:Y"%K>Z^37'1?M96#E-F"]O/356HAM2X(%^9VG>H:XE:.DZBHI+VH%@+L\@GUG+)6+- MK?XJD:$D1-MTLQ`*K<*DXC_N@]Q%\N:\CWI"P\A7\LJ@`2R=INK;+*318Z0: M:V->*YZ6`29LO.LKV]]&;BA6BR=YTPJ;EJY33UDTU2R:8AR)/2AHRDP=!A^A MYY1#IIPRED+Z/0S@.EZ;LSI%`M85O*)9>7!+8&BQ)>^=1\,`%P@,'.`B&%IJ MA1E!@R5`N>&M>I6MP!9`J`U(#=W`"6;CBM4:LN%2%P`OI'EJ^H28$[C@(H`1 M=/Q9/">$KQ?$P2!<&`J:.'Z@]0O! MDO8/#T(C]W4Z*`[YF-0N[0XDK34Z:WL>\`H\L#\9.@MS4;;7F5E5Y+S0ZGF< M034">(5FCKFV7/6$QFFX&T#3T)!*5H@-5?R)IB4:>+]!0?+!D$!L1L3B;(Q5 M`20`U]'524H]IF!._G@#R*!.`+\PA-G4/I(M"!`GXWHQ3=DYAP'Q0@@:K%B" M7@0GWYW"D(%D9!/0Q]QX]PF-`I)OJB2]E5`.R"K8)/[-.2@["XV=42I?&Y\$ MZ^:>.W;UZLB=.AL8.3Z[MS+Q_HK#B/&$\'L'?P;1Z8J>?XVL84[*XQ.O*+2I MZ-]8<.0:RW#.P@BNG8CL1R%8Q/XEW)I1`C$&QGN,$\,YU8@?>^\=EG;PN0$; MA",:2+H%2W;^-"'[%FKC=/#:X$M%^E;5C^OS'L;$)6H:0E:+F;MV(>=.$F_# M1V&,P1WAY<2G;F^\V?@L)V;R_@4?8?$H>0TX_']=4'@8(B,UWP4"%DQC%VJ7EO;4<1'*2%U2C2`F&*1 M/B>%;UC7XE:E8;U-BC.TUM#D!M!B`T)<`.OR=VQ7I'>"79FDMOL%DLW0$C;O M@W`#7.*``,_@O65!TWFOO0=V[K
G:;LI:AW/]$<,#-YPZB9J?>_FD*4` MA/5OW`YLB;>?*4IW"'0IVPQ@EV*P!->+#X@>O;.WZ,,41".->24Y&8SP6@,2 MLC!KZ1NA2S'H&Z;7BXRYLR""T:XG3:@E/5K1UP-IKSE[QN(I6L]ILW'(,I\A M]&A??_*/.^P$8<+/"Y,"YZ(_+JGS0=K_6W)9.=,=2M4P8YC+S6O^MBV'CU<^ M+?/6U?I/+/L:@SMT"WR?#'$P"4+"Z!ABZ!+I0D"^[D)!+&2MTAV9YH4<'%S' MT0RC+:2%(.&9#Y=P#OW*YM?8Z9=KJ"$=-6OEQ`N)A1*&%J.;F]T-\&E^CU5> M]+2+-5&W=!=-PR;6B*>FLHD^LVKO$/(>H.\[@.R/^MQ,L:578)`Q!I)QI MR\:?!%YEZ'TVQ63&38P!B87'B2!_.DYH0.%#+^?HE36A@^7#H-8#*5)Z2>V" MF+CK(RQ/,6!><X<+]QX>E4`.C]AZU;&0Z(#S.SF_A[BKCW M&'%7R@F>PP!&@!;G5;:ND]U[YR^$V8U]4WN$"/G1[AM"&"OF&/<5NG$8H37` M[$Q!CR-M?2E!WV/$`C5\;E$Z%AM5+Z8H" MJ0*FJ8=P"U\'KBAAAY5 M/3T%))_E6",`?%,2_R+C!U=!WH_T+2)0J6=P"OV?5E_1>2 M>KZ&I'#YJ`8(_FQ'XY>%]^>:D<2R&*T#6`]$<:@(77/-PGCJV=B)=94=U3/Z3[E'8>>=U2J M0SDE:@&C<\=E18ZFS%`-E5%8H#ITR@^<2+^'OD7^EC;,*M`P^1YZ&T$[KGFW M%A8?0F^%3,FCI!IQB9R@30X-.T3#5RWGA-HA;9JNKLBL6-U5YPIH*KYJTN3A M`M^JNLI/K,D:HR)7!I_-J*,S;(&U0U39#(:YG[5'T4HOXDAI$!WN>E'2[N1` M>H(P1@_4;#L;\A#M/\+M3+"YC/D;7(;RAJK%9V@L-1N MQ*I(ZSJ.PL@)/,+5B>/3!O\2?.A#ZO[!:Y.G&B<`4A"Z&&XJ; MA%3*(PS;V'7,7D\2454@[U$0K7P94Y;_]H`MH46X-J_B/HA#X&6V ME+:\AU':Y/C0>:(O%X./F8%;10UH:[@;JTU!DN9KU*C;7"^*+>A-R+J1UK#WV&ZHM/0'[[M4)_?:"7'BBN]=Y$IW9)NP MDE%6R">XA,D3OU,P>>ZE+_&FU+X"R6:X:2Q3UF6$;J@Q#$'"[(;LR_U8HBI9VT%;<4ES@3F, M%\\2-9S$T0IA^,7,$FXC9SEU)2[;5NRLM+]JLR]F!=M!<7P+MPM"77VT++BP M;$8G#CUAHS5];Y.-K:_NG!SB4P< MPPAGS%K'K)S?Y-F['&*5NXI"LI>F.>2JIR1^\N!@[XY\T%1-5)&`O3?(N%=* MX?)/$1W%F]\S@!<(KVD&YN;V7J``I/:+MG>X6LUA+3IKIVF[*_L-(,L,NE&Z MO[*WY!JDH*L0K8V@W4*T1MEQHJ6EZ)Z9PLJ2G&!,Z]"9:3S9'3Z3FDO&^8'] MP*,/P9GMDF"$SX'+WXQLR@7M-=%!3&U9A?$M'1+G=JHA,Y?:`V%Y%QB(` MO1;9I8I?L:OA=5K"-J?2O.Q>(#A;;WRT`TELQMQ65$=FF.)I!4;'10#SV\6@ M#'T7SAT6>NB6C_>0J:._32[XEKY'G,1HB*L$\!9XYPB?QQ$Y_-&X>K743'LX MDY.)`8JQAGI2R>@V M<@'PPG,R8<;V-6,H/'L$V(6AJ0!W%]%A!E-:5S<'DMHNB9@YE#:=>TH3"2_H M`U$0>7>(F+"+@)RF@Q"Z'QP_-K(Q],+W>$Q,O^+4UP.H=WU]1SX8[6?W$<#E M*@+>9`NPLP3LCU,G`N<.Q(-57=$I6"G=L*?"PA+64`4MGX[PV=^!5S_KLT?Z MHQ$MY*0\PCV7%U,=#_^H14&(\P==4,_F%0JV(*2:2W4[9'8X_W>:7;M"T2<0 MW0`7+0.:-,][&$;C*D89'YF]ZDF:-HNQC4TQL='D^)/^BG[.R(N-/<]@?(YC MWR+64IJNX$+.NQV,>8.#\8%!D#D8>T?"B-X:XW6$^[HYN:7*^&/OGH"TKYN4 MV%T$883CY/('[?=ZMW*"6B]X4,<84=['%M'M3ZBIWKY5KS'146)B\+#20&F( MV>I6U6A"+`OT]M\@W]B^/RHO;G0VQJ#8,EWLLXO%TV4)K8G$QF+Z%Q)9ABW` M^++!+HNW2>P5;G'H!UU?C9)0JM!F M+Z'!!723&5<*;9N,5?5KUL(J'2K*;%/-+&T_V31-2>;M:^5P;/#I1B'Z=KR% M9N7,>W]B0)9[ZBJME[K24JX58[E1:#NP]7-L,#/#6NBMVX2F!W"O-P`SO_,2 MA>&I@_%N@3`[9II8IBW4K&0+.3;B_.)L`TM+,6?OCN$4N2Q$.0F\LR!B44MV M!XZ=.`1=Q+:QZGW$IC<=>`82/TTQI2Y<^):._XGX."SP*-%4.KH-HYLS1&60;L9GZ9&X**VHQ*B>^\AI"42("2(_Y&@L3@T:N0(Y*;,S(3QX MK*NH[VC0\N)PEMQO&6A+..0JN<1#%87Q&D/E2O#:#Y`K@5P7^WZCX(ZDQHB, MC&DEO`<>?P/_J(3$H[2KFZ$#D+DPS_`?DQ@0#OSJ$/L#;TR\..3^HV?2/P/=_#]!#<`N<$`7`8QU"6^+,8L`W M#3]"$30BE:\K4#WO)U5MVHZF]<..R=@T`)//YTL9FVS!4-D2[?SZF8](2`L``00E#@``!#D!``#M76UOVS@2_G[`_0=>OEP7 M/=>QG31-T`9PXKA-FQ>ODVS:72P*6J)MMC*IDI)C]]LL%H"?#I,V_V"VB`4SIS;RP,SHDGWEH> MGB/QC,P1$[^+]U//'AQ>6*,HMS!"G/K,0EP]`HW$,Y+]__^NU;.24 M(=G$$;CU$;B$2]!J@]:KH_;>T>XK<'=["MJ[K?V@DJBQX$?K&D@HN;3AT`#[()\J[@#'$76JA:I5`+G@#UT(D4 M:#4_7E[<*(57&E!200E*&BE%?-Z0K]8MC2$?J5K1&P6KL=MJQ(`YF'S-P]8Z M/#QLJK=1T4S))!'R]0AR001RT`P1KT_9K(?&T'>\-SO??.C@,4;V3HQ7VUO) MB\O:;P8O=]2(`$"."4@(]:"'*3D&P=/PN>MB,J;'T3/Q5`(YBM`,T1@H+8YD M#[S9X7CF.G*PJ&=3AL9O=N0(:$2,?7;@Z(6`&!6!S&+40?HN:KJ,NF)Z8-'' MZWX(!&1J)[M-OFZ*-I%SL8:\TSS>FCXN0S]<']$F%R-`\952:WM$V6C\PQ43 M;6*"<]3:EE(6='ZX4J)-RW=RR4JJ)4O?"D6`_.%N>*ZS@$JR6#4X=;`M[?\) M=*2=OIDBY.T`;`>:?V:?"PM%JP@`<1!K"HZ%^13+T8T89\K@J*5K+0N$PH"2 MQE\WT]7SI/L\5),T%*=FIMC:[/ M`\A$1TR1AP4T7HF]=)T*9+:KDPF>)<7_DL-N36T!M>=$/$:KGBZD,UTNVZ4) M^CHZ^E8O.*!C<.U*MU-4JV=E.74W4S'4I]2Q$>-GWWSL+67U-F6=!'.:8KE] MFN!NKSIW-QZUOH;M_!<$+=4L;C0!98`EN$*$B]`JF&6%DS"O;#F?^]7Y/(5\ M"OH.?:CG8CF+)S['!/'D$KAZ>)R#.D'+2T%%#W/+H=QG2/P25:V7KQ(;B"=$ MA(\6)%[7LJA//$PF`S&B+>'T)LV@MF0%+^0@S5%,(EB+!)',>M:4LM>UQ"K! M%>HD68D7)>[%JS0O\UFR9' M5F[(VD!6SZ.A)B'AR\UFE"A'6(SF`4-CQ!BRU8.4(ZN MYM%*8O"LMH(5/`G942>0!YZU<*L5A*0+D5^D9%*U,WZ#%--0?U[.R%Z:D:`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`6>4>?B[`H(6,N83KS89)!N+*0U,,SF])PV8 M`!^(`P0A0OFZR@"J1U#1>8F\52+O?04SD=C9("]8S3#UD0U$23I"*ZMWU?ED!Z66U M2M,4GW;>SXHA,)\K`ZA248R2&^O'19T-3) M9"8U&T,QSE7+RC\+VP:B<1"T#I[)]NM=O[*ICBR?J;0M6EB.;R-[S.@LAH;3 M\9I8V:4N8I8BA*\V_I)V8"L2*[@(F2QX_"JY-N@@W[S15Y&^-J%Y#/FJTVHU.Z\6"VZM;/S:$(14/[AW9 M#$94[U$P]!<<%0!1(.(U)Q"ZJF(3.1Y?R6JL9:T0;=@SV2NGJG1.NI;LFD/9 M-:V73P<2OS9J,S"47&GP5$"4>\53U>$259"-[V>[(;QR2K7Z9B>VG=U=[69? MCV^GX=9?-]S)%F;I8KV/W0VVL;LC$4Q`2T`+[NQ1%Y`=R0"#3,X]-),S>P?` ML-2;'8_Y\K8=54IX#)C:MZJ>[;/0KA*Y"SF2]_`$9;DO*F//EV_?,NJ[42-8 MB(\ME]M1(SZ3DMT4A5#7XUZX3W4AMZG2&Z7F=,BF@#5#9"VJK[9#7*H72#7-I)FJO@UF)_?LP==0-,D?==>+(1'4K MH*TRW8>K?(GJOSLQD[HJ66*BSN5@4PM04FN5,Q`6LA=$=R)F#,('&3B:HVXE ME,73=A7BGH41;E\$N*>Q^%98S)7D[&E><_IA:YIH)K^\\$;==R-%AS=1D4EH M/N0":DQO5$;:/"Z>`%W[B\^#C_5NZ1!9E%C806'OW5+Q@VQFP.@>AP1 MV^CAL"4]=(-%1?O0H\PC-,@#5>RQBW7,]BVOA^;(H6YP M5V=<`^'U(`^R99X.8^CP$B6"=Z/@8E7Q`HVP]Y1L10:LUC&/AZQBF-X+MT\> MT%2QO3IZM1JXIY3+K^2-U7Q33729*[@,G9LPN;.^<-!8]8LQZ\Q+ST>W]`8Y M#F+"IX]263]"74NT\Q1]2Y!K![VH*Q?P6-KB;(&8A3DR7>5"V#J2[R%C4`R- M<\Y]F:<[I80@2]:_Q][T'HVX:&@`F4<0ZTX80H;;N,?IHQT1ZH]LX,BE@\[J M*S@!R_/MG@%$_9*6J70A;(*4S/]^UT,'3K,BY7QZNHUO(GL*5AW^ MVVC1T$&V7=6*O>131Q167Z)+R3TZ@YBDK*6M'OY@4YF+JS@RU1V%KW(DVYP9 M]515M#;V\<(-FB;;4$*WO55-?-EAWY]N1)4HI-D:>Z+\GV]H55!%[[8.KLVQ MM&LPVNQGA8M0S!OYE4$7KRP51)@T@#>"JTTQH)$GO`\WR$_TD>$Q=A9M(:4Y M;I9Q([<08[$9SJEBT,#4HM,:R]7]J-X99.3:]]0&)9>"SAP\PCT]DI9 MBSZTU*R^A`L\\V;,5>!8?0O>V;JVH*;-`)PN1)J+:H'OXE MPI]&_1SHNM-1B;I#Z*$>XA;#;C`8JPWJOS*KHL6WD6*78E&;.JMQ+,,7:1I$ ME;]=IPB:-I[117K&F=<*:!\9GQMD<7/FS$6+78W6TD0\11VR. M[#YE.IUS,'^0I+\2CJ4(\N['E\3 MZ4"*_P<4$Z^/YTA-FQM7##:#%*J.5KM2B,HSQ(9H3IVY3-P8.N6KP"RT`$%E MF:B[H)"8IE0*5Z$6P:E0@PQ"$I#FC#UBZOL1$9,.;^[,P9^+J[#[!PXD[=W6 MGD'XDXAT*WGR$E?CO!,=/*WU&B*)UD;,'%W2D/3'T9(?UINC13&X0GTB.V;> MXE&`3#NRPI/F76)?TA%V4-<5*VH0^!ID@BN@U![?T%Q%9=`77550JF&I+GP* MKKL)W-+_`U!+`0(>`Q0````(`)N#K$8$W89&1(4``'8Q!P`1`!@```````$` M``"D@0````!E=F1Y+3(P,34P,S,Q+GAM;%54!0`#A6)2575X"P`!!"4.```$ M.0$``%!+`0(>`Q0````(`)N#K$:!U#7+&`D``&%A```5`!@```````$```"D M@8^%``!E=F1Y+3(P,34P,S,Q7V-A;"YX;6Q55`4``X5B4E5U>`L``00E#@`` M!#D!``!02P$"'@,4````"`";@ZQ&8$UP,1HQ``!G#`,`%0`8```````!```` MI('VC@``979D>2TR,#$U,#,S,5]D968N>&UL550%``.%8E)5=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`FX.L1@CPDFFV3P``C`$$`!4`&````````0`` M`*2!7\```&5V9'DM,C`Q-3`S,S%?;&%B+GAM;%54!0`#A6)2575X"P`!!"4. M```$.0$``%!+`0(>`Q0````(`)N#K$:6T\M75#$``#X4`P`5`!@```````$` M``"D@600`0!E=F1Y+3(P,34P,S,Q7W!R92YX;6Q55`4``X5B4E5U>`L``00E M#@``!#D!``!02P$"'@,4````"`";@ZQ&_;JTNP@/``"#DP``$0`8```````! M````I($'0@$`979D>2TR,#$U,#,S,2YX`L``00E#@`` ;!#D!``!02P4&``````8`!@`:`@``6E$!```` ` end XML 41 R18.htm IDEA: XBRL DOCUMENT v2.4.1.9

Accounting Policies, by Policy (Policies)
3 Months Ended

Mar. 31, 2015

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]
Principles of Consolidation

The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The results of operations for companies acquired are included in the consolidated financial statements from the effective date of the acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation.

Interim Financial Statement [Policy Text Block]
Interim Financial Statements

The accompanying interim unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) on the same basis as the audited consolidated financial statements for the year ended December 31, 2014 and, in the opinion of management, include all adjustments of a normal recurring nature considered necessary to present fairly the Company’s financial position, results of operations and cash flows for the interim periods ended March 31, 2015 and 2014. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015 or any other future periods, due to seasonality and other business factors. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted under the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto for the year ended December 31, 2014, which are included in the Company’s Annual Report on Form 10-K filed with the SEC on March 5, 2015.

Use of Estimates, Policy [Policy Text Block]
Use of Estimates

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, current business factors and other available information. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition and deferred revenue, allowance for doubtful accounts, internal software development costs and website development costs, valuation of long-lived assets, goodwill and other intangible assets, income taxes and stock-based compensation.

Reclassification, Policy [Policy Text Block]
Reclassifications

Certain reclassifications have been made to the prior period financial statements to conform to the March 31, 2015 presentation.

Sale of Stock, Description of Transaction Initial Public OfferingOn April 2, 2014, the Company closed its initial public offering of common stock (“IPO”). The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters’ exercise of their over-allotment option, resulted in net proceeds of $70,622, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling $8,848. As a result of the IPO, the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, all of the Company’s redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision.

Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition and Deferred Revenue

The Company generates its revenue primarily through advertising and sponsorships, and premium services, including subscriptions and licensing fees.

Advertising revenue is recognized in the period in which the advertisement is delivered. Revenue from sponsorships is recognized over the period the Company substantially satisfies its contractual obligations as required under the respective sponsorship agreements. When contractual arrangements contain multiple elements, revenue is allocated to each element based on its relative fair value determined using prices charged when elements are sold separately. In instances where individual deliverables are not sold separately, or when third-party evidence is not available, fair value is determined based on management’s best estimate of selling price.

Subscriptions are generally paid in advance on a monthly, quarterly or annual basis. Subscription revenue, after deducting refunds and charge-backs, is recognized on a straight-line basis ratably over the subscription periods. Licensing revenue is generally recognized over the life of the contract.

Deferred revenue relates to: (i) subscription fees for which amounts have been collected but for which revenue has not been recognized, and (ii) advertising and sponsorship fees and licensing fees billed in advance of when the revenue is to be earned.

Cost of Sales, Policy [Policy Text Block]
Cost of Revenues

Cost of revenues consists principally of the expenses associated with aggregating the total audience across the Company’s portfolio of websites, including (i) royalty expenses for licensing content for certain websites within the portfolio and for the portion of advertising revenue the Company pays to the owners of certain other websites within the portfolio, and (ii) media costs associated with audience aggregation activities. Cost of revenues also includes credit card fees and service charges associated with subscription fees for the Company’s premium services.

Media costs consist primarily of fees paid to online publishers, internet search companies and other media channels for search engine and database marketing, and display and television advertising. These media activities are attributable to revenue-generating and audience aggregation events, designed to increase the audience to the websites the Company operates, increase the number of subscribers to premium services and grow the Company’s registered user base.

Other Income and Other Expense Disclosure [Text Block]
Other Expense

There were no charges reflected as other expense in the three months ended March 31, 2015. In connection with the refinancing of its credit facilities in March 2014, the Company wrote-off unamortized deferred financing costs totaling $2,845 and incurred prepayment fees of $1,016, which, together with the mark-to-market adjustment on certain preferred stock warrants of $253, is reflected as other expense in the accompanying consolidated statements of operations for the three months ended March 31, 2014.

Comprehensive Income, Policy [Policy Text Block]
Comprehensive Income

The Company has no items of other comprehensive income, and accordingly net loss is equal to comprehensive loss for all periods presented.

Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments

Due to their short-term maturities, the carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value. Cash equivalents principally consist of the Company’s investment in highly liquid money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value of the Company’s debt approximates the recorded amounts as the interest rates on the credit facilities are based on market interest rates.

Property, Plant and Equipment, Policy [Policy Text Block]
Property and Equipment

Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from three to five years. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the improvement.

The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of payroll and related benefits, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.

The Company also incurs costs to develop its websites and mobile applications. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of third-party consultants and related charges, and the costs of content determined to provide a future economic benefit, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.

The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s property and equipment during the three months ended March 31, 2015 and 2014.

Segment Reporting, Policy [Policy Text Block]
Segment Information

The Company and its subsidiaries are organized in a single operating segment, providing online health solutions, and the Company also has one reportable segment. Substantially all of the Company’s revenues are derived from U.S. sources

New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Standards

In April 2014, the FASB issued amended guidance for reporting discontinued operations. Under the new guidance, only disposals that represent a strategic shift having a material impact on an entity’s operations and financial results shall be reported as discontinued operations, with expanded disclosures. This amendment will be effective for the first annual reporting period beginning after December 15, 2015. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

In May 2014, the FASB issued amended guidance for revenue recognition. This amendment provides a comprehensive new revenue recognition model. The core principle of the guidance is to recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. As currently issued, this amendment is effective for fiscal years beginning after December 15, 2016, and for interim periods within those fiscal years. Early adoption is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company has not yet selected a transition method and is currently evaluating the effect that the new standard will have on the consolidated financial statements and related disclosures.

In June 2014, the FASB issued updated guidance on stock compensation accounting requiring that a performance target that affects vesting and could be achieved after the requisite service period should be treated as a performance condition. Current GAAP does not contain explicit guidance on how to account for such share-based payments. This updated guidance is effective for fiscal years beginning after December 15, 2015, and for interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

In April 2015, the FASB issued updated guidance on the presentation of debt issuance costs in financial statements. The new guidance requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs will continue to be reported as interest expense. This guidance will be effective for the Company beginning in the first quarter of 2016 on a retrospective basis for all periods presented, with early adoption optional. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

X

- Definition

Interim Financial Statement Policy

+ References

No definition available.

+ Details

Name: evdy_InterimFinancialStatementPolicyTextBlock

Namespace Prefix: evdy_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for comprehensive income.

+ References

No definition available.

+ Details

Name: us-gaap_ComprehensiveIncomePolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.3A-02)

-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph k

-Article 1

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02, 03

-Article 3A

+ Details

Name: us-gaap_ConsolidationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for recognition of costs in the period which correspond to the sales and revenue categories presented in the statement of operations. The accounting policy may include the amount and nature of costs incurred, provisions associated with inventories, purchase discounts, freight and other costs included in cost of sales incurred and recorded in the period. This disclosure also includes the nature of costs of sales incurred and recorded in the statement of operations for the period relating to transactions with related parties.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 50

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51666513&loc=d3e63676-111659

+ Details

Name: us-gaap_CostOfSalesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for determining the fair value of financial instruments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13279-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 60

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260

+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.

+ References

No definition available.

+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.3,6,7,9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

+ Details

Name: us-gaap_PriorPeriodReclassificationAdjustmentDescription

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PropertyPlantAndEquipmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section B

-Paragraph Question 1

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.B.Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18823-107790

+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 45

-Paragraph 23

-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569655-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1B

-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4582445-111684

+ Details

Name: us-gaap_SaleOfStockDescriptionOfTransaction

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for segment reporting.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

+ Details

Name: us-gaap_SegmentReportingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6132-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6061-108592

+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9

Consolidated Statements of Operations (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Revenues:

Advertising and sponsorship revenues $ 36,338us-gaap_AdvertisingRevenue $ 32,692us-gaap_AdvertisingRevenue

Premium services revenues 4,836us-gaap_SalesRevenueServicesNet 4,813us-gaap_SalesRevenueServicesNet

Total revenues 41,174us-gaap_Revenues 37,505us-gaap_Revenues

Operating expenses:

Cost of revenues 14,076us-gaap_CostOfRevenue 11,421us-gaap_CostOfRevenue

Sales and marketing 12,725us-gaap_SellingAndMarketingExpense 10,220us-gaap_SellingAndMarketingExpense

Product development 12,602evdy_ProductDevelopment 10,762evdy_ProductDevelopment

General and administrative 9,804us-gaap_GeneralAndAdministrativeExpense 6,595us-gaap_GeneralAndAdministrativeExpense

Total operating expenses 49,207us-gaap_OperatingExpenses 38,998us-gaap_OperatingExpenses

Loss from operations (8,033)us-gaap_OperatingIncomeLoss (1,493)us-gaap_OperatingIncomeLoss

Interest expense, net (953)us-gaap_InterestIncomeExpenseNet (1,863)us-gaap_InterestIncomeExpenseNet

Other expense (4,114)us-gaap_OtherNonoperatingIncomeExpense

Loss from operations before benefit (provision) for income taxes (8,986) (7,470)

Benefit (provision) for income taxes 918us-gaap_IncomeTaxExpenseBenefit (289)us-gaap_IncomeTaxExpenseBenefit

Net loss $ (8,068)us-gaap_NetIncomeLoss $ (7,759)us-gaap_NetIncomeLoss

Net loss per common share-basic and diluted (in Dollars per share) $ (0.26)us-gaap_EarningsPerShareBasicAndDiluted $ (1.44)us-gaap_EarningsPerShareBasicAndDiluted

Weighted-average common shares outstanding-basic and diluted (in Shares) 31,525,559 5,403,846

X

- Definition

These expenses consist of costs related to the products and services we provide to our audience, including costs associated with the operation and maintenance of the properties in the portfolio we operate.

+ References

No definition available.

+ Details

Name: evdy_ProductDevelopment

Namespace Prefix: evdy_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Revenue from the sale of advertising time (such as television and radio) or space (newspaper or magazine pages). May also include advertising, marketing and promotional services rendered during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_AdvertisingRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate cost of goods produced and sold and services rendered during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

No definition available.

+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net amount of operating interest income (expense).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.10)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

+ Details

Name: us-gaap_InterestIncomeExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_RevenuesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(d))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_SalesRevenueServicesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate total amount of expenses directly related to the marketing or selling of products or services.

+ References

No definition available.

+ Details

Name: us-gaap_SellingAndMarketingExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).

+ References

No definition available.

+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 43 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9

Common Stock and Preferred Stock
3 Months Ended

Mar. 31, 2015

Stockholders' Equity Note [Abstract]

Stockholders' Equity Note Disclosure [Text Block]
6. Common Stock and Preferred Stock

As of March 31, 2015 and December 31, 2014, there were no shares of preferred stock issued and outstanding. The redeemable convertible preferred stock, Series A-G (collectively, the “Preferred Stock”), which was outstanding at the time of the Company’s IPO, fully converted to common stock in connection with the IPO.

In March 2014, the Company’s Board of Directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation effecting a 1-for-1.5 reverse stock split of the Company’s issued and outstanding shares of common stock. The par value of the common stock was not adjusted as a result of the reverse stock split. All issued and outstanding common stock and per share amounts contained in the Company’s consolidated financial statements and related notes thereto have been retroactively adjusted to reflect this reverse stock split for all periods presented. The reverse stock split was effected on March 14, 2014.

In April 2014, in connection with the closing of the Company’s IPO, the Company filed an amended and restated certificate of incorporation with the Secretary of State of the State of Delaware that amended and restated in its entirety the Company’s certificate of incorporation to, among other things, increase the total number of shares of the Company’s common stock that the Company is authorized to issue to 90,000,000, eliminate all references to the various series of preferred stock that were previously authorized (including certain protective measures held by the various series of preferred stock), and to authorize up to 10,000,000 shares of undesignated preferred stock that may be issued from time to time with terms to be set by the Company’s Board of Directors, which rights could be senior to those of the Company’s common stock.

X

- Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9

Long-Term Debt
3 Months Ended

Mar. 31, 2015

Disclosure Text Block [Abstract]

Long-term Debt [Text Block]
5. Long-Term Debt

The Company entered into a credit facility agreement with a syndicated bank group in March 2014, which replaced its then-existing credit facility. The new credit facility consisted of a revolver (“Revolver”) with a maximum borrowing limit of $35,000 and a term loan (“Term Loan”) of $40,000. In November 2014, in connection with the acquisition of DoctorDirectory.com, Inc., the credit facility was amended and restated to, among other things, (i) increase the maximum borrowing limit of the Revolver from $35,000 to $55,000; (ii) increase the Term Loan from $39,000 outstanding as of such date to $60,000; (iii) extend the maturity date of the Term Loan and the due date of principal on the Revolver from March 2019 to November 2019; and (iv) effect certain modifications to the covenants and terms set forth in the credit facility agreement. In March 2015, the amended and restated credit facility was amended twice (as amended, the “Credit Facility”) to, among other things, (i) consent to the acquisition of Cambridge, (ii) increase the Term Loan from $59,250 outstanding as of such date to $67,750; (iii) increase the maximum borrowing limit of the Revolver from $55,000 to $82,250; and (iv) effect certain modifications to the covenants and terms set forth in the Credit Facility agreement. All other materials terms of the Credit Facility, including the applicable interest rates and maturity dates, remained unchanged by the March 2015 amendments.

The repayment terms of the Revolver provide for quarterly interest payments, with the principal being due in full in November 2019. The repayment terms of the Term Loan provide for quarterly interest and principal payments, with a maturity date of November 2019. The interest rate on the Credit Facility is equal to the London Inter-Bank Offered Rate, or LIBOR, plus a variable rate ranging from 2.75% to 4.0% depending on the Company’s consolidated leverage ratio, as defined in the Credit Facility agreement, and there is a 0.50% commitment fee on the unused portion of the Revolver. As of March 31, 2015, the interest rate on the Credit Facility was 3.52%. As of March 31, 2015, there was $67,750 outstanding on the Term Loan and $45,000 outstanding on the Revolver, with $37,250 available to be drawn on the Revolver.

The Credit Facility contains certain financial and operational covenants, including requirements to maintain a minimum consolidated fixed charge coverage ratio and a maximum consolidated leverage ratio, each as defined in the Credit Facility agreement, as well as restrictions on certain types of dispositions, mergers and acquisitions, indebtedness, investments, liens and capital expenditures, issuance of capital stock and the Company’s ability to pay dividends. The Credit Facility is secured by a first priority security interest in substantially all of the Company’s existing and future assets. The Company was in compliance with the financial and operational covenants of the Credit Facility as of March 31, 2015.

In connection with the March 2014 refinancing and the November 2014 amendment and restatement, the Company incurred financing costs totaling $2,899 and, in connection with the March 2015 amendments, the Company incurred financing costs of $722, each of which have been deferred and amortized using the effective interest rate method through the final maturities of the Credit Facility. Deferred financing costs are recorded in other assets in the accompanying consolidated balance sheets. Amortization expense relating to deferred financing costs is included in interest expense in the accompanying consolidated statements of operations.

X

- Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for long-term debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.22)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_LongTermDebtTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9

Significant Accounting Policies (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 1 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Apr. 30, 2014

Significant Accounting Policies (Details) [Line Items]

Debtor Reorganization Items, Write-off of Deferred Financing Costs and Debt Discounts $ 2,845

Debt Prepayment Fees 1,016evdy_DebtPrepaymentFees

Capital Units, Adjustment for Market Changes 253

Number of Reportable Segments 1us-gaap_NumberOfReportableSegments

Software and Software Development Costs [Member]

Significant Accounting Policies (Details) [Line Items]

Property, Plant and Equipment, Estimated Useful Lives three

Website And Mobile Applications [Member]

Significant Accounting Policies (Details) [Line Items]

Property, Plant and Equipment, Estimated Useful Lives three

IPO [Member] | Common Stock [Member]

Significant Accounting Policies (Details) [Line Items]

Stock Issued During Period, Shares, New Issues (in Shares) 5,676,414

Convertible Preferred Stock, Shares Issued upon Conversion (in Shares) 18,457,235

IPO [Member] | Series G Preferred Stock [Member]

Significant Accounting Policies (Details) [Line Items]

Convertible Preferred Stock, Shares Issued upon Conversion (in Shares) 577,055

IPO [Member]

Significant Accounting Policies (Details) [Line Items]

Proceeds from Issuance Initial Public Offering 70,622

Payments for Underwriting Expense 8,848

Common Stock, No Par Value (in Dollars per share) 14.00

Minimum [Member]

Significant Accounting Policies (Details) [Line Items]

Property, Plant and Equipment, Estimated Useful Lives three

Maximum [Member]

Significant Accounting Policies (Details) [Line Items]

Property, Plant and Equipment, Estimated Useful Lives five

X

- Definition

Prepayment fees incurred as a result of re-financing.

+ References

No definition available.

+ Details

Name: evdy_DebtPrepaymentFees

Namespace Prefix: evdy_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: evdy_SignificantAccountingPoliciesDetailsLineItems

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The adjustment for market appreciation or depreciation of capital units or shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 946

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.6-04.16(b)(2))

-URI http://asc.fasb.org/extlink&oid=6488278&loc=d3e603758-122996

+ Details

Name: us-gaap_CapitalUnitsAdjustmentForMarketChanges

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Face amount per share of no-par value common stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockNoParValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares issued for each share of convertible preferred stock that is converted.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

+ Details

Name: us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Amount of write-off of deferred financing costs and debt discounts related to prepetition debt obligations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 852

-SubTopic 10

-Section 55

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=34712771&loc=d3e56145-112766

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 852

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=49172455&loc=d3e55730-112764

+ Details

Name: us-gaap_DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.

+ References

No definition available.

+ Details

Name: us-gaap_NumberOfReportableSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition

Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name: us-gaap_PaymentsForUnderwritingExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash inflow associated with the amount received from entity's first offering of stock to the public.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceInitialPublicOffering

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 35

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=51661791&loc=d3e1205-110223

+ Details

Name: us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: evdy_IPOAxis=us-gaap_IPOMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=evdy_WebsiteAndMobileApplicationsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 46 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9

Acquisitions (Tables) (Estimate of Fair Value Measurement [Member])
3 Months Ended

Mar. 31, 2015

Estimate of Fair Value Measurement [Member]

Acquisitions (Tables) [Line Items]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] The following table summarizes the preliminary allocation of the assets acquired and liabilities assumed based on their fair values on the acquisition date. The fair values presented are based on a preliminary valuation and are subject to adjustment during a measurement period of up to one year from the acquisition date. The measurement period provides the Company with the ability to adjust the fair values of acquired assets for new information that is obtained about circumstances that existed as of the acquisition date.

Accounts receivable $ 4,406

Other current assets 137

Property and equipment 783

Goodwill 15,576

Intangible assets 14,280

Accounts payable and accrued expenses (2,659 )

Deferred revenue (197 )

Other current liabilities (53 )

Total consideration paid $ 32,273

X

- Details

Name: evdy_AcquisitionsTablesLineItems

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

+ Details

Name: us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9

Income Taxes
3 Months Ended

Mar. 31, 2015

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]
9. Income Taxes

The Company’s expected and historic annual net tax provision is generally comprised of a deferred tax provision pertaining to basis differences in indefinite lived intangible assets that cannot be offset by current year deferred tax assets, as well as, to a much lesser extent, a current tax provision for federal, state, local and foreign taxes. Effective March 31, 2015, the tax provision for interim periods is determined using an estimate of the Company’s annual effective tax rate, adjusted for discrete items arising in the quarter, as applicable. As a result of using an estimated annual effective tax rate the Company recorded a benefit for the quarter, which is expected to reverse over the remaining quarters. In each quarter, the Company’s estimate of the annual effective tax rate will be updated and any changes will be recognized in the interim period in which the change occurs. In interim periods prior to March 31, 2015, the tax provision was based upon the estimated deferred and current tax provision for the year rather than the estimated annual effective tax rate, as the Company had historically experienced pretax losses in certain quarters and pretax income in others, and the annual results were expected to be at or near breakeven, and believed that using an annual effective tax rate would result in significant variances in the customary relationship between income tax expense (benefit) and pretax income or loss in interim periods.

The Company’s deferred tax assets relate primarily to net operating loss carryforwards and to a smaller extent stock based compensation and other items. The Company has provided a valuation allowance against deferred tax assets to the extent the Company has determined that it is more likely than not that such net deferred tax assets will not be realizable. In determining realizability, the Company considered various factors including historical profitability and reversing temporary differences, exclusive of indefinite-lived intangibles. The Company’s deferred tax liabilities arose primarily from basis differences in indefinite-lived intangible assets that cannot be offset by current year deferred tax assets.

At December 31, 2014, the Company had approximately $107,000 of net operating loss, or NOL, carryforwards available to offset future taxable income, which expire from 2020 through 2033. The full utilization of these losses in the future is dependent upon the Company’s ability to generate taxable income and may also be limited due to ownership changes, as defined under the provisions of Section 382 of the Internal Revenue Code of 1986, as amended. The Company’s NOL carryforwards at December 31, 2014 included $7,433 of income tax deductions related to equity compensation that are greater than the compensation recognized for financial reporting, which will be reflected as a credit to additional paid-in-capital as realized.

The Company is subject to taxation in the U.S. and various federal, state, local and foreign jurisdictions. In March 2014, an audit of the Company’s U.S. Federal tax return for the year ended December 31, 2011 commenced. As of March 31, 2015, none of the Company’s other tax returns have been examined by any income taxing authority. The Company is not subject to U.S. federal, state or non-U.S. income tax examinations by tax authorities for years prior to 2010. However, to the extent U.S. federal and state NOL carryforwards are utilized, the use of NOLs could be subject to examination by the tax authorities. The Company believes that it has appropriate support for the income tax positions taken and to be taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on assessment of many factors, including past experience and interpretations of tax law. The Company regularly assesses the adequacy of its income tax contingencies in accordance with ASC 740. As a result, the Company may adjust its income tax contingency liabilities for the impact of new facts and developments, such as changes in interpretations of relevant tax law and assessments from taxing authorities.

X

- Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 48 R13.htm IDEA: XBRL DOCUMENT v2.4.1.9

Stock-Based Compensation
3 Months Ended

Mar. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
7. Stock-Based Compensation

The Company has granted non-statutory stock options and restricted stock unit awards to employees, directors and consultants of the Company pursuant to its 2003 Stock Option Plan, as amended (the “2003 Plan”), or 2014 Equity Incentive Plan (the “2014 Plan”), which became effective immediately upon the signing of the underwriting agreement related to the IPO on March 27, 2014. Upon the effectiveness of the 2014 Plan, no additional awards have been or will be granted under the 2003 Plan. The 2014 Plan provides for the grant of stock options, restricted stock units, and other awards based on the Company’s common stock.

As of March 31, 2015, 339,829 shares have been reserved for issuance under the 2014 Plan. The number of shares of common stock reserved for issuance under the 2014 Plan is subject to an automatic increase on January 1 of each year through January 1, 2024, by the lesser of (a) 4% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year and (b) a number of shares determined by the Board of Directors.

Stock Options

The following table summarizes stock option activity for the three months ended March 31, 2015:

Number of
options Weighted-
average
exercise
price Weighted-
average
remaining
contractual
life (years) Aggregate
intrinsic
value

Outstanding at December 31, 2014 5,893,698 $ 9.94 6.48 $ 29,249

Granted 726,100 12.22

Exercised (72,832 ) 7.27

Cancelled (7,415 ) 12.84

Outstanding at March 31, 2015 6,539,551 $ 10.23 6.65 $ 20,931

Exercisable at March 31, 2015 3,896,925 $ 8.45 5.01 $ 17,987

Proceeds from the exercise of options and the total intrinsic value of the options exercised were $460 and $484, respectively, for the three months ended March 31, 2015, and $1,172 and $910, respectively, for the three months ended March 31, 2014.

The weighted-average fair value per share at date of grant for options granted was $5.49 and $7.56 during the three months ended March 31, 2015 and 2014, respectively. The fair value of options granted is estimated on the date of grant using the Black-Scholes option pricing model and recognized in expense over the vesting period of the options using the graded attribution method.

The following table presents the weighted-average assumptions used to estimate the fair value of options granted in the three months ended March 31, 2015 and 2014:

2015 2014

Volatility 44.29 % 49.77 %

Expected life (years) 6.25 6.25

Risk-free interest rate 1.72 % 1.92 %

Dividend yield — —

The expected stock price volatilities are estimated based on historical realized volatilities of comparable publicly traded company stock prices over a period of time commensurate with the expected term of the option award. The expected life represents the period of time for which the options granted are expected to be outstanding. The Company used the simplified method for determining expected life for options qualifying for treatment due to the limited history the Company currently has with option exercise activity. The risk-free interest rate is based on the U.S. Treasury yield curve for periods equal to the expected term of the options on the grant date.

Total stock-based compensation expense related to stock options was $1,958 and $1,069 for the three months ended March 31, 2015 and 2014, respectively.

At March 31, 2015, there was approximately $8,713 of unrecognized compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 1.5 years. The total fair value of stock options vested during the three months ended March 31, 2015 and 2014 was $2,613 and $953, respectively.

Restricted Stock Unit Awards

The Company’s restricted stock unit awards (“RSUs”) are agreements to issue shares of the Company’s common stock to employees in the future, upon the satisfaction of certain vesting conditions, which cause them to be subject to risk of forfeiture and restrict the awardholder’s ability to sell or otherwise transfer such RSUs until they vest. Generally, the Company’s RSU grants vest over three years from the grant date subject to continued employment on the applicable vesting dates. The following table summarizes the RSU activity for the three months ended March 31, 2015:

Number of

RSUs
Weighted
Average
Grant Date
Fair Value

Outstanding at December 31, 2014 — $ —

Granted ⁽¹⁾ 548,424 11.99

Vested —

Cancelled —

Outstanding at March 31, 2015 548,424 $ 11.99

⁽¹⁾ RSUs granted during the three months ended March 31, 2015 includes the grant of 40,000 units of performance-based RSUs that are dependent upon the Company meeting certain performance criteria.

Total stock-based compensation expense related to RSUs was $262 for the three months ended March 31, 2015. As RSUs were issued for the first time in March 2015, there was no stock-based compensation expense related to RSUs in 2014.

At March 31, 2015, there was approximately $5,904 of unrecognized compensation expense related to unvested RSUs, which is expected to be recognized over a weighted-average period of 1.63 years.

2014 Employee Stock Purchase Plan

The 2014 Employee Stock Purchase Plan (“ESPP”), which became effective immediately upon the signing of the underwriting agreement related to the IPO on March 27, 2014, authorizes the issuance of 500,000 shares of the Company’s common stock pursuant to purchase rights granted to employees. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1 of each calendar year from January 1, 2015 through January 1, 2024 by the least of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, (b) 400,000 shares and (c) a number determined by the Board of Directors that is less than (a) and (b). Unless otherwise determined by the Board of Directors, common stock will be purchased for participating employees at a price per share equal to the lower of (a) 85% of the fair market value of a share of the common stock on the first date of an offering, or (b) 85% of the fair market value of a share of the common stock on the date of purchase. Generally, all regular employees may participate in the ESPP and may contribute, through payroll deductions, up to 15% of their earnings toward the purchase of common stock under the ESPP. Under the terms of the ESPP, there are defined limitations as to the amount and value of common stock that can be purchased by each employee.

For the three months ended March 31, 2015, charges incurred under the ESPP totaled $271, and such charges were not material during the three months ended March 31, 2014. As of March 31, 2015, 676,707 shares of common stock were reserved for future issuance under the ESPP.

X

- Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9

Net Loss Per Common Share
3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]
8. Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding for the period.

Diluted net loss per common share is computed by dividing net loss by the weighted-average number of shares of common stock outstanding for the period, adjusted to reflect potentially dilutive securities. Potentially dilutive securities consist of incremental shares issuable upon the assumed exercise of stock options, restricted stock units, and warrants using the treasury stock method, and employee withholdings to purchase common stock under the ESPP. Due to the net losses for the three months ended March 31, 2015 and 2014, the Company had outstanding options, warrants, restricted stock units, and ESPP withholdings which were not included in the computation of diluted net loss per common share, as the effects would have been anti-dilutive. Accordingly, the basic and diluted weighted-average number of common shares outstanding are the same for the following periods presented:

Three months ended

March 31,

2015 2014

Numerator:

Net loss $ (8,068 ) $ (7,759 )

Denominator:

Weighted-average number of common shares outstanding - basic and diluted 31,525,559 5,403,846

Net loss per common share - basic and diluted $ (0.26 ) $ (1.44 )

The following securities were outstanding at the end of the periods presented below and have been excluded from the calculation of diluted net loss per common share because the effect is anti-dilutive:

Three months ended

March 31,

2015 2014

Warrants to purchase common stock⁽¹⁾ 143,782 692,501

Warrants to purchase redeemable convertible preferred stock⁽¹⁾ — 148,650

Redeemable convertible preferred stock⁽¹⁾ — 26,820,270

Stock option awards 6,539,511 6,673,806

RSU awards 548,424 —

Employee stock purchase plan 80,037 —

Total anti-dilutive securities 7,311,754 34,335,227

⁽¹⁾ Upon closing of the IPO on April 2, 2014, all of the Company’s outstanding redeemable convertible preferred stock automatically converted into shares of common stock. In addition, the outstanding warrants to purchase redeemable convertible preferred stock automatically converted into warrants to purchase common stock, or were automatically exercised upon closing of the IPO.

X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for earnings per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R16.htm IDEA: XBRL DOCUMENT v2.4.1.9

Commitments and Contingencies
3 Months Ended

Mar. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]
10. Commitments and Contingencies

The Company is subject to certain claims that have arisen in the ordinary conduct of business. Based on the advice of counsel and an assessment of the nature and status of any potential claim, and taking into account any accruals the Company may have established for them, the Company currently believes that any liabilities ultimately resulting from such claims will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

X

- Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R34.htm IDEA: XBRL DOCUMENT v2.4.1.9

Stock-Based Compensation (Details) - Schedule of restricted stock unit awards (Restricted Stock Units (RSUs) [Member], USD $)
3 Months Ended

Mar. 31, 2015

Restricted Stock Units (RSUs) [Member]

Stock-Based Compensation (Details) - Schedule of restricted stock unit awards [Line Items]

Outstanding, Number of RSUs 548,424

Outstanding, Weighted Average Grant Date Fair Value (in Dollars per share) $ 11.99

Granted (1) 548,424 ^[1]

Granted (1) (in Dollars per share) $ 11.99 ^[1]

Vested 0

Cancelled 0

[1] RSUs granted during the three months ended March 31, 2015 includes the grant of 40,000 units of performance-based RSUs that are dependent upon the Company meeting certain performance criteria.

X

- Details

Name: evdy_StockBasedCompensationDetailsScheduleofrestrictedstockunitawardsLineItems

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(2)(iii)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of equity instruments other than options outstanding, including both vested and non-vested instruments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 52 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9

Stock-Based Compensation (Tables)
3 Months Ended

Mar. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] The following table summarizes stock option activity for the three months ended March 31, 2015:

Number of
options Weighted-
average
exercise
price Weighted-
average
remaining
contractual
life (years) Aggregate
intrinsic
value

Outstanding at December 31, 2014 5,893,698 $ 9.94 6.48 $ 29,249

Granted 726,100 12.22

Exercised (72,832 ) 7.27

Cancelled (7,415 ) 12.84

Outstanding at March 31, 2015 6,539,551 $ 10.23 6.65 $ 20,931

Exercisable at March 31, 2015 3,896,925 $ 8.45 5.01 $ 17,987

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] The following table presents the weighted-average assumptions used to estimate the fair value of options granted in the three months ended March 31, 2015 and 2014:

2015 2014

Volatility 44.29 % 49.77 %

Expected life (years) 6.25 6.25

Risk-free interest rate 1.72 % 1.92 %

Dividend yield — —

Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block] The following table summarizes the RSU activity for the three months ended March 31, 2015:

Number of

RSUs
Weighted
Average
Grant Date
Fair Value

Outstanding at December 31, 2014 — $ —

Granted ⁽¹⁾ 548,424 11.99

Vested —

Cancelled —

Outstanding at March 31, 2015 548,424 $ 11.99

⁽¹⁾ RSUs granted during the three months ended March 31, 2015 includes the grant of 40,000 units of performance-based RSUs that are dependent upon the Company meeting certain performance criteria.

X

- Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (f)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 53 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9

Goodwill and Other Intangible Assets (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Mar. 31, 2014

Dec. 31, 2014

Goodwill and Other Intangible Assets (Details) [Line Items]

Goodwill $ 143,165us-gaap_Goodwill $ 127,115us-gaap_Goodwill

Finite-Lived Intangible Assets, Net 43,777us-gaap_FiniteLivedIntangibleAssetsNet 30,716us-gaap_FiniteLivedIntangibleAssetsNet

Amortization of Intangible Assets 1,219us-gaap_AmortizationOfIntangibleAssets 545us-gaap_AmortizationOfIntangibleAssets

Cambridge [Member] | Customer Relationships [Member]

Goodwill and Other Intangible Assets (Details) [Line Items]

Finite-Lived Intangible Assets, Net 8,810

Finite-Lived Intangible Asset, Useful Life 10 years

Cambridge [Member] | Trade Names [Member]

Goodwill and Other Intangible Assets (Details) [Line Items]

Finite-Lived Intangible Assets, Net 5,470

Finite-Lived Intangible Asset, Useful Life 10 years

Cambridge [Member]

Goodwill and Other Intangible Assets (Details) [Line Items]

Goodwill 15,576

Finite-Lived Intangible Assets, Net 14,280

DD [Member]

Goodwill and Other Intangible Assets (Details) [Line Items]

Goodwill 474

Customer Relationships [Member]

Goodwill and Other Intangible Assets (Details) [Line Items]

Finite-Lived Intangible Assets, Net 24,335 16,053

Trade Names [Member]

Goodwill and Other Intangible Assets (Details) [Line Items]

Finite-Lived Intangible Assets, Net $ 19,163 $ 14,245

X

- Details

Name: evdy_GoodwillandOtherIntangibleAssetsDetailsLineItems

Namespace Prefix: evdy_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=evdy_CambridgeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=evdy_DDMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 54 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9

Consolidated Statements of Stockholders' Equity (USD $)
In Thousands, except Share data

Common Stock [Member]

Preferred Stock [Member]

Treasury Stock [Member]

Additional Paid-in Capital [Member]

Retained Earnings [Member]

Total

Balance at Dec. 31, 2014 $ 314 $ 0 $ (55) $ 292,117 $ (119,090) $ 173,286us-gaap_StockholdersEquity

Balance (in Shares) at Dec. 31, 2014 31,489,196

Exercise of stock options 1 528 529

Exercise of stock options (in Shares) 72,832

Stock-based compensation expense 2,491 2,491

Net loss (8,068) (8,068)us-gaap_NetIncomeLoss

Balance at Mar. 31, 2015 $ 315 $ 0 $ (55) $ 295,136 $ (127,158) $ 168,238us-gaap_StockholdersEquity

Balance (in Shares) at Mar. 31, 2015 31,562,028

X

- Definition

This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415241&loc=d3e4534-113899

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11149-113907

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 13

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11178-113907

+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=51831270

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=51831255

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

+ Details

Name: us-gaap_SharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Number of share options (or share units) exercised during the current period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Value of stock issued as a result of the exercise of stock options.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 55 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9

Goodwill and Other Intangible Assets
3 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]
4. Goodwill and Other Intangible Assets

During the three months ended March 31, 2015, goodwill of $15,576 and definite-lived intangible assets of $14,280 were recorded in connection with the Cambridge acquisition (see Note 3). Additionally, there was $474 of goodwill recorded during the three months ended March 31, 2015 for a working capital purchase price adjustment related to a November 2014 acquisition. The preliminary value of the intangible assets acquired in connection with the Cambridge acquisition consist of customer relationships of $8,810 and trade names of $5,470, each of which has an estimated useful life of 10 years.

The carrying value of the Company’s goodwill was $143,165 as of March 31, 2015. Goodwill is tested for impairment on an annual basis as of October 1, and whenever events or circumstances indicate that the carrying value of the asset may not be recoverable. Application of the impairment test requires judgment and results in impairment being recognized if the carrying value of the asset exceeds its fair value. No indicators of impairment were noted during or since the Company’s last evaluation of goodwill at October 1, 2014. Similarly, the Company’s definite-lived intangible assets with a net carrying value of $43,777 at March 31, 2015, consisting principally of trade names and customer relationships, is reviewed for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s definite-lived intangible assets during the three months ended March 31, 2015 and 2014.

Definite-lived intangible assets consist of the following:

March 31, 2015 December 31, 2014

Gross
carrying
amount Accumulated
amortization Net
carrying
amount Weighted-
average
remaining
useful
life ⁽¹⁾ Gross
carrying
amount Accumulated
amortization Net
carrying
amount Weighted-
average
remaining
useful
life ⁽¹⁾

Customer relationships $ 36,110 $ (11,775) $ 24,335 9.5 $ 27,300 $ (11,247) $ 16,053 9.5

Trade names 24,085 (4,922) 19,163 7.3 18,615 (4,370) 14,245 6.5

Other intangibles 3,900 (3,621) 279 0.5 3,900 (3,482) 418 0.7

Total $ 64,095 $ (20,318) $ 43,777 $ 49,815 $ (19,099) $ 30,716

⁽¹⁾ The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period.

Amortization expense relating to the definite-lived intangible assets totaled $1,219 and $545 for the three months ended March 31, 2015 and 2014, respectively, and is included in general and administrative expense in the accompanying consolidated statements of operations.

Future amortization expense of the intangible assets is estimated to be as follows:

Year ending December 31:

2015 (April 1st to December 31st) $ 4,527

2016 5,373

2017 5,365

2018 5,176

2019 5,176

Thereafter 18,160

Total $ 43,777

X

- Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 56 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9

Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets (USD $)
In Thousands, unless otherwise specified
3 Months Ended

Mar. 31, 2015

Dec. 31, 2014

Finite-Lived Intangible Assets [Line Items]

Gross carrying amount $ 64,095 $ 49,815

Accumulated amortization (20,318) (19,099)

Net carrying amount 43,777us-gaap_FiniteLivedIntangibleAssetsNet 30,716us-gaap_FiniteLivedIntangibleAssetsNet

Customer Relationships [Member]

Finite-Lived Intangible Assets [Line Items]

Gross carrying amount 36,110 27,300

Accumulated amortization (11,775) (11,247)

Net carrying amount 24,335 16,053

Weighted- average remaining useful life 9 years 6 months ^[1] 9 years 6 months ^[1]

Trade Names [Member]

Finite-Lived Intangible Assets [Line Items]

Gross carrying amount 24,085 18,615

Accumulated amortization (4,922) (4,370)

Net carrying amount 19,163 14,245

Weighted- average remaining useful life 7 years 109 days ^[1] 6 years 6 months ^[1]

Other Intangible Assets [Member]

Finite-Lived Intangible Assets [Line Items]

Gross carrying amount 3,900 3,900

Accumulated amortization (3,621) (3,482)

Net carrying amount $ 279 $ 418

Weighted- average remaining useful life 6 months ^[1] 255 days ^[1]

[1] The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period.

X

- Definition

Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

+ Details

Name: us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 57 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.1.9 Html 93 205 1 true 36 0 false 4 false false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://everydayhealth.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://everydayhealth.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://everydayhealth.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://everydayhealth.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://everydayhealth.com/role/ShareholdersEquityType2or3 Consolidated Statements of Stockholders' Equity false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://everydayhealth.com/role/ConsolidatedComprehensiveIncome Consolidated Statements of Cash Flows false false R7.htm 006 - Disclosure - Business Sheet http://everydayhealth.com/role/Business Business false false R8.htm 007 - Disclosure - Significant Accounting Policies Sheet http://everydayhealth.com/role/SignificantAccountingPolicies Significant Accounting Policies false false R9.htm 008 - Disclosure - Acquisitions Sheet http://everydayhealth.com/role/Acquisitions Acquisitions false false R10.htm 009 - Disclosure - Goodwill and Other Intangible Assets Sheet http://everydayhealth.com/role/GoodwillandOtherIntangibleAssets Goodwill and Other Intangible Assets false false R11.htm 010 - Disclosure - Long-Term Debt Sheet http://everydayhealth.com/role/LongTermDebt Long-Term Debt false false R12.htm 011 - Disclosure - Common Stock and Preferred Stock Sheet http://everydayhealth.com/role/CommonStockandPreferredStock Common Stock and Preferred Stock false false R13.htm 012 - Disclosure - Stock-Based Compensation Sheet http://everydayhealth.com/role/StockBasedCompensation Stock-Based Compensation false false R14.htm 013 - Disclosure - Net Loss Per Common Share Sheet http://everydayhealth.com/role/NetLossPerCommonShare Net Loss Per Common Share false false R15.htm 014 - Disclosure - Income Taxes Sheet http://everydayhealth.com/role/IncomeTaxes Income Taxes false false R16.htm 015 - Disclosure - Commitments and Contingencies Sheet http://everydayhealth.com/role/CommitmentsandContingencies Commitments and Contingencies false false R17.htm 016 - Disclosure - Subsequent Events Sheet http://everydayhealth.com/role/SubsequentEvents Subsequent Events false false R18.htm 017 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://everydayhealth.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) false false R19.htm 018 - Disclosure - Acquisitions (Tables) Sheet http://everydayhealth.com/role/AcquisitionsTables Acquisitions (Tables) false false R20.htm 019 - Disclosure - Goodwill and Other Intangible Assets (Tables) Sheet http://everydayhealth.com/role/GoodwillandOtherIntangibleAssetsTables Goodwill and Other Intangible Assets (Tables) false false R21.htm 020 - Disclosure - Stock-Based Compensation (Tables) Sheet http://everydayhealth.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) false false R22.htm 021 - Disclosure - Net Loss Per Common Share (Tables) Sheet http://everydayhealth.com/role/NetLossPerCommonShareTables Net Loss Per Common Share (Tables) false false R23.htm 022 - Disclosure - Significant Accounting Policies (Details) Sheet http://everydayhealth.com/role/SignificantAccountingPoliciesDetails Significant Accounting Policies (Details) false false R24.htm 023 - Disclosure - Acquisitions (Details) Sheet http://everydayhealth.com/role/AcquisitionsDetails Acquisitions (Details) false false R25.htm 024 - Disclosure - Acquisitions (Details) - Preliminary allocation of the assets acquired and liabilities assumed Sheet http://everydayhealth.com/role/PreliminaryallocationoftheassetsacquiredandliabilitiesassumedTable Acquisitions (Details) - Preliminary allocation of the assets acquired and liabilities assumed false false R26.htm 025 - Disclosure - Goodwill and Other Intangible Assets (Details) Sheet http://everydayhealth.com/role/GoodwillandOtherIntangibleAssetsDetails Goodwill and Other Intangible Assets (Details) false false R27.htm 026 - Disclosure - Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets Sheet http://everydayhealth.com/role/ScheduleofdefinitelivedintangibleassetsTable Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets false false R28.htm 027 - Disclosure - Goodwill and Other Intangible Assets (Details) - Schedule of future amortization expense of intangible assets Sheet http://everydayhealth.com/role/ScheduleoffutureamortizationexpenseofintangibleassetsTable Goodwill and Other Intangible Assets (Details) - Schedule of future amortization expense of intangible assets false false R29.htm 028 - Disclosure - Long-Term Debt (Details) Sheet http://everydayhealth.com/role/LongTermDebtDetails Long-Term Debt (Details) false false R30.htm 029 - Disclosure - Common Stock and Preferred Stock (Details) Sheet http://everydayhealth.com/role/CommonStockandPreferredStockDetails Common Stock and Preferred Stock (Details) false false R31.htm 030 - Disclosure - Stock-Based Compensation (Details) Sheet http://everydayhealth.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) false false R32.htm 031 - Disclosure - Stock-Based Compensation (Details) - Schedule of stock option activity Sheet http://everydayhealth.com/role/ScheduleofstockoptionactivityTable Stock-Based Compensation (Details) - Schedule of stock option activity false false R33.htm 032 - Disclosure - Stock-Based Compensation (Details) - Schedule of weighted-average assumptions Sheet http://everydayhealth.com/role/ScheduleofweightedaverageassumptionsTable Stock-Based Compensation (Details) - Schedule of weighted-average assumptions false false R34.htm 033 - Disclosure - Stock-Based Compensation (Details) - Schedule of restricted stock unit awards Sheet http://everydayhealth.com/role/ScheduleofrestrictedstockunitawardsTable Stock-Based Compensation (Details) - Schedule of restricted stock unit awards false false R35.htm 034 - Disclosure - Net Loss Per Common Share (Details) - Basic and diluted net income (loss) Sheet http://everydayhealth.com/role/BasicanddilutednetincomelossTable Net Loss Per Common Share (Details) - Basic and diluted net income (loss) false false R36.htm 035 - Disclosure - Net Loss Per Common Share (Details) - Securities excluded from calculations of diluted net loss per common share Sheet http://everydayhealth.com/role/SecuritiesexcludedfromcalculationsofdilutednetlosspercommonshareTable Net Loss Per Common Share (Details) - Securities excluded from calculations of diluted net loss per common share false false R37.htm 036 - Disclosure - Income Taxes (Details) Sheet http://everydayhealth.com/role/IncomeTaxesDetails Income Taxes (Details) false false All Reports Book All Reports Process Flow-Through: 001 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Mar. 31, 2014' Process Flow-Through: Removing column 'Dec. 31, 2013' Process Flow-Through: 002 - Statement - Consolidated Balance Sheets (Parentheticals) Process Flow-Through: Removing column 'Apr. 30, 2014' Process Flow-Through: 003 - Statement - Consolidated Statements of Operations Process Flow-Through: 005 - Statement - Consolidated Statements of Cash Flows Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2014' evdy-20150331.xml evdy-20150331.xsd evdy-20150331_cal.xml evdy-20150331_def.xml evdy-20150331_lab.xml evdy-20150331_pre.xml true true XML 58 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9

Goodwill and Other Intangible Assets (Tables)
3 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets [Table Text Block] Definite-lived intangible assets consist of the following:

March 31, 2015 December 31, 2014

Gross
carrying
amount Accumulated
amortization Net
carrying
amount Weighted-
average
remaining
useful
life ⁽¹⁾ Gross
carrying
amount Accumulated
amortization Net
carrying
amount Weighted-
average
remaining
useful
life ⁽¹⁾

Customer relationships $ 36,110 $ (11,775) $ 24,335 9.5 $ 27,300 $ (11,247) $ 16,053 9.5

Trade names 24,085 (4,922) 19,163 7.3 18,615 (4,370) 14,245 6.5

Other intangibles 3,900 (3,621) 279 0.5 3,900 (3,482) 418 0.7

Total $ 64,095 $ (20,318) $ 43,777 $ 49,815 $ (19,099) $ 30,716

⁽¹⁾ The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period.

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Future amortization expense of the intangible assets is estimated to be as follows:

Year ending December 31:

2015 (April 1st to December 31st) $ 4,527

2016 5,373

2017 5,365

2018 5,176

2019 5,176

Thereafter 18,160

Total $ 43,777

X

- Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Stock-Based Compensation (Details) - Schedule of weighted-average assumptions (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Schedule of weighted-average assumptions [Abstract]
Volatility	44.29%	49.77%
Expected life (years)	6 years 3 months	6 years 3 months
Risk-free interest rate	1.72%	1.92%
Dividend yield (in Dollars per share)	$ 0	$ 0

Acquisitions (Details) - Preliminary allocation of the assets acquired and liabilities assumed (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Acquisitions (Details) - Preliminary allocation of the assets acquired and liabilities assumed [Line Items]
Property and equipment	$ 25,847us-gaap_PropertyPlantAndEquipmentNet	$ 25,502us-gaap_PropertyPlantAndEquipmentNet
Goodwill	143,165us-gaap_Goodwill	127,115us-gaap_Goodwill
Intangible assets	43,777	30,716
Accounts payable and accrued expenses	25,060	31,722
Other current liabilities	8,977us-gaap_OtherLiabilitiesCurrent	965us-gaap_OtherLiabilitiesCurrent
Cambridge [Member]
Acquisitions (Details) - Preliminary allocation of the assets acquired and liabilities assumed [Line Items]
Accounts receivable	4,406
Other current assets	137
Property and equipment	783
Goodwill	15,576
Intangible assets	14,280
Accounts payable and accrued expenses	(2,659)
Deferred revenue	(197)
Other current liabilities	(53)
Total consideration paid	$ 32,273

Income Taxes (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014
Income Taxes (Details) [Line Items]
Operating Loss Carryforwards	$ 107,000us-gaap_OperatingLossCarryforwards
Deferred Compensation, Share-based Payments [Member]
Income Taxes (Details) [Line Items]
Operating Loss Carryforwards	$ 7,433

Goodwill and Other Intangible Assets (Details) - Schedule of future amortization expense of intangible assets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Schedule of future amortization expense of intangible assets [Abstract]
2015 (April 1st to December 31st)	$ 4,527
2016	5,373
2017	5,365
2018	5,176
2019	5,176
Thereafter	18,160
Total	$ 43,777us-gaap_FiniteLivedIntangibleAssetsNet	$ 30,716us-gaap_FiniteLivedIntangibleAssetsNet

Common Stock and Preferred Stock (Details)	3 Months Ended
Common Stock and Preferred Stock (Details)	Mar. 31, 2014	Mar. 31, 2015	Dec. 31, 2014	Apr. 30, 2014
Stockholders' Equity Note [Abstract]
Preferred Stock, Shares Outstanding		0us-gaap_PreferredStockSharesOutstanding	0us-gaap_PreferredStockSharesOutstanding
Preferred Stock, Shares Issued		0us-gaap_PreferredStockSharesIssued	0us-gaap_PreferredStockSharesIssued
Stockholders' Equity, Reverse Stock Split	In March 2014, the Company’s Board of Directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation effecting a 1-for-1.5 reverse stock split of the Company’s issued and outstanding shares of common stock. The par value of the common stock was not adjusted as a result of the reverse stock split. All issued and outstanding common stock and per share amounts contained in the Company’s consolidated financial statements and related notes thereto have been retroactively adjusted to reflect this reverse stock split for all periods presented. The reverse stock split was effected on March 14, 2014.
Common Stock, Shares Authorized		90,000,000us-gaap_CommonStockSharesAuthorized	90,000,000us-gaap_CommonStockSharesAuthorized	90,000,000us-gaap_CommonStockSharesAuthorized
Preferred Stock, Shares Authorized		10,000,000us-gaap_PreferredStockSharesAuthorized	10,000,000us-gaap_PreferredStockSharesAuthorized	10,000,000us-gaap_PreferredStockSharesAuthorized

Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Assets
Cash and cash equivalents	$ 48,530	$ 50,729
Accounts receivable, net of allowance for doubtful accounts of $523 and $637 as of March 31, 2015 and December 31, 2014, respectively	57,611us-gaap_AccountsReceivableNetCurrent	68,007us-gaap_AccountsReceivableNetCurrent
Deferred tax asset	656	656
Prepaid expenses and other current assets	9,377	5,529
Total current assets	116,174us-gaap_AssetsCurrent	124,921us-gaap_AssetsCurrent
Property and equipment, net	25,847us-gaap_PropertyPlantAndEquipmentNet	25,502us-gaap_PropertyPlantAndEquipmentNet
Goodwill	143,165us-gaap_Goodwill	127,115us-gaap_Goodwill
Intangible assets, net	43,777	30,716
Other assets	5,811us-gaap_OtherAssetsNoncurrent	5,237us-gaap_OtherAssetsNoncurrent
Total assets	334,774us-gaap_Assets	313,491us-gaap_Assets
Liabilities and stockholders’ equity
Accounts payable and accrued expenses	25,060	31,722
Deferred revenue	8,821us-gaap_DeferredRevenueCurrent	6,740us-gaap_DeferredRevenueCurrent
Current portion of long-term debt	2,625us-gaap_LongTermDebtCurrent	3,000us-gaap_LongTermDebtCurrent
Other current liabilities	8,977us-gaap_OtherLiabilitiesCurrent	965us-gaap_OtherLiabilitiesCurrent
Total current liabilities	45,483us-gaap_LiabilitiesCurrent	42,427us-gaap_LiabilitiesCurrent
Long-term debt	110,125us-gaap_LongTermDebtNoncurrent	87,000us-gaap_LongTermDebtNoncurrent
Deferred tax liabilities	6,912	6,673
Other long-term liabilities	4,016us-gaap_OtherLiabilitiesNoncurrent	4,105us-gaap_OtherLiabilitiesNoncurrent
Preferred stock, $0.01 par value: 10,000,000 shares authorized at March 31, 2015 and December 31, 2014; no shares issued and outstanding at March 31, 2015 and December 31, 2014	0us-gaap_PreferredStockValue	0us-gaap_PreferredStockValue
Common stock, $0.01 par value: 90,000,000 shares authorized at March 31, 2015 and December 31, 2014; 31,562,028 and 31,489,196 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively	315us-gaap_CommonStockValue	314us-gaap_CommonStockValue
Treasury stock	(55)us-gaap_TreasuryStockValue	(55)us-gaap_TreasuryStockValue
Additional paid-in capital	295,136us-gaap_AdditionalPaidInCapital	292,117us-gaap_AdditionalPaidInCapital
Accumulated deficit	(127,158)	(119,090)
Total stockholders’ equity	168,238us-gaap_StockholdersEquity	173,286us-gaap_StockholdersEquity
Total liabilities and stockholders’ equity	$ 334,774	$ 313,491

Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities
Net loss	$ (8,068)us-gaap_NetIncomeLoss	$ (7,759)us-gaap_NetIncomeLoss
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	4,662	3,558
Provision for doubtful accounts		215us-gaap_ProvisionForDoubtfulAccounts
Stock-based compensation	2,491us-gaap_ShareBasedCompensation	1,069us-gaap_ShareBasedCompensation
Amortization and write-off of financing costs	107	4,169
Provision for deferred income taxes	241us-gaap_DeferredIncomeTaxExpenseBenefit	241us-gaap_DeferredIncomeTaxExpenseBenefit
Changes in operating assets and liabilities:
Accounts receivable	14,802	10,935
Prepaid expenses and other current assets	(3,641)	(2,645)
Accounts payable and accrued expenses	(9,322)	(8,610)
Deferred revenue	1,884	568
Other current liabilities	32	32
Other long-term liabilities	17	307
Net cash provided by operating activities	3,205	2,080
Cash flows from investing activities
Additions to property and equipment, net	(3,005)	(3,476)
Proceeds from sale of business		152
Payment for business purchased, net of cash acquired	(24,747)evdy_PaymentsToAcquireBusiness
Payment of security deposits and other assets	40us-gaap_PaymentsForOtherDeposits	5us-gaap_PaymentsForOtherDeposits
Net cash used in investing activities	(27,712)	(3,319)
Cash flows from financing activities
Proceeds from the exercise of stock options	460	1,172
Principal payments on capital lease obligations	(180)	(145)
Payments of credit facility financing costs	(722)us-gaap_PaymentsOfFinancingCosts	(2,227)us-gaap_PaymentsOfFinancingCosts
Net cash provided by (used in) financing activities	22,308	(233)
Net decrease in cash and cash equivalents	(2,199)	(1,472)
Cash and cash equivalents, beginning of period	50,729	16,242
Cash and cash equivalents, end of period	48,530	14,770
Supplemental disclosure of cash flow information
Interest paid	1,253us-gaap_InterestPaid	2,262us-gaap_InterestPaid
Income taxes paid	10us-gaap_IncomeTaxesPaid	16us-gaap_IncomeTaxesPaid
Supplemental disclosure of non-cash investing and financing activities
Issuance of common stock for acquired business		919
Due to sellers of acquired business	8,000evdy_DueToSellersOfAcquiredBusiness
Due from stock option exercises	111evdy_DueFromStockOptionExercises
Warrants issued in connection with website partner agreement		1,131
Capital lease obligations incurred		193us-gaap_CapitalLeaseObligationsIncurred
Former Revolving Credit Facility [Member]
Cash flows from financing activities
Repayments of principal		(30,000)
Former Term Loan [Member]
Cash flows from financing activities
Repayments of principal		(41,333)
Revolving Credit Facility [Member]
Cash flows from financing activities
Repayments of principal	(10,000)
Borrowings	25,000	32,300
Term Loan Facility [Member]
Cash flows from financing activities
Repayments of principal	(750)
Borrowings	$ 8,500	$ 40,000

Net Loss Per Common Share (Details) - Basic and diluted net income (loss) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Numerator:
Net loss	$ (8,068)us-gaap_NetIncomeLoss	$ (7,759)us-gaap_NetIncomeLoss
Denominator:
Weighted-average number of common shares outstanding - basic and diluted	31,525,559	5,403,846
Net loss per common share - basic and diluted	$ (0.26)us-gaap_EarningsPerShareBasicAndDiluted	$ (1.44)us-gaap_EarningsPerShareBasicAndDiluted

Acquisitions (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2015
Acquisitions (Details) [Line Items]
Payments to acquire business	$ (24,747)evdy_PaymentsToAcquireBusiness
Due To Sellers Of Acquired Business	8,000evdy_DueToSellersOfAcquiredBusiness
Contingent Earn-out Provisions, Eligibility	5,000
Business Combination, Acquisition Related Costs	169
Closing [Member] \| Cambridge [Member]
Acquisitions (Details) [Line Items]
Payments to acquire business	24,273
Remainder [Member] \| Cambridge [Member]
Acquisitions (Details) [Line Items]
Due To Sellers Of Acquired Business	8,000
Cambridge [Member]
Acquisitions (Details) [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired	100.00%
Business Acquisition, Name of Acquired Entity	Cambridge BioMarketing Group, LLC
Business Combination, Consideration Transferred	$ 32,273

Consolidated Balance Sheets (Parentheticals) (USD $) In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Allowance for doubtful accounts (in Dollars)	$ 523	$ 637
Preferred stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized	10,000,000us-gaap_PreferredStockSharesAuthorized	10,000,000us-gaap_PreferredStockSharesAuthorized
Preferred stock, shares issued	0us-gaap_PreferredStockSharesIssued	0us-gaap_PreferredStockSharesIssued
Preferred stock, shares outstanding	0us-gaap_PreferredStockSharesOutstanding	0us-gaap_PreferredStockSharesOutstanding
Common stock, par value (in Dollars per share)	$ 0.01	$ 0.01
Common stock, shares issued	31,562,028us-gaap_CommonStockSharesIssued	31,489,196us-gaap_CommonStockSharesIssued
Common stock, shares outstanding	31,562,028us-gaap_CommonStockSharesOutstanding	31,489,196us-gaap_CommonStockSharesOutstanding
Common stock, shares authorized	90,000,000us-gaap_CommonStockSharesAuthorized	90,000,000us-gaap_CommonStockSharesAuthorized

Document And Entity Information	3 Months Ended
Document And Entity Information	Mar. 31, 2015	May 08, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	Everyday Health, Inc.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		31,674,117dei_EntityCommonStockSharesOutstanding
Amendment Flag	false
Entity Central Index Key	0001358483
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Mar. 31, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

Accounting Policies, by Policy (Policies)	3 Months Ended
Accounting Policies, by Policy (Policies)	Mar. 31, 2015
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The results of operations for companies acquired are included in the consolidated financial statements from the effective date of the acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation.
Interim Financial Statement [Policy Text Block]	Interim Financial Statements The accompanying interim unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) on the same basis as the audited consolidated financial statements for the year ended December 31, 2014 and, in the opinion of management, include all adjustments of a normal recurring nature considered necessary to present fairly the Company’s financial position, results of operations and cash flows for the interim periods ended March 31, 2015 and 2014. The results of operations for the three months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the year ending December 31, 2015 or any other future periods, due to seasonality and other business factors. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted under the rules and regulations of the Securities and Exchange Commission (“SEC”). These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto for the year ended December 31, 2014, which are included in the Company’s Annual Report on Form 10-K filed with the SEC on March 5, 2015.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, current business factors and other available information. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition and deferred revenue, allowance for doubtful accounts, internal software development costs and website development costs, valuation of long-lived assets, goodwill and other intangible assets, income taxes and stock-based compensation.
Reclassification, Policy [Policy Text Block]	Reclassifications Certain reclassifications have been made to the prior period financial statements to conform to the March 31, 2015 presentation.
Sale of Stock, Description of Transaction	Initial Public OfferingOn April 2, 2014, the Company closed its initial public offering of common stock (“IPO”). The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters’ exercise of their over-allotment option, resulted in net proceeds of $70,622, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling $8,848. As a result of the IPO, the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, all of the Company’s redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition and Deferred Revenue The Company generates its revenue primarily through advertising and sponsorships, and premium services, including subscriptions and licensing fees. Advertising revenue is recognized in the period in which the advertisement is delivered. Revenue from sponsorships is recognized over the period the Company substantially satisfies its contractual obligations as required under the respective sponsorship agreements. When contractual arrangements contain multiple elements, revenue is allocated to each element based on its relative fair value determined using prices charged when elements are sold separately. In instances where individual deliverables are not sold separately, or when third-party evidence is not available, fair value is determined based on management’s best estimate of selling price. Subscriptions are generally paid in advance on a monthly, quarterly or annual basis. Subscription revenue, after deducting refunds and charge-backs, is recognized on a straight-line basis ratably over the subscription periods. Licensing revenue is generally recognized over the life of the contract. Deferred revenue relates to: (i) subscription fees for which amounts have been collected but for which revenue has not been recognized, and (ii) advertising and sponsorship fees and licensing fees billed in advance of when the revenue is to be earned.
Cost of Sales, Policy [Policy Text Block]	Cost of Revenues Cost of revenues consists principally of the expenses associated with aggregating the total audience across the Company’s portfolio of websites, including (i) royalty expenses for licensing content for certain websites within the portfolio and for the portion of advertising revenue the Company pays to the owners of certain other websites within the portfolio, and (ii) media costs associated with audience aggregation activities. Cost of revenues also includes credit card fees and service charges associated with subscription fees for the Company’s premium services. Media costs consist primarily of fees paid to online publishers, internet search companies and other media channels for search engine and database marketing, and display and television advertising. These media activities are attributable to revenue-generating and audience aggregation events, designed to increase the audience to the websites the Company operates, increase the number of subscribers to premium services and grow the Company’s registered user base.
Other Income and Other Expense Disclosure [Text Block]	Other Expense There were no charges reflected as other expense in the three months ended March 31, 2015. In connection with the refinancing of its credit facilities in March 2014, the Company wrote-off unamortized deferred financing costs totaling $2,845 and incurred prepayment fees of $1,016, which, together with the mark-to-market adjustment on certain preferred stock warrants of $253, is reflected as other expense in the accompanying consolidated statements of operations for the three months ended March 31, 2014.
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Income The Company has no items of other comprehensive income, and accordingly net loss is equal to comprehensive loss for all periods presented.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments Due to their short-term maturities, the carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value. Cash equivalents principally consist of the Company’s investment in highly liquid money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value of the Company’s debt approximates the recorded amounts as the interest rates on the credit facilities are based on market interest rates.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from three to five years. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the improvement. The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of payroll and related benefits, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years. The Company also incurs costs to develop its websites and mobile applications. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of third-party consultants and related charges, and the costs of content determined to provide a future economic benefit, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years. The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. There were no indicators of impairment of the Company’s property and equipment during the three months ended March 31, 2015 and 2014.
Segment Reporting, Policy [Policy Text Block]	Segment Information The Company and its subsidiaries are organized in a single operating segment, providing online health solutions, and the Company also has one reportable segment. Substantially all of the Company’s revenues are derived from U.S. sources
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Standards In April 2014, the FASB issued amended guidance for reporting discontinued operations. Under the new guidance, only disposals that represent a strategic shift having a material impact on an entity’s operations and financial results shall be reported as discontinued operations, with expanded disclosures. This amendment will be effective for the first annual reporting period beginning after December 15, 2015. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements. In May 2014, the FASB issued amended guidance for revenue recognition. This amendment provides a comprehensive new revenue recognition model. The core principle of the guidance is to recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. As currently issued, this amendment is effective for fiscal years beginning after December 15, 2016, and for interim periods within those fiscal years. Early adoption is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company has not yet selected a transition method and is currently evaluating the effect that the new standard will have on the consolidated financial statements and related disclosures. In June 2014, the FASB issued updated guidance on stock compensation accounting requiring that a performance target that affects vesting and could be achieved after the requisite service period should be treated as a performance condition. Current GAAP does not contain explicit guidance on how to account for such share-based payments. This updated guidance is effective for fiscal years beginning after December 15, 2015, and for interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements. In April 2015, the FASB issued updated guidance on the presentation of debt issuance costs in financial statements. The new guidance requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs will continue to be reported as interest expense. This guidance will be effective for the Company beginning in the first quarter of 2016 on a retrospective basis for all periods presented, with early adoption optional. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

Consolidated Statements of Operations (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenues:
Advertising and sponsorship revenues	$ 36,338us-gaap_AdvertisingRevenue	$ 32,692us-gaap_AdvertisingRevenue
Premium services revenues	4,836us-gaap_SalesRevenueServicesNet	4,813us-gaap_SalesRevenueServicesNet
Total revenues	41,174us-gaap_Revenues	37,505us-gaap_Revenues
Operating expenses:
Cost of revenues	14,076us-gaap_CostOfRevenue	11,421us-gaap_CostOfRevenue
Sales and marketing	12,725us-gaap_SellingAndMarketingExpense	10,220us-gaap_SellingAndMarketingExpense
Product development	12,602evdy_ProductDevelopment	10,762evdy_ProductDevelopment
General and administrative	9,804us-gaap_GeneralAndAdministrativeExpense	6,595us-gaap_GeneralAndAdministrativeExpense
Total operating expenses	49,207us-gaap_OperatingExpenses	38,998us-gaap_OperatingExpenses
Loss from operations	(8,033)us-gaap_OperatingIncomeLoss	(1,493)us-gaap_OperatingIncomeLoss
Interest expense, net	(953)us-gaap_InterestIncomeExpenseNet	(1,863)us-gaap_InterestIncomeExpenseNet
Other expense		(4,114)us-gaap_OtherNonoperatingIncomeExpense
Loss from operations before benefit (provision) for income taxes	(8,986)	(7,470)
Benefit (provision) for income taxes	918us-gaap_IncomeTaxExpenseBenefit	(289)us-gaap_IncomeTaxExpenseBenefit
Net loss	$ (8,068)us-gaap_NetIncomeLoss	$ (7,759)us-gaap_NetIncomeLoss
Net loss per common share-basic and diluted (in Dollars per share)	$ (0.26)us-gaap_EarningsPerShareBasicAndDiluted	$ (1.44)us-gaap_EarningsPerShareBasicAndDiluted
Weighted-average common shares outstanding-basic and diluted (in Shares)	31,525,559	5,403,846

Consolidated Statements of Stockholders' Equity (USD $) In Thousands, except Share data	Common Stock [Member]	Preferred Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2014	$ 314	$ 0	$ (55)	$ 292,117	$ (119,090)	$ 173,286us-gaap_StockholdersEquity
Balance (in Shares) at Dec. 31, 2014	31,489,196
Exercise of stock options	1			528		529
Exercise of stock options (in Shares)	72,832
Stock-based compensation expense				2,491		2,491
Net loss					(8,068)	(8,068)us-gaap_NetIncomeLoss
Balance at Mar. 31, 2015	$ 315	$ 0	$ (55)	$ 295,136	$ (127,158)	$ 168,238us-gaap_StockholdersEquity
Balance (in Shares) at Mar. 31, 2015	31,562,028